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Abstract 
 
Falls are a common occurrence in older people and multisite pain has been 
identified as a potential falls risk factor in this age group.  This thesis aims to 
describe the relationship between multisite pain and falls in community-dwelling 
older people.   
A systematic review identified 20 studies investigating multisite pain and falls.  
Meta-analysis showed multisite pain increased the odds of falling. 
Data from the North Staffordshire Osteoarthritis Project, a prospective cohort study 
of community-dwelling adults aged ≥50 years with follow ups at three and six 
years, was used. Survey data was linked with general practice (GP) records, 
Hospital Episode Statistics (HES) and Office for National Statistics mortality data.  
Logistic regression tested the relationship between multisite pain and risk of self-
reported falls in 4386 participants with complete data.  Survival analysis tested the 
relationship between multisite pain and risk of GP or HES recorded falls in 11,375 
participants. Analyses were adjusted for confounders and putative influencers of 
the pain-falls relationship. 
Multisite pain most strongly predicted future self-reported falls, followed by GP 
recorded falls.  Multisite pain was not associated with HES recorded falls.  
Increasing age, being female, increasing number of medications used and strong 
analgesic use predicted all future falls; increasing cognitive complaint and previous 
self-reported fall additionally predicted GP recorded falls and all confounders and 
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putative influencers predicted self-reported falls and had a significant association 
with multisite pain. 
These data suggest that multisite pain is an independent risk factor for self-
reported falls.  In addition, multisite pain is a likely influencer of the relationship 
between other risk factors and future falls.  
Primary care should proactively identify older adults with multisite pain due to their 
increased risk of falling and instigate falls prevention management according to 
current guidelines.  Future research will establish the impact of pain management 
interventions on future risk of falls. 
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Chapter 1 Context of the thesis  
1.1 Overview  
This chapter sets the context of the thesis.  A brief rationale is presented, followed 
by a list of thesis aims and objectives; a chapter layout is also presented to aid 
navigation through the thesis. 
 
1.2 Context  
I began my clinical academic career in 2006 when I completed the new Academic 
Clinical Foundation Year 2 training at Keele University and University Hospital 
North Staffordshire.  I undertook a research project and started to develop my own 
interests in academic medicine.  My research interest continued throughout my 
Academic Clinical Fellowship (ACF) in General Practice and I completed an MPhil 
degree in health sciences research.  
I developed my interest in epidemiology and medicine for older people within the 
context of primary care during my ACF and, after witnessing the many 
consequences of falls and recognising their subsequent burden, I proposed a 
research project exploring the relationship between pain and falls in order to try to 
reduce the risk of falls in older people.  I was awarded a Doctoral Research 
Fellowship from the National Institute of Health Research and commenced the 
work for this thesis after completing my ACF and obtaining my Certificate of 
Completion of Training in General Practice in 2011.   
 I have continued to work as a part time general practitioner throughout the 
Doctoral Research Fellowship and consequently the thesis retains a clinical focus, 
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with my conclusions and recommendations aimed at practising health 
professionals and policy makers.    
 
1.3 Thesis rationale  
Falls become increasingly common in advancing age and bear significant 
consequences for individuals, families and wider society.  The UK population is 
ageing; falls are therefore occurring more often and are consequently more costly.  
There are many well-documented risk factors for falls that form national and 
international falls prevention guidelines, for example the World Health 
Organisation’s Falls Prevention guidance published in 2007 (World Health 
Organisation, 2007).  Despite widely published guidance, falls continue to impact 
on the daily lives of older people and create a financial burden for health and 
social care; novel ways of preventing falls must therefore be sought to reduce 
older people’s risk of falls.  Pain occurring in multiple body locations (also termed 
‘multisite pain’) has been identified as a new risk factor for falls in a small cohort of 
older adults in the United States of America (Leveille et al, 2009).  This thesis 
seeks to further examine the relationship between multisite pain and falls in a UK-
based population of community dwelling older adults and make recommendations 
for health professionals and policy makers concerning falls prevention.   
 
1.4 Thesis aims  
The aim of this thesis is to describe the relationship between multisite pain and 
falls in older people.  To address this aim, the thesis will meet the following 
objectives: 
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i) To describe the prevalence of self-reported falls, falls that require 
primary health care attendance and falls that require hospital admission 
in a population-based sample of community-dwelling older people;  
 
ii) To test the hypothesis that older people with multisite pain are more 
likely to experience a future self-reported fall than older people with no 
pain;  
 
iii) To test the hypothesis that older people with multisite pain are more 
likely to seek primary health care for a future fall than older people with 
no pain;  
 
iv) To test the hypothesis that older people with multisite pain are more 
likely to be admitted to hospital as a result of a future fall than older 
people with no pain. 
 
 
1.5 Thesis organisation 
The thesis is organised into Chapters, as demonstrated in figure 1.1.  Relevance 
to clinical practice is discussed where necessary throughout the thesis and 
summarised in Chapter 12.   
 
1.6  Chapter summary   
This chapter has set the thesis context, outlined the hypotheses and given a 
chapter overview.  The background chapters will now describe multisite pain and 
falls in greater detail.  
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Chapter 2: Multisite pain  
2.1 Overview  
This chapter introduces the concept of pain, including both a broad definition of 
pain and a more focused definition of multisite pain.  The epidemiology of pain is 
presented and the role of general practice in managing pain is summarised to 
provide clinical context to this thesis.  
 
2.2 Definition of pain  
Pain is defined as “an unpleasant sensory and emotional experience associated 
with actual or potential tissue damage, or described in terms of such damage” 
(Merskey & Bogduk, 1994).   Experiencing pain is necessary for survival (Patel, 
2010). Neural pathways are activated when the body is exposed to a noxious 
stimuli and a behavioural response is triggered to remove the body from potential 
danger (Patel, 2010).  Congenital insensitivity to pain is a rare genetic condition, 
first described by Dearborn’s case study in 1932, which causes loss of nociceptors 
and thus leads to multiple injuries and death as a result of the inability to feel and 
react to pain (Golshani et al, 2014).  
Pain becomes problematic when it is no longer part of an essential human survival 
reaction.  For example, pain that persists beyond an initial injury, or in a chronic 
disease process, for example knee pain that persists in osteoarthritis.  Thus 
follows definitions of pain based on time-frame and utility.  ‘Acute pain’ does not 
overwhelm the body’s responses and resolves in days or weeks (Loeser & 
Melzack, 1999); it is therefore considered a useful response that reduces the risk 
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of ongoing injury.  ‘Chronic pain’ has been recognised as ‘pain which persists past 
the normal time of healing (Bonica, 1953 in: Merskey & Bogduk, 1994).  In 
practice, this may be less than one month or more than six months depending 
upon the likely cause of the pain, for example nerve damage is likely to take longer 
to heal than a skin laceration (Merskey & Bogduk, 1994).  This thesis uses a 
definition of ‘pain on most days in the last four weeks’ (described in Chapter 6).  
Although not conforming to the dominant definition of chronic pain lasting for more 
than three months (McBeth et al, 2010), this measure is likely to capture primarily 
chronic-type pain in those reporting a widespread pattern of pain, since once a 
widespread pattern is established, it is unlikely to resolve over time (Papageorgiou 
et al, 2002); pain over the life course is discussed further in Section 2.3.5. 
 
2.3 Multisite pain 
 
2.3.1 Defining multisite pain  
Pain can be experienced in any part of the body; when pain is experienced in 
more than one location it is termed ‘multisite pain’.   Experiencing multisite pain is 
more common than experiencing single site pain.  In their population-based cross-
sectional survey of pain amongst an adult Dutch population, Picavet and Schouten 
(2003) reported the majority of those reporting pain reported pain at more than one 
site; the 12 month period prevalence of pain in one site was reported as 24.5%, 
pain at 2 or 3 sites was 29.4% and pain at four or more sites was 20.6%; thus the 
period prevalence of multisite pain was twice that of single site pain (Picavet & 
Schouten, 2003).    
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A subsequent UK population-based cross-sectional survey by Carnes et al (2007) 
reported that, from 2445 adults aged 18 years and older, 45% reported pain for 
more than half the days in the last year.  Of those reporting pain, 25% reported 
single-site pain, 52% reported pain in two, three or four sites, 18% had pain in five, 
six or seven sites and 4% reported more than eight sites of pain; therefore about 
three-quarters of the pain sample reported multisite pain (Carnes et al, 2007).   
 
2.3.2 Associations with multisite pain in the general population 
 
2.3.2.1 Health-related functioning  
Multisite pain has a significant impact on individuals.  It is associated with poor 
health-related functioning.   Saastamoinen et al (2006) investigated the impact of 
pain (duration, pain location and number of pain sites) on health-related 
functioning in 5829 Finnish employees aged 40–60 years (Saastamoinen et al, 
2006).  Saastamoinen et al, (2006) used the Short Form 36 (SF-36) to measure 
eight domains of physical and mental health functioning and well-being and found 
that, when compared with pain-free individuals, those with pain had significantly 
poorer functioning levels.  The number of pain sites had the greatest effect on 
functioning levels with those reporting four or more pain sites functioning 
significantly worse than those with no pain.  The acute or chronic nature of the 
pain and the location of pain only modestly affected functioning (Saastamoinen et 
al, 2006).  
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Kamaleri et al (2008) undertook a cross-sectional survey of 3325 adults aged 24–
76 years residing in Norway to further explore the functional impact of localised 
and widespread musculoskeletal pain.  Respondents were asked to indicate 
whether they had experienced pain in the last week, and where the pain had 
occurred using ten predefined body sites.  Not only did the study confirm that pain 
was associated with functional limitations and that those with more pain had 
worsening levels of functional ability, there appeared to be an almost linear 
relationship between an increasing number of pain sites and increasing levels of 
functional ability, even when adjusted for age and sex (Kamaleri et al, 2008).  
 
2.3.2.2 Work-related disability  
Multisite pain is also associated with future work-related disability.  A cohort of 
1354 working age people from Kamaleri’s 2008 cross-sectional survey were 
followed over 14 years and a strong dose-response relationship between the 
number of pain sites at baseline and future work-related disability was 
demonstrated (Kamaleri et al, 2009).  This finding has important economic 
consequences for individuals and for society.  Work-related disability prevents 
workers from fulfilling job roles and can lead to lost days from the workplace due to 
sickness absence. Sickness absence impacts upon workplace productivity and, if 
sickness absence is prolonged, requires financial support from central agencies, 
for example disability and sickness benefits paid by the UK Government.  It is 
widely recognised that being employed improves individuals’ health and well-being 
(Waddle & Burton 2006), thus unemployment is detrimental.  Mclean et al (2005) 
reviewed the evidence for worklessness and health and reported a strong 
relationship between psychiatric morbidity and unemployment; complex 
9 
 
relationships between worklessness, poverty, poor health and mortality were also 
highlighted (McLean et al, 2005).  Work-related disability as a consequence of 
multisite pain is therefore a considerable problem, particularly if long-term sickness 
absence and worklessness follow.   
 
2.3.2.3 Mortality  
The presence of multisite pain has also been associated with an increased risk of 
death from cancer, cardiovascular disease and all-cause mortality.  McBeth et al 
(2009) conducted a cohort study of 4515 people aged 16 years and over, 
assessing pain status (no pain, number of pain sites, regional pain and 
widespread pain) at baseline and vital status (whether respondents were alive or 
dead) at 8 years.  A greater number of pain sites was associated with increased 
risk of death from cancer (mortality rate ratio of 1.06 (95% CI 1.01-1.10)) or 
cardiovascular disease (mortality rate ratio 1.02 (95% CI 0.99-1.1)) (McBeth et al, 
2009).  A more recent systematic review exploring this association found that the 
presence of multisite pain increased the risk of all-cause mortality and cancer and 
cardiovascular-related deaths, although these associations were not statistically 
significant and the heterogeneity between studies was high (Smith et al, 2014).  
 
2.3.3 Multisite pain as a continuous measure  
 
Health-related physical functioning and future work-related disability have a linear 
relationship with the number of pain sites; the greater the number of pain sites, the 
greater the negative impact on physical functioning and work-related disability.  It 
may therefore be useful to consider multisite pain as a continuous measure, with 
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the number of pain sites representing a continuum of the pain spectrum as 
proposed by Croft (2009).   
This approach mirrors Rose’s view that diseases should not be dichotomised into 
disease presence or absence (Rose, 1992).   Instead, such variables need to be 
considered in continuous distributions to take account of the incremental increased 
risk of experiencing a poor outcome associated with each incremental increase in 
the variable (Rose, 1992; Croft, 2009).  For example, the risk of myocardial 
infarction increases as the blood pressure rises and the risk of poor health-related 
physical functioning increases as the number of pain sites increases.  Thus 
multisite pain is considered as a continuous variable in this thesis as detailed in 
Chapter 6.  
 
2.3.4 Multisite pain as an ordinal measure  
Taking the concept of multisite pain as a continuum, points on this continuous 
scale can be selected and an ordinal measure created with the categories i) no 
pain; ii) single site pain; and iii) widespread pain. 
This ordinal measure represents a measure of how widespread the pain is.  
Widespread pain has a specific definition: “pain that affects multiple (including 
non-joint) sites in the body” (McBeth et al, 2014).  How widely spread the pain is 
(termed ‘widespreadness’ in this thesis) is defined using the American College of 
Rheumatology (ACR) criteria for fibromyalgia, a widely recognised classification 
system for widespreadness (Wolfe et al, 1990).  This classification requires 
participants to have pain in locations above and below the waist, on the right and 
left sides of the body and in the axial skeleton (Wolfe et al, 1990).  Thus the ACR 
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widespread pain criterion is a more stringent measure of widespreadness than a 
simple count of pain sites.  For example, it would be possible to report only five 
sites of pain (the right wrist, right hand, left knee, left foot and lower back) to be 
classified as ‘widespread pain’, yet one could report six sites of pain that could be 
further defined as regional shoulder pain with associated referred pain (reporting 
pain at the neck, left upper arm, left scapula, left elbow, left wrist and left hand).  
Using the ACR definition of widespread pain to classify respondents’ pain moves 
beyond a simple count of painful body sites towards a classification that carries 
with it connotations of chronic widespread pain syndromes such as fibromyalgia.  
Using this more extreme form of multisite pain may reveal stronger associations 
with detrimental outcomes than using a simple count of pain sites since 
widespread pain has been associated with poorer psychological health (Hunt et al, 
1999), fatigue (Hunt et al, 1999), sleep disturbance (Hunt et al, 1999), and, more 
recently increasing frailty (Wade et al, 2016).   The measurement of pain is 
discussed further in Chapter 6.   
 
2.3.5 Multisite pain over the life course  
The number of reported pain sites appears to be stable over many years.  
Papageorgiou et al (2002) found that, once widespread pain is established, it is 
likely to persist, or recur, particularly if accompanied with somatic symptoms and 
older age (Papageorgiou et al, 2002).  For example, Papageorgiou et al (2002) 
found,  in their cohort of 1386 adults, that 77% of those aged 50 years and older 
who reported chronic widespread pain and had dry eyes, dry mouth and day time 
tiredness at baseline reported chronic widespread pain seven years later.   The 
number of pain sites may be established in childhood; a UK study of 1,440 school 
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children found a widespread pain prevalence of 14.6% (Jones et al, 2003).  The 
trajectory of multisite pain and all its associations may be therefore set early in life 
and any recommendations made in this thesis about the management of pain in 
relation to falls must consider that intervention to reduce pain early in the life 
course is important.  
  
2.4 Pain in older people 
 
2.4.1 Epidemiology of pain in the community 
Prevalence estimates of pain in community-dwelling older people vary across 
studies according to sample size, estimation period and age group.  A review of 
studies examining the prevalence of pain in older people reported the crude 
prevalence of any type of pain ranged from 0% to 93% (Abdulla et al, 2013).    
Nested within these pain prevalence estimates, multisite pain is a common 
complaint of older community dwelling adults with prevalence estimates ranging 
from 31% to 47% as outlined in table 2.1.    
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Table 2.1 The prevalence of multisite pain in community dwelling older adults 
 
Study author (year) Age (years) n Multisite pain % 
Thomas et al (2004) 50 + 7878 47% 
Stubbs et al (2015) 
Mean age 
77 
295 31% 
Levielle et al (2009) 70+ 749 40% 
 
 
Comparing the prevalence of multisite pain with other long-term conditions 
experienced in old age (whose primary care management is incentivised by the 
UK Government through the Quality and Outcomes Framework) demonstrates that 
multisite pain is more common than type 2 diabetes (prevalence between 13.3% 
and 26.2% in those aged 50 years and older (Diabetes UK, 2016)), cancer 
(prevalence in adults aged 65 years and older was 12.5% in 2010 (Maddams et al, 
2012)) and chronic kidney disease (13.5% for people aged 65-74 and 32.7% for 
people aged 75 and over (Public Health England, 2011)) .  
Evidence suggests that musculoskeletal diagnoses are the most common 
contributor to pain in older people. Mäntyselkä et al (2001) analysed 3417 primary 
care consultations for adults aged 40 years and older.   Pain was a primary or 
secondary reason for visiting in 42% of analysed consultations and 
musculoskeletal diseases were the most common diagnoses (41% of those with 
pain) made during these pain-related consultations (Mäntyselkä et al, 2001).   
 
There is a similar picture in UK primary care, where 1 in 3 adults aged 65 years 
and older visit their GP at least once over a 12 month period for any 
musculoskeletal pain (Jordan et al, 2010).   Furthermore, Jordan et al (2010) 
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found, in their analysis of general practice records, that consultation rates for 
multisite musculoskeletal pain increased with age in men, accounting for 887 
consultations per 10,000 registered men aged 75 years and older; consultation 
rates were much higher in women, at 1049 per 10,000 registered population aged 
45-64 years, peaking at 1388 per 10,000 registered population between ages 65 
and 74, and falling slightly to 1370 per 10,000 registered women aged 75 years 
and older.  
 
The existing evidence suggests that multisite pain is a common occurrence in 
older adults, it is most likely to be caused by, at least in part, underlying 
musculoskeletal conditions, and that it is responsible for a high number of primary 
care consultations.  
 
 
2.4.2 Impact of multisite pain in older adults  
Not only is multisite pain a common complaint in older people that generates 
multiple primary care visits, evidence is emerging to indicate multisite pain as an 
entity is associated with detrimental health and wellbeing experiences.  
For example, Westoby et al (2009) demonstrated a statistically significant 
association between pain lasting longer than 4 weeks and reporting a subjective 
cognitive complaint.  Older adults who reported pain also reported a greater 
degree of cognitive complaint in a dose-response relationship; this relationship 
also held when the pain groups were divided into no pain and widespread pain 
groups.   
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More recently, multisite pain has been associated with poorer health-related 
quality of life, with increasing number of pain sites statistically significantly 
associated with reduced quality of life scores on the Short Form-12 survey (Lacey 
et al, 2014).   Again, this relationship followed a dose-response pattern with 
increasing number of pain sites linked with deteriorating quality of life scores 
(Lacey et al, 2014).   
Data from a UK population-based cohort study, the English Longitudinal Study of 
Ageing, were used at two time points to measure the association between pain 
and subsequent development of frailty.  5,316 men and women responded to the 
surveys and those reporting moderate or severe pain were significantly more likely 
to be frail at follow up (Wade et al, 2017).  This relationship also held when 
analysing chronic widespread pain.  In a different study population of 2,736 
European men aged 40-79 years, those reporting chronic widespread pain at 
baseline were statistically significantly more likely to develop frailty 4 years later 
with a 70% higher frailty index at follow up compared to their pain-free 
counterparts (Wade et al, 2016).  
 
2.5 The place of general practice in managing pain  
Multisite pain is a common experience in older people; it generates a high number 
of general practice consultations and is associated with detrimental consequences 
for patients, families and the wider community.  Understanding the role of general 
practice in managing multisite pain provides the context in which results will be 
placed to ensure useful, practical recommendations are made to general practice 
clinicians and policy makers.    
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General practice is a cornerstone of healthcare systems around the world.  It is 
usually the point of first medical contact within a health care system and deals with 
all health problems regardless of age, sex or other personal characteristics 
(European Academy of Teachers in General Practice, 2011).  It is further defined 
by the efficient use of health care resources by coordinating care with other 
professionals in primary and secondary care and the promotion of health and well-
being through ‘appropriate and effective intervention’ (European Academy of 
Teachers in General Practice, 2011). 
General practice involves a holistic approach in understanding and respecting 
values, culture and family beliefs and the way in which these affect the experience 
and management of health and sickness (General Medical Council & Royal 
College of General Practitioners, 2013).  Considering pain as a biological, 
psychological and social entity, general practitioners and other healthcare 
practitioners working in general practice are therefore ideally placed to manage 
multisite pain.  
 
2.6 Summary  
This chapter has defined pain and placed it within a general practice context.  Pain 
is a common life experience across the age spectrum and multisite pain is 
associated with poor outcomes including health-related physical functioning, work-
related disability, cognitive complaint and frailty.  The next chapters will explore the 
epidemiology of falls in older people, the current evidence around falls prevention 
and emerging evidence that multisite pain is associated with an increased risk of 
falls.   
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Chapter 3: Falls  
3.1  Introduction: why research falls in older people?  
Falls are a significant problem for older people, their families and communities, for 
health and social care services and for the UK economy.  Falls are common, 
become more frequent with advancing age and frailty, and have serious 
consequences.  As the UK population ages, falls will become an even greater 
burden and the need to mitigate this is pressing.  This chapter outlines the size of 
the problem, first by introducing the concept of population ageing and frailty, then 
describing the prevalence, severity and consequences of falls in older people.  A 
definition of falls is put forward and a chapter summary is provided.   
 
3.2  The ageing population  
The world’s population of older people is increasing.  The World Health 
Organisation (2012) predicts that between 2000 and 2050 the global population’s 
proportion of adults aged 60 years and over will double, from 11% to 22% (World 
Health Organisation, 2012).  In the UK, the number of people aged 65 years and 
over is expected to rise from 10.3 million in 2010 to 16.9 million in 2035.  The 
number of people aged 80 years and over is expected to rise from 2.9 million in 
2010 to almost 5.9 million in 2035 (Office for National Statistics, 2012).   
Since the annual costs of health and social care are significantly greater for older 
people (The Kings Fund, 2017), the ageing population may well increase overall 
health and social care spending, particularly for problems associated with older 
people, for example increasing frailty and falls.   Alternatively, if older people 
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remain well in advancing age, their continued contribution to society through paid 
work, spending power, volunteering and donations will be possible and there may 
be additional benefits to the economy (The Kings Fund, 2017).   
Therefore, as the population ages and health problems associated with ageing 
increase, exploring ways to reduce falls and their consequences is necessary to 
ensure people remain well through their advancing years.    
3.3 Frailty, aging and falls 
Frailty is a defined as “a state of vulnerability to poor resolution of homeostasis 
after a stressor event” (Clegg et al, 2014).  Frailty is a consequence of age-related 
decline in many physiological systems including musculoskeletal, cardio-
respiratory, renal, endocrine and neurological systems (Clegg et al, 2014). This 
means that recovery from stressor events including falls is more difficult with 
increasing frailty and advancing age as physiological systems have reduced 
capacity to recover to previous levels of functioning.  Frailty therefore has a 
significant impact on the ability of older people to recover from falls. 
3.4 Defining falls  
The internationally recognised definition of a fall, proposed by the Prevention of 
Falls Network Europe (ProFaNE) group is “an unexpected event in which the 
participants come to rest on the ground, floor, or lower level” (Todd & Skelton, 
2004).    
There are many different definitions of falls used in the literature although most are 
based upon the gold standard definition from ProFaNE, for example the National 
Institute for Health and Care Excellence’s (NICE) definition in the Falls Prevention 
guideline:  “an unintentional or unexpected loss of balance resulting in coming to 
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rest on the floor, the ground, or an object below knee level” (National Institute for 
Health and Care Excellence, 2013).  
 
The ProFaNE definition makes sense from clinical and research perspectives; it is 
general enough to ensure that multiple aetiologies are accounted for (for example, 
collapse due to postural hypotension and loss of balance due to medication side 
effects) and ensures that vague terms including ‘stumble’ or ‘trip’ are classified as 
falls if they result in coming to rest on the ground, floor or lower level.   
 
The lay definition of fall is more problematic as the concept of ‘being a faller’ is 
surrounded by negativity, for example the stigma of ‘becoming old and frail’ (Age 
UK, 2017).  For example, an older person who stumbles backwards onto a chair or 
bed might not consider themselves as a faller for fear of the consequences of 
being labelled as ‘frail’.  This may result in misclassification bias as subjects are 
reluctant to classify themselves as fallers and thus impact upon research findings.   
 
3.5  Falls prevalence in older people  
Falls are common in older people and prevalence increases with age.  In 2005, the 
cross-sectional Health Survey of England surveyed 4259 adults aged 65 years 
and older living in private households.  29% of women and 23% of men reported at 
least one fall in the previous 12 months and falls prevalence increased with age in 
men and women, with approximately 42% of adults aged 85 years and older 
reporting one or more falls in the preceding 12 months, as demonstrated in Figure 
3.1 (National Statistics and NHS Information Centre, 2007).   
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Another cross-sectional UK study, the English Longitudinal Study of Ageing, 
surveyed 4352 adults aged 60 years and older and found that falls prevalence 
increased from 20.8% in those aged 60-69 years, through 27.7% for those aged 
70-79 years to 33.2% for those aged 80 years and older (Gale et al,  2016).   
 
Figure  3.1 Prevalence of falls in older people 
 
 
A smaller cohort of UK-based community-dwelling adults aged 90 years and older 
(90 women and 20 men) were followed over a 12 month period;  58% were 
reported to have fallen at least once in the previous year and 60% reported at 
least one fall in the prospective 12 month follow-up (Fleming et al, 2008).  These 
UK-based studies of community-dwelling older people all demonstrate the same 
trend, that falls are common, even amongst the youngest old, and falls increase in 
prevalence with advancing age.   
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This picture is reproduced globally, for example Dore et al (2015) undertook a 
cross-sectional survey of 1,619 community-dwelling adults with a mean age of 62 
years old and found approximately 20% reported a fall in the preceding 12 months 
(Dore 2015).   A cross-sectional survey of 2,096 community-dwelling adults aged 
65 years and older in Nigeria found that 24% of women and 18% of men reported 
a fall in the previous 12 months (Bekibele & Gureje, 2010).  In Japan, a survey of 
1,351 community dwelling adults aged 65-74 years found that 19% had fallen in 
the past year (Harada et al, 2015); this figure is lower than the prevalence quoted 
in other studies, perhaps due to a younger sample and only those without physical 
activity restriction being selected.  Falls are therefore common in older people 
worldwide.     
Comparing prevalence of other common chronic diseases in the UK provides a 
reference for the prevalence of falls.  For example, as presented in Chapter 2, the 
comparatively low prevalence of diabetes mellitus (13.3-26.2% (Diabetes UK, 
2016) and cancer (12.5% (Maddams et al, 2012) demonstrate that falls are a 
common and important problem in older people.   
3.6   Fall severity 
There is a spectrum of fall severity, ranging from falls that require no medical 
assistance to falls that result in serious injury, hospital admission and death.  This 
categorisation of falls relies on healthcare seeking behaviour, an activity that can 
be measured with routinely collected healthcare data.   Of course, ‘no healthcare 
assistance sought’ does not necessarily equate to ‘no healthcare assistance 
required’, and many people will turn to lay resources for help including family, 
friends and charities.  
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3.7  Consequences of falls 
Any type of fall within the falls ‘severity’ categorised according to healthcare needs 
has significant consequences for individuals, their families and wider society, 
whether it is a fall that does not require healthcare assessment or a fall that results 
in a prolonged hospital admission.  An arbitrary categorisation of the biological, 
psychological and social consequences of falls is useful to present evidence, 
although these are not mutually exclusive entities.   
 
3.7.1 Biological consequences 
The biological consequences of falls, including fractures and death, increase 
towards the tip of the falls pyramid.   Falls are the most common cause of 
accidental injury and accidental death in adults aged 75 years and older (British 
Geriatrics Society, 2007, Scuffham & Chaplin, 2002).   
A systematic review of falls resulting in injury (termed injurious falls) reporting 
(Schwenk et al, 2012) found the proportion of injurious falls to all falls ranged from 
3.6 % to 63.5%, with studies using only fracture outcomes finding the lowest 
proportion and studies using a broader definition of injury including bruises, cuts 
and abrasions reporting the highest proportion of injuries in relation to all falls 
(Schwenk et al, 2012).   In the UK, this equates to 65,000 hip fractures occurring 
each year (Royal College of Physicians, 2015).    Of these hip fractures, the UK 
Department of Health report that up to 14,000 people die annually in the UK 
(Department of Health, 2001).    
Falls have a considerable impact on everyday clinical management of common 
medical conditions in general practice.  For example, part of the management of 
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future falls risk involves medication modification or withdrawal (National Institute 
for Health and Care Excellence, 2013).  In practice this may mean stopping 
medication that is benefitting other symptoms to reduce the risk of falls, for 
example benzodiazepines that provide relief from anxiety and insomnia or 
gliclazide that improves glycaemic control in diabetes mellitus.  Although the falls 
risk is reduced, the impact of withdrawing medication previously of benefit must be 
carefully weighed to assess impact on all aspects of patients’ daily lives, including 
the biological aspects of other diseases.   The biological consequences of falls are 
wide ranging and considerable, particularly as falls severity increases.  
3.7.2 Psychological consequences 
The psychological consequences of falling can be severe across the falls iceberg; 
even a fall that does not require healthcare assistance is enough to induce a fear 
of falling.  Fear of falling is a recognised risk factor for future falls (National 
Institute for Health and Care Excellence, 2013) and is common amongst older 
adults who have fallen or nearly fallen with up to 85% of older community dwelling 
adults reporting a fear of falling (Scheffer et al, 2008).   Loss of self-efficacy 
(defined as an individual’s perception of capabilities within a particular domain of 
activities (Bandura, 1977)), activity avoidance and loss of self-confidence are other 
psychological sequelae of falls (Legters et al, 2002).  
Loss of independence associated with falling is a significant concern for older 
people; a survey of older women found that 80% would rather be dead than 
experience the loss of independence and quality of life resulting from a hip fracture 
and subsequent nursing home admission (Salkeld et al, 2000).  Older people 
fearing loss of independence from any fall, even those not requiring healthcare 
assistance, do so for good reason; for a home-visiting GP, safety at home is a key 
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consideration and if an older person is considered to be at high risk of falling (and 
a history of falls or near-falls forms part of this risk assessment) and thus not safe 
at home, then an emergency social care admission is often advised and arranged 
and personal independence is inevitably compromised.    
3.7.3 Social consequences  
The activity avoidance and loss of confidence arising from experiencing a fall has 
a significant impact upon social participation amongst older people and impacts 
upon individuals, families and communities.  The grandmother who has stopped 
attending the local community centre to help out at coffee mornings because the 
steps on the bus are too difficult to negotiate, or the retired clockmaker who has 
stopped helping at local ‘fix it’ events because the ground is too uneven outside 
the host building are just two examples of decisions that older people are making 
on a daily basis due to their fear of falling and reduced confidence; actions which 
result in losses to all involved.  
Furthermore, there is evidence that reduced social participation in older adults is 
associated with poorer mental health (Thraen-Borowski et al. 2013), greater 
cardiovascular risk (Kamiya et al, 2010) and increased mortality (Glass et al, 1999, 
Dale et al, 2012).   Reduced social participation therefore has far-reaching 
consequences.     
An increase in social support and care is often required after a fall if help is 
needed with activities of daily living, for example washing, dressing, preparing 
meals and shopping.  This help can be provided by formal social care structures, 
for example residential homes and caring services or by family, friends or 
neighbours.  The Kings Fund (2013) analysed healthcare data in a cohort of older 
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people in Torbay, UK by costing care in the 12 months preceding and 12 months 
immediately following a fall (Tian et al, 2013).  This study found both community 
care costs (community hospital inpatient and community health visits) and social 
care costs (domiciliary care, day care and care homes) increased after a fall (GP 
services and prescriptions were not included in the analysis) (Tian et al, 2013).  
Moreover, Pin & Spini (2016) found that one fall event, regardless of physical 
consequences, independently predicted increased social support.  This increased 
need has obvious consequences for families and communities including creating 
time for caring roles at the expense of other activities including work.   
Falls therefore impact upon individuals, families, communities and local health and 
social care services through reduced social participation and increasing social 
support needs.   
3.7.4 A note on ‘injurious’ falls 
The term ‘injurious’ is commonly seen in the literature addressing falls.  ‘Injurious’ 
is defined as ‘causing damage or harm; deleterious; hurtful’ (Collins English 
Dictionary, 2016). Hence, a fall that results in a deleterious effect can be described 
as ‘injurious’.  As outlined in Section 3.7, the consequences of falls are far-ranging 
and can arise from a fall of any severity.  This thesis therefore avoids using the 
term ‘injurious’ fall and will classify falls according to healthcare use.   
3.8  Economic consequences of falls in older people 
Falls have an economic impact upon health and social care services.  The English 
Longitudinal Study of Ageing found 28.4% of adults aged 60 years and older 
experienced a fall that did not require healthcare attendance (Gale et al, 2016).  
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There is little data available on the number of primary care attendances due to 
falls.  Gribbin et al (2009) used The Health Improvement Network (THIN) database 
of GP consultations to research falls and medication use finding 79,295 recorded 
fall events in 61,248 individuals over 3 years.  
It is difficult to tease out the proportion of older adults who experience a fall that 
requires Emergency Department attendance or hospital admission since these 
figures are generally quoted as numbers of falls, rather than number of fallers.  
Number of falls remains a useful estimate of the impact on healthcare services as 
fallers will need to undergo similar resource use whether they are a new or 
recurrent faller.  Accordingly, there were 647,721 A&E attendances for fall-related 
injuries in adults aged 60 years and older in 1999 (Scuffham & Chaplin, 2003).  
These A&E attendances generated 204,424 admissions to hospital due to fall-
related injuries (Scuffham & Chaplin, 2003).  Although these figures are from 
1999, they are unlikely to have reduced significantly and may have risen due to 
the effect of an ageing population.    
More recent metrics on falls that required hospital admission come from the 
Torbay Cohort (Tian et al, 2013) who identified fallers requiring hospital admission 
from hospital and GP data and analysed associated health and social care costs 
(Tian et al, 2013).  Around 1% of the study population (adults aged 65 years and 
older living in the community) were admitted to hospital due to falls between July 
and December 2010.    
Falls have recently been estimated to cost the NHS £2.3 billion per year (National 
Institute for Health and Care Excellence, 2017), from approximately £116 billion 
total NHS spend in the same year (The Kings Fund,  2017).   This compares to a 
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total annual cost of £1.4 billion to manage diabetes mellitus and its complications 
(Diabetes UK, 2012) and £5 billion per year to treat cancer (Department of Health, 
2015).  
The numbers quoted above, although not directly comparable, provide a snapshot 
of healthcare utilisation and associated costs and demonstrate that falls in older 
people require substantial healthcare resources in the UK.   
 
3.9 Summary  
This chapter has defined falls, highlighted their prevalence, associated healthcare 
use and consequences and thus provided the reasoning behind studying falls in 
this thesis.  The next chapter explores risk factors for falls and places this 
information in a clinical context through outlining the role of general practice in falls 
prevention for older people.   
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Chapter 4: Risk factors for falls  
4.1 Chapter overview  
This chapter provides an overview of the risk factors for falls in older people, 
derived from current clinical guidelines relating to the prevention of falls and from 
personal clinical experience.   Research establishing an association between pain 
and falls is discussed to provide a foundation for this thesis’ development.   The 
chapter is then summarised.   
 
4.2 Falls risk factors: review of current evidence   
4.2.1 Overview   
Many risk factors for falls have been identified in the literature.  This section 
presents a description of the key evidence behind traditional risk factors that are 
commonly cited in clinical guidelines and highlights other risk factors that are not 
as widely recognised in clinical practice but are important to consider in the 
context of this thesis.  Where relevant, the associations with pain are also 
discussed to provide a more clinically representative ‘real-life’ hypothesis of how 
the risk factor might interact with pain to impact upon falls risk.   
The purpose of this section is to synthesise key information from current evidence 
that is later drawn upon in the thesis to decide which covariates are important to 
include in analyses with pain and falls; it is not intended to reproduce published 
literature reviews nor provide a comprehensive systematic review of falls risk 
factors as this work has already been undertaken, for example by Gillespie et al 
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(2012) who conducted and continue to update the Cochrane systematic review of 
interventions for preventing falls in older people living in the community.    
The direction of this chapter was steered by personal clinical experience in 
assessing and managing older people who are at risk of falls or have already 
fallen within a primary care setting.  Knowledge of current falls prevention 
guidelines (for example the NICE (2013) guidance on falls prevention) provided 
the starting point for literature exploration to examine the evidence behind falls risk 
factors within these guidelines.  Experience of current daily clinical practice in 
primary care, falls prevention clinics and local GP educational events led to further 
literature searches to assess the evidence around additional factors that made 
clinical sense and seemed to be more common in patients who fell, for example 
hearing impairment, health anxiety, low mood.  What now follows is a description 
of proven or possible falls risk factors that are considered for inclusion in this 
thesis’ analyses.   
 
4.2.2 Risk factors: demographic information 
4.2.2.1 Age 
Increasing age is a known risk factor for falls, a finding that has been reproduced 
by many studies through the years.  In addition to the evidence presented in 
Chapter 3, Blyth et al (2007) found that, in a population of community-dwelling 
older adults, the relative risk of falls in the past 12 months increases with 
advancing age.  Using the age group 40-59 years as the comparator group, Blyth 
et al (2007) reported a non-statistically significant increased relative risk of 1.09 
(95% confidence interval 0.94-1.25) in those aged 60-69 years, a statistically 
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significantly increased relative risk of 1.74 (95% confidence interval 1.48-2.05) for 
those aged 70-79 years and a statistically significant increased relative risk of 1.37 
(95% confidence interval 1.23-1.53) for those aged 80 years and older.  Barrett-
Connor et al (2009) found that women aged 80 years and older had a statistically 
significant odds ratio of falling equal to 1.53 when compared with women aged 50-
69 years old and Deandrea et al (2010) found that, for every 5 year increase in 
age, the odds of falling increased by 12%, a statistically significant finding.     
4.2.2.2 Sex 
Studies exploring falls risk factors give conflicting results for the influence of sex 
on falls risk.  For example, Campbell et al (1990) found no difference in fall rate 
between females and males in their community based prospective study of 761 
older adults.  However, Blyth et al (2007) found that the relative risk of females 
falling over the past 12 months compared to males was 1.37, a statistically 
significant finding in their sample of 3181 subjects aged 49 years and older.  Gale 
et al (2016) analysed their results in a different way, grouping subjects by sex, and 
then by age, using the youngest age group as the baseline risk of falls.  Men and 
women were both more likely to fall with increasing age, although the risk of falls 
with advancing age was more pronounced in men; this is likely to be because 
women overall fell more frequently and so the baseline risk was higher (at ages 
60-69 years, 20.8% of men and 26.6% of women fell in the last two years, and this 
increased at ages 70-79 with 27.7% of men and 30.5% of women falling and again 
at ages 80 years and older with 33.2% of men and 35.1% of women falling) (Gale 
et al, 2016).  Although there is some discrepancy over the exact relationship 
between falls and sex at different ages, sex does impact upon the risk of falls.  
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4.2.2.3 Ethnicity 
Few studies have explored the influence of ethnicity on falls risk.  Nevitt et al 
(1989) found that caucasians were more likely to fall than their afro-caribbean, 
hispanic or south asian counterparts and Friedman et al (2002) confirmed this 
finding as part of an exploratory study for falls risk factors.  More recently, Geng et 
al (2017) conducted an analysis to specifically measure the influence of ethnicity 
on falls risk using cross-sectional study data from 6277 women aged 65 – 90 
years old.  They found that 28.5% of non-hispanic white women, 27.8% hispanic 
women, 23.4% black and 20.1% asian women had fallen in the past year, with 
asian and black women significantly less likely to fall when compared to white 
women (Geng et al 2017).  
 
4.2.2.4 Socio-economic position  
Socio-economic position refers to the socially derived economic factors that 
influence what positions individuals or groups hold within the multiple-stratified 
structure of a society (Galobardes et al 2007).  There is evidence that 
socioeconomic factors influence health and as such the relationship between 
socio-economic status, pain and falls is likely to be complex.  Barnett et al (2012) 
undertook a large cross-sectional study extracting medical record data from 
1,751,841 patients in Scotland and found that multimorbidity is likely to begin 10 to 
15 years earlier in people living in the most deprived areas compared with the 
most affluent.  Furthermore, those in socio-economic deprivation were found to be 
much more likely to have pain disorders and mental health disorders as 
comorbidities (Barnett et al, 2012).  These findings from a large scale study 
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suggest that the influence of socio-economic status on health and comorbidity is 
complex and one that must be considered in this thesis since this might also 
subsequently impact upon risk of falls.  For example, if respondents reporting pain 
are more likely to be from deprived socio-economic groups, then the pain groups 
will have an unequal distribution of socio-economic statuses i.e. the pain-free 
group will have proportionally less individuals from lower socio-economic 
categories than the some pain or widespread pain groups.  This means that 
differences in falls rates might be explained by socio-economic status rather than 
pain status, or that socio-economic status is acting as a confounder in the 
relationship between pain and falls.  Furthermore, those in more deprived socio-
economic groups may have more multimorbidity at a younger age.  Thus any 
relationship between pain and falls within different age groups may be (at least 
partly) explained by the difference in multimorbidity patterns due to socio-
economic status.   
 
4.2.3 Risk factors: Physical health factors 
 
4.2.3.1 Multimorbidity 
Many medical conditions have been identified as risk factors for falls including 
circulatory disease, chronic obstructive pulmonary disease, depression and 
arthritis (Lawler et al, 2003).  Loss of peripheral sensation as a result of diabetes 
(Luukinen et al, 1995) or arthritis (Nevitt et al, 1989) may increase the risk of falls.  
Urinary incontinence is a common finding amongst populations of older fallers 
(American Geriatrics Society et al, 2001); perhaps this is as a part of general 
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frailty, or due to the urgency required to attend to toileting needs which generates 
an additional risk associated with mobility problems and falls.   
  
Compounding this, the burden of multiple chronic diseases has long been a known 
risk factor for falls, with Lawler et al (2003) finding the odds ratio for each 
additional chronic disease, when adjusted for the total number of medications, was 
1.39 (1.29-1.51), a significantly increased risk of falls with increasing number of 
medical conditions.   Deandrea et al (2010) also found the odds of falling per each 
additional comorbidity was statistically significantly increased (OR 1.2 (95% 
confidence interval (95% CI) 1.2-1.3)).   
 
Multiple chronic medical conditions in an individual is termed ‘multimorbidity’ 
(Wallace et al, 2015) and this often results in polypharmacy (Wallace et al, 2015), 
a risk for falls in its own right which is discussed below.  Marengoni et al (2011) 
conducted a systematic review exploring ageing with multimorbidity and found 22 
studies reporting significant negative impacts of multimorbidity on disability, quality 
of life and high health care use (Marengoni et al, 2011). Four studies also found 
that increasing numbers of conditions were consistently associated with increasing 
risk of disability, although it is worth noting one study reporting a contrary finding of 
no relationship between multimorbidity and physical functioning (Hudon et al, 
2008).  Multimorbidity is therefore a risk factor for falls which may be driven by the 
associated polypharmacy and the impact of chronic disease burden upon physical 
functioning and resulting disability and thus increased risk of falls; a clinical picture 
that is common in daily general practice.   
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4.2.3.2 Dizziness 
Many different interpretations are inferred from the use of descriptive terms such 
as ‘dizziness’ and ‘unsteadiness’.  Dizziness may describe a sensation of light-
headedness, for example due to postural hypotension or a vasovagal episode.  
Unsteadiness may describe symptoms relating to the inner ear or cerebellum.  
Balance and gait impairment may be due to central or peripheral causes.  The 
wide differential diagnosis of underlying causes of these symptoms therefore 
makes it difficult to use particular diagnoses as indicators of ‘dizziness’.  Taken as 
a symptom, dizziness, or unsteadiness, is a long established falls risk factor, 
demonstrated by Tinetti et al (1988) in her study of falls risk factors in older 
people.  Tinetti et al (1988) found that the presence of ‘more than six balance and 
gait abnormalities’ (of unsteady sitting down, unable to stand on one leg 
unsupported, unsteady turning, unsteady after a gentle push on the sternum, 
increased trunk sway, unable to pick up walking pace, increased path deviation)’ 
had an OR for falls of 1.9 (95% CI 1.0 – 3.7).  Dizziness has since appeared in 
national and international fall-related guidelines around the world for example 
NICE (2013) and American Geriatric Society guidelines (2001).   
 
4.2.3.3 Hearing impairment 
A recent systematic review and meta-analysis exploring the relationship between 
hearing loss and falls in older adults identified 12 studies and reported a pooled 
odds ratio of 2.39 (95% confidence interval 2.11-2.68) (although it must be noted 
that the studies included were predominantly cross-sectional and thus a temporal 
relationship was not possible to ascertain (Jiam et al, 2016)).  Given this 
association and biological explanations including possible co-existent vestibular 
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dysfunction and resulting unsteadiness, the increased cognitive requirements of 
hearing loss reducing overall additional capacity for tasks including balance (Jiam 
et al, 2016)  and the potential loss of special awareness (Keller et al, 1999), it is 
necessary to consider the influence of hearing on falls risk during analyses.    
 
4.2.3.4 Visual defects  
Reduced visual functioning is a well-established risk factor for falls with potential 
mechanisms for falls resulting from visual impairment relating to inability to see 
obstacles, reduced spatial awareness and reduced cognitive capacity for balance 
with the increased load of visual impairment.  The Blue Mountain Eye Study 
conducted by Ivers et al (1998) found a statistically significant increase in risk of 
two or more falls with having reduced visual impairment.  Subsequent research 
confirms this finding (Abdelhafiz & Austin, 2003; Patino et al, 2010), and visual 
impairment routinely forms part of the falls prevention agenda with organisations 
including the British Geriatrics Society and the College of Optometrists leading a 
national programme in eye health to reduce falls in older people (British Geriatric 
Society & British College of Optometry, 2010) . 
 
4.2.3.5 BMI  
A low body mass index (BMI) has been traditionally considered a risk factor for 
falls due to associated sarcopaenia and resulting muscle weakness and balance 
problems.  Tinetti et al (1995) found that low body mass index was a risk factor for 
falls (OR 1.8, 95% CI 1.2-2.5) in her study of 1103 community dwelling older 
people.  More recently, a high body mass index has been found to contribute to 
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falls risk.  Hooker et al (2016) prospectively studied 5,834 older men and found 
that obesity (defined as BMI of 35 or more) was independently associated with 
statistically and clinically significantly higher fall rates (Hooker et al, 2016).  This 
finding was later replicated in a Canadian study by Handrigan et al (2017) who 
found in their 15,860 sample of older community dwelling adults that there was a 
significantly higher odds of falling in obese men compared to normal weight (BMI 
between 20-25) men.  This relationship did not exist for women.  Furthermore, 
men classified as ‘underweight’ (BMI less than 20) had more falls than their 
‘normal’ counterparts, although this was not a significant association (Handrigan et 
al, 2017).  Since there are significant associations between BMI and falls it is 
prudent to account for this in analyses to ensure that any association between 
pain and falls is less likely to be attributed to BMI.   
 
4.2.4 Risk factors: mental health markers 
4.2.4.1 Cognitive impairment  
Cognitive impairment is an established risk factor for falls and features widely in  
national guidelines.   A recent systematic review and meta-analysis exploring the 
association between cognitive impairment and falls found that cognitive 
impairment as a disease-specific diagnosis (for example Alzheimer’s disease) 
conferred a statistically significant risk of falls, although the evidence relating to 
other measures of global cognitive impairment (for example the Mini Mental State 
Examination) showed mixed findings, perhaps due to the high risk of bias or the 
subtleties of cognitive impairment that are not scored as such in the assessment 
tool (Muir et al, 2012).   
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Subjective cognitive impairment has been shown to be significantly associated 
with the presence of pain in older people (Westoby & Mallen 2009) and it is 
biologically plausible that cognitive impairment appears on the pathway between 
the experience of pain and subsequent falls; thus cognitive impairment is an 
important risk factor for falls.  
4.2.4.2 Depression  
A recent prospective study by Hoffman et al (2017) demonstrated a statistically 
significant association between the reporting of depressive symptoms and 
subsequent falls risk when controlled for baseline physical functioning, vision, 
chronic conditions, social support and neighbourhood social cohesion (Hoffman et 
al, 2017).  Although this significance was lost when use of psychiatric medicines 
was added to the model, the importance of the relationship between depressive 
symptoms and falls remains since psychiatric medication would not be necessary 
if depressive symptoms did not exist.   
An earlier study by Antsey et al (2008) demonstrated that, over 8 year follow up, 
the relationship between depressive symptoms and subsequent falls remained 
significant when controlled for sociodemographics, psychotropic medication, 
comorbidity and sensorimotor function. 
It is known that older adults who report musculoskeletal pain are more likely to 
have comorbid depressive symptoms (Mallen et al, 2008).  It is therefore important 
to take account of these symptoms since it may be that the relationship between 
pain and depression is exerting an influence on the association between pain and 
falls.   
38 
 
4.2.4.3 Anxiety  
The relationship between anxiety symptoms and falls risk has been less 
extensively investigated than depressive symptoms and falls risk.  The first study 
available in the literature specifically designed to explore the relationship between 
anxiety and falls was published in 2016.  Holloway et al (2016) found that anxiety 
was associated with an almost three-fold increased risk of future falls in older men.  
The increased risk in older women was subsequently explained by psychotrophic 
medication use, poor mobility and socioeconomic status (Holloway et al, 2016).   
Jones et al (2010) found those who do not report musculoskeletal pain had low 
levels of anxiety (and also low levels of depression and psychological distress), 
leading to the hypothesis that those reporting high levels of musculoskeletal pain 
would also report higher levels of anxiety.  It is plausible that anxiety may act as a 
confounder in the same manner as depression might as cited in section 4.2.4.2; 
thus it is important to consider the presence of anxiety symptoms in analyses. 
   
4.2.5 Risk factors: medication 
4.2.5.1 Total medication count  
In 2009, a meta-analysis of the impact of 9 medication classes on falls in older 
people demonstrated use of sedatives, neuroleptics, antipsychotics, hypnotics, 
antidepressants, benzodiazepines and non-steroidal anti-inflammatory drugs 
(NSAIDs) showed a significant association with falls (Woolcott et al, 2009).   There 
are many individual studies included in this review that found significant 
associations between medication use and falls, for example Lawlor et al (2003) 
who found an increased risk of falls associated with use of hypnotics, anxiolytics 
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and antidepressants when adjusted for chronic disease status in 3742 community 
dwelling older women in the UK.  This study also found a ‘strong linear 
association’ between the total number of medications and subsequent fall, 
although this lost statistical significance when adjusted for chronic disease status, 
physiological parameters and socioeconomic position (Lawler et al, 2003).    When 
the number of medications is analysed categorically, more than four medications 
(irrespective of type) has been shown to attribute a significant risk of falls, for 
example by Robbins et al (1989)  The latest research to date addressing 
polypharmacy and falls found that, after adjusting for covariates, polypharmacy did 
not remain a significant risk factor for falls in older adults although consumption of 
two or more ‘high risk’ medications  including cardiovascular agents, central 
nervous system drugs, analgesics and endocrine drugs remained a significant risk 
factor for falls (Zia et al, 2017).  This paper categorised medications differently to 
other publications, for example classifying polypharmacy as ‘5 or more 
medications’ and including endocrine medications as fall risk increasing drugs.  
Nevertheless, the message that multiple medications increase falls risk remains. 
 
4.2.5.2 Analgesic use  
Pain is associated with analgesic use, and analgesics, particularly opiates and 
NSAIDs have been associated with an increased risk of falls in older people (Zia et 
al, 2017).   A  prospective study including 4231 older people found that, for those 
with or at risk of knee osteoarthritis, use of opiates (and antidepressants) 
conferred an increased risk of future falls when adjusting for covariates (Lo-
Ciganic et al, 2017).   However, it must be noted that Leipzig et al (1999) did not 
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find a significant relationship between opiates or NSAIDs and falls in their 
systematic review and meta-analysis of analgesic drugs and risk of falls (Leipzig et 
al, 1999) and Woolcott did not find a significant association between narcotics and 
falls in older people in his meta-analysis of medication and falls risk (Woolcott et 
al, 2009).  The relationship between analgesic use and future falls is important to 
consider in this thesis, since increased risk of falls from analgesic use mean 
recommendations for pain management using pharmacological means will be 
more challenging.    
 
4.2.6 Risk factors: physical functioning  
Impaired mobility results in a limitation of physical functioning, which in turn leads 
to more sedentary behaviour, loss of muscle power and thus an increased risk of 
falls (Todd & Skelton, 2004).  The presence of pain is also associated with mobility 
limitation (Mottram et al, 2008; Landi et al, 2009).  Thus, physical functioning and 
mobility limitation might conceivably influence the relationship between pain and 
falls; the group with the most pain will also have the highest levels of mobility 
limitation and therefore the increased risk of falls might then be attributed to 
physical functioning rather than the presence of pain.  
  
4.2.7 Risk factors: previous history of falls  
Nevitt et al (1989) found that a history of at least three previous falls or one fall 
resulting in injury was statistically significantly associated with future falls risk (the 
unadjusted relative risks were 2.2 (95% CI 1.70-3.0) and 2.6 (95% CI 1.6-4.4) 
respectively).  Barrett-Connor et al (2009) analysed data from 66,134 post-
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menopausal women in a large prospective cohort and found that, after adjusting 
for multiple variables, the strongest single predictor of future falls was a history of 
falls, with an odds ratio of 2.67 (2.56-2.79).  A history of falls is therefore an 
important risk factor for falls in older people.   
 
4.2.8 Risk factors: summary  
There are multiple risk factors for falls, including demographic, medical, 
psychological and physical health-related variables.  These risk factors are not 
mutually exclusive and combinations of variables further increase risk of falls.  For 
example, Barrett-Connor et al (2009) found the risk of falling increased linearly 
with the number of risk factors present, increasing between 2% and 9% for each 
additional risk factor.  This increased risk is obviously due to the addition of each 
individual risk factor but is also likely due to the complex relationships between 
variables.  For example, an older person with two chronic diseases might be taking 
four different medications and the side effects of these medications might make 
them feel a bit dizzy so activity is limited for fear of falls.  This person already has 
two clear risk factors in multimorbidity and polypharmacy; when dizziness, fear of 
falling and activity limitation are added the risk of falling increases further.   
 
 
4.3 Multisite pain and falls  
A further potential risk factor for falls was identified by Leveille et al in 2009.  They 
proposed that, on the basis of their population based cohort study, multisite pain is 
associated with an increased risk of falls in older people.  Alongside personal 
clinical interest in care of older people and falls and the frustration that, despite 
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guidelines, our older patients are still falling, Leveille’s (2009) study proved the 
starting point for this thesis and will now be discussed in more detail.   
 
4.3.1 Leveille et al, 2009: study design 
In 2009, Leveille et al published the first population-based cohort study to establish 
a link between the presence of multisite pain and future falling.  This section will 
outline the study design and findings.  A thorough critical appraisal, performed as 
part of the systematic review and meta-analysis that follows in Chapter 5, found 
the overall risk of bias for the study to be low.    749 community-dwelling older 
adults residing in Boston (USA) completed baseline assessment and 18 monthly 
falls postcards, yielding a response rate of 53% (Leveille et al, 2009).  
Respondents were included if they were aged 70 years and older, were able to 
walk 20 feet without personal assistance, able to communicate in English, had 
sufficient vision to read the study material and were intending to stay in the area 
for two years (Leveille et al, 2009).  Exclusion criteria were severe visual or 
hearing deficits and cognitive impairment scores suggestive of significant memory 
difficulties.  
Recruitment took place over a 27 month period from 2005 and included sending 
letters to local community hubs and randomly selecting households within the 
locality to receive study information.  A home interview and clinical examination 
were performed at baseline and 18 months, and monthly falls calendars (where 
respondents mark daily whether they have fallen or not) were completed 
throughout study duration.  76% of participants completed all 18 monthly 
calendars and more than 95% completed calendars at 6, 9, 12 and 18 month 
points.  
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The study focussed on ‘chronic musculoskeletal pain’ and therefore asked 
respondents about pain present in the previous year and present for at least three 
months in that previous year (Leveille et al, 2009).  A thirteen item questionnaire 
was used to assess musculoskeletal pain in the hands, wrists, shoulders, back, 
chest, hips, knees and feet.  Chest pain associated with angina was excluded.  
Pain was classified as i) no pain ii) single site pain ii) pain in two or more locations.  
A second set of pain location measures were defined according to pain site and 
followed the pattern: i) pain in the knee(s) and 1 or more other joint locations; ii) 
pain in the knee(s) only; and iii) no knee pain.  Pain severity and pain interference 
were also measured.  Finally, pain was also assessed monthly during study follow 
up using a single pain question designed to measure severity of pain over the past 
month; severity was recorded on the monthly falls calendars.    The authors later 
refer to pain as ‘joint pain’ and present pain in more than one location as 
‘polyarticular pain’.   
The study also measured age, sex, ethnicity, education, cognitive status, physical 
activity, physician-diagnosed self-reported heart disease, stroke, Parkinson’s 
Disease, rheumatoid arthritis, spinal stenosis and spinal disc disease.  Peripheral 
neuropathy, peripheral arterial disease, BMI, diabetes mellitus, osteoarthritis of the 
hand and knee, vision, standing balance and depression were assessed clinically.  
Information about medication, including over-the-counter medication was collected 
from recent prescriptions and questionnaires.  
Falls were measured prospectively using a monthly falls calendar that participants 
completed daily and submitted monthly; this is the current gold standard of falls 
data collection in surveys, highlighted by the ProFaNE group (Hauer et al, 2006).  
Falls history in the 12 months prior to baseline survey was also ascertained.  
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4.3.2 Leveille et al, 2009: Study results  
Leveille et al (2009) found that a fall in the past year was statistically significantly 
associated with the presence of pain, and the risk was greater amongst those 
reporting multisite pain compared to single site pain.  Prospectively, the risk (rate 
ratio) of falls associated with single site pain was 1.19 (95% confidence interval 
(CI) 0.90 – 1.56) and, associated with multisite pain, was 1.70 (95% CI 1.34-2.16) 
when adjusted for age and sex.  When adjusted for all the covariates outlined 
above, the final model demonstrated a rate ratio of falls of 1.11 (0.84-1.47) for 
single site pain and 1.53 (1.17-1.99) for multisite pain.   Pain measured as severity 
or interference also statistically significantly increased the risk of future falls 
(Leveille et al, 2009).   
 
4.4 Taking current research into pain and falls further  
 
Leveille et al (2009) were the first group to provide evidence that pain in multiple 
locations is associated with an increased risk of falls.  This thesis seeks to explore 
this relationship further in a larger study sample with a longer follow-up period in a 
UK-based community-dwelling population so that results can be interpreted with 
clinical relevance to UK general practice.  Leveille et al (2009) also found that the 
increased falls risk persisted when controlled for factors that might be responsible 
for the cause of underlying joint pain, for example osteoarthritis, spinal disc 
disease and peripheral neuropathy; a finding that suggests  there is something 
about the experience of pain itself that contributes to falls risk.  This thesis seeks 
to further explore this relationship using the following different methods:  
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i) Using a broader definition of pain, including headaches and abdominal 
pain and thus not restricting to musculoskeletal, or joint, pain 
ii) Taking account of a different set of covariates that are derived from 
current evidence around falls risk factors and from a pragmatic clinical 
stance  
iii) Using different statistical techniques to explore self-reported falls and 
falls requiring primary or secondary health care utilisation 
The next step in this thesis’ development is to consider Leveille et al’s (2009) 
research findings within the current evidence base examining the relationship 
between pain and falls.  A systematic review and meta-analysis undertaken to 
address this next step is detailed in Chapter 5.  The evidence presented in this 
chapter will be considered in conjunction with the findings of the systematic 
review and meta-analysis; selected covariates for inclusion in analysis are then 
described in Chapter 6.   
 
4.5  A conceptual framework for the exploration of pain and falls  
Finally, taking current research into pain and falls further must be done within the 
broader context of the themes discussed in the thesis in Chapters 2,3 and 4 in 
order to underpin and direct future analyses.  Figure 4.1 presents a conceptual 
framework for the thesis in which the analysis is embedded within the broader 
context of frailty and population ageing.  The thesis seeks to investigate the 
relationship between the independent variable (multisite pain) and the dependent 
variable (falls) whilst taking account of known falls risk factors and confounding 
variables and thus their potential influence on both the pathway between multisite 
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pain and falls and their influence upon the dependant and independent variables 
under investigation.   
 
Figure 4.1 A conceptual framework for the thesis’s exploration of multisite pain and 
falls in older people  
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4.6  Summary  
This chapter has provided an overview of the known risk factors for falls in older 
people, derived from current clinical guidelines relating to the prevention of falls 
and from personal clinical experience.   The first prospective cohort study to 
suggest a link between multisite pain and falls has been presented and the ways 
in which this thesis will build upon those findings have been outlined.  Finally, a 
conceptual model has been presented to link together the broader themes 
underpinning the thesis and to aid future analyses.  The next chapter considers 
additional evidence relating to pain and falls in a systematic review and meta-
analysis. 
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Chapter 5: Multisite pain and falls: systematic review and 
meta-analysis 
5.1 Overview  
This chapter describes the process of the systematic review and meta-analysis 
undertaken to identify and synthesise the current evidence investigating pain as a 
risk factor for falls in older people.  Results are presented and discussed, with the 
findings used to develop this thesis’ research methodology.    
 
5.2 Systematic review and meta-analysis: aims and objectives  
5.2.1 The role of systematic reviews and meta-analysis 
Previous chapters have discussed risk factors for falls, and have highlighted 
Leveille et al (2009)’s finding that pain is statistically significantly associated with 
falls (Leveille et al, 2009).   Further exploration of the current medical literature is 
required to fully identify additional research examining the association between 
pain and falls to enable this thesis to build on existing evidence and identify 
potential novel areas for further investigation.  
Further exploration of the literature will be undertaken using a systematic 
approach, guided by the widely recognised process of systematic reviewing.  The 
Cochrane Collaboration defines systemic review as an approach that ‘attempts to 
identify, appraise and synthesise all the empirical evidence that meets pre-
specified eligibility criteria to answer a given research question’ (Higgins & Green, 
2011a).   Where possible, summary statistics from each study will be combined to 
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provide an overall summary risk estimate of the relationship between pain and 
falls; this will be done using meta-analysis, an established technique of combining 
results from individual studies to produce a more precise effect estimate in order to 
reduce uncertainty (Higgins & Green, 2011a).   
 
5.2.2 Aims and objectives 
The systematic review and meta-analysis will identify existing research examining 
the relationship between multisite pain and falls, appraise individual studies for 
quality and risk of bias, and synthesise results into an overall summary in order to 
meet the following objectives:  
i) To establish whether there is an increased risk of falls in older adults who 
experience multisite pain; and 
ii) To identify gaps in the current evidence base that will be used to inform the 
design of this thesis’ research to examine the relationship between multisite 
pain and falls in greater detail. 
 
5.3 Methods  
5.3.1 Medical literature databases and additional searches 
Seventeen online bibliographic databases were searched from inception until 30th 
September 2016.  The full list of the databases searched is found in Appendix 1. 
The search included databases storing medical research (including Medline, 
EMBASE, The Cochrane Library), nursing and allied health research (including 
CiNAHL and the British Nursing Index), behavioural science and mental health 
related research (including PsychInfo), health management research (for example 
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the HMIC Health Management Information Consortium) and health economics 
information (including the Kings Fund).   
Additional data sources that were searched include journal conference 
proceedings (through the Conference Proceedings Citation Index), the Electronic 
Thesis Online Service and relevant charity or society websites (for example Age 
UK, British Geriatric Society).  References of relevant papers were hand-searched 
to ensure relevant research not extracted previously was captured.   A complete 
list of resources searched is found in Appendix 1.   
 
5.3.2 Search strategy  
The search was designed to maintain broad terms to ensure adequate capture of 
all relevant studies.  A pilot search strategy using focussed search terms failed to 
extract key papers and thus the search strategy described below was used.  The 
search terms were limited to appear in title, abstract or keywords.  
5.3.2.1 Search terminology: pain   
The general term ‘pain’, either as a MeSH term ‘exploded’ (a method of 
broadening a search that is built into database search software) or as free text had 
to be used to ensure capture of relevant research after a pilot search using terms 
more specific to multisite pain (pain in more than one part of the body, extracted 
using the search term ‘mulit$ adj3 pain’) failed to capture key studies. 
In addition to ‘pain’, other terms used to capture multisite pain included 
musculoskeletal diseases, osteoarthritis, arthralgia and specific pain phenotypes 
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for example pain(ful) hip, pain(ful) knee); each were either ‘exploded’ as MeSH 
terms or searched as ‘free text’.   
5.3.2.2 Search terminology: falls  
Fall-related terms varied across databases.  MeSH terms searched and ‘exploded’ 
were: ‘Accidental falls’, ‘falls risk’, ‘falls risk assessment’ and ‘falling’.  The free text 
term ‘fall*’ was used to cover fall, falls, falling, fallen, falls and faller.   A complete 
list of search terminology is detailed in Appendix 2. 
5.3.2.3 Search study design 
Studies were not excluded on the basis of study design alone.  The systematic 
review seeks to establish whether there is an increased risk of falls in adults who 
experience multisite pain compared to those who with no pain; cross-sectional, 
prospective and retrospective cohort studies, and case-control studies are 
therefore all included from the outset and the quality of the study and interpretation 
of the conclusions take account of study design. 
5.3.2.4 Search term combination and search limits  
Pain search terms were combined using the Boolean operator ‘or’ to generate an 
overall ‘pool’ of pain-related search terms.  Fall search terms were also combined 
using the ‘or’ operator.   
The two separate ‘pools’ of pain terms and fall terms were then combined using 
the Boolean operator ‘and’ to extract literature containing both pain and fall-related 
search terms in either the title, associated keywords, or abstract.   
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Searches were limited to human studies only; no other limitations were applied 
including language.  Translators were found for Italian, French, German, Dutch, 
Spanish, Portuguese and Japanese articles.  Google Translate (Google, 2013) 
was used to translate one paper written in South Korean.  No papers were 
excluded on basis of language alone.    
5.3.2.5 Inclusion and exclusion criteria  
Studies were included in the review if all of the inclusion criteria were met:  
i) Study population  
The study population must be community dwelling adults aged 50 years and older.  
Where a study contains a wider age range that includes adults aged 50 years and 
older, they remain included and, where possible, data for sub-groups is extracted 
or authors are contacted for further information.   
ii) Exposure of interest  
Participants must have multisite pain i.e. pain in more than one part of the body.  
iii) Comparator group  
There must be a group with no pain to enable comparison.  
iv) Outcome  
There must be a measure of falls, either as a baseline covariate or as a study 
outcome.  
Studies were excluded if one or more of the following criteria were met:  
i) Study population  
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The study population resided in nursing homes or were hospital inpatients.  
ii) Exposure of interest 
The pain measure does not quantify the number of pain sites, or there is only one 
body part that is being examined (e.g. a study exclusively about the knee) and so 
multisite pain cannot be assumed.  
iii) Further information on pain and/or falls data was not available 
Some studies appeared to have collected information on number of pain sites or 
falls as part of a larger piece of work but the information was not specifically 
reported in the publication.  In these instances, author’s names and online activity 
relating to the study were searched for further information.  Study authors were 
also contacted for further information.  Where no further information was available 
(either unable to find contact details, no response from enquiry, or author unable 
to provide the data), studies were excluded. 
  
5.3.2.6 Data collection   
Data collection took place in five stages as outlined below.  The study selectors at 
all stages were VW, the author of this thesis, and Dr Lorna Clarson (LC), an 
academic general practitioner.   
i) Title screening 
The broad search strategy extracted a large volume of titles, often unrelated to 
pain and falls.  Where there was no doubt as to the study subject from the title, 
irrelevant titles were excluded. Where more information was required, titles were 
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carried forward to stage two.  A pilot round of title screening involving 50 titles was 
initially undertaken to ensure consensus amongst the two screeners (VW & LC).  
Each title was screened individually by both reviewers and the decisions were 
discussed.  Inter-rater reliability was 100% with no discrepancies between 
reviewers.  
ii) Abstract screening  
All abstracts were screened by VW and LC.  Studies were included for full text 
review if there was a possibility that the manuscript might contain information on 
multisite pain and falls, or if the abstract was poor quality and more information 
was required in order to reject it. Each reviewer screened half of the abstracts, 
split according to database source.  Due to referencing software instability, 
duplicates were not removed and so it is likely that a substantial number of 
references were screened twice.   
iii) Full text screening 
The articles requiring full-text review were divided between VW and LC.  
Disagreements between reviewers were resolved by consultation with a third 
reviewer (Dr John McBeth, PhD Supervisor and Deputy Director of the Arthritis 
Research UK Centre for Epidemiology).  The articles were not blinded before they 
were reviewed since evidence shows that blinding reviewers to authors makes 
little difference to decision-making (Berlin,1997).  
Authors from articles selected for full text review were contacted for further 
information under the following circumstances:  
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a) If the manuscript or related work contained variables relating to pain and 
falls that were not explicitly linked in the manuscript but could feasibly 
provide information about the MSP and falls relationship 
b) If more details were required to aid decision to include study, for example 
the exact information about pain held by the authors 
If the information were available, authors were requested to conduct further 
analyses using multisite pain as the independent variable and falls as the 
dependent variable. 
 
5.4 Quality assessment  
5.4.1 Quality assessment tool design: QUIPs  
There are numerous tools available to assist in the critical appraisal of prognostic 
studies including the Quality in Prognostic Studies (QUIPS) assessment tool 
(Hayden et al, 2006), a validated and widely adopted measure used to assess bias 
in prognostic studies (Hayden et al, 2006).  QUIPS is the tool of choice for The 
Cochrane Collaboration when reviewing prognostic factors (The Cochrane 
Collaboration, 2012) and is therefore used for this systematic review.  
The QUIPS tool considers sources of potential bias within a framework of six 
domains: study participation, study attrition, prognostic factor measurement, 
outcome measurement, confounding measurement and account and analysis 
(Hayden et al, 2006).  A version of the checklist provided by the Cochrane 
Collaboration (The Cochrane Collaboration, 2012) is used to appraise each study 
included in the review.  Each question in each domain is assessed and recorded 
as ‘yes, partial, no or unsure’ and then a summary for each domain is recorded as 
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a risk of bias ‘high, moderate or low’.   Accordingly, the information presented in 
Box 5.1 was extracted from each paper.  An example of the scoring system is 
found in Figure 5.1.  
Box 5.1 Information extracted from included studies 
 
 
5.4.2 Quality assessment of studies 
Quality assessment of all full text studies was undertaken independently and 
agreement on quality assessment score was reached with the second reviewer 
(LC) in 100% of cases.   
 
5.5 Data extraction 
Data extraction of the information listed in Box 5.1 was performed by VW and 
entered into a purpose-designed spreadsheet.   
  
Country of study setting 
Sample size 
Participant characteristics 
Recruitment details 
Inclusion and exclusion criteria 
Follow up duration 
Response rate 
Loss to follow up 
Description and classification of multisite pain  
Potential confounders 
Fall definition 
Falls measurement 
Fall-related outcomes 
Study conclusion 
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Figure 5.1 The QUIPS critical appraisal tool (The Cochrane Collaboration, 2012) used to appraisal full text studies included in this 
thesis’ review  
Domain  Item  Rating of reporting Rating of Risk of Bias  
1. Study participation  
a. Source of target population  The source population or population of interest is 
adequately described for key characteristics*  
Yes /  partial /  no / unsure 
 
b. Method used to identify 
population  
The sampling frame and recruitment are adequately 
described, including methods to identify the sample 
sufficient to limit potential bias  
 
c. Recruitment period Period of recruitment is adequately described  
d. Inclusion and exclusion criteria  Inclusion and exclusion criteria are adequately described   
e. Adequate study participation There is adequate participation in the study by 
individuals** 
 
f. Baseline characteristics The baseline study sample is adequately described for key 
characteristics* 
 
Summary: Study participation  The study sample represents the population of interest on 
key characteristics, sufficient to limit potential bias of the 
observed relationship between prognostic factor outcome  
 
High / Moderate / Low 
 
2. Study Attrition  
a. Proportion of baseline sample 
available for analysis 
Response rate is adequate  
Yes /  partial /  no / unsure 
 
b. Attempts to collect information 
on participants who dropped out 
Attempts to collect information on participants who 
dropped out of the study are described  
 
c. Reasons and potential impact of 
subjects lost to follow up  
Reasons for loss to follow-up are provided  
d. Outcome and prognostic factor 
information on those lost to 
follow up  
i) Participants lost to follow up are adequately 
described for key characteristics* 
 
ii) There are no important differences between 
key characteristics and outcomes in 
participants who completed the study and 
those who did not  
 
Summary: Study Attrition  Loss to follow-up is not assocated with key characteristics 
sufficient to limit potential bias to the observed 
relationship between prognostic factor and outcome  
 
High / Moderate / Low 
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3. Prognostic factor measurement  
a. Definition of prognostic factor  A clear definition or description of prognostic factor is 
provided  
Yes /  partial /  no / unsure 
 
b. Valid and reliable measurement 
of prognostic factor 
i) Method of prognostic factor measurement is 
adequately valid and reliable to limit 
misclassification bias  
 
 ii) Continuous variables are reported or appropriate 
cut-points are used  
 
c. Method and setting of 
prognostic factor measurement  
The method and setting of measurement of prognostic 
factor is the same for all study participants 
 
d. Proportion of data on prognostic 
factor available for analysis  
Adequate proportion of study sample has complete data 
for prognostic variable  
 
e. Method used for missing data Appropriate methods of imputation are used for missing 
prognostic factor data 
 
Summary: Prognostic factor Prognostic factor is adequately measured in study 
participants to sufficiently limit potential bias  
 High / Moderate / Low 
  
4. Outcome measurement  
a. Definition of the outcome  A clear definition of outcome is provided, including 
duration of follow up and level and extent of the outcome 
construct  
Yes /  partial /  no / unsure 
 
b. Valid and reliable measurement 
of the outcome  
The method of outcome measurement used is adequately 
valid and reliable to limit misclassification bias  
 
c. Method and setting of outcome 
measurement 
The method and setting of outcome measurement is the 
same for all study participants  
 
Summary: outcome measurement  Outcome of interest is adequately measured in study 
participants to sufficiently limit potential bias  
 High / Moderate / Low  
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5. Study confounding  
a. Important confounders 
measured  
All important confounders, including treatments, are 
measured*** 
Yes /  partial /  no / unsure 
 
b. Definition of the confounding 
factor 
Clear definitions of the important confounders measured 
are provided  
 
c. Valid and reliable measurement 
of confounders 
Measurement of all important confounders is adequately 
valid and reliable  
 
d. Method and setting of 
confounding measurement 
Method and setting of confounding measurement are the 
same for all study participants  
 
e. Method used for missing data Appropriate methods are used if imputation is used for 
missing confounder data 
 
f. Appropriate accounting for 
confounding 
i) Important potential confounders are 
accounted for in the study design  
 
 ii) Important potential confounders are 
accounted for in the analysis 
  
Summary: study confounding Important potential cofounders are appropriately 
accounted for, limiting potential bias with respect to the 
relationship between prognostic factor and outcome  
 High / Moderate / Low 
 
6. Statistical analysis reporting 
a. Presentation of analytical 
strategy  
There is sufficient presentation of data to assess the 
adequacy of the analysis  
Yes /  partial /  no / unsure 
 
b. Model development strategy  i) The strategy for model building is appropriate 
and is based on a conceptual framework or 
model  
 
 ii) The selected statistical model is adequate for 
the design of the study 
 
c. Reporting of results  There is no selective reporting of results  
Statistical analysis and presentation 
summary 
The statistical analysis is appropriate for the design of the 
study, limiting potential for presentation of invalid or 
spurious results  
 High / Moderate / Low 
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5.6 Data analysis  
Raw data was extracted from the manuscripts, or from author correspondence 
where applicable.  Raw data and effect estimates were entered into a purpose-
built spreadsheet.  All effect estimates were standardised to odds ratios to enable 
comparison; in cases where relative risk or alternative risk estimates were 
presented the raw data was used to calculate odds ratios and 95% confidence 
intervals.   Odds ratios and confidence intervals were logarithmically converted 
and then Stata Statistical Software Release 14 (StataCorp, 2015) was used for 
analysis using the metan command.  Forest plots were generated to display the 
effect size and associated 95% confidence interval for each individual study and 
the overall pooled estimate is presented.   
Unadjusted odds ratios were used in the first instance to ensure that the studies 
that required an odds ratio to be calculated are comparable to studies that provide 
an odds ratio.  
An analysis using adjusted odds ratios was then conducted to test the summary 
effect estimate under conditions that are more representative of clinical practice, 
for example considering putative confounders including age, sex, comorbidities 
and medication use.  
A third analysis using only prospective cohort studies was than undertaken to 
obtain a pooled effect estimate for the risk of pain and future falls.  
Following critical appraisal and a thorough understanding of each study’s 
population and methodologies, it was reasonable to assume that the different 
studies are estimating slightly different yet related effects of pain on falls; this 
requires a random-effects meta-analysis, the simplest of which is the DerSimonian 
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and Laird (D&L) method (Higgins & Green, 2011b).  Pooled odds ratios were 
therefore calculated using the D&L method in Stata Statistical Software Release 
14 (StataCorp, 2015). 
5.6.1 Measuring heterogeneity 
To assess the consistency between studies, forest plots are drawn to enable odds 
ratios and their confidence intervals to be compared.  If there is poor overlap of the 
confidence intervals for each individual study this may indicate the presence of 
statistical heterogeneity (Higgins & Green, 2011c).  A formal measure of this 
heterogeneity is the Chi-squared test, where a low p value provides evidence of 
heterogeneity i.e. that the variation in estimate effects are unlikely to be due to 
chance alone, although it must be noted that a non-significant result does not 
mean absence of heterogeneity.    
Since the studies included in the meta-analysis have different clinical populations 
and employ different methodologies, it is reasonable to assume that heterogeneity 
exists.  The question is therefore not whether heterogeneity exists or not, but 
rather how much of an impact the heterogeneity has upon the effect estimate 
(Higgins & Green, 2011c).   I2 is thus used to describe the degree of inconsistency 
between studies, i.e. the percentage of variability in the effect estimate that is due 
to heterogeneity rather than chance (Higgins & Green, 2011c).  Thresholds for I2 
are 0-40% (might not be important), 30-60% (may represent moderate 
heterogeneity), 50-90% (may represent substantial heterogeneity) and 75-100% 
(there is considerable heterogeneity) (Higgins & Green, 2011c).   
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5.7  Assessment of publication bias 
Publication bias arises when studies with statistically significant results are more 
likely to be published than those with statistically non-significant, or unfavourable, 
results (Easterbrook et al, 1991; Ahmed & Riley, 2012).  Studies with significant 
results are more likely to lead to multiple publications and to be published in 
journals with high citation rates, and are hence more likely to be found and 
included in systematic reviews (Easterbrook et al, 1991; Sterne et al, 2001).   
Publication bias can be measured using funnel plots to chart the size of the effect 
estimate (x axis) with a measure of the study size (y axis).  Because larger studies 
provide a more precise estimate of the effect, their effect estimates are more 
similar between studies (notwithstanding the impact of bias in effect estimation) 
and cluster around the true effect size.  Smaller studies will have a more 
widespread distribution of effect estimates and these will be spread along the 
bottom of the graph horizontally. Theoretically, if all studies that measured the 
same outcome were plotted, a symmetrical inverted funnel shape would occur with 
smaller studies spread across the bottom of the graph and clustering occurring as 
sample size increases further up the y axis.   Funnel plots will therefore be 
generated to explore the potential impact of publication bias on the summary risk 
estimate.  
Funnel plots rely on subjective interpretation of symmetry, and so a statistical 
measure of symmetry is preferable although tests for funnel plot asymmetry 
should generally only be used when there are at least 10 studies included in the 
meta-analysis (Sterne et al, 2011).  Begg’s and Egger’s tests are traditionally used 
to test funnel plot asymmetry.  Begg’s test looks for correlation between the 
individual study estimates and meta-analysis weight, i.e. whether the study 
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estimate is related to the study size. (Begg & Mazumdar, 1994) and Egger’s test 
looks at the relationship between effect size and its standard error (since standard 
errors are dependent on effect size) (Egger et al, 1997).  A p value of <0.05 
associated with Begg’s or Egger’s testing means that publication bias may 
significantly impact results. 
 
5.8 Results  
5.8.1 Study identification  
The search yielded 44,223 articles.  A substantial proportion of these titles were 
not specifically evaluating the relationship between pain and falls.  The search 
strategy did not indicate whether falls or pain was the outcome measure.  
Therefore, many studies identified discussed the impact of falls causing pain and 
injuries.  Furthermore, since no age limit was applied, many studies related to 
childhood accidents and falls with resulting pain.  3031 titles proceeded to abstract 
review.  After excluding studies not meeting inclusion criteria and duplicates, 451 
articles proceeded to full text review.  Twenty studies were included in the 
qualitative appraisal and 18 were included in meta-analyses; Figure 5.2 presents 
the study flow chart.    
Three authors responded to requests for further information to enable analyses to 
be conducted (Bebikele, 2010; Holt, 2011; Marshall, 2016 (whose request for 
further information in 2013 was included in her paper subsequently published in 
2016 and now included in this review)) and studies to be included in the full text 
review.  
64 
  
Twenty studies were eligible for inclusion into the systematic review.  Table 5.1 
summaries key study characteristics.  The studies cover all continents.  North 
America and Japan contribute the greatest number of studies.  There were no 
studies identified from South Asia.  
5.8.2 Study purpose  
Eight studies set out in their primary objectives to investigate the association 
between the number of pain sites and falls (Asai et al, 2015; Kitayuguchi et al, 
2015; Kitayuguchi et al, 2016; Dore et al, 2015; Marshall et al, 2016; Stubbs et al, 
2015; Leveille et al, 2009; Patel et al, 2014).    One study (Leveille et al, 2002) 
explored the relationship between musculoskeletal pain and falls by categorising 
pain into widespread pain, moderate or severe pain in at least one region of the 
body (but not fulfilling widespread pain) and ‘other pain’ that did not fit into the 
aforementioned categories (Leveille et al, 2002).  Two studies (Ho et al, 1996; 
Bebikele et al, 2010) set out to explore correlates of falls and included the 
covariate of pain.  Two studies explored specific body sites and their relationship 
with falls (Harada et al, 2015: knee pain and low back pain; Holt et al, 2011: neck 
pain and back pain).  Six studies explored risk factors for falls in populations with 
painful conditions and included a measure of pain sites as a covariate.  Oswald et 
al (2006), Stanmore et al (2013), Brenton-Rule et al (2016) and Hayashibara et al 
(2010) investigated populations with rheumatoid arthritis, Furuya et al (2009) 
explored falls risk in those with polyarthritis and Jones et al (2011) and Goes et al 
(2012) investigated those with fibromyalgia.     
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Figure 5.2 Summary of the systematic review search process for multisite pain and falls 
 
44223 Potential studies identified & titles screened 
 43998 Database search records  
 225 Other source records (references of key papers, 
 journal supplements of conferences, websites of key 
 organisations) 
41192 excluded after title screening   
3031 abstract screening 
 3011 Database search records 
 20 Other source records  
2580 excluded after abstract screening  for reasons including not 
community dwelling, population not including adults aged 50yrs +, 
falls not measured, pain not measured. 
111 duplicates 
451 full text screening 
 447 Database search records 
 4 Other source records  
431 excluded* 
 8 Do not have community dwelling population 
 304 Unable to extract information about multisite pain 
 56 No falls measures 
 4 Conference abstracts same as included full study  
 5 Same cohort as included study  
 14 Review article / plenary lecture report / 
 educational article /study protocol / withdrawn and 
 updated Cochrane review  
 15 No further information from author contact  
 26No further information available / no author contact 
 details available  
*the numbers of specific exclusions do not total 431 since papers were 
rejected for more than one reason  
20 included in qualitative synthesis  
2 excluded due to data presentation incompatible with meta-
analysis 
18 included in meta-analysis 
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Table 5.1 Articles included in the systematic review: key study characteristics 
Author Study setting Study type Study population 
Pain measurement and 
classification 
Falls measure 
Funding source 
Ho et al, 
1996
 
Hong Kong; 
nationwide 
Cross-
sectional 
n = 1947 
 
Men and women 
 
Aged 70 years and 
older 
Musculoskeletal pain in 
different sites experienced 
in the previous month 
 
Single site and multisite 
pain measurements 
 
Retrospective: falls in 
the previous 12 months 
The Croucher 
Foundation, United 
Kingdom 
Leveille 
et al, 
2002
 
United States; 
community 
Prospective 
cohort 
n = 940 
 
Older women with 
disability 
 
Widespread pain 
group mean age 76.5 
years (SD 7.3) 
 
Comparator group 
mean age 80.2 years 
(SD 8.1) 
Pain in the hand, wrist, 
back, chest (excluding 
angina), hip, knee or foot 
on most days for at least 
a month in the previous 
year 
 
Single site pain (moderate 
or severe lower extremity 
pain (hip, knee or foot)) 
 
Multisite pain (widespread 
musculoskeletal pain 
(pain in upper extremities 
(hand or wrist) and lower 
extremities (hip, knee or 
foot) and axial skeleton 
(back or chest) with at 
least moderate pain 
(score >4 on numerical 
rating scale) in one site) 
 
No pain or only mild pain 
(score <4 on numerical 
rating scale) 
Retrospective: falls in 
the previous 6 months 
prior to follow up; six-
monthly follow-up over 3 
years 
 
 
National Institute on 
Ageing 
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Author Study setting Study type Study population 
Pain measurement and 
classification 
Falls measure 
Funding source 
Oswald 
et al, 
2006
 
United 
Kingdom; 
outpatient 
rheumatology  
clinic 
Cross-
sectional 
n = 316 
 
Women with 
established 
inflammatory 
polyarthritis satisfying 
American Rheumatism 
Association criteria 
 
Mean age 59 years 
(SD 13.2) 
Presence and total 
number of tender joints 
Retrospective: falls in 
the previous 12 months 
Not explicitly stated 
Furuya 
et al,  
2009
 
Japan; 
outpatient 
rheumatology 
clinic 
Cross-
sectional 
n = 4996 
 
Men and women with 
rheumatoid arthritis 
satisfying American 
College of 
Rheumatology 
definition 
 
Median age 60 years 
(range 49-74.8 years) 
Presence and total 
number of tender joints 
Retrospective: falls in 
the previous 6 months 
‘36 pharmaceutical 
companies’ and a 
grant from the 
Japanese 
Osteoporosis 
Foundation 
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Author Study setting Study type Study population 
Pain measurement and 
classification 
Falls measure 
Funding source 
Leveille 
et al, 
2009
 
United States; 
community 
Prospective 
cohort 
n = 749 
 
Men and women 
 
Mean age 78 years 
(SD 5years) 
 
 
Pain for at least 3 months 
in the previous year in 
hands, wrists, shoulders, 
back, hips, knees, feet, 
chest (excluding angina). 
 
Multisite pain (pain in two 
or more locations); single 
site pain (pain in a single 
location); no pain 
 
Prospective: monthly 
falls postcards 
completed daily 
National Institute on 
Aging 
Coding of 
medication data 
supported by grant 
from Pfizer (non of 
which supported 
salary, stipends or 
other funding 
except salaries of 
researchers) 
Bebikele
& 
Gureje,  
2010
 
Nigeria; 
community 
Cross-
sectional 
n = 2096 
 
Men and women aged 
65 years and older 
 
Mean age of fallers 
75.2 years;  mean age 
of non-fallers 75.1 
years 
 
Pain in back, neck, chest, 
joints, headache and 
‘persistent pain in any 
other part of the body’ 
experienced in previous 
12 months. 
 
No pain, single site pain 
(pain in a single location) 
and multisite pain (pain in 
two or more locations) 
Retrospective: falls in 
the previous 12 months 
Wellcome Trust 
Hayashi-
bara et 
al, 2010
 
Japan; 
outpatient 
rheumatology 
clinic 
Prospective 
cohort 
n = 84 
 
Women with ‘definitive 
diagnosis’ of 
rheumatoid arthritis 
 
Mean age 65.3 (range 
50-82 years) 
Tender joint count 
Prospective: monthly 
falls calendars 
completed daily 
Grant-in-Aid from 
the Ministry of 
Education, Culture, 
Sports, Science 
and Technology of 
Japan 
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Author Study setting Study type Study population 
Pain measurement and 
classification 
Falls measure 
Funding source 
Holt et 
al, 2011
 
New Zealand 
and Australia; 
community 
chiropractor 
clinics 
Cross-
sectional 
n = 101 
 
Men and women 
 
Mean age 72 years 
(standard deviation 
5.9, range 65-92 
years) 
Presence or absence of 
back and/or neck pain 
 
Multisite pain (pain in the 
neck and back); single 
site pain (pain in back or 
neck); no pain 
Retrospective: falls in 
the previous 12 months 
Grant from the 
Australian Spinal 
Research 
Foundation 
Jones et 
al, 2011
 
United States; 
Outpatient 
fibromyalgia 
clinic & local 
university 
Case-
control 
n = 52 (27 
fibromyalgia, 25 health 
controls) 
 
Men and women 
 
Cases: fibromyalgia 
diagnosed according 
to American College 
Rheumatologists’ 
definition
 
 
Healthy controls 
 
Mean age 48.6 years 
(standard deviation 
9.7, range 30-59 
years) 
Number of painful body 
regions recorded on body 
diagram 
 
Mean number of painful 
body regions in 
fibromyalgia and control 
group reported 
Retrospective: falls in 
the previous 6 months 
National Institutes 
of Health, 
Fibromyalgia 
Information 
Foundation 
  
70 
  
Author Study setting Study type Study population 
Pain measurement and 
classification 
Falls measure 
Funding source 
Goes et 
al, 2012
 
Brazil; 
inpatient 
rheumatology 
ward and local 
community 
Case-
control 
n = 32 (16 
fibromyalgia, 16 health 
controls matched for 
BMI, age and physical 
activity) 
 
Women 
 
Cases: fibromyalgia 
diagnosed according 
to American College of 
Rheumatology 
definition
 
 
Healthy controls 
 
Age range 29 – 50 
years; mean age 
fibromyalgia group 
41.5years (standard 
deviation 5.92); mean 
age control group 
40.4years (standard 
deviation 6.45) 
Presence of pain on the 
day of study: presence of 
tender points in lower 
limbs and general pain 
 
 
 
Falls in the previous 6 
months 
Grant from the 
Coordination for the 
Improvement of 
Higher Education 
Personnel, Brazil 
Dore et 
al,  2015 
United States, 
community 
Prospective 
cohort 
study 
n = 1619 
 
men and women, 
African-American or 
Caucasian 
 
with or without OA 
 
mean age 62 years 
(range 45-89) 
Symptomatic OA for left 
or right hip or knee - 
presence of pain, aching 
or stiffness on most days 
and associated with 
radiographic changes.  
Categorised into 
symptomatic OA / mild 
symptoms / moderate or 
severe symptoms and 
Kellgren/Lawrence grade 
>=2 at hip or knee. 
Retrospective recall of 
falls of any type in the 
previous 12 months and 
number of falls. 
 
National Center for 
Advancing 
Translational 
Sciences/NIH, 
CDC/Association of 
Schools of Public 
Health and the 
National Institute of 
Arthritis and 
Musculoskeletal 
and Skin Diseases. 
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Author Study setting Study type Study population 
Pain measurement and 
classification 
Falls measure 
Funding source 
Stan-
more et 
al,  2013 
United 
Kingdom, 
Rheumatology 
out patient 
clinics 
Prospective 
cohort 
study 
n=535 
 
men and women 
 
all with rheumatoid 
arthritis defined by 
American College of 
Rheumatology
 
mean age 62 years 
(48-75 years) 
Number of swollen or 
tender joints 
Prospective: monthly 
falls calendars 
completed daily over 12 
months 
Arthritis Research 
UK, Wellcome 
Trust Clinical 
Research Facility, 
Manchester. 
Patel et 
al, 2014 
United States, 
community or 
residential 
setting 
Cross 
sectional 
survey 
n=7601 
 
men and women 
 
older people receiving 
Medicare 
 
aged 65yrs and over 
Bothered by pain in the 
last month and indication 
of pain site on a card 
Retrospective: falls in 
the previous 12 months 
and how many 
National Insitute on 
Aging through 
cooperative 
agreement with the 
John Hopkins 
Bloomberg School 
of Public Health 
Harada 
et al, 
2015 
Japan, 
community 
setting 
Cross 
sectional 
survey 
n=1351 
 
men and women able 
to partake in physical 
activity 
 
aged 65-74 years 
 
 
Experience of knee pain 
or low back pain in the 
past month 
Retrospective: falls in 
the previous 12 months 
Grant-in-Aid for 
Research Fellows 
of the Japan 
Society for the 
Promotion of 
Science; Waseda 
University Grant for 
Special Research 
Projects; Global 
COE Program 
“Sports Sciences 
for the Promotion of 
Active Life” from 
the Japan Ministry 
of Education, 
Culture, Sports, 
Science and 
Technology. 
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Author Study setting Study type Study population 
Pain measurement and 
classification 
Falls measure 
Funding source 
Asai et 
al, 2015 
Japan, local 
community 
association 
centre 
Cross 
sectional 
survey 
N=112 
 
Men and women with 
normal motor function 
 
Mean age 73.5 years 
(68.9 – 78.1 years) 
Presence of pain at back, 
hip, knee, foot or toe, 
lasting 1 month or more in 
the previous year and 
also present in the 
previous month. 
Number of pain sites 
counted and grouped into 
no pain, single-site pain 
and 2 or more pain sites 
Retrospective: falls in 
the preceding 12 
months 
This study was 
supported by a 
Grant-in-Aid for 
Young Scientists 
(B) (22700685) 
from KAKENHI in 
Japan. 
Kitayug-
uchi et 
al, 2015 
Japan, general 
community 
attending falls 
prevention 
clinic 
Cross 
sectional 
survey 
N = 491 
 
Men and women aged 
60 years and older 
 
Mean age 72.2 (66.2-
78 years) 
How much low back pain 
and knee pain 
experienced in the last 
week: none, mild, severe, 
very severe.  Mild to very 
severe classed as 'pain' 
group. 
 
Falls in the last 12 
months 
Not explicitly 
stated. 
Stubbs 
et al, 
2015 
UK, 
community 
setting 
Cross 
sectional 
survey 
N = 295 
 
Men and women 
 
Mean age 77.5 years 
(69.4 – 85.6 years) 
Report of musculoskeletal 
pain present over the past 
month and for at least 3 
months of the previous 
year.  Classified into no 
chronic musculoskeletal 
pain (CMP), single site 
CMP and multisite CMP 
Retrospective recall of 
falls over the preceding 
12 months 
Vice Chancellor’s 
scholarship at the 
University of 
Greenwich 
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Author Study setting Study type Study population 
Pain measurement and 
classification 
Falls measure 
Funding source 
Marshall 
et al, 
2016 
USA, 
community 
setting 
Prospective 
cohort 
study 
N= 6,841 
 
Women aged 65 years 
and older 
 
Mean age 73.1 years 
(standard deviation 
5.0, 4.8)for the no pain 
group and mild pain 
group. 73.3 years (4.9) 
for the moderate pain 
group and 73.7 years 
(standard deviation 
5.1) for the severe 
pain group 
‘Any back pain in the last 
12 months?'. Those 
reporting 'yes' marked on 
a drawing where their 
back pain usually 
occurred (upper, middle, 
lower). This was classified 
into lower back only, 
upper back only, mid back 
only, and number of pain 
sites as 1, 2 and 3.   
Presence or absence of 
hip pain 
 
Retrospective recall of 
fall and number of fall 
every 4 months 
following baseline 
The Study of 
Osteoporotic 
Fractures is 
supported by the 
National Institute on 
Aging through grant 
numbers R01 
AG005407, R01 
AR35583, R01 
AR35584, 
R01 AG005394, 
R01 AG027574, 
and R01 
AG027576. 
Kitayug-
uchi et 
al, 2016 
Japan, 
community 
based 
Prospective 
cohort 
study 
N = 1890 
 
Men and women 
 
Mean age 68.3 years 
(SD 5.9 years) 
Low back pain (LBP) and 
knee pain (KP) presence.  
Pain classified into current 
pain lasting longer than 3 
months, current pain 
lasting less than 3 
months, no pain.  Multisite 
pain defined as no chronic 
LBP or KP, either chronic 
LBP or KP, both LBP and 
KP. 
Retrospective recall of 
falls over the past 12 
months 
This study was 
supported 
by a Grant-in-Aid 
from the Ministry of 
Health, Labor and 
Welfare of Japan 
(H20-Junkankitou-
Ippan-001). 
Brenton-
Rule  et 
al, 2016 
New Zealand 
rheumatology 
outpatient 
department 
Cross 
sectional 
study 
N= 201 
 
Men and women 
 
Mean age 64.7 years 
(SD 11) 
 
All participants have 
rheumatoid arthritis 
Tender joint count: total 
and lower limb. 
Retrospective: falls in 
the past 12 months and 
number of falls 
Arthritis New 
Zealand and the 
Health Research 
Council of New 
Zealand 
SD = standard deviation; OA = osteoarthritis 
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5.8.3 Study design  
Three different study designs were employed.  Eleven studies used a cross-
sectional design (Ho et al, 1996;  Oswald et al, 2006; Furuya et al, 2009; Bebikele 
et al, 2010; Holt et al, 2011; Patel et al, 2014; Harada et al, 2015; Asai et al, 2015; 
Kitayuguchi et al, 2015; Stubbs et al, 2015; Brenton-Rule et al, 2016), seven used 
a prospective cohort approach (Leveille et al, 2002; Leveille et al, 2009; 
Hayashibara et al, 2010;  Dore et al, 2015; Stanmore et al, 2013; Marshall et al, 
2016; Kitayuguchi et al, 2016) and two utilised a case-control study design (Jones 
et al, 2011; Goes et al, 2012). 
5.8.4 Study population  
15 studies investigated falls risk in men and women (Leveille et al, 2009; Ho et al, 
1996; Furuya et al, 2009; Bebikele et al, 2010; Holt et al, 2011; Jones et al, 2011; 
Dore et al, 2015; Stanmore et al, 2013; Asai et al, 2015; Kitayuguchi et al, 2015; 
Kityuguchi et al, 2016; Patel et al, 2014; Stubbs et al, 2015; Harada et al, 2010; 
Brenton-Rule et al, 2016) and five studies included only women (Leveille et al, 
2002; Oswald et al, 2006; Hayashibara et al, 2010; Goes et al, 2012; Marshall et 
al, 2016).   
Twelve study populations are aged 65 years and older (Kitayuguchi et al, 2015; 
Kitayuguchi et al, 2016; Marshall et al, 2016; Stubbs et al, 2015; Harada et al, 
2010; Leveille et al, 2002; Leveille et al, 2009; Bebikele et al, 2010; Holt et al, 
2011; Patel et al, 2014; Ho et al, 1996; Asai et al, 2015).  The remaining study 
populations are made predominantly of adults aged 50 years and older, although 
seven studies included a small number of younger participants (Stanmore et al, 
2013; Oswald et al, 2006; Furuya et al, 2009; Jones et al, 2011; Hayashibara et al, 
2010; Goes et al, 2012; Dore et al, 2015).  
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The total number of study participants is 32,203.  The largest study included 7601 
participants in the analysis (Patel et al, 2014) and the smallest study included 32 
participants (Goes et al, 2012).   
 
5.8.5 Pain measurement   
Pain was defined in different ways using varying time frames and body sites.  
Regarding time frame, pain presence ranged from simply the ‘presence of pain’ 
(Holt et al, 2011), to ‘pain experienced in the last week’ (Kitayuguchi et al, 2015), 
‘pain in the last 12 months’ (Marshall et al, 2016) and ‘pain experienced for at least 
three months in the previous year’ (Leveille et al, 2009).  Three studies classified 
the pain group as those reporting pain in the previous month (Ho et al, 1996; Patel 
et al, 2014; Harada et al, 2015).  Some definitions incorporated the requirement of 
current pain alongside a history of pain in the preceding year (Asai et al, 2015; 
Stubbs et al, 2015; Kitayuguchi et al, 2016).  Some studies used varying 
definitions to elicit chronic pain pictures rather than acute episodes, for example 
‘persistent pain’ (Bebikele et al, 2010), ‘pain on most days for at least a month 
(Leveille et al, 2002), pain lasting for one month or more (Asai et al, 2015) and 
pain lasting for at least three months (Stubbs et al, 2015; Leveille et al, 2009).  
Studies investigating specific populations used disease-specific measures, for 
example the presence and number of tender joints for studies investigating 
inflammatory arthritides (Oswald et al, 2006; Furuya et al, 2009; Hayashibara et al, 
2010; Stanmore et al, 2013; Brenton-Rule et al, 2016) and a diagnosis of 
fibromyalgia (Goes et al, 2012, Jones et al, 2011).  One study used pain in 
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associated with radiographic changes to define the pain population (Dore et al, 
2015).   
Categorisation of multisite pain varied between studies.  Some studies included 
severity of pain as part of their classification, for example Leveille et al (2002) 
grouped pain into widespread pain which included at least moderate pain in one 
region, lower extremity pain and a pain reference group of no pain or mild pain 
(scoring less than 4 on a numerical pain scale).  
Some studies included contribution of pain in many different parts of the body to 
total number of pain sites and multisite pain status; some studies investigated 
specific body sites.  Most studies surveyed their participants using specific 
questions about body parts.  Two studies (Goes et al, 2012; Marshall et al, 2016) 
included a body manikin for participants to highlight pain sites.  
All included studies used a group that reported no pain as the comparator group.  
5.8.6 Falls measurement  
Nine studies provided no formal definition of falls (Leveille et al, 2002; Oswald et 
al, 2006; Furuya et al, 2009; Bebikele et al, 2010; Holt et al, 2011; Dore et al, 
2015; Harada et al, 2015; Asai et al, 2015; Marshall et al, 2016) and five studies 
used the gold standard PRoFaNE definition (Hauer et al, 2006) (Leveille et al, 
2009; Stanmore et al, 2013; Kitayuguchi et al, 2015; Stubbs et al, 2015; 
Kitayuguchi  et al, 2016; Brenton-Rule et al, 2016).  The remaining five studies 
provided definitions that were adapted from the gold standard definition 
(Hayashibara et al, 2010; Jones et al, 2011; Goes et al, 2012, Ho et al, 1996; Patel 
et al, 2014).  
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The majority of studies collected retrospective information on falls in the preceding 
12 months (Ho et al, 1996; Oswald et al, 2006; Bebikele et al, 2010; Holt et al, 
2011; Dore et al, 2015; Patel et al, 2014; Harada et al, 2010; Asai et al, 2015; 
Kitayuguchi et al, 2015; Stubbs et al, 2015; Kitayuguchi et al, 2016; Brenton-Rule 
et al, 2016).   Four studies requested retrospective information on falls in the 
preceding 6 months (Leveille et al, 2002; Furuya et al, 2009; Jones et al, 2011; 
Goes et al, 2012) and Marshall et al (2016) requested falls information every four 
months following study baseline.   
Three studies used the gold standard method of prospective falls data collection 
through the use of a falls calendar that is completed daily (Leveille et al, 2009; 
Hayashibara et al, 2010; Stanmore et al, 2013).  
5.8.7 Quality Appraisal 
Table 5.2 provides a summary of the QUIPS assessment; more detailed analyses 
are found in Appendix 3.     
Study participation descriptions were generally of low quality, with 80% of studies 
providing inadequate information about the source population or providing details 
of study sampling frame and recruitment.  
Study attrition scored as high risk of bias across all studies; response rate was 
documented in seven studies and other measures including information on 
participants who dropped out the study were poorly recorded; no studies provided 
enough information to be confident of a low risk of bias due to study attrition.   
Prognostic factor measurement was of higher quality, with 50% of individual 
studies defining pain and its measurement detail and 45% providing partial 
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explanations.  Eight studies provided information on the proportion of pain data for 
analysis and 12 studies did not.  Overall, the domain of pain measurement 
conferred the lowest risk of bias, with half of studies achieving a ‘yes’ score 
(meaning that the prognostic factor was adequately measured to sufficiently limit 
potential bias).   
Falls measurement was a potentially significant source of bias amongst studies, 
with only 15% of studies provided a description of falls adequate to limit potential 
bias.  The primary problem was the underreporting of falls definitions (55% of 
studies) and the reliance on recall for falls (85%).   
The domain addressing study confounders scored low across most categories and 
in overall scores, with only two studies providing enough information to sufficiently 
limit potential bias.  The main problems were failure to measure important 
confounders, failure to describe the measurement or use reliable measures and, 
most crucially failure to discuss missing confounder data (18 from 20 studies).  
The consideration of study confounders is therefore a potentially significant source 
of bias. 
Statistical reporting was more reliably recorded, with 50% of studies reporting 
information sufficient to limit the potential bias.    
Nine studies were deemed to be at high risk of bias, seven studies were judged to 
be of medium risk and four studies had a low risk of bias.  The domain conferring 
the highest risk of bias was study attrition, with no studies achieving the level 
required to limit the potential bias.  Falls outcome measurements, confounder 
measurements and study participation are also areas in which the potential for 
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bias is not limited in 80% or more studies.  Statistical reporting and measurement 
of pain found 50% of studies to be at risk for potential bias within these domains.    
Overall, the quality appraisal has found that each domain has the potential to 
introduce bias and the majority of studies are judged to be of either high or 
medium risk of bias; results of the systematic review and meta-analysis must 
therefore be interpreted with this in mind. 
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Table 5.2 Summary of the quality appraisal assessment for studies included in the multisite pain and falls systematic review  
QUIPS assessment domain 
Author 
Study 
participation 
Study 
attrition 
Measure of 
Pain 
Measure of 
Falls 
Study 
confounding 
Statistical analysis & 
reporting 
Summary of 
bias 
Leveille et al, 2002 Yes Unclear Yes Partial Partial Yes Medium 
Oswald et al, 2006 Unclear Partial Yes Partial Partial Yes High 
Furuya et al, 2009 Unclear Unclear Partial Partial Partial Partial High 
Leveille  et al, 2009 Yes Unclear Yes Yes Yes Yes Low 
Bekibele & Gureje 2010 Yes Unclear Partial Partial Yes Partial Medium 
Hayashibara et al,  2010 Unsure Unsure Yes Yes Partial Yes Low 
Holt et al, 2011 Unclear Unclear Partial Partial No Partial High 
Jones et al, 2011 Partial Unclear Yes Partial No Partial High 
Goes et al, 2012 unclear Unclear Partial Partial Partial yes High 
Ho et al, 1996 Unclear Unclear no Partial Partial Partial High 
Dore et al, 2015 Partial Unclear Partial Partial Partial yes Medium 
Stanmore et al, 2013 Partial No Yes Yes Partial yes Low 
Patel et al, 2014 yes Partial Partial Partial Partial yes Low 
Harada et al, 2015 unclear unclear Partial Partial No yes High 
Asai et al, 2015 unclear unclear Partial Partial Partial yes High 
Kitayugachi et al, 2015 unclear unclear yes Partial Partial Partial High 
Marshall et al, 2016 unclear Unclear yes Partial Partial Partial Medium 
Stubbs et al, 2015 Partial unclear Partial Partial Partial Partial Medium 
Kitayuguchi et al, 2016 Unclear unclear yes Partial Partial Partial Medium 
Brenton-Rule et al, 2016 Unclear Unclear Yes Partial Partial Partial Medium 
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5.8.8 Systematic review results  
Fourteen studies demonstrated a statistically significant association between the 
presence of multisite pain and falls when adjusting for confounding factors; six 
studies found no statistically significant relationship between multisite pain and 
falls after adjusting for confounders.   The study with the lowest overall risk of bias 
rating was Leveille et al (2009), who found that pain in two or more locations had a 
relative risk of 1.53 (1.17-1.99) for future falls risk when adjusted for 
socioeconomic variables, chronic conditions, physical and cognitive status, 
physical performance and psychotherapeutic medications, analgesic use and hand 
and knee arthritis. 
 Studies designed to measure a potential dose-response relationship found that 
the more pain sites experienced, the higher the risk of falls (Dore et al, 2015; 
Leveille et al, 2002; Patel et al, 2014; Marshall et al, 2016); for example Patel et al 
(2014) found a dose-response relationship between number of pain sites and 
cross-sectional self-reported falls, with the prevalence ratio rising from 1.53 (1.31-
1.79) for those reporting two pain sites, to 1.75 (1.51-2.04) for those reporting four 
pain sites.   
This systematic review suggests that multisite pain does increase the risk of falls 
in both cross-sectional and prospective analyses.  There is wide variation however 
between study design, populations, pain and falls measurements and 80% of 
studies were considered to be at medium or high risk of bias.  A meta-analysis 
was performed to assimilate individual risks and produce a summary effect 
estimate to better understand the association between pain and falls.   
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5.8.9 Meta-analysis results   
5.8.9.1 Multisite pain and falls: unadjusted summary statistic  
The D&L pooled estimate summary for the unadjusted association between 
multisite pain and falls is 1.83 (1.54-2.19), meaning that the presence of multisite 
pain is associated with almost double the risk of falls compared with a no-pain 
group.   Figure 5.3 provides a Forest plot of individual study effect estimates and 
the pooled effect estimate along with corresponding weightings.   
Heterogeneity is likely to have significantly affected the pooled estimate with an I2 
of 69.2% and a Cochran Q probability of <0.01.   
Those studies presenting only mean tender joint counts (Hayashibara et al, 2010; 
Brenton-Rule et al, 2016) or where odds ratios are not able to be calculated (Patel 
et al, 2014) are not included in the pooled estimate. Ho et al (1996) had bilateral 
wrist pain included in the unadjusted analysis and chronicity multisite measure 
was used from Kitayuguchi et al (2016).  
Publication bias is assessed by the funnel plot in figure 5.4.  The funnel plot 
appears asymmetrical with four points lying outside the 95% confidence interval, 
three of which lie on the side where the OR>1.  This indicates possible publication 
bias supported by Egger’s test statistic where p=<0.01.  Begg’s test however gives 
a p=0.22, demonstrating the potential instability of the test when a small number of 
studies are included.   
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Figure 5.3 Meta-analysis of the unadjusted odds for multisite pain and falls in cross-sectional, cohort and case-controlled studies 
NOTE: Weights are from random effects analysis
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Figure 5.4  Funnel plot of publications examining the unadjusted relationship 
between multisite pain and falls for cross-sectional, cohort and case-controlled 
studies 
 
 
 
5.8.9.2 Multisite pain and falls: adjusted summary statistic  
Studies were included in this summary statistic if risk estimates were provided that 
had been adjusted for confounding factors and potential influencing covariates.  
Table 5.3 lists the covariates that were taken account of during analysis in one or 
more studies.   
The D&L pooled estimate summary for the adjusted association between multisite 
pain and falls is 1.56 (1.40-1.75), meaning that the presence of multisite pain is 
statistically significantly associated with the risk of falls when compared with a no-
pain group.   Figure 5.5 provides a Forest plot of individual study effect estimates 
and the pooled effect estimate along with corresponding weightings.   
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Heterogeneity is unlikely to have significantly affected the pooled estimate with an 
I2 of 0.0% and a Cochran Q probability of 0.64.   
The funnel plot in figure 5.6 shows all points remain within the 95% confidence 
intervals and publication bias is therefore less likely to be significantly impacting 
results, although there does appear to be asymmetry with skewing towards an 
effect size of >1; Begg’s test p=0.09 and Egger’s test p=<0.01 indicated that there 
is a risk of publication bias that must be taken account of during results 
interpretation.  
 
Table 5.3 Putative confounders and influencing covariates that were adjusted for 
in one or more study 
Group Variables  
Demographics  Demographics: Age Sex Ethnicity Education 
 
Physical health BMI, Mediation conditions (hip fracture, angina pectoris, diabetes 
mellitus, peripheral arterial disease, stroke, Parkinson’s disease, 
depression, lung problems, neurological problems, TKR, THR, Smoking, 
Dizzy or unsteadiness, Fatigue score DAS28 score ) 
Mental health self-reported psychological distress, Cognitive functioning 
Medication use psychoactive medications, daily use of analgesic medications, total 
number , narcotic use , taking 4+ medications, steroids , NSAID use, 
osteoporosis drug use, vitamin D3 use 
Physical functioning Walking disability , lower limb functional decline   
Fall-related history Previous falls, fear of fall, History multiple falls History of injuries from 
previous fall 
Physical tests gait speed, balance test score, exercise time , timed up and go test , 
Four-test balance scale , chair stand test 
Blood tests ESR CRP 
 
Self-rated scoring Self-rated health & health related quality of life  
 
THR = total hip replacement; TKR = total knee replacement; DAS28 = disease activity score 28; ESR = 
erythrocyte sedimentation rate; CRP = C-reactive protein 
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Figure 5.5  Meta-analysis for the adjusted odds for multisite pain and falls in cross-sectional, cohort and case-controlled studies 
NOTE: Weights are from random effects analysis
Overall  (I-squared = 0.0%, p = 0.635)
Study
Dore et al (3-4),2015
Ho et al, 1996
Asia et al, 2015
Harada et al, 2015
Furuya et al, 2009
Stubbs et al, 2015
Dore et al (2), 2015
Kitayuguchi et al, 2015
Stanmore et al, 2013
Levielle et al, 2002
Kitayuguchi et al, 2016
1.56 (1.40, 1.75)
Ratio (95% CI)
1.85 (0.96, 3.55)
Odds
1.40 (1.10, 1.80)
5.31 (1.40, 21.50)
1.93 (1.35, 2.78)
1.39 (1.14, 1.70)
1.92 (0.89, 4.13)
1.74 (1.19, 2.53)
1.50 (0.67, 3.30)
1.70 (1.10, 2.80)
1.60 (1.25, 2.21)
2.03 (0.95, 4.33)
100.00
Weight
2.89
%
20.36
0.66
9.46
30.92
2.10
8.68
1.94
5.66
15.20
2.15
  
1.0465 21.5
Odds ratio 
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Figure 5.6  Funnel plot of publications examining the unadjusted relationship 
between multisite pain and falls for cross-sectional, cohort and case-controlled 
studies 
 
 
 
 
5.8.9.3 Multisite pain and falls: summary statistic from prospective cohort 
studies  
Prospective cohort studies were included in this analysis.  Five studies were 
eligible for inclusion, one study did not have an odds ratio or raw data to enable 
odds ratio calculation (Hayashibara et al, 2010) and two studies had unadjusted 
and adjusted risk estimates available (Leveille et al, 2002 and Stanmore et al, 
2013).  The unadjusted analysis is presented by the Forest plot in figure 5.7.  The 
D&L pooled estimate summary for the association between multisite pain and 
future falls is an odds ratio of 1.70 (1.49-1.94), meaning that the presence of 
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multisite pain is associated with an increased odds of future falls compared to 
those with no pain.   Heterogeneity is unlikely to have significantly affected the 
pooled estimate with an I2 of 0.0% and a Cochran Q probability of 0.57.   
The funnel plot for this analysis shows all points remain within the 95% confidence 
interval and there is no asymmetry.  Begg’s test has a p=1.00, demonstrating that 
this test is not useful in small analyses with less than 10 studies included (Sterne 
et al, 2011).  Egger’s test has a p=0.15 which suggests that publication bias does 
not pose a significant problem within this analysis.   
The adjusted analysis, presented by the Forest plot in figure 5.8, provides a 
summary effect estimate of OR 1.63 (1.28-2.07), with an I2 of 0.0% and a Cochran 
Q probability of 0.83.   Since the analysis includes only two studies, testing for 
publication bias is not undertaken.   
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Figure 5.7 Meta-analysis of the unadjusted odds of multisite pain and falls in prospective cohort studies  
 
 
NOTE: Weights are from random effects analysis
Overall  (I-squared = 0.0%, p = 0.568)
Stanmore et al, 2013
Levielle et al, 2009
Study
Marshall et al, 2016
Levielle et al, 2002
1.70 (1.49, 1.94)
2.00 (1.30, 2.80)
2.01 (1.39, 2.90)
Odds
Ratio (95% CI)
1.60 (1.37, 1.88)
1.71 (1.14, 2.59)
100.00
11.40
12.41
%
Weight
66.23
9.96
  
1.345 2.9
Odds ratio 
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Figure 5.8 Meta-analysis of the adjusted odds of multisite pain and falls for prospective cohort studies   
 
NOTE: Weights are from random effects analysis
Overall  (I-squared = 0.0%, p = 0.828)
Stanmore et al, 2013
Study
Levielle et al, 2002
1.63 (1.28, 2.07)
Odds
1.70 (1.10, 2.80)
Ratio (95% CI)
1.60 (1.25, 2.21)
100.00
%
27.11
Weight
72.89
  
1.357 2.8
Odds ratio 
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5.9 Discussion 
5.9.1 Summary of findings  
Older people with multisite pain have statistically significant increased odds of 
falling when compared to their pain-free counterparts.  The unadjusted analysis of 
all study designs found that those with multisite pain had an odds ratio of 1.83 
(1.54-2.19), this reduced to 70% increased odds of falling in the unadjusted 
analysis for prospective cohort studies only and further reduced, although 
remained statistically significant, to 50% increased odds of falling compared to 
those with no pain.   
5.9.2 Strengths  
This systematic review and meta-analysis is comprehensive, drawing on evidence 
from many different sources and not imposing language limitations. The broad 
search strategy ensured maximum capture of relevant research and the rigorous 
approach enabled the huge volume of titles to be managed efficiently.   
The inter-rater concordance of 100% at each stage of the review demonstrates a 
high level of internal validity.  The large volume of references resulted in 
referencing software instability and an inability to remove duplicates until a late 
stage in the review process; this meant that references were likely to be reviewed 
twice, thus increasing the likelihood that important references were not missed.  
The systematic review and meta-analysis includes a variety of different pain 
phenotypes (for example, hip, knee, lower limb, back, neck, widespread pain) and 
a variety of diagnoses were used to derive study samples (for example, 
osteoarthritis and rheumatoid arthritis) thus representing a wide spectrum of pain 
presentations.  Furthermore, the review included swollen or tender joint count as a 
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measure of multisite pain to ensure that specific types of pain (e.g. inflammatory) 
were not excluded.  The purpose of this thesis is to measure the impact of the 
global burden of pain on falls risk regardless of pathology, thus different 
pathological conditions are included.  Excluding studies only including those with 
rheumatoid arthritis on the basis of a potentially different or exaggerated 
pathophysiological process contributing to falls risk (for example, inflammatory 
responses and specific joint erosions contributing to falls risk which may not be 
present in those without rheumatoid arthritis) would mean excluding any specific 
pathological conditions and thus render the exercise clinically illiterate.  
Nevertheless, these different pathological processes must be considered in 
interpretation of findings.  In this review, the risk of falls associated with tender or 
swollen joint count did not cluster around one value and was spread throughout 
the other studies’ risk estimates; thus including this measure reflects clinical 
practice and does not appear to bias results.   
Although there are significant differences between studies in terms of study 
design, pain measures, falls outcomes and consideration of putative confounders 
and a high I2 score for the unadjusted analysis, the adjusted analysis has an I2 = 0 
and is therefore less likely to be affected by heterogeneity, thus meaning that 
results can be more confidently accepted.   
 
5.9.3 Limitations 
The large number of references to screen conferred a risk that important 
references were overlooked as they were nested within thousands of irrelevant 
titles.  The risk was minimised by self-awareness and careful consideration of 
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each title, the likelihood of references being reviewed twice due to duplication and 
the high inter-rater reliability.   
The review includes cross-sectional studies in which causality cannot be 
measured, since it is not possible to know that the pain reported simultaneously 
with falls occurred before or after the fall.  Stubbs et al (2015) removed this risk in 
his cross-sectional study by specifically asking those who had fallen and reported 
pain if the pain had occurred as a consequence of the fall and then excluding 
those who replied that it had. Cross-sectional studies were included to increase 
the number of studies and therefore power of the analysis since there were only 
five prospective cohort studies included in the final 20 articles.  The inclusion of 
cross-sectional studies means a more precise overall summary estimate of the 
(strength of) association between multisite pain and falls can be measured; the 
analysis confined to prospective studies is indicative that multisite pain is a risk 
factor for future falls.  
The risk of bias of included studies was significant, particularly for study 
participation and outcome measurement.  Some studies did not report response 
rates and attrition rates and reasons were unclear.  If those not partaking in the 
study, or dropping out during follow up are doing so because of advancing age, 
poorer health and increased frailty compared to participants, this may 
underestimate the risk of falls since those more likely to fall (due to advancing age, 
poor health and increased frailty) are not included in the study.  85% of studies 
relied on recall of previous falls; the problems associated with this recall bias are 
well documented, for example Hannan et al (2010) found that people over aged 70 
were able to recall 70% of all falls that had occurred in the previous three month 
period and, of those who fell, 25% were misclassified as non-fallers (Hannan et al, 
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2010).  Therefore, use of retrospective falls recall may underestimate the true 
effect estimate of pain on falls.  
5.9.4 Identifying the knowledge gap  
The most significant gap in the literature is the lack of large, long duration 
prospective cohort studies examining the relationship between pain status and 
future falls risk.  Five studies in the review were prospectively designed to capture 
future falls risk, four of which were included in the meta-analysis which exclusively 
included prospective studies.  The prospective cohort studies had a range of 
sample sizes from n=84 to n=6,841; only one study (Marshall et al, 2016) 
contained more than 1,000 participants.  The longest studies followed participants 
for three years (Leveille et al, 2009; Leveille et al, 2002). 
A further significant gap in the literature examining the association between 
multisite pain and falls is the lack of variation in the falls outcome.  All of the 
studies used self-reported falls as the outcome measure, with little or no indication 
of fall severity, associated health-care use or injury.  It is therefore not possible to 
ascertain the consequences of the reported falls.   
Finally, the risk of bias attributed to the handling of putative confounders was high, 
with 18 from 20 studies judged to provide insufficient evidence such that risk of 
bias was not sufficiently limited; thus there appears to be a lack of studies taking 
account of confounding.   
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5.9.5 Addressing the knowledge gap  
This thesis will seek to address these knowledge gaps by using a prospective 
design with a large sample size with a longer follow period than is currently found 
in the evidence base.  Different ‘types’ of falls will be explored to examine 
differences in their relationship with multisite pain and a variety of putative 
confounders will be considered to reduce the risk of bias due to confounding.   
5.9.6 Summary  
This chapter has described the process and results of a systematic review and 
meta-analysis of multisite pain and falls in older people.  Multisite pain is 
associated with an increased odds of falling in unadjusted and adjusted analyses 
and the pooled summary estimate for prospective cohort studies found that the 
presence of multisite pain predicts future falls.  The knowledge gap has been 
identified and this thesis will seek to address these in subsequent chapters, 
starting with a description of the data sources and data acquisition process in 
Chapter 6.  
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Chapter 6: Data sources and measurement of multisite 
pain, falls and covariates  
6.1  Overview   
This chapter reviews the thesis’ aims and objectives and describes the data 
sources required to address the knowledge gap highlighted by the systematic 
review and meta-analysis in Chapter 5. The measurements of multisite pain, 
covariates that may impact upon an association between pain and falls, and falls 
are then outlined and the chapter is summarised.     
6.2 Revisiting this thesis’ aims and objectives 
The systematic review and meta-analysis described in Chapter 5 has identified 
knowledge gaps in the evidence examining the relationship between multisite pain 
and falls.  The aims of this thesis therefore to address these knowledge gaps 
through the following objectives:  
i) To describe the prevalence of self-reported falls, falls that require 
primary health care attendance and falls that require hospital admission 
in a population-based sample of community-dwelling older people;  
 
ii) To test the hypothesis that older people with multisite pain are more 
likely to experience a future self-reported fall than older people with no 
pain;  
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iii) To test the hypothesis that older people with multisite pain are more 
likely to seek primary health care for a future fall than older people with 
no pain;  
 
iv) To test the hypothesis that older people with multisite pain are more 
likely to be admitted to hospital as a result of a future fall than older 
people with no pain. 
Addressing these hypotheses requires specific data on pain, covariates and falls 
and this information is not contained in a single database.  Therefore, multiple data 
sources are required and these must then be linked at an individual level to enable 
analyses.  Each data source will now be described in turn, and a time frame for the 
study period including each data source is summarised.   
 
6.3 Data sources 
6.3.1 The North Staffordshire Osteoarthritis Project (NorStOP) 
NorStOP is a population based observational cohort study whose primary 
objective was to determine the course and prognosis of pain syndromes and the 
impact of these syndromes on participation and health care use (Thomas et al, 
2004).   The project consists of three linked population based surveys, named 
NorStOP1, NorStOP2 and NorStOP3, whose sampling frame comprises all 
individuals aged 50 years and over who were registered to receive care from one 
of eight general practices in North Staffordshire, United Kingdom.  The study was 
approved by the North Staffordshire Research Ethics Committee; the Local 
Research Ethics Committee reference numbers are 05/Q2604/20 for NorStOP1, 
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05/Q2604/72 for NorStOP2 and 06/Q2801/90 for NorStOP3.  Full details of study 
design and methodology have been published by Thomas et al (2004).  
Participants were mailed two surveys, a General Health questionnaire and a 
Further Pain questionnaire to complete if pain in the hand, hip, knee or foot was 
reported.  These surveys were accompanied by a letter from the GP practice and 
a study information leaflet explaining that the research was being conducted to 
ensure the local health economy was providing the ‘right type of services’.  
Participants were informed that the purpose of the study was to ‘find out how many 
people suffer from joint pain in the local population’; no specific mention of other 
factors, including falls, was made.  Participants were asked if they consented to 
medical record review and those who did were recorded as consenters in the 
study database.  Reminders were sent to non-responders after two and four 
weeks.   The same surveys were sent again at 3 year and 6 year follow up with 
similar non-responder reminders.  NorStOP1, NorStOP2 and NorStOP3 all 
followed the same methodology and their survey waves dates are displayed in 
table 6.1.   Note that NorStOP3’s second follow up is 7 years due to clinics 
overrunning (this follow up will however continue to be referred to as ‘six year 
follow up’ to encompass each NorStOP cohort’s final follow up wave).  The 
NorStOP study population is described further in Chapter 7.   
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Table 6.1 NorStOP survey: dates of baseline, three and six year follow up 
 NorStOP 1 NorStOP 2 NorStOP 3 
Baseline survey April 2002 
July 2002-August 
2003 
February 2004 – 
April 2005 
Three year 
follow up 
April 2005 
October 2005-
September 2006 
February 2007 – 
April 2008 
Six year follow 
up 
April 2008 
January 2009 – 
December 2009 
July-August 2011* 
*=7 year follow up 
 
6.3.2 General practice medical records  
Each baseline survey respondent who consented to medical record review has 
linked data available from their general practice consultations.  Information is 
extracted from general practice consultations by a Health Informatics team, linked 
to survey responses by a unique survey identifier and stored in a consultation 
database.  The general practice consultation database contains information 
including reason for consultation, diagnosis and treatments including medication.   
The medical record data extends to the end of the three year survey wave for 
three year non-responders or respondents who stopped consenting at three year 
follow up.  For  non-responders of the six year follow up, responders who withdrew 
consent at 6 year follow up and respondents who consented and completed six 
year follow up, the medical record data extends to the end of the six year follow up 
period.  Figure 6.1 provides a timeline of the dates described.   
Primary Care clinical coding was developed in the late 1960s when Dr John Perry 
wrote the Oxford Medical Information System (OXMIS), based on the International 
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Classification of Diseases Eighth Revision (ICD-8) (Benson, 2011).  This system 
became widely used in general practice as computers became integrated into 
clinical practice.  This system was largely superseded by the READ code 
nomenclature, developed in the early 1980s by Dr James Read (Benson, 2011).  
This code is based on the International Classification of Diseases version 9 (ICD-
9) (for diagnoses), although Dr Read himself developed codes for symptoms, 
examination findings, preventative care and investigation results, among others 
(Benson, 2011).  
The READ codes are organised in a hierarchy, with groups of codes separated 
into chapters.   Each code of the 5-Byte coding system contains 5 characters (or 
bytes); the addition of each character makes the code increasingly more specific.  
The codes are divided into ‘chapters’ according to groups of diseases, symptoms, 
laboratory findings and so on.  Table 6.2 demonstrates the hierarchical system of 
5-Byte READ codes, as extracted from the Clinical Terminology Browser Version 3 
(NHS Information Authority, 2011).  
Table 6.2 An example of the READ code 5-byte hierarchy used in GP 
consultations to code consultations in general practice 
Level  Descriptor Characters  
Level 1 Circulatory system diseases G…. 
Level 2 Ischaemic heart disease G3… 
Level 3 Angina pectoris G33.. 
Level 4 Angina decubitus G330. 
Level 5 Nocturnal angina G3300 
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The GP consultation records used in this study contain the 5-byte coding system, 
both the full 5 character code and the chapter heading (for example using table 
6.2, the record would contain a chapter heading G and the full code G3300).  
 
6.3.3 Prescription records  
The GP consultation records also contain detailed information about prescriptions.  
This information is extracted by an informatics team, linked with the NorStOP 
survey data using a unique survey identifier and stored in a separate database to 
the GP consultations given the enormous amount of data.  The information in the 
prescription database includes the medication name and the corresponding 
chapter code in the British National Formulary (BNF), for example ‘naproxen’ and 
Chapter 10.1.1 (Joint Formulary Committee, 2014). 
 
6.3.4 Hospital Episode Statistics (HES)  
HES is a comprehensive records based system that contains identifiable patient 
information from all NHS Trusts in England (NHS Information Centre, 2010).  Two 
HES data sources were requested from the NHS Information Centre; the Admitted 
Patient Care (APC) dataset and the Accident and Emergency (AE) dataset. In this 
thesis only the APC database could be used for analysis as it was not possible to 
extract information about specific diagnoses from the AE dataset.   The APC 
database uses two different coding systems to record information in a 
standardised fashion.  The International Classification of Disease version 10 (ICD-
10), which superseded ICD-9 in 1995, is used to record information relating to 
diagnosis, for example cause of admission and diagnosis.   The Office for 
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Population, Censuses and Surveys: Classification of Interventions and Procedures 
version 4 (OPCS-4) is used to record details of any procedures or interventions 
performed, for example hip replacements.  Information about falls and fall-related 
injuries is extracted from the HES APC dataset.   Data was requested from the 
NHS Health and Social Care Information Centre (NHSIC) from 1st January 2002 
through to 31st December 2012 inclusive.  
 
6.3.5 Office for National Statistics mortality data  
The Office for National Statistics (ONS) dataset contains identifiable patient 
information on cancer incidence and cause of death as detailed on the death 
certificate (Office for National Statistics, 2010), and is a reliable method of 
determining occurrence, date and cause of death.  Data was requested from the 
NHSIC 1st January 2002 through to 31st December 2012 inclusive.  The time line 
for the data collection of each data source is depicted in figure 6.1.  
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Figure 6.1 A time line depicting data collection for each of the data sources  
 
 
6.4 The data linkage process  
The NorStOP survey data, GP consultation records, prescription records, HES and 
ONS data were linked using individual level identifiable data sent to the NHSIC.  
Permission to undertake this data linkage was obtained from the Secretary of 
State for Health under Section 251 of the NHS Act 2006 because NorStOP 
responders had not provided consent for this specific use of their identifiable data 
(postcode, NHS number, date of birth, sex).  In reality, this process took 18 
months; Appendix 5 provides an in-depth analysis of the ethical and legal aspects 
of using identifiable data for secondary research purposes without consent; this 
includes details of a literature review to explore the evidence around this challenge 
and a Patient and Public Involvement exercise which informed the basis of the 
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application for the correct approvals.  Appendix 6 contains study approval 
documentation from the Local Research Ethics Committee and the Ethics and 
Confidentiality Committee ran by the National Information Governance Board.   
 
6.5  Selecting covariates to include in analysis 
Once the data sources had been established and the availability of potential 
confounders or influencers of the pain-falls relationship confirmed, the covariates 
were selected based on the evidence presented in Chapter 4 and upon those that 
had been measured by studies included in the systematic review (Chapter 5).  The 
next section describes the measurement of all the variables included in analysis: 
pain, potential confounders and influencing factors (called ‘covariates’ in this 
thesis) and falls.   
6.6 Measurement of the independent variable: pain  
6.6.1 Data collection and survey tool  
Information relating to pain was derived from the NorStOP General Health 
Questionnaire at baseline, three year follow up and six year follow up.  Participants 
were asked, as a screening question, whether they had ‘experienced any pain, 
lasting at least one day, during the past month’. A yes or no response was 
recorded.  Those replying positively were asked to indicate the site(s) of their pain 
in a body manikin as demonstrated in figure 6.2 (Lacey et al, 2005).   The body 
manikin records 44 discrete anatomical areas.  Participants were asked to include 
‘any ache, discomfort or stiffness’ in their consideration of pain and were asked to 
exclude pain caused by feverish illness and menstrual pain.   
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Figure 6.2  The body manikin used in the NorSTOP survey to measure pain 
 
Body manikins are often used as a screening instrument to estimate the 
prevalence of pain in selected body areas (Lacey et al, 2005).  Lacey et al (2005) 
found a high degree of inter-rater reliability when scoring completed manikins and 
a high degree of consistency in the classification of widespread pain between 
multiple raters.  For example, eight trained non-clinical staff were asked to score 
completed manikins and complete scoring agreement among all raters ranged 
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from 78% to 100% (kappa>0.60) with 98% complete agreement over the presence 
or absence of widespread pain (kappa = 0.98) (Lacey et al, 2005).  
 
 
6.6.2 Classification of pain  
Using the manikin data, pain will be classified using two different measures: 
i) A continuous measure of the total number of pain sites, from 0-44  
ii) A measure of the spread of pain (henceforth termed ‘widespreadness’)  
 
6.6.2.1 Number of pain sites  
The number of pain sites is a simple count of the number of shaded areas on the 
manikin, as coded by the NorStOP survey team using a standard transparent 
template overlaying the completed manikin.  Participants who answered ‘no’ to the 
pain screening question and then went on to shade the manikin (n=75) or those 
who answered ‘yes’ to the pain screening question and did not shade any areas 
on the manikin (n=211) were classified as inconsistent pain responders.  Those 
respondents with such discrepancies were excluded from the analysis to ensure 
that the pain measure was consistent across all participants. The number of pain 
sites is measured on a continuous scale from 0 to 44.    
 
6.6.2.2 Widespread pain  
Widespread pain is defined as pain that affects multiple (including non-joint) sites 
in the body (McBeth et al, 2014).  It is used in this thesis to explore the relationship 
between more extensive pain phenotypes and falls.  Here widespread pain was 
classified according to the criteria included in the American College of 
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Rheumatology (ACR) criteria for fibromyalgia (Wolfe et al, 1990).  These criteria 
require participants to have pain above and below the waist, on the right and left 
sides of the body and in the axial skeleton (McBeth et al, 2010).  Using the ACR 
definition of widespread pain to classify respondents’ pain moves beyond a simple 
count of painful body sites towards a classification that carries with it connotations 
of chronic widespread pain syndromes such as fibromyalgia.  At the severe end of 
the ‘pain spectrum’, using widespreadness as a measure may reveal stronger 
associations with falls than using a simple continuous measure of pain sites, since 
widespread pain has been associated with poorer psychological health, fatigue 
and sleep disturbance (Hunt et al. 1999), factors which may potentially increase 
the risk of falls.   
For this thesis, widespread pain scores (‘no pain’, pain but not widespread pain 
termed ‘some pain’, ‘widespread pain’) were generated.  To do this, each 
respondent had a binary code generated for reporting the presence or absence of 
pain in the right upper limb, left upper limb, right lower limb, left lower limb and 
axial skeleton.  Next, the codes were combined to identify respondents who meet 
the ACR criteria for widespread pain (those who reported pain in the left upper 
limb, right lower limb and axial skeleton or those who reported pain in the right 
upper limb, left lower limb and axial skeleton).  Finally, respondents who reported 
pain in the pain screening question and who shaded the manikin but who didn’t 
meet the criteria for widespread pain are coded as a distinct group ‘some pain’ and 
those who stated they had no pain and did not shade the manikin are grouped as 
‘no pain’.  Although abdominal pain was excluded from the widespreadness 
measure, it is included in the ‘some pain’ grouping.   Thus, widespreadness was 
analysed using three categories: ‘widespread pain’, ‘some pain’ and ‘no pain’.  
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6.7 Covariate measurements 
6.7.1 Potential confounding factors  
The association between pain and falls may be altered by confounding factors.  A 
confounding factor (also termed ‘confounding variable’ or ‘confounder’) is a 
variable that is correlated either directly or inversely to both the dependant variable 
and the independent variable; a confounder must affect or predict the risk or rate 
in the unexposed (referent) group, and not be affected by the exposure or the 
outcome (Rothman et al, 2008).  For example, the socio-economic status of 
respondents may act as a confounder since there is an association between pain 
and lower socio-economic status, and socioeconomic status might influence the 
risk of falls. Thus socio-economic status may explain any observed association 
between pain and falls rather than the pain itself.  Importantly, socio-economic 
status and other confounding variables are not in the causal pathway between 
pain and falls i.e. having pain does not directly influence socio-economic status, 
which in turn directly affects the risk of falls.  A variable that may plausibly appear 
on the causal pathway between pain and falls is considered as a ‘mediator’ of the 
relationship between pain and falls and this is discussed below.   
Reviewing the evidence presented thus far, the potential confounders of the 
association between pain and falls considered in this thesis’ analyses are age, sex 
and socioeconomic position.  Table 6.3 presents the potential confounders, data 
source and measurement; a brief discussion of the measures of age and socio-
economic position now follows.    
 
109 
 
Table 6.3 Potential demographic confounders, their data sources and 
measurement 
Potential confounder  Data source  Measurement  
Age  
General practice 
consultation records 
Continuous measure  
Categorical measure 
(categories split 5 yearly)  
Sex  General practice 
consultation records 
Categorical: female / 
male 
Socio-economic 
position 
NorStOP questionnaire & 
Index of Multiple Deprivation 
indicator  
Categorical data  
 
6.7.1.1 Age 
The United Nations defines older people as those aged 60 years and older (United 
Nations, 2017).  However, the systematic review and meta-analysis reported in 
chapter 5 found researchers used different age limits in their studies of older 
people; the majority of studies including adults aged 65 years and older, some 
studies included adults aged 70 years and older (for example Leveille et al, 2009) 
and some studies included adults aged 50 years and older (for example 
Hayashibara et al, 2010).  This thesis uses a population of adults aged 50 years 
and older.  Whilst this population may be younger than traditional convention as 
described by the UN definition of older people, 50 years is used as the youngest 
age in order to capture to falls experiences of those transitioning into later life over 
the duration of this longitudinal study.   
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6.7.1.2 Socio-economic position 
Socio-economic position includes constructs around the individual and groups 
within the structure of society.  For example, an individual’s education level is 
constrained by educational opportunities available within society and according to 
family circumstances (Galobardes et al, 2007).  Measures of socio-economic 
position therefore include constructs relating to the individual (for example, 
educational attainment, income, occupation, wealth) and to the area (for example, 
deprivation indices).  Area level indicators are useful when individual level data is 
not available and can serve as a proxy to individual level socioeconomic position, 
however the potential for measurement bias arising from giving all individuals the 
same score must be considered and bias resulting in underestimating or 
overestimating an effect size has been reported (Davey-Smith et al, 1998; 
Subramanian et al, 2006; Geronimus, 2006).   The most commonly used proxy 
indicator for area level socio-economic position in the UK for small areas is the 
Index of Multiple Deprivation (IMD).  ‘Small areas’ are generated by the Office for 
National Statistics as a standard way to divide the UK into areas of approximately 
1500 residents (Department for Communities and Local Government, 2016).  The 
IMD combines information from seven domains that are weighted to produce an 
overall relative measure of deprivation.  In order of weighted proportion, the 
domains are income, employment, education, health deprivation and disability, 
crime, barriers to housing and services, and living environment deprivation 
(Department for Communities and Local Government, 2015).  A score is derived 
from the individual’s postcode and then categorised into quintiles ranging from 
most deprived to least deprived.   As demonstrated above, socio-economic status 
may well be a confounding factor in the association between pain and falls; it must 
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therefore be taken account of to ensure a measure of the independent effect of 
pain on falls in obtained.   Composite measures of socio-economic status are 
acceptable in this situation, as the researcher is aiming to control the effects as a 
confounder rather than looking specifically at the relationship between falls and 
socio-economic status (Galobardes et al, 2007).    
It is recognised that socio-economic position has the potential to change over the 
life course as one moves through childhood and parental influences through to 
working age and into retirement.  Thus, the present thesis uses the IMD as an 
area-level indicator and educational attainment, occupation and an income 
measure as individual indicators over the life course.  Educational attainment is a 
long-established facet of individual socio-economic position and is easy to 
measure in self-administered questionnaires (Galobardes et al, 2007); it can be 
viewed as measuring the transition from childhood socio-economic position into an 
individual position (Galobardes et al, 2007).  There is some evidence that lower 
levels of education are associated with reduced risk of falling as found in a 
statistically significant relationship by Barrett-Connor et al (2009) and again in a 
non-significant trend by Deandrea et al (2010).  This might be possibly explained 
by those with lower levels of educational achievement being more likely to be in 
manual jobs and therefore be more physically active and thus less likely to fall.  
The present study uses educational attainment as measured in NorStOP, in which 
participants were asked whether they had attended full time education or 
university after leaving school; with dichotomous yes / no responses and an 
unsure category subsequently coded in the NorStOP database.  
Occupational status is another traditional measure of individual socio-economic 
position.  The NorStOP survey derived classifications from the Office for National 
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Statistics (2000) and the Office for National Statistics (2002) (categories are (1) 
higher managerial and professional, (2) lower managerial / professional, (3) 
intermediate occupations, (4) self-employed, (5) lower supervisory/ technical, (6) 
semi-routine, (7) routine; these categories were subsequent collapsed to form non-
manual (including (1) through (5) and non-manual work (6) and (7)).     
Income and wealth are indicators that most directly measure material 
circumstances (Lynch & Kaplan, 2000).  The NorStOP survey team developed a 
question to capture the concept of income, although this has not been repeated in 
future epidemiological surveys to date.  Taken in combination with other SEP 
indicators, income is a useful addition to measure socio-economic position, 
notwithstanding the possible challenges of changeable income and the inverse 
causality effect whereby those with ill health have reduced earning potential and 
thus lower incomes, rather than lower income being a cause of poorer health 
(Galobardes et al, 2007).  Table 6.4 summarises the measures used in the present 
thesis. 
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Table 6.4 Measures of socio-economic position in this thesis’ study  
Measure  Derivation  Categories  
Educational 
attainment  
 
 
Did you go from school to full-time 
education or university?  
Yes / No  
Yes /No / 
Unknown  
Income  
 
 
Thinking about the cost of living as it 
affects you, which of these descriptions 
best describes your situation:  
i) find it a strain to get by from 
week to week;   
ii) have to be careful with money;  
iii) able to manage without much 
difficulty;  
iv) quite comfortably off  
Adequate / 
Inadequate / 
Unknown  
Occupational 
status 
 
 
What is your current employment 
status?  
i) Employed;  
ii) Not working due to ill health; 
iii) retired; 
iv) unemployed / seeking work; 
v) housewife; 
vi) other 
 
If working, what is your job title 
(examples are factory worker, welder, 
office worker, shop assistant, lawyer)? 
 
If you are not working, or are retired, 
what was your last job title?  
Manual / Non-
manual / Unknown  
Index of Multiple 
Deprivation IMD) 
 
 
Post code of respondent, confidentially 
matched to IMD indicator  
Least deprived / 
2nd least deprived /  
middle quintile / 
2nd most deprived / 
most deprived 
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6.7.2 Established falls risk factors and additional potential influencing covariates  
In addition to potential confounders, other covariates that might influence the 
relationship between pain and falls must be considered in order to reflect ‘real life’ 
and be clinically meaningful.  Therefore, traditional falls risk factors and other 
potential influencers of the pain-falls relationship must be measured and taken 
account of.   Table 6.5 presents a summary of the potential influencing covariates 
selected to include in the thesis’ analysis along with their data source and 
measurements.  Those variables whose measurements require an explanation 
beyond that provided in table 6.5 are now discussed.    
6.7.2.1 Multimorbidity   
Multimorbidity was measured using the Charlson Comorbidity Index (CCI), a 
measure that takes into account the number and seriousness of co-morbid 
conditions to predict all-cause mortality at one year (Charlson et al, 1987; Khan et 
al, 2010).  The CCI has been validated in different populations (Khan et al, 2010) 
and has been shown to be a valid summary co-morbidity measure for use in 
epidemiological studies to predict an outcome (Austin et al, 2015).  Using a 
weighting system to acknowledge that certain conditions are more problematic 
than others (for example, diabetes with microvascular and macrovascular 
complications including visual problems, peripheral neuropathy and renal 
impairment requiring multiple medications is scored higher than diabetes with no 
complications) means the CCI is more reflective of ‘real life’ than a simple 
morbidity count; the potential for misclassification bias is also minimised, for 
example where one respondent may score 2 on a simple morbidity count with end 
stage chronic obstructive pulmonary disease and peripheral vascular disease 
requiring surgery and another may score 2 with hypertension and squamous cell 
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carcinoma of the skin completely excised, yet  the morbidities in the former 
scenario have a much more serious life impact.   
 
The CCI considers 16 diagnostic categories and each category is allocated a 
weight, for example ‘metastatic tumour’ carries the highest weight of 6, and mild 
liver disease carries the lowest weight of 1; appendix 7 provides disease 
categories and their weightings.  Each respondent is scored according to the 
presence of the listed diagnostic categories as indicated by the READ codes in 
their medical records.  Extracting the data from the general practice consultation 
records to ensure all relevant diagnostic READ codes were included was a 
complex undertaking, a summary of which is provided in 7; the list of READ codes 
used to extract information is available upon request from the thesis’ author VW.   
The CCI scores range from 0-33 (the highest score within the thesis samples was 
8).  The measure was treated categorically, with categories of 0, 1-2 and 3-8 
respectively dichotimised at the mean value excluding 0.    
 
6.7.2.2 Cognitive impairment  
Cognitive impairment is an established risk factor for falls in national guidelines 
(for example the NICE guidelines on falls prevention (NICE, 2013)).  Muir et al 
(2012) confirmed this statistically significant increased risk in their systematic 
review and meta-analysis of cognitive impairment in falls risk.  The NorStOP 
survey used the alertness behaviour subscale (ABS), one of the twelve 
dimensions of the validated Sickness Impact Profle (SIP) (Bergner et al 1981) to 
measure cognitive ‘complaint’ rather than ‘impairment’.  The components of the 
ABS-SIP are found in appendix 8 and include yes /no responses to questions 
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about multitasking, minor accidents, reaction times, task completion, problem 
solving, orientation, forgetfulness, attention span, mistakes and concentration 
skills.   Each question is weighted and summed to provide an overall score, 
ranging from 0 to 100.  The ABS-SIP score is analysed both on a continuous scale 
and categorically using 0 as no cognitive complaint, 1-14 as mild cognitive 
complaint, 15-38 as moderate cognitive complaint and 39-100 as severe cognitive 
complaint; this is based on even categories of non-zero scores with 33% of 
respondents in each category, as used by Westoby et al (2009).  The thesis will 
henceforth use the term cognitive ‘complaint’ rather than ‘impairment’, although 
recorded difficulties with each of the ABS-SIP score components is also indicative 
of cognitive impairment, defined by the ‘symptomatic pre-dementia stage on the 
continuum of cognitive decline, characterised by objective impairment in cognition 
that is not severe enough to require help with the usual activities of daily living’ 
(Langa & Levine, 2014).  
6.7.2.3 Anxiety and depression  
Anxiety and depression were measured using the Hospital Anxiety and 
Depression scale (HADS) (Zigmond & Snaith, 1983).  The HADS has a high 
degree of validity for anxiety and depression case finding and for assessment of 
symptom severity and performs well in a variety of settings including primary care 
(Bjelland et al, 2002).   Here, the HADS anxiety and depression subscales are 
used as continuous measures (range 0-21) with the mean HADS score for both 
subscales explored within the different pain groups.  The HADS is also considered 
a categorical variable  using the following cut off points: 0-7 in respective 
subscales are considered normal, 8-10 are considered borderline and 11 or over 
indicates clinical 'caseness' of either anxiety or depression (Snaith, 2003).  
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6.7.2.4 Medication  
Medications are prescribed using the electronic system in primary care and are 
therefore very likely to appear in medical records.  There may be occasions where 
a GP has hand-written a prescription and not updated the records accordingly but, 
from experience, these are likely to be rare events and are most likely to be one-
off prescriptions for analgesia or antibiotics.  This information is captured in the 
general practice prescription records as detailed above and uses codes according 
to chapters defined in the BNF.  The chapter codes are then searched for each 
respondent for the three months prior to baseline survey return date, or in the 
three months prior to three year follow up where necessary.  Three months prior 
was determined through clinical experience; most repeat prescriptions are 
prescribed either monthly or two monthly, therefore to use prescriptions from only 
a month prior would potentially miss repeat prescribing on a two-monthly basis.     
Each respondent will have a total count of different medication generated.  The 
different medication is captured by using BNF sub-chapters and identifying the 
same medications to ensure they are only counted once (for example, a repeat 
prescription of ramipril appearing three times in the dataset will only be counted 
once, and a similar but not identical medication (for example candesartan) will be 
counted as a separate medication).   
 
6.7.2.4.1 Total medication count  
The mean number of the total medication count was used to compare pain groups.   
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6.7.2.4.2 Analgesic use including NSAIDs  
In the UK, there are more than 300 different analgesic preparations available for 
GPs to prescribe (Joint Formulary Committee, 2013), and many different 
compounds of similar strengths.  A system is therefore required to group similar 
analgesics together and streamline the database.  Given the mixed evidence 
about analgesic use presented in Chapter 4, particularly for narcotic (or opiate) 
medication, the present thesis aims to identify the maximum strength of analgesic 
a respondent has been prescribed and use this as the variable to ensure analgesic 
use is taken account of in analysis.  Such a classification system was developed 
by Bedson et al (2013), who derived a heriarchical analgesic categorisation 
according to equipotency across medication classes (Bedson et al, 2013; Ndlovu 
et al, 2014).  Using sub-chapter codes from the BNF, medications were coded 
according to the following groups:  
0) No analgesics  
1)  Basic analgesics 
2) Weak combination opioids  
3) Moderate combination opioids and opioids  
4) Strong combination opioids and opioids  
5) Very strong single opioids  
NSAID use was coded as a separate variable to enable analysis of NSAID use 
separately to other analgesic use.  
Analgesic use was defined as prescriptions for analgesia in the three months prior 
to baseline survey return date or in the three months prior to three year follow up 
where necessary.  The highest numerical category (the strongest analgesic 
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category) was taken to represent analgesic use in respondents.  Those who had 
no prescriptions in that time period were coded as ‘no analgesic use’.  Over the 
counter medication cannot be accounted for within this data set, so it is possible 
that some respondents classified as ‘no analgesic use’ were self-administering 
over the counter medication from group 1, which may lead to misclassification bias 
and underestimation of the impact of medication on falls risk.  NSAID use was also 
defined in the three months prior to baseline survey completion.  A separate 
variable for NSAID use was generated to ensure that, as a group ‘6’ drug in the 
original hierarchy developed by Bedson et al (2013), the highest numerical 
category would not supersede the preceding opiate categories and therefore 
exclude opiate use from analysis.   
 
6.7.2.5 Physical functioning  
Physical functioning is measured in NorStOP using the Medical Outcomes Study 
SF-36 Physical Functioning scale (MOS-SF 36), with the ten separate items and 
an overall component score (Thomas et al, 2004; Ware & Sherbourne,1992) being 
available for analysis.  The single item “Does your health limit you in walking 100 
yards?” was selected to extract information about physical functioning as this item 
was found by Mottram et al (2008) and the NorStOP survey team to measure the 
most severe level of mobility limitation; Bohannon et al (2004) also previously used 
this single item to measure mobility limitation.  Moreover, combining items from the 
physical functioning subscale of the MOS-SF-36 to give an overall score has been 
demonstrated to be mathematically flawed, since some of the items are ordinal in 
nature and thus cannot be combined unless transposed into interval data (Muller 
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et al, 2009; Merbitz et al, 1989; Wright, 1989).  Finally, missing data is evident in 
the physical functioning items within NorStOP; the question assessing ability to 
walk 100 yards has the least amount of missing data (0.8% missing compared to 
1.6% for an item relating to climbing stairs and 3.6% missing when the ten items 
are combined).   
For this thesis, physical functioning is measured using the single item question 
regarding walking for 100 yards and is analysed as ordinal data with outcomes 
corresponding to “no, not limited”, “yes, limited a little” and “yes, limited a lot”. 
Table 6.5 Summary of covariate measurements and the data source from which 
they were derived  
Potential influencing 
variable  
Data source and derivation 
Multimorbidity  General practice consultation records  
Dizziness 
 
 NorSTOP survey: have you experienced ‘dizziness or unsteadiness’ over the past 
three months? Yes or no  
Poor hearing NorStOP survey: have you ‘suffered from deafness?’  Yes / no  
Poor vision 
 
NorStOP survey: ‘have you had problems with eyesight (excluding the need for 
glasses)?’ Yes or no  
BMI Height and weight as recorded by NorStOP respondents in the survey  
Depression  NorStOP survey HADS depression subscale 
Anxiety NorSTOP survey HADS anxiety subscale 
Cognitive impairment 
 
NorStOP survey  
ABS-SIP 
Total medication count 
 
General practice prescription records:  
Total number of medications from different BNF chapters prescribed  
Maximum strength 
analgesia  
General practice prescription records:  
Most potent opioid-based analgesic prescribed  
NSAID use  
General practice prescription records:  
Prescription of NSAID yes/ no  
Physical functioning 
 
NorStOP survey  
MOS SF36 Physical Component Scale  
Previous history of fall  NorStOP baseline survey self-reported fall  
HADS = Hospital Anxiety and Depression Subscale; ABS-SIP = Alertness Behaviour Subscale-Sickness Impact 
Profile; MOS SF36= Medical Outcomes Study SF36 
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6.8 Falls  
6.8.1 Self-reported falls  
Information on self-reported falls is gathered from the NorStOP survey, which 
asked respondents to report any falls they had experienced in the three months 
prior to questionnaire completion using the following question:  
“Thinking back over the past 3 months, have you suffered from any of the 
following? 
a. a fall or falls …” 
The question was repeated in the same format at three year follow up and six year 
follow up and required respondents to answer ‘yes’ or ‘no’.  
6.8.2 Falls requiring primary health care utilisation: GP-recorded falls  
There is a paucity of literature exploring the use of fall-related codes in general 
practice and the literature to date focuses on using falls data recorded in HES data 
or collected directly from the patient.  As such, there are no examples from which 
to draw to aid the decision over which codes to use to ensure maximum capture of 
falls; a pragmatic approach based on clinical experience is therefore adopted.   
Information about GP-recorded falls is extracted from the general practice medical 
records using READ codes.  The NHS Clinical Terminology Browser (NHS 
Information Authority, 2011), an interactive computer programme that contains all 
READ codes in use in clinical practice was searched for READ codes pertaining to 
falls.  The codes found are listed in table 6.6.  
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Table 6.6 Fall related READ codes that are used to extract GP-recorded falls 
status  
5 byte READ code  Meaning  
16D.. 
16D1.  
16D2. 
16D3. 
16D4. 
16D5. 
Falls  
Recurrent falls 
Number of falls in the last year 
Does not fall 
No fear of falls 
Fall onto outstretched hand 
U10.. 
U100. 
U101.  
 
U102.  
 
U103. 
 
U104. 
 
U105. 
U106. 
U107. 
U108. 
U109. 
U10A. 
U10B. 
U10C. 
U10D. 
U10E. 
U10F. 
U10G. 
 
U10H.  
[X] Falls  
[X] Fall on same level involving ice and snow 
[X] Fall on same level from slipping, tripping and 
stumbling 
[X] Fall involving ice-skates skis roller-skates or 
skateboards 
[X] 0th fall same level due collision/ pushing by another 
person 
[X] Fall while being carried or supported by another 
person  
[X] Fall involving wheelchair 
[X] Fall involving bed 
[X] Fall involving chair 
[X] Fall involving other furniture  
[X] Fall involving playground equipment  
[X] Fall in and from stairs and steps 
[X] Fall on / from ladder 
[X] Fall on and from scaffolding  
[X] Fall from, out of or through building or structure  
[X] Fall from tree 
[X] Fall from cliff 
[X] Diving / jumping into water causing injury other 
than drowning or submersion  
[X] Other fall from one level to another 
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U10J. 
U10z. 
[X] Other fall on same level  
[X] Unspecified fall  
TC… 
TC0.. 
TC1.. 
TC2.. 
TC3.. 
TC4,, 
TC5,, 
TC6.. 
 
TC7.. 
TCy.. 
TCz.. 
Accidental falls  
Fall on or from stairs or steps 
Fall on of from ladders or scaffolding  
Fall from our out of building or other structure  
Fall into hole or other opening in surface 
Other fall from one level to another 
Fall on same level from slipping, tripping or stumbling 
Fall on same level– collision/push/shove by/ with other 
person 
Fracture, cause unspecified 
Other falls  
Accidental falls NOS  
 
As table 6.6 demonstrates, to search using a three-byte READ code might include 
codes that are not relevant and thus introduce misclassification bias. For example, 
the code U10G. (diving or jumping into water) is not related to the falls under 
investigation in this thesis, yet would be included as fall if ‘U10’ was searched.  
Each of the 4byte codes in the table were searched to ensure that irrelevant codes 
would not be captured and none of these 4-byte codes appeared in the dataset.  
Thus, information on falls was extracted from the GP consultation data using the 
three-byte codes ‘16D’ and ‘U10’ and the two byte code ‘TC’.   
To ensure that no codes were missing from the extraction strategy, academic GPs 
working within the research centre were asked to provide a list of READ codes 
that they used to code falls within their consultations.  All seventeen GPs replied 
with a combination of the codes listed above; no additional codes appeared.  All of 
the GPs highlighted that their most frequent coding practice for consultations 
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involving a fall were to code either the cause of the fall (for example, ‘urinary tract 
infection’ of ‘dizziness’) or the consequences of the fall (for example, (pain in the 
back, knee or lower limb, or soft tissue injuries).  The implications of this coding 
practice are discussed at length in the discussion sections of the relevant analysis 
chapter.   
It is possible that multiple fall-related codes are generated on the same day by a 
patient attending the GP, then seeing the practice nurse for a wound dressing.  A 
search of the dataset revealed no falls codes on the same date for the same 
respondent.  Some respondents had multiple fall-related codes entered over a 
short time period, for example over a two-week period.  Since these may represent 
frequent fallers or falls that resulted in an injury requiring frequent attendance (for 
example, frequent dressings of a pretibial laceration), it was decided that, due to 
uncertainty, these consultations were coded as new ‘falls’.  
Two falls measurements are taken from the GP consultation records: i) the 
number of respondents who have a fall (any fall) recorded in their GP 
consultations ii) the total number of falls for each respondent.   
 
6.8.3 Falls requiring secondary health care utilisation: HES-recorded falls  
HES APC data uses ICD-10 codes to record diagnosis or cause of admission in up 
to twenty different data fields.  The ICD-10 was searched to obtain fall-related 
codes to use to extract fall-related codes from the HES data.  Table 6.7 presents 
all ICD10 fall-related codes.  Not all these codes are relevant to the thesis, for 
example W02 (fall involving ice-skates, skis, roller skates or skateboards) is not 
likely to be relevant to the study population.  
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Referring to the published literature does not provide a consensus view on which 
ICD-10 codes should be used to extract out falls coded in HES-APC data.  Annual 
reports published by NHS Data (for example the Monthly HES summaries from 
April 2012-February 2013) provide summaries of falls data including total number 
of falls and falls admissions rates.  This data does not distinguish specific type of 
fall and includes all the codes above (NHS Digital, 2017).  The most common 
codes for falls were ‘unspecified’ [W19] (36.2%), ‘falls on the same level through 
slipping, tripping and stumbling’ [W01] (21.8%) and ‘other fall in the same level’ 
[W18] (12.7%) NHS Digital, 2017).   Other studies using HES data to measure falls 
or fall-related injuries have used ICD10 codes W00-W19 and excluded codes that 
suggest work-related injuries, for example W12 (fall from scaffolding) (Gilbert et al, 
2010).  In their analysis of unintentional falls in older people in the UK, Scuffham et 
al (2003) used W01, W05, W06, W07, W08, W09, W10, W18 and W19.  
Taking a pragmatic approach based upon Scuffham’s (2003) work, W09 (fall from 
playground equipment) is excluded due to the pathophysiological mechanism 
resulting in that kind of fall is unlikely to be representative of the pathophysiology 
of the falls explored in this thesis (i.e those related to ageing, frailty, dizziness, 
sarcopaenia amongst other reasons) and W17 is included (fall from one level to 
another) as a possible code used by healthcare professionals to capture fall from a 
pavement to the road, or down a step, both of which could be falls arising from the 
factors under examination in this thesis.  The HES falls codes used in this thesis 
are therefore: W01, W05, W06, W07, W08, W10, W17, W18 and W19 (as 
indicated by * in table 6.7).      
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Table 6.7 ICD-10 Codes used to extract fall-related information from secondary 
care admission data (HES) 
HES code/ 
ICD-10 
Code name 
W00 Fall on same level involving ice and snow 
 
W01* Fall on same level from slipping, tripping and stumbling  
 
W02  Fall involving ice-skates, skis, roller-skates or skateboards 
W03  Other fall on same level due to collision with, or pushing by, another 
person  
W04  Fall whilst being carried or supported by others e.g. being 
accidentally dropped while being carried  
W05* Fall involving wheelchair 
W06* Fall involving bed 
W07* Fall involving chair 
W08* Fall involving other furniture 
W09 Fall involving playground equipment  
W10* Fall on and from stairs and steps including fall on or from escalator, 
incline, involving snow and ice on stairs and steps, ramp  
W11 Fall from ladder 
W12 Fall from scaffolding  
W13 Fall from, or out of or through building or structure 
(includes fall from balcony, bridge, building, flag-pole, floor, railing, 
roof, tower, turret, viaduct, wall, window)  
(excludes collapse of a building or structure, fall or jump from 
burning structure) 
W14 Fall from tree 
W15 Fall from cliff  
W16 Diving or jumping into water causing injury other than drowning or 
submersion including striking or hitting again bottom when jumping 
or diving, wall or diving board of swimming pool, water surface  
W17* Other fall from one level to another including fall from or into cavity, 
cherry picker, dock, haystack, hole, lifting device, mobile elevated 
work platform, pit, quarry, shaft, sky lift, tank, well  
W18* Other fall on the same level including fall from bumping against 
object, from or off toilet, on same level NOS 
W19* Unspecified falls including accidental fall NOS 
*codes that are used to extract falls information in the thesis 
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It is possible that some patients will receive more than one HES falls code within a 
24-hour period.  This can be generated through admissions to different wards, 
each generating their own set of associated codes to enable correct payment for 
services.  For example, a patient may fall and fracture their hip and be admitted on 
a ‘fractured neck of femur’ pathway under the care of orthopaedics on an 
admissions unit, then have their operation and go through to recovery, then be 
transferred to a temporary ward bed on a general surgical ward whilst waiting for 
an orthopaedic bed, thus generating four different admission episodes.  Duplicate 
dates relating to fall codes were identified and duplicate entries were excluded 
from the total falls count.  
Thus, two HES-fall outcomes were recorded: i) number of respondents who have 
ever had a HES-recorded fall ii) the total number of HES-recorded falls for each 
respondent.   
 
6.9 Summary  
This chapter has restated this thesis’ aims and objectives and described the data 
sources that were required to undertake analysis.  Selection of covariates have 
been described and measurements of the independent variable (pain), the 
dependent variable (falls) and covariates to be accounted for in analysis due to 
their impact on any association between pain and falls have been presented.  The 
next chapter will provide a summary of the NorStOP study population, describe 
how the study samples used in this thesis are derived and compare the thesis 
study samples to local and national statistics.  
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Chapter 7: NorStOP and the thesis study samples 
 
7.1 Introduction 
This chapter presents a summary of the NorStOP study and describes the 
processes through which the baseline NorStOP study sample was obtained.  The 
samples used in this thesis (named thesis sample A and thesis sample B) to 
address the hypotheses are derived from the NorStOP baseline population and 
this process is explained with a study flow chart and presentation of inclusion and 
exclusion criteria.  Thesis samples A and B are then assessed descriptively for risk 
of bias.  A comparison is made with NorStOP baseline, local and national 
populations.   Next, bias due to non-response and to other respondent losses at 
baseline is explored.  Finally, bias from study attrition is considered and a chapter 
summary is provided.     
 
7.2 Deriving the NorStOP sample  
The NorStOP sampling frame consisted of 26,705 adults aged 50 years and older 
who were registered at eight different general practices in North Staffordshire, as 
identified by the Keele GP Research Network.     
Before mail out, GPs were asked to screen out people with severe psychiatric or 
terminal illness so that they could be excluded from the survey mail out. This 
occurred before baseline surveys for NorStOP1, NorStOP2 and NorStOP3.  After 
exclusions, 26,625 people were mailed the NorStOP surveys and accompanying 
information.  Further exclusions were undertaken during the mailout process as 
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events including unknown addresses and deaths became apparent.  Table 7.1 
provides a summary of the sampling frame, drop outs and subsequent survey 
response rates.  The total number of people eligible to partake in the NorStOP 
surveys was therefore 26,129.   
 
Table 7.1 NorStOP: Summary of the sampling frame, drop outs and baseline 
survey response rate 
 Total NorStOP1 NorStOP2 NorStOP3 
Number 
identified  
26,705 11,309 8,984 6,412 
Excluded 
prior to 
mailing 
80 
79  
55 deaths and 
departures 
24 on GP screen 
0  
1  
1 death  
Number 
eligible for 
mailout  
26,625 11230  8984 6411 
Excluded 
during 
mailing 
496 
175  
45 deaths and 
departures 
25 withdrawals 
105 returns 
addressee 
unknown 
221  
98 deaths and 
departures 
 28 withdrawn (19 
ill and 9 
ineligible) 
95 returned 
addressee 
unknown 
100  
43 deaths and 
departures 
16 withdrawn (4 ill, 12 
ineligible) 
 41 returned 
addressee unknown 
Eligible 
baseline 
health survey 
population 
26,129 11055 8763 6311 
Responders 18,497 7,878 (71.3%)  
6,108 (69.7%)  
 
4,511 (71.5%) 
 
Non-
responders/ 
refusals 
7632 
3177  
109 ill health 255 
refused 
2813 non-
response  
2655  
83 ill health 
223 refused 
2349 non-
response 
1800  
49 ill health 
1589 refused 
162 non-response 
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7.3 Deriving the thesis study sample  
Starting with NorStOP responders (n=18,497), figure 7.1 charts respondent flow 
through the study and into the final samples used for analysis in this thesis.  
Consent to medical record review was provided by 13,831 respondents and their 
survey responses were linked with their general practice consultation and 
prescription records.   
Figure 7.1 Thesis study population flow chart: from responding to NorStOP 
baseline survey to end of six year follow up 
 
 
NorStOP consenters (n=13,831) had their information sent to the NHSIC as 
detailed in Chapter 6 to link HES and ONS data.  854 identifiers were returned 
with unmatched records; these respondents were subsequently excluded from 
analysis.  Data for the general practice consultation and prescription databases 
were still being extracted as the thesis started and so the 298 NorStOP 
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respondents who did not have complete general practice consultation and 
prescription records were excluded from analysis.  Exclusion criteria were 
therefore unmatched HES or ONS records and incomplete general practice 
consultation or prescription records.  
Inclusion criteria were based upon responses to the two pain questions in the 
NorStOP survey: a) have you experienced any pain, lasting at least one day, 
during the past month? (yes or no response); and b) Indicate the site(s) of pain by 
shading the body manikin (shading or no shading response).  Respondents were 
included if they:  
i) Answered ‘yes’ to the pain screening question and shaded the manikin  
ii) Answered ‘no’ to the pain screening question and did not shade the 
manikin  
Respondents who answered ‘yes’ to the pain screening question but who did not 
shade the manikin, and those answering ‘no’ but proceeded to shade the manikin 
were excluded from analysis since their answers were nonsensical and it was not 
possible to infer which answer represented the true pain experience.  
Respondents who provided incomplete responses to the pain questions were also 
excluded; thus 1390 exclusions were made due to incomplete or inconsistent pain 
responses.   
A total of 2158 respondents were therefore excluded due to unmatched HES and 
ONS records, incomplete general practice and prescription data and incomplete or 
inconsistent pain responses; there are respondents who fulfilled more than one 
exclusion criteria, hence the number 2158 does not equate to simple addition of 
numbers in each exclusion category.  11,375 respondents were therefore included 
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in this thesis’ analyses to examine the prevalence of self-reported, GP and HES-
recorded falls.  This sample (n=11,375) was also used to measure the relationship 
between pain and future GP and HES recorded falls.  The sample of 11,375 
respondents will now be termed thesis sample A.   
 As demonstrated in figure 7.1, 7,345 of the 11,375 respondents completed three 
year follow up and, of those, 6503 respondents continued to be included in this 
thesis’ study sample due to their complete and consistent answers to the pain 
questions described above; 842 respondents were excluded due to incomplete or 
inconsistent pain answers in their three year follow up survey.  4386 respondents 
remained in the study at six year follow up after 2117 failed to return their survey.  
The sample consisting of 4386 respondents who have three and six year follow up 
with complete pain data is referred to as thesis sample B, this sample (n=4386) 
will be used to examine the relationship between multisite pain and self-reported 
falls.  
This thesis will therefore undertake analyses using two samples.  Both sample A 
and B contain information on pain and covariates for 11,375 respondents all taken 
at the baseline survey time point, i.e. the pain measures and self-reported 
covariates are derived from the baseline NorStOP survey and covariates extracted 
from general practice consultations and prescriptions are derived during the three 
months prior to the baseline NorStOP survey distribution date for each NorStOP 
cohort.  The larger size of sample A (n=11,375) compared with sample B (n=4386) 
means risk estimates using the larger sample A are closer to the true population 
risk because there are more individual values from which an average estimate can 
be formed, thus sample A will be used to address examine falls prevalence and 
the relationship between pain and future GP and HES-recorded fall.  The 
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relationship between multisite pain and self-reported falls will be examined using 
thesis sample B (n=4386) since this contains complete follow up information and is 
therefore less at risk of bias from missing data.    
 
7.4 Assessing the thesis samples for risk of bias  
Before analyses are undertaken, it is prudent to assess risk of bias within the 
thesis samples A and B since this may impact upon the validity of results.  This 
thesis aims to address the hypotheses using a cohort of respondents who have 
been followed up over a six year period.  Cohort studies have potential sources of 
bias including the choice of sampling frame and subsequent sample 
representativeness compared to local and national figures, non-response to 
surveys and attrition from follow up.   In this thesis, additional potential sources of 
bias come from differences between those who consented to medical record 
review and those who did not, those who had incomplete or inconsistent pain 
responses and those who did not, and those who had unmatched HES, ONS or 
general practice or prescription records and those who did not .  These risks will 
now be assessed in the sections that follow.  
 
7.4.1 Representativeness of the thesis samples A and B compared to NorStOP, 
local and national populations 
The purpose of this thesis is to provide evidence to GPs and policy makers to 
ensure that pain experience is taken into account when assessing and managing 
falls risk in older people, if a link is found.  Therefore, the results of this thesis must 
be generalisable to a wider population.  To enable to results to be generalisable, 
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this thesis’ study population must be representative of the wider population, for 
example the eligible baseline health survey population, the local Staffordshire 
population and the national English population.  This section will now compare 
basic demographic information within thesis study samples A (n=11,375) and B 
(n=4386), the NorStOP eligible health survey population, local (Staffordshire) 
census data and national (England) census data.   
 
7.4.1.1 Age and sex distributions 
Table 7.2 provides a breakdown of age distribution in England, Staffordshire, the 
eligible NorStOP population and thesis samples A and B and table 7.3 provides 
the age and sex distributions of England, Staffordshire, the NorStOP eligible 
population and thesis samples A and B.    
 
Table 7.2 The age distribution of national and local populations, the NorStOP 
eligible population and the thesis’ study samples A (n=11,375) and B (n=4386) 
 
Age 
(years) 
England 
(2001 census)  
% 
Staffordshire 
(2001 census) 
% 
NorStOP eligible 
population  % 
Thesis sample A 
% 
Thesis sample B 
% 
50- 54 21.1 21.9 15.7 14.1 18.1 
 55 - 59 17.3 18.7 19.4 18.6 22.7 
60 - 64 14.9 15.4 15.0 15.6 18.7 
 65 - 69 13.4 13.3 13.8 16.0 18.0 
70 -74 12.0 11.8 12.2 13.4 12.0 
 75- 79 10.0 9.4 10.4 11.3 7.4 
 80- 84 6.5 5.8 7.7 7.2 2.5 
 85 - 89 3.4 2.8 3.8 2.9 0.6 
 90 + 1.4 1.1 2.0 1.0 0.0 
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Table 7.3 Age and sex distributions of national and local populations, the NorStOP 
eligible population and thesis study samples A (n=11,375) and B (n=4,386) 
 
Age  
(years) 
England 
(2001 census) 
Staffordshire 
(2001 census) 
NorStOP 
eligible 
population 
Thesis sample A 
 
Thesis sample B 
 
 % 
Male 
% 
female 
% 
male 
% 
female 
% 
male 
% 
female 
% 
male 
% 
female 
% 
male 
% 
female 
50-54 49.6 50.4 50.3 49.7 50.2 49.8 45.3 54.7 43.3 56.7 
 55-59 49.5 50.5 49.9 50.1 50.2 49.8 48.3 51.8 44.1 55.9 
60-64 49.1 50.9 50.3 49.7 50.2 49.8 49.7 50.3 47.7 52.3 
65-69 48.0 52.0 48.6 51.4 48.3 51.7 49.6 50.4 48.5 51.5 
70-74 45.5 54.5 45.9 54.1 43.8 56.2 46.1 53.9 45.0 55.0 
75-79 41.8 58.2 42.2 57.8 42.6 57.4 45.0 54.9 46.9 53.1 
 80-84 37.0 63.0 36.7 63.3 35.5 64.5 38.6 61.4 37.9 62.2 
85-89 30.4 69.6 29.9 70.1 30.0 70.0 33.5 66.5 42.8 57.1 
90-94 23.5 76.5 23.0 77.0 21.2 78.8 23.6 76.4 0.0 100.0 
95-99 18.8 81.2 17.8 82.2 15.9 84.1 36.4 63.4 -- - 
 100 + 20.3 79.7 26.8 73.2 0.0 100.0 - - - - 
 
The NorStOP eligible population is generally representative of Staffordshire and 
England populations although there are a slightly higher proportion of women in 
the oldest old age group compared to local and national figures.  Thesis samples 
A and B have more men included in the oldest old categories than would be 
expected from local and national census projections.  The NorStOP eligible 
population has a lower proportion of adults aged 50-54 years old and a higher 
proportion of adults aged 55 years and older compared to the local and national 
population.  This difference is seen in thesis sample A until aged 85 years and 
older, where there are fewer of the oldest old in thesis sample A than in the local 
and national samples.  Thesis sample B has even fewer respondents aged 75 
years and older than the local and national samples.  This reduction in proportion 
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of the oldest old within thesis sample A and B is likely due to attrition due to 
advancing age and ailing health, with only the fittest older people remaining in the 
study of the six year follow up; this is known as the healthy cohort effect and is 
discussed throughout the thesis, particularly in Chapter 12.  
 
 7.4.1.2 Occupational class  
Table 7.4 presents occupational class distribution across England, Staffordshire 
and thesis samples A and B, as defined in the Office for National Statistics (2000 
and 2002).  This information is not available for the NorStOP eligible study 
population.  
 
Table 7.4 Distribution of occupational class in national and local population and 
thesis study samples A (n=11,375) and B (n=4,386)  
Occupational class  England  % Staffordshire 
% 
Thesis sample 
A 
% 
Thesis sample 
B 
% 
1 Higher managerial and 
professional  
5.8 5.8 6.0 7.1 
2 Lower managerial and 
professional  
13.5 13.6 13.0 16.7 
3 intermediate 
occupations  
6.4 5.8 11.3 13.3 
4 self-employed 7.8 8.0 6.2 6.2 
5 lower supervisory / 
technical  
5.3 6.0 6.0 5.7 
6 Semi-routine  9.3 9.8 22.7 24.1 
7 Routine  7.8 8.9 27.4 22.1 
8 Retired / not working 
/inadequate title/ 
student / voluntary 
work 
1.6 1.6 0.8 0.66 
9 unclassified  42.6 40.3 6.5 4.1 
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The key difference between thesis samples A and B and the local and national 
figures lies in the ‘unclassified’ occupations.  The census information has a higher 
percentage of ‘unclassified’ occupations, perhaps as a result of misclassification of 
semi-routine and routine jobs that have a higher proportion in thesis sample A and 
B.   
 
7.4.1.3 Respondent distribution across participating general practices 
 Table 7.5 shows the percentage of respondents from each of the eight general 
practices from which the NorStOP study population were sampled.   
 
Table 7.5 The distribution of GP practices that provided the NorStOP sample 
within the NorStOP eligible population and thesis sample A (n=11,375) and B 
(n=4386)    
 
General 
practice    
NorStOP eligible 
population % 
Thesis sample A % Thesis sample B % 
 
A 
 
13.9 
 
16.6 
 
19.0 
E 10.3 9.5 8.4 
H 13.9 14.3 13.8 
I 19.3 18.9 19.1 
L 8.9 8.2 8.6 
M 13.7 12.7 12.0 
N 6.9 7.7 8.5 
P 13.0 12.2 10.7 
 
The highest proportion of survey responders come from practices I and A and the 
lowest proportions are derived from practices L and N.  Although the distribution of 
practices follows a similar pattern in the NorStOP eligible population and thesis 
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samples A and B, a greater percentage of respondents in thesis samples A and B 
are from general practice A and there are fewer respondents from general practice 
P in the thesis sample B.   
7.4.1.4 Ethnicity  
Staffordshire has very little ethnic diversity; 98.6% of adults aged 50 to 54 years 
and 99.5% of adults aged 90 years and older are recorded as ‘white’ in the 2001 
Census.   The NorStOP population is therefore representative of Staffordshire with 
more than 99% of respondents self-reporting their ethnicity as ‘white’.  This is not 
completely representative of England, where 94.9% of 50 to 54 year olds and 
98.6% of adults aged 90 years and older were recorded as ‘white’.  There is thus a 
difference is ethnicity structure in the youngest age groups of older people in 
England, although ethnicity of the oldest age groups is close to the NorStOP study 
population, this must be taken into account when interpreting this thesis’ results.  
7.4.1.5 Sample representativeness: summary  
In summary, when compared to local and national populations, there are fewer of 
the oldest old in both thesis sample A (n=11,375) and B (n=4386), and this is more 
marked in thesis sample B.  There are more semi-routine and routine occupations 
in the thesis samples A and B when compared England and Staffordshire figures 
and there is a preponderance for more respondents to be registered at a particular 
general practice than in the NorStOP eligible population.  Thesis samples A and B 
entirely reflect the ethnicity of the Staffordshire population, although this local 
population is not representative of England for adults aged 50-54 years, where the 
proportion of adults self-identifying as ‘white’ is greater.   
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7.4.2  Risk of bias from respondent losses at baseline  
7.4.2.1 Assessing non-response bias   
Non-response bias, where groups of responders differ in characteristics to non-
responders, is a potential source of bias that reduces a study’s results validity. 
Basic demographic information about age and sex is available for non-responders 
to the baseline NorStOP survey and for those who were excluded during the 
mailout; these are now compared to the baseline NorStOP survey returners in 
table 7.6 and table 7.7.   
Table 7.6 The age profile of the local population, the NorStOP mailout population 
and NorStOP responders and non-responders 
 
Age 
group 
(years) 
Staffordshire 
% 
NorStOP 
mailout % 
NorStOP 
responders % 
NorStOP non-
responders % 
50-54 21.9 15.7 13.9 19.2 
55-59 18.7 19.4 18.3 22.0 
60-64 15.4 15.0 15.5 14.2 
 65-69 13.3 13.8 15.3 10.7 
70-74 11.8 12.2 13.6 9.0 
75- 79 9.4 10.4 11.3 8.4 
80-84 5.8 7.7 7.7 7.9 
 85-89 2.8 3.8 3.3 5.0 
90 + 1.1 2.0 1.2 3.7 
 
Table 7.6 demonstrates that the NorStOP mailout sample contained fewer people 
aged 50-54 years compared to the general Staffordshire population.  The non-
responders were younger overall than the responders, with fewer people in the 
older age groups and more people in the younger age groups; correspondingly; 
the NorStOP responders had a smaller number of people aged 50-54 years 
compared with the mailout population and Staffordshire.    
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Table 7.7 Age and sex distribution of  the local population,  NorStOP mailout 
population , NorStOP non-responders and the NorStOP baseline study sample 
 
Age 
group 
(years) 
Staffordshire 
 
NorStOP 
mailout 
NorStOP non-
responders 
NorStOP baseline 
sample 
 % 
male 
% 
female 
%  
male 
% 
female 
% 
male 
% 
female 
% 
male 
% 
female 
50-54 50.3 49.7 50.2 49.8 58.3 41.7 45.2 54.8 
55-59 49.9 50.1 50.2 49.8 55.6 44.5 46.9 53.1 
 60- 64 50.3 49.7 50.2 49.8 55.5 44.5 47.7 52.3 
 65- 69 48.6 51.4 48.3 51.7 52.7 47.3 46.8 53.2 
 70- 74 45.9 54.1 43.8 56.2 46.3 53.7 42.9 57.1 
 75- 79 42.2 57.8 42.6 57.4 41.6 58.4 42.8 57.2 
 80-84 36.7 63.3 35.5 64.5 30.7 69.3 37.2 62.8 
 85- 89 29.9 70.1 30.0 70.0 26.0 74.0 32.5 67.6 
90- 94 23.0 77.0 21.2 78.8 21.9 78.1 21.1 79.0 
 95-99 17.8 82.2 15.9 84.1 12.3 87.7 30.0 70.0 
 100 + 26.8 73.2 0.0 100.0 0.0 100.0 0.00 0.00 
 
As table 7.7 shows, a larger proportion of non-responders were men compared 
with both the local population and the NorStOP mail out population and this trend 
continued until aged 70 years old, when a larger proportion of women became 
non-responders compared to both Staffordshire and the NorStOP mailout 
population.  The NorStOP baseline sample therefore had proportionally less men 
between ages 50 and 64 years than the NorStOP mailout sample and local 
population, although the oldest old categories had proportionally more women 
than the local population and NorStOP mailout comparison group.    Overall, the 
age and profile of the NorStOP responders is not entirely reflective of that of 
Staffordshire, with the NorStOP responders generally older than the Staffordshire 
population.  The sex profile is similar in the Staffordshire, responders and non-
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responder samples and there are a greater proportion of women in most age 
groups within the NorStOP responder sample compared to the local population.  
7.4.2.2 Assessing baseline drop-out risk of bias 
NorStOP respondents were also excluded according to non-consent to medical 
record review, incomplete or inconsistent pain information, incomplete general 
practice consultation and prescription records and unmatched HES or ONS data.  
Tables 7.8 and 7.9 compare age and sex profiles for consenters, non-consenters 
and other excluded respondents with the initial NorStOP respondents the 
subsequently derived thesis sample A to investigate any systematic differences 
between groups and therefore risk of bias.  
Table 7.8 Age distribution of NorStOP responders, consenters, non consenters 
and those included  in thesis sample A 
 
Age 
(years) 
NorStOP 
responders 
% 
NorStOP 
consenters 
% 
NorStOP 
non-
consenters % 
Additional 
baseline drop 
outs  % 
Thesis sample 
A 
% 
50- 54 13.9 14.2 13.0 14.7 14.1 
 55 - 59 18.3 18.6 17.2 17.6 18.6 
60 - 64 15.5 15.5 15.5 14.3 15.6 
 65 - 69 15.3 15.9 13.6 15.1 16.0 
70 -74 13.6 13.6 13.9 14.4 13.4 
 75- 79 11.3 11.2 11.8 11.3 11.3 
 80- 84 7.7 7.2 9.1 7.7 7.2 
 85 - 89 3.3 3.0 4.1 3.9 2.9 
 90 + 1.2 1.0 1.7 1.9 1.0 
NorStOP respondents n=18,497; NorStOP consenters (those consenting to medical record 
review) n=13,381; NorStOP non-consenters (those not consenting to medical record 
review) n=4666; Additional baseline loss (no HES match, no complete medical record data 
or incomplete pain data) n=2158; Thesis sample A n=11,375 
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Table 7.8 shows that the group who consented to medical record review was 
similar in age distribution to the NorStOP baseline survey population.  A lower 
proportion of the non-consenter group were aged 50-54 years and the non-
consenters had higher proportions of older age groups that the consenting group.   
The age profile of the consenters and the non-consenters is statistically 
significantly different, with the probability that they are the same calculated using a 
t-test as < 0.01.  The additional baseline drop out group also contains a higher 
proportion of adults aged 70 years and older than the NorStOP respondent group.  
These differences are not carried into thesis sample A (n=11,375), which has an 
age profile generally matching the NorStOP responders and consenters.   
Table 7.9 Age-sex distribution of NorStOP respondents, additional baseline drop 
outs and thesis sample A (n=11,375) 
 
Age 
(years) 
NorStOP 
respondents 
NorStOP 
consenters 
NorStOP non-
consenters 
Additional 
baseline loss 
Thesis sample A 
 % 
male 
% 
female 
% 
male 
% 
female 
%  
male 
% 
female 
%  
male 
% 
female 
%  
male 
% 
female 
50-54 45.2 54.8 45.6 54.4 43.9 56.1 50.6 49.4 45.3 54.7 
50-59 46.9 53.1 48.6 51.4 41.5 58.5 52.9 47.1 48.3 51.8 
60-64 47.7 52.3 50.5 49.5 39.7 60.3 53.6 46.4 49.7 50.3 
65-69 46.8 53.2 49.3 50.7 38.1 61.9 48.5 51.5 49.6 50.4 
70-74 42.9 57.1 45.5 54.5 35.6 64.4 44.1 56.0 46.1 53.9 
75-79 42.8 57.2 45.2 54.8 36.25 63.75 45.3 54.7 45.1 54.9 
80-84 37.2 62.8 39.9 60.1 31.0 69.0 45.5 54.6 38.6 61.4 
 85 - 89 32.45 67.55 33.8 66.2 29.5 70.5 35.3 64.7 33.5 66.5 
 90 - 94 21.05 78.95 26.6 73.4 12.3 87.7 40.9 59.1 23.6 76.4 
 95 - 99 30.0 70.0 36.4 63.6 22.2 77.8   36.4 63.6 
  100 +           
NorStOP respondents n=18,497; NorStOP consenters (those consenting to medical record review) 
n=13,381; NorStOP non-consenters (those not consenting to medical record review) n=4666; Additional 
baseline loss (no HES match, no complete medical record data or incomplete pain data) n=2158; Thesis 
sample A n=11,375  
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Table 7.9 shows that the NorStOP baseline sample has proportionally more 
women than men in all age categories.   The non-consenters had an even greater 
difference in proportions with more women than men dissenting from medical 
record review in all age groups.  Men and women were more evenly distributed 
across the age groups in the additional baseline loss group.   The impact of the 
marked non-response in women is to balance thesis sample A, with more equal 
groups of men and women until age 70 years, when a larger proportion are 
women in each subsequent age group, reflecting the NorStOP baseline sample.   
Table 7.10 Education status, income adequacy and pain reporting in NorStOP 
respondents according to consent status, additional baseline drop outs and thesis 
sample A (n=11,375) 
 
Variable  NorStOP 
sample 
 
n=18497 
NorStOP 
consenters 
 
n=13381 
NorStOP 
non-
consenters 
n=4666 
Additional 
baseline 
losses 
n=2158 
Thesis 
sample A 
 
n=11375 
FT education  
Yes (%) 
No (%) 
Missing (%) 
 
2127 (11.5) 
15889 (85.9) 
481 (2.6) 
 
1633 (12.2) 
11454(85.6) 
294 (2.2) 
 
443 (9.5) 
4046 (86.7) 
177 (3.8) 
 
255 (11.8) 
1808(83.8) 
95 (4.4) 
 
1382 (12.2) 
9793 (86.1) 
200 (1.8) 
Income 
adequacy  
Adequate (%) 
Inadequate (%) 
Unknown (%) 
 
 
9989(54.0) 
8009(43.3) 
499 (2.7) 
 
 
7447 (55.7) 
5667(42.4) 
267(2.0) 
 
 
2291 (49.1) 
2156 (46.2) 
219 (4.7) 
 
 
896 (41.5) 
1189 (55.1) 
73 (3.4) 
 
 
6320 (42.7) 
4858 (55.6) 
197 (1.7) 
Number of pain 
sites 
Mean (range) 
SD 
Missing n (%) 
 
 
9.5 (0-50) 
SD 8.4 
6552 (35.4) 
 
 
9.6 (0-50) 
SD 8.3 
4120 (30.8) 
 
 
9.0 (0-50) 
SD 8.5 
1982 (42.5) 
 
 
3.8 (0-43) 
SD5.5 
1390 (64.4) 
 
 
6.1 (0-44) 
SD7.2 
0 (0) 
Widespread pain  
No pain (%) 
Some pain (%) 
Widespread (%) 
Missing n (%) 
 
4736 (25.6) 
7252 (39.2) 
4201 (22.7) 
2308 (12.5) 
 
3388  (25.3) 
5611 (41.9) 
3294 (24.6) 
1088 (8.1) 
 
1376 (29.5) 
1596 (34.2) 
924 (19.8) 
770 (16.5) 
 
321 (41.8) 
343 (44.7) 
104 (13.5) 
1390 (64.4) 
 
3062 (27.6) 
5175 (45.5) 
3138 (26.9) 
0 (0) 
NorStOP consenters are those consenting to medical record review; NorStOP non-
consenters are those not consenting to medical record review;  Additional baseline loss are 
those with no HES match, no complete medical record data or incomplete pain data; Pain 
score calculated for the NorStOP sample, consenters and non-consenters by summarizing 
the number of pain sites if the screening question was answered as ‘yes’;  SD = standard 
deviation ; FT education = continuing education after aged 16 years 
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NorStOP non-consenters had a lower proportion of adults undertaking further 
education than consenters and the NorStOP baseline sample, as table 7.10 
shows.  The additional baseline losses group had a similar proportion of adults 
moving on to further education to the NorStOP baseline sample.  The non-
response and additional losses groups did not impact on the transition from 
NorStOP baseline survey group to thesis sample A as proportions in full time 
education remained similar overall. 
There is a difference between consenters and non-consenters, with a greater 
proportion of consenters reporting income adequacy.  The additional baseline 
losses group had the lowest proportion of respondents reporting income adequacy 
and these differences have a marked impact upon thesis sample A, where the 
difference in income adequacy is very different to the NorStOP baseline sample; 
42.7% (6320 respondents) report income adequacy in thesis sample A compared 
to 54% (9989 respondents) in the NorStOP baseline sample.  This difference must 
be considered in the context of other markers of socioeconomic status.   
The prevalence of pain within thesis sample A (n=11,375) and B (n=4386) is 
presented and discussed in Chapter 8.  It is also included briefly here to compare 
between samples to determine whether thesis sample A is fundamentally different 
in terms of pain reporting that the baseline NorStOP sample.  The mean number of 
pain sites in the NorStOP baseline sample is 9.5 and is 6.1 in thesis sample A.  
This is obviously different and means that any effect measure relating to pain as 
derived from thesis sample A is likely to underestimate the true impact given that 
the number of pain sites is less.  Rounded to a whole number, the difference in 
mean number of pain sites between consenters and non-consenters is 1; the 
consenters and non-consenters are therefore not fundamentally different in terms 
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of pain.   The additional baseline loss group is very different, with a mean number 
of pain sites 4, quite different to the NorStOP sample mean of 10.  This might be 
explained by the exclusion of respondents who did not complete the pain 
questions or did so inconsistently.  Perhaps respondents assume that, by not 
shading the manikin, it is obvious that they don’t have pain and therefore the pain 
screening question becomes superfluous.  Therefore, more pain free respondents 
were excluded than those with pain, thus the mean number of pain sites for 
additional baseline losses is lower.   
Widespread pain distribution follows a similar pattern to number of pain sites, with 
a much greater proportion of the additional baseline losses group reporting no pain 
when compared to the NorStOP baseline sample.  NorStOP non-consenters had a 
lower proportion of widespread pain compared to consenters.  Thesis sample A 
reported a greater proportion of all three categories compared to the NorStOP 
baseline population, although approximately one quarter of both samples reported 
widespread pain and some pain was the commonest category in each group.  The 
greater proportion of all three pain categories in thesis sample A compared to 
NorStOP baseline is due to the missing data from the NorStOP baseline 
population; however thesis sample A broadly reflects the NorStOP baseline 
population.  
7.4.2.3 Summary of bias risk due to respondent losses at baseline  
NorStOP responders are generally older than the Staffordshire population, and 
there are proportionally more women in most of the age categories except ages 
85-89 years and 95-99 years old, this difference may impact upon the 
generalisability of results to a population that does not have as high a proportion of 
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older people; this will be discussed in Chapter 12.   Despite the differences in age 
profile within responders and non-responders, thesis sample A (n=11,375) follows 
a similar age structure to the NorStOP baseline sample.  There are a greater 
proportion of women non-consenters compared to consenters yet the age-sex 
distribution of thesis A resembles the NorSTOP baseline sample such that risk of 
bias relating to age and sex from baseline additional losses is low.  Educational 
attainment is similar in the NorStOP baseline sample and thesis sample A and so 
the risk of bias is low.  Income adequacy distribution is very different across the 
groups and the pattern is reversed in thesis sample A, where income inadequacy 
more common than adequacy.  This must be considered with other measures of 
socio-economic position and there is a potential for bias in this difference.  The 
mean number of pain sites is lower in thesis sample A than the NorStOP baseline 
sample and any risk estimates relating to pain must consider this potential source 
of underestimation.  The distribution of widespreadness is similar between the 
NorStOP baseline sample and thesis sample A.     
7.4.3 Attrition through follow up  
Loss of respondents during the follow up period, or attrition, can impact upon 
results if those that do not complete follow up are different to those who do.   Table 
7.11 shows that thesis sample B (n=4386) has a higher proportion of adults aged 
50 - 69 compared to thesis sample A (n=11,375).  This is due to natural attrition of 
older adults who have become increasingly frail or have died and are therefore 
unable to complete follow up surveys.  This is reflected in the age distribution of 
the drop out group who have higher proportions of adults aged 70 years and older.  
The age-sex distribution (table 7.12) shows a higher proportion of men in the 65-
89 year age groups compared with thesis sample A.    
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Table 7.11 Age distribution of thesis samples A (n=11,375) and B (n=4386) and 
baseline NorStOP responders who dropped out of follow up  
 
Age group (years) Thesis sample A 
n=11375 
Drop outs 
n=6989 
Thesis sample B 
n=4386 
50 –54 (n, %)  1605 (14.1) 811 (11.6) 794 (18.1) 
55- 59 (n, %) 2112 (18.6) 1117 (16.0) 995 (22.7) 
60 –64 (n, %) 1771 (15.6) 952 (13.6) 819 (18.7) 
65–69 (n, %) 1818 (16.0) 1030 (14.7) 788 (18.0) 
70 –74 (n, %) 1521 (13.4) 997 (14.3) 524 (12.0) 
75-79 (n, %) 1285 (11.3) 959 (13.7) 326 (7.4) 
80 - 84 (n, %) 821 (7.2) 710 (10.2) 111 (2.5) 
85 -89 (n, %) 325 (2.9) 297 (4.3) 28 (0.6) 
90- 94 (n, %) 106 (0.9) 105 (1.5) 1 (0.0) 
95-99 (n, %) 11 (0.1) 11 (0.2) 0 (0.0) 
Drop outs are 3 year follow up non-responders or incomplete pain information 
 
Table 7.12 Age-sex distribution of thesis samples A (n=11,375) and B (n=4386) 
and baseline NorStOP responders who dropped out of follow up  
 
Age 
(years) 
Thesis sample A 
n=11375 
 
Drop out  between thesis 
sample A and B 
 n=6989 
Thesis sample B 
n=4386 
 Female 
 (n, %) 
Male  
(n, %) 
Female 
 (n, %) 
Male 
 (n, %) 
Female  
(n, %) 
Male  
(n, %) 
50- 54 878 (54.7) 727 (45.3) 428 (52.8) 383 (47.2) 450 (56.7) 344 (43.3) 
55 - 59 1093 (51.8) 1019 (48.3) 537 (48.1) 580 (51.9) 556 (55.9) 439 (44.1) 
60 - 64 891 (50.3) 880 (49.7) 463 (48.6) 489 (51.4) 428 (52.3) 391 (47.7) 
65 - 69 916 (50.4) 902 (49.6) 510 (49.5) 520 (50.5) 406 (51.5) 382 (48.5) 
70 -74 820 (53.9) 701 (46.1) 532 (53.4) 465 (46.6) 288 (55.0) 236 (45.0) 
75- 79 706 (54.9) 579 (45.1) 533 (55.6) 426 (44.4) 173 (53.1) 153 (46.9) 
 80- 84 504 (61.4) 317 (38.6) 435 (61.3) 275 (38.7) 69 (62.2) 42 (37.8) 
85 - 89 216 (66.5) 109 (33.5) 200 (67.3) 97 (32.7) 16 (57.1) 12 (42.9) 
90 - 94 81 (76.4) 25 (23.6) 80 (76.2) 25 (23.8) 1 (100.0) 0 (0.0) 
95 -99 7 (63.6) 4 (36.4) 7 (63.6) 4 (36.4)   
  100 +       
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Lower levels of deprivation and satisfactory income adequacy are more prevalent 
in thesis samples A and B than and the drop out group (table 7.13), this is 
expected given the association of lower socio-economic position and poor health 
leading to study attrition.   
 
Table 7.13 The distribution of socio-economic position indicators in thesis samples 
A (n=11,375) and B (n=4386) and respondents who dropped out of follow up  
 
Variable Thesis 
sample A  
(n=11375) 
Drop out between 
thesis sample A 
and B  (n=6989) 
Thesis sample B 
(n=4386) 
FT Education (n, %) 
   Yes 
    No  
missing 
 
1382 (12.2) 
9793 (86.1) 
200 (1.8) 
 
706 (10.1) 
6150 (88.0) 
133 (1.9) 
 
676 (15.4) 
3643 (83.1) 
67 (1.5) 
Income adequacy (n, %) 
   Adequate 
   Inadequate  
   Unknown  
 
4858 (55.6) 
6320 (42.7) 
197 (1.7) 
 
3688 (45.2) 
3157 (52.8) 
144 (2.1) 
 
2632 (60.0) 
1701 (38.8) 
53 (1.2) 
IMD (n, %) 
Least deprived  
2
nd
 least deprived 
Mid deprived 
2
nd
 most deprived 
Most deprived 
missing 
 
2295 (20.2) 
2351 (20.7) 
2265 (19.9) 
2211 (19.4) 
2250 (19.8) 
0.0 
 
1332 (19.1) 
1327 (19.0) 
1385 (19.8) 
1411 (20.2) 
1532 (21.9) 
0.0 
 
963 (22.0) 
1024 (23.4) 
880 (20.1) 
800 (18.2) 
718 (16.4) 
0.0 
 FT Education= continuing education after aged 16 years; IMD = Index of Multiple 
Deprivation 
 
 
The pain measures of thesis samples A and B and the drop outs is very similar 
(table 7.14).  All groups have a mean number of pain sites of 6 and the 
widespread pain measures are almost identically proportioned in all three groups. 
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Table 7.14 The distribution of pain in thesis samples A (n=11,375) and B (n=4386) 
and respondents who dropped out of follow up 
Variable Thesis 
sample A 
(n=11375) 
Drop out between 
thesis sample A 
and B  (n=6989) 
Thesis sample B 
(n=4386) 
Number of pain sites 
Mean (range) 
standard deviation (SD) 
 
6.1 (0-44) 
SD 7.2 
N=11,375 
 
6.1 (0-44) 
SD 7.3 
N=6989 
 
6.0 (0-44) 
SD 7.0 
N=4386 
Widespread pain (n, %) 
No pain 
Some pain 
Widespread pain 
 
3138 (27.6) 
5175 (45.5) 
3062 (26.9) 
 
1919 (27.5) 
3210 (45.9) 
1860 (26.6) 
 
1219 (27.8) 
1965 (44.8) 
1202 (27.4) 
   
In summary, attrition over follow up has the age and sex structure of thesis sample 
B compared with thesis sample A, with more men in the older age groups and 
fewer respondents aged 70 years and older in thesis sample B. Thesis sample B 
also has a greater proportion of respondents in the least deprived IMD categories.  
All of these differences can be explained by the healthy cohort effect whereby 
those in the poorest health are unable to continue in study follow up and the fitter 
‘survivors’ populate the follow up cohorts.  The pain measures are similar across 
thesis sample A, B and those who were lost to follow up, thus pain differences 
between groups is not likely to be a significant source of bias.  
7.5 Chapter summary  
This chapter has described in detail the derivation of thesis samples A and B in 
preparation for analyses.  There is a risk of bias within the sample derivation and 
this must be considered when interpreting results, for example the NorStOP 
baseline study population are older and have proportionally more semi-routine and 
routine occupations in the sample than corresponding local and national 
populations.  This impact is mitigated by responder losses at baseline and through 
NorStOP follow up which have resulted in thesis samples A and B having an age-
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sex structure similar to local and national populations.   The mean number of pain 
sites is lower in thesis samples A and B than the NorStOP baseline sample and 
any risk estimates associated with pain must be considered as potential 
underestimations.  Having gained a clear understanding of the thesis sample 
development and the local and national context, the next chapter will describe the 
demographics and pain epidemiology of thesis samples A and B.  
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Chapter 8: Thesis study sample demographics and pain 
associations  
8.1 Overview  
This chapter describes the distribution of pain and covariates of thesis sample A 
(n=11,375, containing NorStOP baseline responders who consented for medical 
record review and who provided consistent responses to pain measures) and 
thesis sample B (n=4386, containing NorStOP respondents who completed all 
stages of follow up and provided consistent responses to pain measures), building 
on the detail from Chapter 7 which compared age, sex and socioeconomic position 
to local and national samples.  The rationale for the chapter is explained and 
methods used to present information about pain and covariate distributions within 
thesis samples A and B are discussed.  Covariate distributions across thesis 
samples A and B are presented and compared; this is followed by an analysis of 
pain distributions in thesis samples A and B and pain and univariate associations 
in thesis sample A.  The results are discussed and implications for future analyses 
within this thesis are examined.  
 
8.2 Rationale and chapter objectives 
Pain and covariate distributions across thesis sample A and thesis sample B are 
presented to provide an overview of the demographic and health status of study 
respondents to set the scene for future analyses.  Covariate distributions between 
thesis samples A and B are compared statistically to enable quantitative 
evaluation of the impact of drop out as respondents move between thesis sample 
152 
 
A and B; Chapter 5 (systematic review and meta-analysis) demonstrates why 
knowledge about respondent attrition is important to minimise risk of bias 
introduced through drop out.  The covariate distributions between samples are 
therefore compared to enable clearer consideration of this potential source of bias.  
Univariate associations between pain and covariates enable statistically significant 
relationships to be identified and thus have their impact considered during later 
analyses examining the relationship between pain and falls.  For example, if 
depression is found to be highly correlated with pain status (either the number of 
pain sites or the widespread measure of pain), then any association between pain 
and falls found in this thesis may be, at least partly explained by the presence of 
depression.  This is explained in greater detail in chapter 11, where the impact of 
putative influencers of the pain-falls relationship is discussed.  It is important to 
know which covariates are associated with pain in this analysis so that due 
consideration is given in future analyses.  
This chapter therefore seeks to: 
i) describe the distributions of pain and covariates in thesis sample A and 
B, and quantify any differences; 
ii) describe the univariate associations between covariates and pain 
measures 
8.3 Methods  
8.3.1 Presentation of pain and covariate distributions  
Simple frequencies are used to describe the distribution of all covariates in thesis 
samples A (n=11,375) and B (n=4386).   
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8.3.2 Comparison of pain and covariate distributions between samples  
8.3.2.1 Distribution of pain and covariates  
The distribution of each continuous variable was measured and non-parametric 
distributions were confirmed.  For example, the total medication count is skewed 
towards no medication, anxiety and depression scores are clustered towards the 
lower scoring end.   Covariates that are expected to follow a normal distribution do 
not strictly exhibit this pattern; age is clustered between 50-60 years rather than 
the midpoint age in the sample range (75 years) and BMI is centred on 26.7kg/m2, 
not the midpoint of the sample range 41.5 kg/m2).   Since continuous covariates 
are all distributed non-parametrically, non-parametric statistical tests are used in 
this analysis.   
8.3.2.2 Comparison of mean values between groups  
Continually distributed covariates have their mean values compared between 
thesis sample A and thesis sample B using the non-parametric Kruskal Wallis one-
way analysis of variance (KW) test.  The KW test (Kruskal and Wallis, 1952) is a 
multiple-sample generalisation version of a rank sums test that tests the 
hypothesis that several samples are from the same population (Stata, 2013).  For 
example, in the context of this study considering the mean number of pain sites 
within thesis sample A and thesis sample B, the ‘same population’ would mean 
that all respondents with the same mean number of pain sites score would be in 
the same sample group.  The test ranks the number of pain sites and 
corresponding thesis sample groups and assesses whether the same ranking 
would appear if the population was the ‘same’.  The result is given as a chi-
squared calculation with an associated probability (p), with a probability (p) of 
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<0.05 giving a statistically significant result, i.e. the populations are significantly 
different, or, in the example given, the number of pain sites varies significantly 
between thesis sample groups.    The level of significance for the p-value is set at 
0.05, a commonly used cut off point such that if the observed p-value is <0.05 it is 
considered good evidence that the null hypothesis can be rejected (Peacock & 
Peacock, 2010). 
8.3.2.3 Comparison of categorical covariate distributions between samples  
Comparison of categorical variable distributions between thesis samples A and B 
is done using the chi squared test.  The chi squared test tests the null hypothesis 
that there is no association between the categorical variables by calculating 
expected frequencies and comparing these with observed values (Peacock & 
Peacock, 2010).  Chi squared values are presented with an estimate of probability 
on how likely the result is to have been obtained if the variables are not 
associated, for example, how likely the differences in distribution are if there is no 
association with being in either thesis sample A or thesis sample B.  A p-value of 
<0.05 means that the null hypothesis is rejected as the probably of this result 
occurring by chance alone in a situation where variables are not associated is less 
than 5%.   
8.3.3 Pain and univariate associations  
The association between the number of pain sites and categorical covariates is 
measured using the KW test since this involves a comparison of the mean number 
of pain sites across different categories.  
The association between the number of pain sites and continuously distributed 
variables is done using the Spearman’s rank correlation or the Kendall’s tau, tests 
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that are used to measure the association between two continuously distributed 
non-parametric variables.  Since there are ties within the data (for example, many 
respondents share the same number of pain sites and many respondents share 
the same anxiety score), Kendall’s tau test is most appropriate (Peacock & 
Peacock, 2010).  Kendall’s tau test examines the null hypothesis that there is no 
tendency for one variable either to increase or to decrease as the other variable 
increases (Peacock & Peacock, 2010), for example that the number of pain sites 
does not change when depression score increases.  The analysis program 
provides the tau-b estimate and a probability score (p-value).  The test takes 
account of ranking value rather than the true value of the measurement and so the 
only conclusion that can be drawn is whether the association follows the null 
hypothesis, thus a p value < 0.05 means the null hypothesis (for example, that 
anxiety score and number of pain sites are independent) is rejected.     
The association between the widespread pain measure (no pain / some pain / 
widespread pain) and categorically distributed covariates is measured using the 
chi squared test.  The association between the widespread pain measure and 
continuously measured covariates is evaluated using the KW test.    
Thesis sample A will be used to measure cross-sectional associations between 
pain and covariates since this is the larger sample that contains more data and will 
therefore provide estimates that are more representative of the wider population. 
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8.4 Results  
8.4.1 Pain and covariate distributions in thesis sample A and thesis sample B  
8.4.1.1 Age and sex  
Table 8.1 provides a reminder of the age and sex distributions in thesis samples A 
and B.  50% (5701 respondents) of thesis sample A and 60% (2602 respondents) 
of thesis sample B are aged between 55 and 69 years of age.  The mean age of 
thesis sample A is 65.9 years (SD 10.0, range 50 years to 99 years) and the mean 
age of thesis sample B is 62.9 years (SD 8.3, range 50 years to 90 years).  There 
were 1263 (11%) adults aged 80 years and older in thesis sample A and 40 (3%) 
in thesis sample B.  The age distribution between thesis sample A and B is 
statistically significantly different (p=<0.01).   
 
Table 8.1. Age and sex distribution in thesis sample A and thesis sample B 
Age 
(years) 
Thesis sample A 
n=11375 
 
Thesis sample B 
n=4386 
 Female 
 (n, %) 
Male  
(n, %) 
Female  
(n, %) 
Male  
(n, %) 
50- 54 878 (54.7) 727 (45.3) 450 (56.7) 344 (43.3) 
55 - 59 1093 (51.8) 1019 (48.3) 556 (55.9) 439 (44.1) 
60 - 64 891 (50.3) 880 (49.7) 428 (52.3) 391 (47.7) 
65 - 69 916 (50.4) 902 (49.6) 406 (51.5) 382 (48.5) 
70 -74 820 (53.9) 701 (46.1) 288 (55.0) 236 (45.0) 
75- 79 706 (54.9) 579 (45.1) 173 (53.1) 153 (46.9) 
 80- 84 504 (61.4) 317 (38.6) 69 (62.2) 42 (37.8) 
85 - 89 216 (66.5) 109 (33.5) 16 (57.1) 12 (42.9) 
90 - 94 81 (76.4) 25 (23.6) 1 (100.0) 0 (0.0) 
95 -99 7 (63.6) 4 (36.4)   
  100 +     
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8.4.1.2 Socioeconomic position measures  
Table 8.2 demonstrates approximately 50% of the respondents were employed in 
semi-routine or routine occupations in both samples (5704 respondents in thesis 
sample A and 2024 in thesis sample B).  Approximately 85% of respondents had 
not gone on to full time education after completing schooling in both samples 
(9793 in thesis sample A and 3643 in thesis sample B) and income inadequacy 
was reported by 4858 respondents (42.7%) in thesis sample A and 1701 
respondents (38.8%) in thesis sample B.  Distribution across IMD quintiles showed 
more respondents in the least and second least deprived categories in thesis 
sample B compared with thesis sample A.  All the socioeconomic position 
measures were statistically significantly different across samples. 
Table 8.2 Socio-economic position indicators in thesis samples A (n=11,375) and 
B (n=4386)  
Variable  Thesis sample 
A n (%) 
Thesis sample B 
n (%) 
Difference test 
of significance 
Occupational class  
 1 higher managerial and professional 
2 lower managerial and professional 
3 intermediate occupations 
4 self-employed 
5 lower supervisory / technical  
6 semi-routine 
7 routine 
8 retired  
9 unclassified  
 
683 (6.0) 
1479 (13.0) 
1289 (11.3) 
703 (6.2) 
685 (6.0) 
2587 (22.7) 
3117 (27.4) 
1 (0.8) 
831 (6.5) 
 
313 (7.1) 
734 (16.7) 
584 (13.3) 
272 (6.2) 
249 (5.7) 
1055 (24.1) 
969 (22.1) 
0 (0.0) 
210 (4.8) 
 
p=<0.01 
Full Time education  
   Yes 
    No  
   Unknown 
 
1382 (12.2) 
9793 (86.1) 
200 (1.8) 
 
676 (15.4) 
3643 (83.1) 
67 (1.5) 
 
p=<0.01 
Income adequacy  
   Adequate 
   Inadequate  
   Unknown  
 
6320 (55.6) 
4858 (42.7) 
197 (1.7) 
 
2632 (60.0) 
1701 (38.8) 
53 (1.2) 
 
p=<0.01 
IMD  
 Least deprived  
 2
nd
 least deprived 
 Mid deprived 
 2
nd
 most deprived 
 Most deprived  
Unknown  
 
2295 (20.2) 
2351 (20.7) 
2265 (19.9) 
2211 (19.4) 
2250 (19.8) 
3 (0.0) 
 
963  (22.0) 
1024 (23.4) 
880  (20.1) 
800  (18.2) 
718  (16.4) 
1 (0.0)  
 
p=<0.01  
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8.4.1.3 Physical health indicators  
Table 8.3 presents the prevalence of physical health indicators within thesis 
samples A & B.  8471 respondents (74.5%) in thesis sample A and 3510 
respondents (80.0%) in thesis sample B had a multimorbidity score of 0, indicating 
absence of any medical conditions included in the CCI.  Approximately 15% of 
respondents had one included medical condition (1899 respondents in thesis 
sample A and 622 respondents in thesis sample B); 1005 respondents (8.8%) in 
thesis sample A and 254 respondents (5.8%) in thesis sample B had a CCI score 
of 2 or more.  A quarter of thesis sample A (2809 respondents) reported dizziness, 
one fifth (2102 respondents) reported hearing impairment and one fifth (2359 
respondents) reported visual impairment.  The corresponding prevalence in thesis 
sample B were one fifth (873 respondents), 14% (631 respondents) and 15% (671 
respondents) respectively.  Mean BMI in thesis samples A and B was 27kg/m2, 
indicative of an ‘overweight’ status.   The differences between samples was 
statistically significant for all physical health indicators except BMI.  
Table 8.3 The distribution of physical health indicators in thesis sample A 
(n=11,375) and B (n=4386)  
Variable  Thesis sample A 
n (%) 
Thesis sample B 
n (%) 
Difference test of 
significance 
Multimorbidity CCI  
0 (score 0) 
1 (score 1)  
2 (score 2-8) 
 
8471 (74.5) 
1899 (16.7) 
1005 (8.8) 
 
3510 (80.0) 
622 (14.2) 
254 (5.8) 
 
p=<0.01 
Dizziness 
Yes  
No  
 
2809 (24.7) 
8566 (75.3) 
 
873 (19.9) 
3513 (80.1) 
 
p=<0.01 
Hearing impairment 
Yes  
No  
 
2102 (18.5) 
9273 (81.5) 
 
631 (14.4) 
3755 (85.6) 
 
p=<0.01 
Visual impairment 
Yes  
No 
 
2359 (20.7) 
9016 (79.3) 
 
671 (15.3) 
3715 (84.7) 
 
p=<0.01 
BMI (kg/m
2
) mean, SD  
Missing  
26.7 (11.9-71.5), 4.7 
416 (3.7%) 
26.9 (15.1-71.5), 4.5 
105 (2.4%) 
 
p=0.15 
CCI=Charlson Comorbidity Index; BMI = body mass index  
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8.4.1.4 Mental health markers  
As presented in table 8.4, the mean ABS-SIP score for cognitive complaint was 
14.7 for thesis sample A and 11.5 for thesis sample B; the ABS-SIP score range is 
0-100; both sample scores indicate a low average impact score.  The mean 
Hospital Anxiety and Depression subscales scores for thesis sample A were 4.8 
for depression and 6.7 for anxiety; corresponding means in thesis sample B were 
4.1 and 6.5.  Since a HADS score of between 0 and 7 on each subscale is 
considered within the normal range (Snaith, 2003).  The sample mean 
experiences of depression and anxiety are within the normal range.   The 
differences between groups were statistically significant for cognitive impairment 
and depression, but not for anxiety. 
 
Table 8.4 The distribution of mental health indicators in thesis sample A 
(n=11,375) and B (n=4386)  
 
Variable  Thesis sample A 
% 
(n given in cells) 
Thesis sample B 
% 
(n given in cells) 
Difference test 
of significance 
Cognitive complaint 
Mean (range) 
Standard deviation 
Number in sample (%) 
Missing (%) 
 
14.7 (0-100) 
23.4 
10774 (94.7) 
604 (5.3) 
 
11.5 (0-100) 
SD 19.9 
4232 (96.5) 
154  (3.5) 
 
 
p=<0.01 
Depression 
Mean (range) 
Standard deviation 
Number in sample (%) 
Missing (%) 
 
4.8 (0-21) 
3.7 
11120 (97.8) 
255 (2.2) 
 
4.1 (0-21) 
3.4 
4311 (98.3) 
75 (1.7) 
 
p=<0.01 
Anxiety 
Mean (range) 
Standard deviation 
Number in sample (%) 
Missing (%) 
 
6.7 (0-21) 
4.2 
11,110 (97.7) 
265 (2.3) 
 
6.5 (0-21) 
4.1 
4311 (98.3) 
75 (1.7) 
 
p=0.15 
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8.4.1.5 Medication  
The mean number of medications in both samples was 3 (see table 8.5).  23% 
(2,587) of thesis sample A had no medication prescribed in the three months prior 
to baseline NorSTOP survey and 763 (6.7%) of respondents had 10 or more 
medications prescribed.   1187 (27.0%) of thesis sample B had no medications 
prescribed and 154 respondents (3.5%) had 10 or more medications prescribed.   
Approximately three-quarters of thesis samples A (8231 respondents) and B (3421 
respondents)  did not have paracetamol and / or opiate-based analgesia 
prescribed.  Of those who did, 23.0% (1505 respondents) of thesis sample A and 
24.0% (493 respondents) of thesis sample B had strong or very strong opioids 
prescribed.  10% of thesis sample A (1233 respondents) and thesis sample B (464 
respondents) were prescribed NSAIDs.   The difference in total medication count 
and pain medication prescriptions is statistically significantly difference between 
samples; this is not the case for NSAID medication. 
Table 8.5 The distribution of medication measures in thesis sample A (n=11,375) 
and B (n=4386) 
Variable Thesis sample A 
(n=11,375) 
Thesis sample B 
(n=4,386) 
Difference test of 
significance 
Total medication 
count 
Mean (range) 
SD 
 
 
3.5 (0-20) 
3.5 
 
 
2.8 (0-20) 
3.0 
 
 
p=<0.01 
Pain medication 
maximum category 
0 (n, %) 
1 (n, %) 
2 (n, %) 
3 (n, %) 
4 (n, %) 
 
 
8231 (72.3) 
867 (7.6) 
772 (6.8) 
780 (8.9) 
725 (6.4) 
 
 
3421 (78.0) 
259 (5.9) 
213 (4.9) 
261 (6.0) 
232 (5.3) 
 
 
p=<0.01 
NSAID use 
Yes (n, %) 
No (n, %) 
 
1233 (10.8) 
10142 (89.2) 
 
464 (10.6) 
3922 (89.4) 
 
p=0.48 
 
Pain medication maximum category:  0 No analgesics, 1 Basic analgesics, 2 Weak combination 
opioids, 3 Moderate combination opioids and opioids , 4 Strong combination opioids and opioids, 
5 Very strong single opioids; SD = standard deviation; NSAID = non-steroidal anti-inflammatory 
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8.4.1.6 Physical functioning  
7928 respondents (69.6%) in thesis sample A and 3501 respondents (79.8%) in 
thesis sample B reported no difficulty walking 100 yards (table 8.5); 1378 
respondents (12.1%) in thesis sample A and 281 respondents (6.4%) in thesis 
sample B reported a lot of difficulty walking 100 yards.   The difference between 
samples is statistically significant.   
 
Table 8.6 The distribution of physical functioning in thesis sample A (n=11,375) 
and B (n=4386)  physical functioning 
 
Physical functioning 
(difficulty walking 100 
yards) n (%) 
Thesis sample A 
 
Thesis sample B 
 
Difference 
test of 
significance 
Yes, a lot 
Yes, a little 
No 
Missing 
1378 (12.1) 
1876 (16.5) 
7918 (69.6) 
203 (1.8) 
281 (6.4) 
560 (12.8) 
3501 (79.8) 
44 (1.0) 
p=<0.01 
 
8.4.1.7 Covariates: missing data  
Variables obtained from general practice consultation and prescription records 
have no data missing and variables obtained exclusively from the NorStOP survey 
have some data missing.   Education status, income, anxiety, depression, BMI and 
physical functioning have <5% of data missing therefore the impact of this missing 
data is therefore likely to be low.  604 respondents (5.3%) in thesis sample A did 
not complete the ABS-SIP scale and have missing data.  This may impact on 
results if those with missing data all had a higher, or lower, level of cognitive 
impairment.   
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  8.4.1.8 Pain and covariates: summary  
Respondents in thesis samples A and B are from a range of ages and the 
proportion of males and females follows national trends.  Thesis samples A and B 
contain a high proportion of semi-routine or routine occupations and the majority 
have not gone on to further education after leaving school; more respondents 
report income inadequacy than adequacy and this is also reported more frequently 
in thesis sample B.  There are proportionally more respondents from the least 
deprived IMD groups in thesis sample B.  Thesis sample B contains statistically 
significant lower proportions of physical health indicators and depression and 
cognitive impairment than thesis sample A and proportionally fewer medications 
and strong analgesics are prescribed in thesis sample B.  The majority of both 
samples have no CCI-linked comorbidities, anxiety, depression and cognitive 
complaint measures in the ‘normal’ range and do not take analgesics.  A greater 
proportion of respondents reporting no limitation in physical functioning are found 
in thesis B than thesis A.   The differences between thesis samples A and B are 
largely explained by the ‘healthy cohort’ effect, whereby the healthiest people (i.e. 
those with least comorbidities, mental health difficulties and polypharmacy) remain 
in the cohort until the study ends.   
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8.4.2 Pain and associations 
8.4.2.1 Pain distributions  
The prevalence of reported pain within thesis sample A and thesis sample B is 
72.4% (n=8237) and 72.2% (n=3167) respectively.  The number of pain sites is 
skewed towards 0, with 26.6% (3,026 respondents) of the sample reporting no 
pain in thesis sample A.   In thesis sample A, 5.3% (605) of respondents reported 
single site pain, indicating that multisite pain was the most common presentation 
of pain within the sample.  8.0% (910) reported two sites of pain, 6.4% (728) 
reported 3 sites, 8.1% (921) reported 4 sites and then the frequencies reduced 
from 5.7% (652) reporting 5 pain sites to 7 people (0.06%) reporting 44 pain sites.  
Figure 8.1 presents the distribution of number of pain sites.  Thesis sample B 
followed a very similar pattern of pain distribution and the difference between the 
mean number of pain sites between thesis samples A (mean number of pain sites 
6.09 (95% CI 5.96-6.23) and B (mean number of pain sites 6.00 (95% CI 5.79-
6.21)) was not statistically significant (p=0.56).   
 
27.6% (3,138) of respondents reported no pain, 45.5% (5,175) reported some pain 
and 26.9% (3,062) met the criteria for ACR definition for widespread pain in thesis 
sample A; the corresponding figures for thesis sample B were 27.8% (1,219) 
reported no pain, 44.8% (1,965) reported some pain) and 27.4% (1,202) reported 
widespread pain.  The differences in distribution of the widespread pain measure 
between thesis samples was not significant (p=0.47).   
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Figure 8.1 The distribution of the number of pain sites within thesis sample A 
(n=11,375) 
 
 
 
8.4.2.2 Pain and demographic covariates  
Table 8.7 outlines associations with the number of pain sites, pain 
widespreadness and demographic covariates.  The mean number of pain sites is 
not statistically significantly associated with age when analysed as a continuous 
measure; age is statistically significantly associated with widespreadness although 
a difference in mean age of less than 12 months suggests that this difference is 
not clinically significant.  Females are statistically significantly more likely to report 
more number of pain sites (mean number for women rounded to 7, compared with 
a mean for men of 5) and report more widespread pain.  
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Table 8.7 Cross-sectional associations between multisite pain and demographics 
in thesis sample A (n=11,375) 
 
  Variable 
Number of pain 
sites 
Mean (95% CI) 
No pain  
n=3138  
Some pain 
n=5175 
Widespread 
pain 
n=3062 
P values 
Age, years 
Mean (95% CI) 
 
50-54 5.9 (5.5-6.2)  
66.1  
(65.7-66.4) 
 
 
66.2  
(65.9-66.5) 
 
 
65.3 
 (65.9-66.4) 
 
NPS & 
categorical age: 
chi squared 
 p= 0.07 
 
NPS & 
continuous age: 
Tau-b p of H0 = 
0.27 
 
Widespread pain 
measure: p=0.01 
55-59 6.3 (6.0-6.6) 
60-64 6.4 (6.0-6.7) 
65-69 6.1 (5.8-6.4) 
70-74 5.6 (5.3-6.0) 
75-79 6.2 (5.8-6.6) 
80-84 6.2 (5.7-6.7) 
85-89 5.7 (5.0-6.5) 
90-94 6.0 (4.6-7.4) 
95-99 3.2 (0.8-5.5) 
Sex 
Male (n, %) 
Female (n, %) 
 
5.4 (5.3-5.6) 
6.7 (6.5-6.9) 
 
1575 (29.9) 
1563 (25.6) 
 
2459 (46.7) 
2716 (44.4) 
 
1229 (23.3) 
1833 (30.0) 
NPS: Chi squared 
p< 0.01 
Widespread 
pain: 
P<0.01 
Education > 16y 
Yes 
No 
Missing 
 
5.2 (4.8-5.5) 
6.2 (6.1-6.4) 
6.6 (5.6-7.4) 
 
465 (33.7) 
2623 (26.8) 
50 (25.0) 
 
613 (44.4) 
4476 (45.7) 
86 (43.0) 
 
304 (22.0) 
2694 (27.5) 
64 (32.0) 
NPS: Chi squared 
p <0.01 
Widespreadness: 
P<0.01* 
Occupational 
class 
Manual 
Non-manual 
Unknown 
 
6.3 (6.1-6.5) 
5.6 (5.4-5.8) 
7.0 (6.5-7.6) 
 
1669 (26.1) 
1274 (30.7) 
195 (23.4) 
 
2881 (45.1) 
1903 (45.8) 
391 (47.0) 
 
1839 (28.8) 
977 (23.5) 
246 (29.6) 
NPS: Chi squared 
p <0.01 
Widespreadness: 
P<0.01 
Income 
adequacy 
Adequate 
Inadequate 
Unknown 
 
 
4.9 (4.8-5.1) 
7.5 (7.3-3.8) 
7.2 (6.1-8.3) 
 
 
2022 (32.0) 
1074 (22.1) 
42 (21.3) 
 
 
2941 (46.5) 
2143 (44.1) 
91 (46.2) 
 
 
1357 (21.5) 
1641 (33.8) 
64 (32.5) 
NPS: Chi squared 
p <0.01 
 
Widespreadness: 
P<0.01 
IMD 
Least deprived 
2
nd
 least dep. 
Mid deprived 
2
nd
 most dep. 
Most deprived 
Missing 
 
5.2 (4.9-5.4) 
5.5 (5.2-5.8) 
6.0 (5.7-6.3) 
6.6 (6.3-6.9) 
7.2 (6.9-7.6) 
2.3 (-5.9-13.9) 
 
700 (30.5) 
704 (29.9) 
618 (27.3) 
587 (26.6) 
528 (23.5) 
1 (33.3) 
 
1089 (47.5) 
1078 (45.9) 
1044 (46.1) 
982 (44.4) 
981 (43.6) 
1 (33.3) 
 
506 (22.1) 
569 (24.2) 
603 (26.6) 
642 (29.0) 
741 (32.9) 
1 (33.3) 
 
NPS: Chi squared 
p <0.01 
 
Widespreadness: 
P<0.01 
NPS = number of pain sites; P of H0 = probability of null hypothesis being true; *this significance value 
tests for differences between groups, excluding the ‘unknown’ categories; IMD = Index of multiple 
deprivation; Education > 16y = continuing in full time education beyond aged 16 years; dep.=deprived 
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Full time education status is statistically significantly associated with both pain 
measures, with a lower number of pain sites and widespread pain reported 
amongst those continuing in full time education after leaving school.  Occupational 
class is also statistically significantly associated with both pain measures; manual 
workers reported a greater number of pain sites than non-manual workers 
although when the number is rounded the mean number of 6 it is the same for 
both groups.  Manual workers also reported more widespread pain than non-
manual workers (28.8% (1839 respondents) compared with 23.5% (977 
respondents).   IMD is statistically significantly associated with the number of pain 
sites and the distribution of the widespread pain measure.  The number of pain 
sites increases with rising levels of deprivation from 5.2 in the least deprived 
category to 7.2 in the most deprived category.  The prevalence of widespread pain 
also increases with increasing deprivation, from 22.1% (506 respondents) in the 
least deprived area to 32.9% (741 respondents) in the most deprived area.   
8.4.2.3 Pain and medical condition covariates 
Multimorbidity was statistically significantly associated with pain, with a greater 
number of pain sites and prevalence of widespread pain reported amongst those 
with higher CCI scores; for example, the mean number of pain sites and 
percentage of respondents reporting widespread pain was 5.6 and 25.5% (2159 
respondents) respectively for those with no Charlson-scored morbidities and 7.8 
and 32% (322 respondents) respectively for those with CCI scores between 2 and 
8 (table 8.8).   Respondents with a BMI in the normal range had statistically 
significant lower mean number of pain sites and proportion of widespread pain 
compared to their underweight, overweight and obese counterparts, although the 
mean BMIs for each widespread category were all within the ‘overweight’ range 
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and the two-point difference in BMI (25.7kg/m2 compared to 27.6kg/m2) is not 
clinically significant.   Respondents reporting dizziness, hearing impairment or 
visual impairment were all statistically significantly more likely to report a larger 
number of pain sites and more widespread pain.  The most marked difference was 
seen in the dizziness grouping, where those reporting dizziness had 4 additional 
pain sites and 20% more reported widespread pain than their non-dizzy 
counterparts.   
Table 8.8 Cross-sectional associations between multisite pain and physical health 
indicators in thesis sample A (n=11,375) 
 
Variable 
Number of pain 
sites 
Mean (95% CI) 
No pain 
(%) 
Some pain 
(%) 
Widespread 
pain (%) 
P values 
Multimorbidity 
CCI 
0 
1 
2 
 
5.6 (5.5-5.8) 
7.2 (6.9-7.6) 
7.8 (7.3-8.4) 
 
2461 (29.1) 
443 (23.3) 
234 (23.3) 
 
3851 (45.5) 
875 (46.1) 
449 (44.7) 
 
2159 (25.5) 
581 (30.6) 
322 (32.0) 
NPS: Chi squared 
p <0.01 
Widespreadness: 
P<0.01 
BMI 
n = 10959 
Underweight 
Normal weight 
Overweight 
Obese 
Very obese 
Missing 
 
Continuous 
Mean 
range 
n 
 
 
6.5 (5.2-7.7) 
5.1 (4.9-5.3) 
6.1 (5.9-6.3) 
7.8 (7.5-8.2) 
11.3 (9.8-12.8) 
6.4 (5.6-7.1) 
 
 
 
 
 
 
 
 
 
 
 
25.7 
14.4-60.2 
3030 
 
 
 
 
 
 
 
 
 
 
26.7 
13.8 – 70.3 
4982 
 
 
 
 
 
 
 
 
 
 
27.6 
11.9 – 71.5 
2947 
NPS & 
categorical BMI: 
Chi squared p 
<0.01 
 
NPS & 
continuous BMI: 
Tau-b = 0.11 
P of H0 < 0.01 
 
Widespreadness: 
p<0.01 
 
Dizziness 
Yes 
No 
 
9.4 (9.1-5.1) 
5.0 (4.9-5.2) 
 
466 (16.6) 
2672 (31.2) 
 
1155 (41.1) 
4020 (46.9) 
 
1188 (42.3) 
1874 (21.9) 
NPS: Chi squared 
p <0.01 
Widespreadness: 
P<0.01 
Hearing 
problem 
Yes 
No 
 
7.3 (6.9-7.6) 
5.8 (6.7-6.0) 
 
435 (20.7) 
2703 (29.2) 
 
994 (47.3) 
4181 (45.1) 
 
673 (32.0) 
2389 (25.8) 
NPS: Chi squared 
p <0.01 
Widespreadness: 
P<0.01 
Vision problem 
Yes 
No 
 
 
7.8 (7.4-8.1) 
5.7 (5.5-5.8) 
 
 
518 (22.0) 
2620 (29.0) 
 
 
1036 (44.0) 
4139 (45.9) 
 
 
805 (34.1) 
2257 (25.0) 
NPS: Chi squared 
p <0.01 
Widespreadness: 
P<0.01 
NPS= number of pain sites; CCI = Charlson comorbidity Index: 0 = no CCI morbidities, 1= 1 CCI 
morbidity, 2= 2-8 CCI morbidities; BMI = body mass index 
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8.4.2.4 Pain and mental health covariates  
The mean number of pain sites is statistically significantly associated with 
increasing scores on the anxiety symptom scoring scale, from a mean of 5 pain 
sites reported in those with minimal symptoms and 10 in those with likely clinical 
anxiety (table 8.9).   
Table 8.9 Cross-sectional associations between multisite pain and mental health 
indicators in thesis sample A (n=11,375)  
Variable  Number of 
pain sites 
Mean (95% CI) 
No pain (%) Some pain 
(%) 
Widespread 
pain (%) 
P values 
Anxiety score 
0-7 
8-10 
11+ 
Missing (n=265) 
n= 11110* 
 
Continuous 
Mean score 
SD 
n=11110 
 
4.6 (4.5-4.8) 
7.4 (7.1-7.7) 
9.8 (9.4-10.2) 
6.4 (5.5-7.4) 
 
 
 
 
 
 
 
 
 
5.2 (0-21) 
SD 3.8 
n= 2077* 
 
 
 
 
 
 
 
 
6.6 (0-21) 
SD 4.0 
n= 5043 
 
 
 
 
 
 
 
 
8.4 (0-21) 
SD 4.3 
n= 2990 
 
NPS & 
categorical 
anxiety score: 
Chi squared 
p=<0.01 
 
Widespreadness: 
p<0.01 
 
Depression 
0-7 
8-10 
11+ 
Missing 
n=11120 
 
Continuous 
Mean score 
SD 
n=11110 
 
5.0 (4.9-5.2) 
9.1 (8.7-9.5) 
11.4 (10.8-12.0) 
6.2 (5.3-7.2) 
 
 
 
 
 
 
 
 
 
3.4 (0-21) 
SD 3.2 
n= 3078 
 
 
 
 
 
 
 
 
4.7 (0-21) 
SD = 3.5 
n= 5049 
 
 
 
 
 
 
 
 
6.3 (0-21) 
SD = 3.9 
n= 2993 
 
NPS & 
categorical 
depression 
score: 
Chi squared 
p=<0.01 
 
Widespreadness: 
p<0.01 
 
Cognitive 
complaint 
No  
Mild  
Moderate 
Severe  
Missing  
n=10774* 
 
Continuous 
Mean (range) 
SD 
n=10774 
 
 
4.3 (4.2-4.5) 
6.9 (6.6-7.3) 
7.9 (7.5-8.2) 
9.9 (9.4-10.4) 
7.1 (6.4-7.7) 
 
 
 
 
 
 
 
 
 
 
 
 
 
8.6 (0-100) 
SD 18.2 
n=3018 
 
 
 
 
 
 
 
 
 
 
14.0 (0-100) 
SD 22.5 
n=4897 
 
 
 
 
 
 
 
 
 
 
22.3 (0-100) 
SD 27.4 
n=2859 
 
NPS & 
categorical 
cognitive 
complaint score:  
Chi squared 
p=<0.01 
 
Widespreadness: 
p<0.01 
 
n=xxxxx* = number of non-missing values in each variable; anxiety and depression scale scores: 0-7 = 
normal, 8-10 = borderline, 11 or over = clinical 'caseness'; NPS= number of pain sites 
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The same pattern was seen in depression, where the mean number of pain sites 
increased from 5 in those with minimal symptoms to 11 in those with likely clinical 
depression.  This pattern is reflected in the widespreadness measure; widespread 
pain was reported in one fifth of respondents with low anxiety or depression scores 
and in almost half of those with high anxiety and depression scores.   Cognitive 
complaint followed a similar trend, with lower scores statistically significantly less 
likely to report multisite pain and widespread pain.   
8.4.2.5 Pain and medication  
Table 8.10 shows that stronger analgesics statistically significantly associated with 
a greater number of pain sites and more widespread pain (table 8.10).   
Table 8.10 Cross-sectional associations between multisite pain and medication 
measures in thesis sample A (n=11,375) 
Variable  Number of pain 
sites 
Mean (95% CI) 
No pain (%) Some pain 
(%) 
Widespread 
pain (%) 
P values 
Total medication 
0 meds  
1-2 meds 
3-4 meds 
5-7 meds 
8+meds  
 
Continuous 
Mean  
SD 
n 
 
3.8 (3.6-3.9) 
5.0 (4.8-5.2) 
6.0 (6.8-6.4) 
7.8 (7.5-8.1)  
9.9 (9.4-10.3) 
 
 
 
 
 
 
 
 
 
 
 
2.5 (2.4-2.6) 
2.8 
3,138 
 
 
 
 
 
 
 
 
3.4 (3.4-3.6) 
3.4 
5,175 
 
 
 
 
 
 
 
 
4.6 (4.5-4.8) 
3.9 
3,062 
NPS & categorical 
total medication:  
Chi squared 
p=<0.01 
 
Widespreadness:  
p<0.01 
 
Pain medication  
  0  
   1  
   2  
   3  
   4  
 
4.6 (4.5-4.8) 
7.0 (6.5-7.5) 
10.2 (9.6-10.9) 
10.6 (10.0-11.2) 
12.2 (11.5-12.9) 
 
2838 (34.5) 
163 (18.8) 
55 (7.1) 
53 (6.8) 
29 (4.0) 
 
3696 (44.9) 
433 (49.9) 
376 (48.7) 
433 (45.9) 
312 (43.0) 
 
1697 (20.6) 
271 (31.3) 
341 (44.2) 
369 (47.3) 
384 (53.0) 
NPS: Chi squared 
p=<0.01 
 
Widespreadness:  
p<0.01 
 
NSAID use  
  Yes 
  No  
 
10.3 (9.8-10.8) 
5.6 (5.5-5.7) 
 
75 (6.1) 
3063 (30.2) 
 
596 (48.3) 
4579 (45.2) 
 
562 (45.6) 
2500 (24.7) 
NPS: Chi squared 
p=<0.01 
Widespreadness:  
p<0.01 
NPS= number of pain sites; Pain medication maximum category:  0 No analgesics, 1 Basic analgesics, 2 
Weak combination opioids, 3 Moderate combination opioids and opioids , 4 Strong combination opioids 
and opioids, 5 Very strong single opioids; SD = standard deviation; NSAID = non-steroidal anti-
inflammatory drugs 
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The total medication number increases with the number of pain sites, from a mean 
of 4 pain sites reported by those with no prescribed medication and those with 8 or 
more medications reporting a mean of 10 pain sites.  From all those taking 8 or 
more medications, almost three times the number of respondents have 
widespread pain than no pain.  The mean number of pain sites increases with 
increasing analgesic strength and this is statistically significant.  Fewer NSAIDs 
are prescribed in the widespread group than the ‘some pain’ group.  
8.4.2.6 Pain and physical functioning  
Declining physical functioning, as measured by difficulty walking, is statistically 
significantly associated with increasing number of pain sites (table 8.11).  
Respondents reporting a lot of difficulty had a mean number of pain sites of 12, 
compared to those reporting no difficulty with a mean of 4.  Almost 50% (655 
respondents) of those with a lot of difficulty reported widespread pain, twice the 
number of those who reported widespread pain with no physical functioning 
problems (19.9% (1572 respondents).   
Table 8.11 Cross-sectional associations between multisite pain and physical 
functioning in thesis sample A (n=11,375) 
 
Variable  Number of pain 
sites 
Mean (95% CI) 
No pain (%) Some pain 
(%) 
Widespread 
pain (%) 
p values 
Physical functioning 
(difficulty walking 
100 yards)  
  
  Yes, a lot  
   Yes, a little  
   No  
   Missing (n=203) 
n=11172 
 
 
 
 
11.7 (11.3-12.3) 
9.2 (8.6-9.6) 
4.4 (4.3-4.5) 
5.2 (4.2-6.1)  
 
 
 
 
130 (9.4) 
236 (12.6) 
2714 (34.3) 
58 (28.6) 
 
 
 
 
593 (43.0) 
850 (45.3) 
3682 (45.9) 
100 (49.3) 
 
 
 
 
655 (47.5) 
790 (42.1) 
1572 (19.9) 
45 (22.2) 
 
 
 
NPS: Chi p<0.01 
 
Widespreadness:  
p<0.01 
significance value tests for differences between groups, excluding the ‘unknown’ category 
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8.4.2.7 Pain and covariate associations: summary 
This section has found that the only covariate not statistically significantly 
associated with pain was age.  Women reported a greater number of pain sites 
and more widespread pain than men.  Indicators of lower socioeconomic position 
were associated with more pain sites and more widespreadness of pain.  Those 
reporting higher numbers of pain sites had more comorbidities, poorer mental 
health indicator scores, were taking more medication and had worse physical 
functioning than those reporting lower number of pain sites.   
 
8.5 Discussion 
8.5.1 Summary of findings  
This chapter has described the distribution of pain and covariates in thesis 
samples A (n=11,375: baseline NorStOP respondents who consented to medical 
record review and who gave consistent answers to the pain questions) and B 
(n=4386: respondents from thesis sample A who completed all NorStOP survey 
follow up and provided consistent answers to the pain question).  The prevalence 
of pain, the mean number of pain sites and the distribution of the widespread pain 
measure are very similar in both samples.  With the exceptions of NSAID use, 
anxiety scores, BMI and sex, all other covariates are distributed statistically 
significantly differently between thesis samples A and B.  These differences mean 
thesis sample B has lower proportions of multimorbidity, dizziness, visual 
disturbance and hearing impairment, lower scores on depression and cognitive 
complaint measures, fewer prescribed medications and fewer strong analgesics, 
and less difficulties with physical functioning than thesis sample A.  These 
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differences are likely to be due to the healthy cohort effect, where survivors who 
remain in the cohort study generally do so because they are fitter and in better 
overall health.   
All covariates are statistically significantly associated with pain status except age 
and must therefore all be considered at possible influencers of the relationship 
between pain and falls.   
 
8.5.2 How findings fit with current literature and what is new  
The prevalence of multisite pain in thesis sample A (73.4%) is higher than 
comparable point prevalence rates taken over a 4-week period, for example 
Scudds et al (2001) who reported a prevalence of 55% in adults aged over 70 
years old.   This could be explained by the construction process of thesis sample 
A, in which NorStOP respondents who did not complete the pain questions 
consistently (see Chapter 7) were excluded.  Thus, it may be that those who did 
not have pain did not feel the need to complete the pain questions and were 
excluded.  Excluding a greater proportion of those with no pain would lead to a 
higher prevalence of pain within thesis sample A.   
The prevalence of widespread pain in thesis sample A was 26.9%, a higher 
prevalence than other studies have found.  For example Docking et al (2015) 
found that the prevalence of chronic widespread pain (defining using the ACR 
definition provided in Chapter 2) was 21.0% in adults aged 55 years and older 
residing in rural communities, higher than the 17% for those living in urban 
communities (Docking et al, 2015).   The prevalence estimate in thesis sample A 
might be due to the measure of pain in the last month rather than pain lasting for 
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at least 3 months in accordance with the ACR definition of widespread pain.    The 
relatively high prevalence of widespread pain within thesis sample A may also be 
reflective of the local population who have preponderance for lower socioeconomic 
position, a status which has been shown to increase the risk of developing 
widespread pain (Davies et al, 2009). 
Multisite pain was more common than single site pain in the thesis samples; this is 
an excepted finding as it is now well documented that single site pain is less likely 
than multisite pain, for example by Picavet and Schouten (2003).   
Finding that age is not statistically significantly associated with pain is expected, 
since evidence suggests that multisite pain is established as early as childhood 
and its course is unlikely to change over time (Papageorgiou et al, 2002).  
Nevertheless this is an interesting finding that has yet to be satisfactorily explained 
within the literature.  Perhaps this is due to older people’s normalisation of the pain 
experience and their belief that it is not treatable or curable.    
The magnitude of anxiety and depression symptoms and the impact on number of 
pain sites is important; a score suggestive of diagnosable anxiety or depression in 
respondents in thesis sample A doubled the number of pain sites reported 
compared to pain-free counterparts.  It is well known that anxiety and depression 
are associated with pain, for example Nicholl et al. (2014) who reported that those 
with multisite pain are more likely to have depressive disorders and Heer et al. 
(2014) who found the presence of anxiety was statistically significantly associated 
with a higher pain scores.  The strength of this association in thesis sample A 
suggests that particular attention is paid to these factors during analysis to ensure 
that any risk of falls associated with pain has taken account of mood disturbance.   
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Another key finding is the statistically significant association of pain with dizziness, 
hearing and vision, especially since pain reporting does not significantly increase 
with advancing age.  Associations between these covariates and pain are not 
widely reported in the literature and it is important that this link is explored further 
outside this thesis.  Perhaps it is the side effects of medications prescribed for pain 
that is responsible for this association, for example, amitriptyline is often trialled for 
widespread pain and dizziness is a possible side effect of this medication.  
Perhaps the pain precludes exercise due to the associated limitation in physical 
functioning, as demonstrated by Mottram et al (2008).  In turn, this reduced 
exercise reduces general health, contributes to increasing comorbidities (as 
demonstrated in this analysis, that pain is associated with higher multimorbidity 
scores) and therefore dizziness is a consequence of physical health problems and 
side effects of medication used to manage multimorbidity.  This cross-sectional 
analysis can only measure associations between variables, it cannot suggest 
causality and so it is not possible to conclude that the poor vision, poor hearing 
and dizziness are contributing to the pain, or vice versa.  However these variables 
are linked, it is likely to be a complex pathway with many additional influencing 
factors and this certainly warrants further explanation, particularly in the context of 
general practice.  Would reducing hearing deficits by ensuring older people have 
access to hearing assessments and aids, or reducing visual disturbances by 
ensuring timely access to phacoemulsification (cataract surgery), screening for 
type II diabetes mellitus or advising particular diets to help reduce the burden of 
wet macular degeneration, or more aggressive investigation and management of 
dizziness result in lowering the prevalence of multisite pain?    
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8.5.3 Strengths  
This chapter has been able to test the direction and strength of association 
between pain and a wide variety of covariates that may also be associated, or are 
known to be associated, with an increased risk of falls.   Testing the associations 
of these variables with pain means a better understanding of their possible 
influence on the relationship between pain and falls in this thesis.  Covariates can 
now be accounted for during analyses to minimise the risk of bias due to 
confounding, or misinterpretation of results that may, in part, be contributed to by 
other covariates.    
Thesis sample A is a large study sample containing 11,375 older adults; as such 
these univariate associations are more likely to be close to the true effect estimate 
than would be seen in a smaller sample.   
This chapter has measured the impact of study attrition on the distribution of 
covariates in thesis sample B when compared to sample A.  Knowledge of this 
difference in samples enables the risk of bias due to study attrition to be minimised 
sufficiently.   
The pain measures used in this chapter, and thesis, are widely used and were 
derived by a validated tool using a body manikin (Lacey et al, 2014).  Furthermore, 
misclassification bias is reduced as respondents who completed the pain 
screening question and body manikin inconsistently were excluded from analysis; 
the pain measure is therefore designed and used in a way that sufficiently limits 
bias from this source.   
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8.5.4 Limitations  
The main limitation of this chapter is the exclusive restriction to univariate analysis.  
Whilst this serves the purpose of establishing which covariates are likely to impact 
the relationship between pain and falls due to their statistically significant 
relationship with pain, it does not explore those individual associations in a real life 
clinical context.  For example, it may be that one of the statistically significant 
associations with pain disappears when a second variable is added to the 
equation.   
All measured associations between pain and covariates are cross-sectional as the 
information is taken at the same time point.  It is therefore not possible to establish 
causality or temporality.  For the purpose of this thesis, a cross-sectional 
association is satisfactory evidence of an association that is statistically significant 
and must be accounted for when analysing the relationship between pain and falls.  
Future studies measuring any pain-falls relationship may find it useful to assess 
changes in covariates according to pain status over time as this may be useful in 
further reducing the risk of falls in older people.  For example, if hearing and visual 
impairments are managed proactively, does this reduce the overall burden of pain 
and thus might reduce the risk of falls?  Mundal et al (2016) undertook a study 
designed to explore the change in the number of pain sites and associations over 
an 11 year period in 78,973 adults aged 20 years and older in Norway; 26,875 
individuals completed all follow ups and had complete information about pain 
status. The study found that, within the 78,973 population, the mean number of 
pain sites didn’t change over the 11 year period.  Within-subject analyses however 
found that a change in number of pain sites was not dependent on pain extent at 
baseline; anxiety and depression symptoms, sleeping problems and a high BMI 
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were found to be the strongest predictors of an increase in pain sites recorded 
over time (Mundal et al, 2016).  This is significant for this thesis; if a temporal 
relationship between pain and covariates can be established, then control of these 
covariates from baseline (for example, identifying and treating depression at an 
early stage) may reduce future pain levels and therefore reduce the risk of future 
falls.   This thesis is not designed to answer this question, although moving 
forward this would be an interesting point to explore further with a clear potential 
role for primary care health professionals.   
8.5.5 Informing the thesis   
All covariates, except age, are significantly associated with pain in thesis sample 
A.  A case can therefore be made to include all of these covariates in analyses 
measuring the risk of falls due to pain, regardless of whether each covariate is 
associated with falls in univariate analysis.  Undertaking statistical testing of 
interactions goes some way towards formally measuring such complex 
relationships between these covariates and this is explained further and 
undertaken during analyses in Chapters 10 and 11.  Given the association of pain 
and all covariates except age, the exclusion of any covariate on the basis of a non-
statistically significant association with falls in univariate analysis (conducted in 
chapter 9) may lead to an analysis that is not reflective of real life daily clinical 
practice, where patients present with multisite pain, display some depressive 
symptoms, have trouble with their memory and are on multiple medications.    
8.5.6 Chapter summary  
This chapter has described the distribution of pain across thesis sample A and B 
and put this into context with existing literature.  Covariate distributions in thesis 
samples A and B have been presented and shown to be statistically significant 
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different with thesis sample B containing respondents with fewer comorbidities, 
better mental health measures, fewer medication and strong analgesic 
prescriptions and less physical functioning limitation.  Univariate associations 
between pain and covariates have found that all but age are statistically 
significantly associated and the majority of these associations are to be expected 
based on the current literature.  Associations with hearing, vision and dizziness 
are new findings which warrant further exploration in future studies, along with 
further study of change in covariates and pain status over time and the role that 
this may have in falls prevention.  The next chapter examines the prevalence of 
falls within the study samples and explores univariate associations between 
covariates and falls.   
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Chapter 9: falls prevalence and univariate analyses of 
putative falls predictors 
 
9.1 Overview  
This chapter describes the prevalence of self-reported, GP-recorded and HES-
recorded falls in thesis sample A (n=11,375).  Univariate associations with self-
reported are then explored and placed within the context of the current literature.   
 
9.2 Rationale and chapter objectives   
Chapter 8 concluded that all covariates must be included in an analysis that 
explores the relationship between pain and falls.  To undertake a clinically useful 
examination of the pain and falls relationship it is first necessary to describe the 
prevalence of falls within the thesis’ study sample to appreciate the size of the 
problem in clinical practice.  It is also essential to understand any association 
between covariates and falls in univariate analysis to then begin to interpret the 
possible impacts of each covariate on the pain-falls relationship.  Therefore, this 
chapter seeks to:  
i) Describe the prevalence of self-reported, GP-recorded and HES-
recorded falls in thesis sample A  (the sample containing baseline 
NorStOP respondents who consented to medical record review and 
completed pain questions consistently); 
ii) To undertake univariate analyses of pain and each covariate and their 
relationship with future self-reported falls. 
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9.3 Methods  
9.3.1 Study sample, pain, covariates and fall measures 
Thesis sample A will be used to measure prevalence since its larger size means it 
is more likely to be powered sufficiently to detect a difference between groups.    
Thesis sample B will be used to explore univariate relationships with future self-
reported falls since this sample has complete follow up; thesis sample A would 
have a large number of missing data for three and six year self-reported falls due 
to loss to follow up at three and six years.   
Pain and covariates are measured as described in Chapter 6 and information on 
covariates is taken from the baseline NorSTOP survey.    
The prevalence of GP-recorded and HES-recorded falls will be examined using 
two outcomes i) the number of respondents who have a GP-recorded or HES-
recorded fall in their records (i.e. ‘ever fallen’); and ii) the total number of GP-
recorded or HES-recorded falls for each respondent.    
9.3.2 Falls prevalence time frames  
For self-reported falls, period prevalence is estimated over the three months prior 
to survey return.  Thus, there is a gap of 2 years and 9 months during which 
respondents may fall but that fall would not be recorded here.  The implications of 
the gap in the self-reporting period are explored in this chapter’s discussion.  
For falls recorded in GP consultation records and HES data, the period prevalence 
is estimated from the start of the respondent’s corresponding NorStOP baseline 
survey mail out until the end of NorStOP3 six year follow up for respondents who 
completed all follow up surveys.  For respondents who did not complete three year 
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follow up, their study period ends at the end of the corresponding three year 
survey mailout period.  Therefore, respondents in NorStOP1 who complete follow 
up surveys will have data over ten years, those in NorStOP3 who complete all 
follow up surveys will have data over six years and those in any of the NorStOP 
cohorts who do not complete three year follow up will have their data collected 
over three years.  The implications of these differences are explored in this 
chapter’s discussion.  The number of respondents who have a GP or HES 
recorded fall within this time frame will be used as the ‘faller’ group in univariate 
and cross-sectional analyses.   
 
9.3.3 Statistical testing  
9.3.3.1 Prevalence of falls 
Simple frequencies are used to describe the prevalence of self-reported, GP-
recorded and HES-recorded falls within thesis sample A.  The number of 
individuals who fall and the number of falls that each individual sustains is 
calculated.   
9.3.3.2 Univariate associations with falls  
9.3.3.2.1 Logistic regression theory 
Logistic regression is used to measure the univariate association between each 
covariate and future self-reported falls within thesis sample B.  Logistic regression 
is now a standard method of analysis when describing the relationship between a 
binary response variable (falls) and one or more explanatory variables (for 
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example pain, anxiety, depression and other covariates) (Hosmer & Lemeshow, 
2000).   
The basic premise of logistic regression is a ‘logit transformed’ formula  
g(x)=β0 + β1x 
where g(x) is the log of the conditional mean of Y given x when the logistic 
distribution is used (Hosmer & Lemeshow, 2000), for example, the conditional 
outcome of falls as predicted by the presence of pain.  Logistic regression 
becomes clinically useful when multiple outcome predictors are considered, which 
is discussed further in Chapter 10.   
 
9.3.3.2.2  Interpretation of logistic regression model output  
Logistic regression is interpreted using odds ratios.  An odds ratio is a measure of 
association that looks at how much more likely the outcome is in the exposed 
group compared to the unexposed group, for example how much more likely 
respondents with pain are to fall than respondents with no pain.  In this thesis’ 
analyses, an odds of 1 means that there is no difference between groups with pain 
or no pain, or between different numbers of pain sites; an odds ratio <1 means 
that the odds of falling with pain (or a greater number of pain sites) are less than 
those without pain (or a lower number of pain sites); an odds ratio of >1 means 
that the odds of falling in those with pain (or a greater number of pain sites) is 
higher than those with no pain (or a lower number of pain sites).   
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9.4 Results: Prevalence of falls   
 
9.4.1 Self-reported falls  
12.5% (1,417) of thesis sample A reported a fall in the baseline NorStOP survey; 
falls prevalence in the three months prior to baseline survey is therefore 12.5%.   
14.4% (1,056) of respondents reported a fall in the three months prior to the 3 year 
follow up survey and 14.2% (685) reported a fall in the three months prior to 6 year 
follow up.   
 
9.4.2 GP-recorded falls  
783 respondents had one or more GP-recorded fall, giving a period prevalence of 
6.9%.  508 respondents (4.5%) had one fall and 275 (2.4%) had more than one 
fall.  Table 9.1 presents the number of falls for each respondent.  Two respondents 
had 20 or more fall-related codes in their records throughout the study period.   
 Table 9.1 The frequency of GP-recorded falls within thesis sample A (n=11,375).   
Number of GP-recorded 
falls per respondent 
Frequency (%) 
0 10,592 (93.1) 
1 508 (4.5) 
2 143 (1.3) 
3 61(0.7) 
4 32 (0.4) 
5 9 (<0.1) 
6 12 (0.1) 
7 4 (<0.1) 
8 6 (<0.1) 
9 3 (<0.1) 
11 1 (<0.1) 
12 2 (<0.1) 
20 1 (<0.1) 
23 1 (<0.1) 
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9.4.3 HES recorded falls  
804 respondents had one or more HES-recorded fall, giving a period prevalence of 
7.1%.  648 respondents had one HES-recorded fall (5.7%) and 156 respondents 
(1.4%) had more than one HES-recorded fall.  Two respondents had 8 HES-
recorded falls; two of these fall dates were clustered within 48 hours and other 
dates were spread across the study period.    
Table 9.2 The frequency of HEs-recorded falls in thesis sample A (11,375)  
 
Number of HES recorded 
falls per respondent 
Frequency (%) 
0 10,571 (92.9) 
1 648 (5.7) 
2 103 (0.9) 
3 33 (0.3) 
4 14 (0.1) 
6 3 (<0.1) 
7 1 (<0.1) 
8 1 (<0.1) 
 
9.4.4 Fall-related injuries recorded in HES  
To assess the reliability of coding falls within the HES dataset, the prevalence of 
fall-related injuries is measured.  738 respondents (6.5%) were admitted to 
hospital with fall-related injuries during the equivalent time period, fewer than the 
number of respondents admitted with a HES fall-related code. 
9.4.5 Summary  
Self-reported falls were the most prevalent amongst respondents in thesis sample 
A (12.5%).  The prevalence of HES-recorded falls was higher than GP-recorded 
falls (7.1% and 6.9% respectively).  These results will be explored further in the 
Discussion section of this chapter.  
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9.5 Results: Univariate associations with future self-reported falls  
 
 A summary of the univariate associations between baseline pain and covariates 
and future self-reported falls at three and six years is provided in table 9.3.   
Increasing age, higher deprivation levels, a higher BMI, the presence of dizziness, 
hearing difficulty and vision impairment, 2 or more CCI comorbidities, increasing  
anxiety, increasing depression and increasing cognitive complaint scores, 
increasing total medication count, all categories of analgesics (except very strong 
opioids, likely due to small numbers) , NSAID use, limitation in physical functioning 
and baseline self-reported fall were all associated with a statistically significant 
increased risk of future three, or six, year self-reported fall.   
The biggest predictors of future self-reported falls are baseline reported fall, where 
the odds of falling at three years are 4.64 greater than those with no baseline fall, 
and 3.67 greater for a fall at six years.  A ‘lot‘ of limitation in physical functioning 
conferred odds of 3.89 for three year fall and 4.42 for six year fall compared to 
those with no limitation in physical functioning.  Respondents who reported 
dizziness had more than double the odds of falling at three and six years than their 
non-dizzy counterparts.   
Being male and reporting adequate income were associated with a statistically 
significant reduced risk of future three, or six, year reported fall; being male 
reduced the odds of falling at three and six years by approximately 30%.   
Not continuing in full time education and manual occupations are statistically 
significantly associated with three year fall but not six year future fall.   
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Table 9.3 Self-reported falls and univariate associations with multisite pain and 
covariates in a sample of complete cohort follow up  
Covariate (OR, 95% CI) 3 year self-reported fall 6 year self-reported fall 
Age   1.02 (1.01-1.03)  1.04 (1.03-1.05)  
Sex  
Female  
Male  
 
Referent  
0.67 (0.56-0.80)  
 
Referent  
0.68 (0.57-0.81)  
Full time education >16y (n=4319) 
Yes  
No  
 
Referent  
1.28 (0.99-1.67)  
 
Referent  
0.98 (0.77-1.23)  
Occupational Class (n=4176) 
Manual  
Non-manual  
 
Referent  
0.67 (0.56-0.81)  
 
Referent  
0.86 (0.72-1.03)  
Income adequacy (n=4333) 
Inadequate  
Adequate  
 
Referent  
0.61 (0.51-0.73)  
 
Referent  
0.57 (0.48-0.67)  
IMD (n=4385) 
Least deprived  
2
nd
 least deprived  
Mid-deprived  
2
nd
 most deprived  
Most deprived  
 
Referent  
0.99 (0.75-1.31)  
1.15 (0.87-1.53)  
1.40 (1.06-1.85)  
1.59 (1.20-2.10) 
 
Referent  
1.28 (0.98-1.68)  
1.32 (1.00-1.74)  
1.28 (0.96-1.69)  
1.85 (1.41-2.43)  
BMI (n=4281) 1.04 (1.03-1.06) 1.03 (1.02-1.05)  
Dizziness  2.36 (1.94-2.85)  2.83 (2.36-3.40)  
Hearing difficulty  1.18 (0.93-1.50)  1.33 (1.06-1.67) 
Visual disturbance 1.58 (1.27-1.97)  1.78 (1.44-2.19)  
Comorbidities  (CCI) 
0 
1 
2-8 
 
Referent  
1.21 (0.95-1.55)  
1.18 (0.81-1.69)  
 
Referent  
1.22 (0.96-1.55)  
1.74 (1.27-2.39)  
Anxiety score  (n=4311) 1.11 (1.09-1.13)  1.07 (1.05-1.10)  
Depression score(n=4311) 1.14(1.12-1.17)  1.13 (1.10-1.15)  
Cognitive complaint (n=4232) 1.03 (1.02-1.03)  1.02 (1.02-1.02)  
Total medication number 1.14 (1.11-1.17)  1.13 (1.11-1.16)  
Maximum analgesic category 
No medication  
Basic analgesics 
Weak opioids  
Moderate opioids 
Strong opioids  
Very strong opioids 
 
Referent  
1.75 (1.24-2.47)  
2.29 (1.62-3.24)  
2.44 (1.79-3.34)  
3.58 (2.64-4.86)  
5.70 (0.95-34.2)  
 
Referent  
1.58(1.13-2.21) 
2.36(1.70-3.29)  
2.15 (1.57-2.92)  
3.14 (2.32-4.26)  
1.88 (0.21-16.8)  
NSAID use  
No  
Yes  
 
Referent 
1.47 (1.14-1.90)  
 
Referent 
1.76 (1.38-2.23)  
Physical functioning (n=4342) 
No limitation  
A little limitation 
A lot of limitation 
 
Referent  
2.31(1.84-2.91)  
3.89 (2.95-5.12)  
 
Referent  
2.81 (2.26-3.49)  
4.42 (3.39-5.78)  
Baseline self-reported fall 4.64 (3.68-5.83)  3.67 (2.92-4.63)  
n = 4386 unless otherwise stated; OR = odds ratio; 95% CI= 95% confidence interval; p = p 
value;  p<0.05 highlighted in bold; Full time education >16y = continuing in full time 
education beyond aged 16 years; IMD= Index of Multiple Deprivation; BMI = body mass 
index; Charlson Comorbidity Index (CCI) score: 0 = no CCI comorbidities, 1 = 1 CCI 
comorbidity, 2-8 = 2 or more CCI comorbidities;NSAID = non steroidal anti=inflammatory. 
187 
 
9.5.1 Summary: univariate associations with self-reported falls 
Advancing age and being female are statistically significantly associated with 
recording of future self-reported falls.  Manual work is statistically significantly 
associated with future self-reported falls and continuing in full time education is not 
statistically significantly associated with future self-reported falls.  Income 
inadequacy and increased levels of deprivation are statistically significantly 
associated with future self-reported falls.   
Multimorbidity, dizziness, vision and hearing impairment, total medication count 
and analgesic use (excepting NSAIDs) are statistically significantly associated with 
future self-reported falls.  Anxiety, depression and cognitive complaint scores are 
statistically significantly associated with future self-reported falls and the difference 
in cognitive scores in particular is clinically meaningful.  Physical functioning is 
statistically significantly associated with future self-reported falls.  
9.6 Discussion  
9.6.1  Summary of findings  
The prevalence of falls within thesis sample A (n=11,375) is 12.5% for self-
reported falls, 6.9% for GP-recorded falls and 7.1% for HES-recorded falls.  
Univariate analysis found that increasing age, being female, increasing 
mulitmorbidity, the presence of dizziness, vision or hearing impairment, an 
increase in all mental health measures, an increasing total medication count, 
stronger analgesics and worsening physical functioning are statistically 
significantly associated with an increased risk of future self-reported fall.  
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9.6.2 How findings fit in the current literature and what is new  
Compared to previous research exploring self-reported falls, the falls prevalence 
reported in this thesis is low.  For example, a recent UK-based study found that 
28.4% of community dwelling adults aged 60 years and over had fallen in the past 
two years (Gale et al, 2016), with women falling more than men (29.1% and 23.5% 
respectively).  The higher prevalence may be explained by the older cohort and 
the two year recall period.  The extended recall period meant that respondents had 
more time in which to risk falling and therefore report higher falls prevalence than 
the thesis’ sample in which respondents only considered a three month period; 
indeed, the difference in recall period is a recognised contributor to the variation in 
number of falls reported across the literature (Hauer et al, 2006). 
The prevalence of GP-recorded falls is lower in the thesis than current published 
evidence, although no direct comparisons are available which is perhaps due to 
the challenges of coding of falls in GP records, a problem widely recognised by the 
GPs consulted over falls coding practices in this study.  Gribbin et al (2009) 
analysed the incidence and mortality of falls amongst older people in primary care 
using The Health Improvement Network primary care database (THIN).  The 
authors found 79,295 recorded fall-events over three years in 61,248 individuals, 
giving a falls rate of 3.58 (3.56-3.61 95% CI) recorded falls per 100 person years 
(Gribbin et al, 2009).  Summing the number of GP falls reported in table 9.1 gives 
a total number of GP falls in thesis sample A of 1,403 falls in 11,375 respondents.  
Using a very approximate calculation to obtain an extrapolated estimate of falls 
prevalence in thesis sample A (these numbers or not comparable as the GP falls 
prevalence is taken over at least a three year period in this thesis), extrapolation of 
this thesis’ sample to a similar size study as Gribbin’s et al (2009), one might 
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expect to find approximately 20,000 falls.  The difference between this 
approximate extrapolation figure of 20,000 and the recording of 79,295 fall events 
in Gribbin et al’s (2009) study indicates that falls are likely to be under-coded in the 
GP records used in this thesis and the resulting prevalence is therefore likely to 
underestimate the true number of falls presenting to general practice.   
There are no direct comparison of HES-recorded falls prevalence in published 
research.  The closest comparison and most robust study is from The King’s Fund 
who following the Torbay cohort, identified fallers requiring hospital admission from 
hospital and GP data and analysed associated health and social care costs (Tian 
et al, 2013).  They found just over 1% of the Torbay population (adults aged 65 
years old living in the community) had fallen between July and December 2010 
(Tian et al, 2013).  If this is extrapolated to represent my study time period 
(notwithstanding the impact of poor weather and icy conditions during the winter 
months and other external factors that would impact on the likelihood of falling), 
this would give an expected HEs-recorded falls prevalence in thesis sample A of  
approximately 24%, a considerably lower estimate than the presented prevalence 
of 7.1%).  In order to check the reliability of falls-coding in HES in the event that 
evidence might suggest under-recording of HES falls, information was collected on 
fall-related injuries.  The number of fall-related injuries is less than the number of 
fallers identified, thus indicating that falls likely to be coded relatively reliably in 
HES-APC data.  The difference in fall rates between the two studies may be due 
to the inclusion of all fall-related ICD-10 codes including those related to 
occupational causes of fall which were excluded from this thesis’ fall coding (as 
described in Chapter 6) or due to the older population of Torbay.  It cannot be due 
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to a misclassification bias between the two studies since the same datasets were 
used.   
Logic suggests that more respondents saw their GP about a few than ended up 
with a hospital admission relating to a fall, however the prevalence of GP-recorded 
falls is lower than HES-recorded falls within thesis sample A.  The reasons for this 
are not clear.  The most likely cause of this is under-coding of falls by GPs.  This 
risks introducing misclassification bias where respondents who did attend their GP 
with a fall-related problem but were not coded as such were classified as a non-
GP-recorded faller.  This in turn may lead to an underestimation of associations 
with falls.   
The majority of associations between covariates and falls reflect the literature 
covered in the review of falls risk factors detailed in Chapter 4.  Unexpected 
associations are now highlighted, reasons for these associations are hypothesised 
and suggestions for future study are made.   
Hearing impairment has been demonstrated to be a risk factor for self-reported 
falls.   Assessment of hearing does not form part of the multifactorial risk 
assessment for falls prevention in older people advised by NICE (2013).  The 
systematic review of hearing loss and falls by Jaim et al (2016) discussed in 
Chapter 4 also found an association, although the studies from which effect 
estimates were pooled were primarily cross-sectional. Jaim et al (2016) present 
biologically plausible explanations for this association, including co-existent 
vestibular dysfunction and resulting imbalance, and it will be interesting to explore 
whether this relationship exists during multivariable analysis.   
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Increasing anxiety and depression scores were found to be statistically 
significantly associated with future self-reported falls; these covariates do not 
currently feature in fall prevention guidelines (for example NICE, 2013).  These 
findings reflect the literature, for example Hoffman et al (2017) who found that 
reporting depressive symptoms was a statistically significant risk factor for future 
falls risk, although this result was attenuated during multivariate analysis.  It is 
imperative to assess the influence of depression upon future falls risk in 
multivariate analysis during subsequent thesis analyses since this may provide 
further evidence that depression is association with an increased risk of falls in 
older people and requires intervention to reduce falls risk.  Anxiety has recently 
been association with an increased risk of future falls (Holloway et al, 2016) and it 
is important that further multivariate analyses are conducted to examine the 
ongoing relationship between anxiety and falls when other potentially influencing 
factors are accounted for.   
Pain medication strength is statistically significantly associated with future self-
reported falls.  The relationship between pain medication strength and falls is also 
interesting as the group using moderate strength medications are less likely to 
self-report a fall than those using weak pain medications or strong pain 
medications. Perhaps this is due to better pain control that therefore reduces the 
risk of falls i.e. the risk of using opiate medication is negated by the overall 
reduction in pain and thus reduced risk of falls.  This finding warrants further 
exploration as an extension to the thesis.    
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9.6.3 Strengths 
As discussed in Chapter 8, one strength of this analysis is the relatively large 
sample size, larger than those studies included in the systematic review.  Known 
falls risk factors have had their associations confirmed within thesis sample B, thus 
demonstrating that this sample is not an anomalous group that may not be 
comparable to the general population.   
The use of three different fall measures enables a wider perspective of falls 
prevalence to be obtained; using only self-reported falls would not capture the 
burden of falls resulting in hospital admission, and using only hospital admission 
data would mean many respondents would be misclassified as ‘non-fallers’.   
Systematically measuring the association between each covariate and self-
reported falls has provided a good understanding of the potential role of each 
covariate in future multivariable analyses.   
9.6.4 Limitations  
The reported prevalence of self-reported, GP-recorded and HES-recorded falls are 
not comparable due to the different time frames over which data were collected, 
thus conclusions about relative prevalence cannot be drawn.  However, given that 
the self-reported falls are gathered over a three month period and GP and HES-
recorded falls are gathered over a minimum three year period, it is reasonable to 
state that self-reported falls were the most prevalent type of fall in this study.   
GP-recorded and HES-recorded falls identified respondents who have fallen 
multiple times.  For example, one respondent was found to have 23 GP-recorded 
falls and two respondents had 8 HES-recorded falls.  Steps were taken to reduce 
likelihood of the same fall event being counted multiple times by coding all falls 
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recorded on the same date as one fall.  It is possible that multiple falls recorded 
over a 24 or 48 hour period may be reflect new falls, particularly in HES-APC data  
where sustaining a fall whilst an inpatient is not an unusual clinical scenario, thus 
fall-related codes that were more than 24 hours apart were counted as additional 
falls.  Further inspection of the records of the respondent who had 23 GP-recorded 
falls found some of the fall dates were clustered together over a two week period.  
Multiple appointments in close succession could include frequent dressings of a 
fall-related injury or frequent follow up for new medications started (or stopped) 
since falling.  Whatever the reason for GP attendance, it is clear that falls generate 
multiple appointments and add to the GP workload.   
The self-report of falls relies on respondent recall and is therefore susceptible to 
recall bias, as found by Hannan et al (2010) who compared telephone recall with 
daily falls calendar completion and found that older people failed to recall 25% of 
falls they had documented on their calendar in the three months prior to the 
telephone call.  Self-reported fall prevalence in this thesis may therefore be an 
underestimate of the true picture due to recall bias.   
As discussed above, the low prevalence of GP-recorded falls suggests that thesis 
sample A may be susceptible to misclassification bias, whereby respondents are 
wrongly coded as ‘non-fallers’ simply because the GP has not coded the 
consultation using a fall-related READ code, this might lead to an underestimation 
of the true association between pain and GP-recorded falls.   
Taking a wider view of the use of HES-APC data to capture falls requiring hospital 
admission, it is suspected that HES-APC data might be susceptible to under-
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recording of falls since often the patient presents with the consequence of the fall 
and this is what is recorded.   
 
9.6.5  Informing the thesis  
The identification of a relatively low prevalence of self-reported, GP-recorded and 
HES-recorded falls may lead to an underestimation of the magnitude of the 
relationship between pain and falls.  This potential problem has been highlighted 
and future analyses can now be interpreted within this context.  Almost all of the 
covariates tested have been found to be statistically significantly associated with 
future self-reported falls in univariate analysis.  Knowledge that each covariate 
(except age) is associated with both pain and falls enables results of the 
multivariate analyses in Chapters 10 and 11 to be interpreted in the context of 
multiple likely correlations between pain, covariates and falls.   
 
9.7 Chapter summary  
This chapter has described the prevalence of self-reported, GP-recorded and 
HES-recorded falls in thesis sample A and presented univariate analyses of pain 
and each covariate and their relationship with future self-reported falls in thesis 
sample B.  These findings have been placed in the context of the current evidence 
base and novel findings that warrant further investigation have been highlighted.  
An understanding of the associations between covariates and falls has been 
obtained and more comprehensive multivariate analyses of the relationship 
between pain and falls can now be undertaken in chapters 10 and 11.   
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Chapter 10: Pain as a predictor of self-reported falls 
10.1 Overview  
This chapter examines the relationship between baseline pain status and covariate 
measurements with future self-reported falls at three and six year follow up.  The 
rationale for the chapter is explained, the methods used to examine the 
association between multisite pain and self-reported falls are discussed and 
results presented.  Study findings are placed within the current evidence base, 
novel results are highlighted and implications for the thesis are presented.    
 
10.2 Rationale and chapter objectives  
This chapter seeks to examine the role of pain as a predictor of future risk of self-
reported falls using a prospective study design.  The systematic review and meta-
analysis in Chapter 5 highlighted a dearth of good quality prospective studies to 
establish the risk between multisite pain and falls.  This chapter aims to address 
this knowledge gap by using baseline pain and covariate scores to predict self-
reported falls and three and six year follow up.  Univariate cross-sectional 
associations between pain, covariates and baseline future self-reported falls were 
established in Chapter 9.  This chapter moves on to conduct prospective analyses 
using thesis sample B (containing NorStOP respondents who completed all follow 
up, who consented to medical record review and who consistently completed the 
two pain questions) to meet the following objective:   
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i) to undertake prospective multivariate analysis to establish the 
relationship between multisite pain and future self-reported falls in the 
context of  putative fall predictors  
 
10.3 Methods  
10.3.1 Variable measurements  
Pain is analysed using the number of pain sites (0-44) as a continuous measure 
and the categories of widespreadness (no pain / some pain / widespread pain) as 
a categorical measure, as described in Chapter 6.  Covariates are measured as 
described in Chapter 6, and baseline self-reported falls is used as an indicator of 
previous history of fall.  
Information on self-reported falls is taken from the NorStOP survey data at three 
and six year follow up.   
 
10.3.2 Statistical methodology: logistic regression  
Logistic regression is used to measure the association between pain and self-
reported falls within thesis sample B, as described in Chapter 9.  For logistic 
regression to become clinically useful, multiple predictors of the outcome in 
question must be considered in the measure of any relationship between the 
variables of interest.  For example, in the case of pain contributing to a risk of falls, 
it must be considered that sex will also impact upon this relationship, since it is 
known that women experience more widespread pain than men, as demonstrated 
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in chapter 9.  Multiple variables are considered in the multivariable logistic 
regression model and the logit of this model is:  
G(x) = β0 + β1x1 + β2x2 +…+βpxp 
 where p is the number of independent variables under consideration (Hosmer & 
Lemeshow, 2000).   Thus, in multivariable logistic regression models, ‘each 
estimated coefficient provides an estimate of the log odds adjusting for all other 
variables included in the model’ (Hosmer & Lemeshow 2000).    
 
10.3.3 Dealing with potential confounding  
Potential confounding must be taken account of during analysis.   As discussed in 
earlier chapters, a confounder is defined as a variable that is related both to the 
independent variable of interest and the outcome (Bland, 2000).  For example, the 
presence of comorbidities might be a confounder of the relationship between pain 
and falls since the number of comorbidities might increase the risk of falls and the 
degree of pain may be influenced by the presence of comorbidities.  In logistic 
regression, confounders are accounted for by adding them into the multivariable 
logistic regression model so that the potential confounder’s influence on the 
independent variables is also measured. 
 
10.3.4 Interactions   
An interaction takes place when the association between the risk factor and 
outcome varies according to the level of the interaction variable.  For example, the 
association between pain and falls varies according to the number of medications 
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i.e. the odds ratio for the odds of falling with pain compared to no pain is lower for 
respondents who do not take medication than for respondents who take more than 
four medications.  In this case, medication would be an ‘effect modifier’ (Hosmer & 
Lemeshow, 2000).  To test whether variables are ‘effect modifiers’ rather than 
confounders, an interaction term must be added to the model.  For example, the 
variable ‘medication’ would be added as an individual covariate and then 
combined with ‘pain’ as an interaction term (commonly notated as 
medicationXpain).  It is possible to then assess if the variable ‘medication’ is a 
confounder (i.e. the odds ratio associated with pain changes when ‘medication’ is 
added to the model) and if it is also a significant effect modifier (how much the 
odds ratio of the variable of interest changes when the interaction term is added 
and whether the p-value associated with the interaction term’s coefficient is 
<0.05).  Hence, a variable is considered to be an effect modifier when the 
interaction term added to the model is clinically meaningful and statistically 
significant (Hosmer & Lemeshow, 2000).   It is important to identify effect modifiers 
as odds ratios of the variable of interest (pain) must be recalculated.   
 A pragmatic approach is adopted when testing interactions.  Since the 
independent variable of interest is pain, and univariate analysis of the association 
between pain and covariates in Chapter 8 found all but age to be statistically 
significant, interactions between pain and each covariate (except age) are tested.  
The impact of an interaction is demonstrated using the example of widespread 
pain and cognitive complaint.  The statistically significant association between 
widespread pain and cognitive complaint means that the effect of pain status 
differs across different levels of cognitive complaint.  When considering only 
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widespread pain and cognitive complaint as the predictor variables for future falls 
risk, the equation must include the interaction term and is therefore:  
Falls = ß0 + ß1*widespread pain + ß2*cognitive complaint + ß3*WP*cognitive 
complaint  
where ß0 is the intercept, and ß , ß2 and ß3 are the coefficients that correspond to 
the odds ratio in the logistic regression model.  Thus, the unique effect of pain is 
not limited to the term ‘widespread pain’, it also depends on the value of ‘cognitive 
complaint’ and the interaction term ‘WP*cognitive complaint’.  The unique effect of 
pain is now represented by everything that is multiplied by cognitive impairment.  
ß1 can be considered to indicate the unique effect of widespread pain on falls only 
when ß2*cognitive impairment is equal to zero.  Thus, when building the logistic 
model to take account of possible confounders, modifiers and interaction terms, 
the ß coefficient, or final odds ratio, must be taken from the model that contains 
the interaction terms to ensure that interactions are accounted for (unless the 
likelihood ratio test accepts that a smaller model excluding the interaction terms is 
nested in the bigger model containing the interaction terms, as discussed below).   
 
10.3.5 Model building for logistic regression 
There are many strategies for building a logistic regression model and it is 
important that the final models are clinically meaningful from both biologically 
plausible and pragmatic viewpoints; this will often mean inclusion of the minimum 
number of variables.  For the purpose of this thesis, multivariable logistic 
regression models are built to measure the future risk of three and six year self-
reported falls associated with baseline pain status and taking account baseline 
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covariate measures.  Firstly, univariate analysis will be undertaken for all variables 
including pain measures.  One method for deciding which variables to include in 
multivariables analysis is put forward  by Mickey and Greenland (1989) who 
suggest a criteria for model inclusion of univariate analysis p-value of <0.25, after 
demonstrating that using of a p-value <0.05 tends to miss variables that are known 
to be important (Mickey & Greenland, 1989; Hosmer & Lemeshow, 2000).  
However, this analysis will include all covariates, measured according to Chapter 
7, since the model must also reflect real-life clinical practice.  For example, if all 
the covariates that do not have significant univariate associations with self-
reported falls in prospective analysis are removed from any mathematical 
modeling, then there would be covariates that have been excluded despite 
demonstrating their statistically significant relationship with pain status in Chapter 
8.  The model would no longer reflect real-life as any potential effect modifiers of 
the pain-falls relationship due to their significant association with pain would be 
excluded, something that is not possible to do in a clinical scenario.  Covariates 
are therefore added in the following groups to in a stepwise fashion to build 
models according to the plan in box 10.1.  
Interactions are tested and those that are found to be clinically and statistically 
significant will be added to the model and compared with the model containing all 
the non-interaction terms using the likelihood ratio test.   The likelihood ratio test is 
used to determine the likelihood that the small model (the model not containing the 
interactions) is nested within the large model (the model containing the interaction 
terms); if the likelihood ratio test has a probability of less than 0.05, this means 
that the likelihood of the small model being nested in the large model is less than 
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5%, and therefore the large model must be taken as the final model from which to 
draw conclusions. 
Box 10.1: Logistic regression model building  
 
 
10.3.6 Choice of study sample  
The analysis outcomes are i) self-reported fall at three year follow up (yes/ no); 
and ii) self-reported fall at six year follow up (yes / no).  Since the outcome is 
binary (i.e. there is no option for missing falls data that is due to loss to follow up), 
thesis sample B (n=4,386) must be used; thesis sample A would have a large 
number of missing data for three and six year self-reported falls due to loss to 
follow up at three and six years.   
Model 1: unadjusted relationship with pain  
Model 2: Model 1 + demographic covariates (full time education status, 
income adequacy, IMD, occupational class) 
Model 3: Model 2 + physical health (BMI, comorbidities, dizziness, vision, 
hearing) 
Model 4: Model 3 + mental health (anxiety, depression, cognitive 
impairment) 
Model 5: Model 4 + medications (total medication count, use of NSAIDs, 
maximum category of analgesic medication) 
Model 6: Model 5 + physical functioning 
Model 7: Model 6 + history of baseline self-reported fall  
Model 8: Model 7 + interaction terms 
Model 9: Model 8 (or Model 7) + interaction terms 
 
202 
 
10.4 Results  
10.4.1 Baseline pain and covariate measurements and three year self-reported fall 
10.4.1.1 Number of pain sites and three year self-reported fall  
Table 10.1 presents odds ratios (the beta co-efficient) and 95% CIs for multivariate 
logistic regression predicting self-reported falls at three year follow up.  The table 
presents results from each step of the model build-up as described in box 10.1, 
from model 1 (unadjusted) through to model 8 (adjusted for all covariates and 
statistically significant interaction terms).  Statistically significant interaction terms 
added to model 7 were ‘number of pain sites*maximum analgesic category’, 
‘number of pain sites*occupational class’, ‘number of pain sites*age’.  The 
likelihood ratio test p-value is <0.01, therefore the model containing the interaction 
terms must be used to interpret odds ratios.   
The number of pain sites remains statistically significantly associated with three 
year self-reported fall across all models; the final model (model 8) gives an odds 
ratio of 1.12 (1.01-1.24) p=0.04 for the odds of falling for each unit increase in the 
number of pain sites.   
Other covariates that were statistically significant in model 8 once interactions are 
adjusted for that increased the risk of three year self-reported fall are increasing 
age (OR 1.04 (1.02-1.05) p=<0.01), cognitive impairment (OR 1.01 (1.01-1.02) 
p=<0.01), total medication count (OR 1.05 (1.00-1.09) p=0.04) , strong opioids 
(OR 2.34 (1.31-4.19) p=<0.01) and baseline self-reported falls (OR 2.60 (1.94-
3.48) p=<0.01).  Covariates statistically significantly associated with reduced odds 
of falling are non-manual occupation (OR 0.62 (0.46-0.85) p=<0.01) and a CCI 
score of 2 or more (OR 0.54 (0.33-0.88) p=<0.01).  
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Table 10.1 Odds ratios (95% CIs) of a self-reported fall at three year follow up according to baseline number of pain sites in a 
multivariate logistic regression model 
Covariate  
OR (95% CI) 
Model 1 
n=4,386 
Model 2  
n=4,089 
Model 3  
n=4,015 
Model 4  
n=3,830 
Model 5 
n=3,830 
Model 6 
n=3,801 
Model 7 
n=3,801 
Model 8  
n=3,801  
Number of 
pain sites 
1.06(1.05-1.07) 1.06(1.04-1.07) 
 
1.05(1.03-1.06) 
 
1.03(1.02-1.05) 
 
1.03 (1.01-1.04) 1.02 (1.01-1.04) 1.02 (1.00-1.04) 
 
1.12 (1.01-1.24) 
 
Age (years)  1.03 (1.01-1.04) 1.03(1.01-1.04) 1.03(1.01-1.04) 1.02(1.01-1.04) 1.02(1.01-1.03) 1.02 (1.01-1.04) 1.04(1.02-1.05) 
Sex: Male   0.74 (0.60-0.89) 0.78 (0.63-0.95) 0.74 (0.60-0.92) 0.76 (0.61-0.95) 0.78 (0.62-0.97) 0.83 (0.66-1.04) 0.83 (0.66-1.04) 
FT Ed >16y: 
No 
 0.96 (0.73-1.28) 
 
0.97 (0.72-1.30) 
 
1.09 (0.79-1.49) 
 
1.09 (0.79-1.94) 
 
1.06 (0.77-1.45) 
 
1.06 (0.77-1.46) 
 
1.04 (0.75-1.43) 
 
Income 
adequate 
 0.80 (0.65-0.97) 
 
0.83 (0.67-1.01) 
 
1.05 (0.84-1.31) 
 
1.08 (0.86-1.35) 
 
1.10 (0.88-1.38) 
 
1.07 (0.85-1.34) 
 
1.08 (0.86-1.35) 
Occ Class 
non-manual 
 0.74 (0.61-0.91) 
 
0.75(0.61-0.93) 
 
0.78 (0.63-0.97) 
 
0.79 (0.63-0.98) 
 
0.77 (0.62-0.97) 
 
0.75(0.60-0.94) 
 
0.62(0.46-0.85) 
 
IMD  
1)least dep. 
2) 2
nd
 least 
3)mid dep. 
4) 2
nd
 most 
5)most dep. 
  
referent 
0.93 (0.69-1.25) 
1.04 (0.77-1.40) 
1.19 (0.88-1.62) 
1.09 (0.80-1.49) 
 
referent 
0.95 (0.70-1.29) 
1.08 (0.79-1.46) 
1.23 (0.90-1.68) 
1.04 (0.75-1.44) 
 
referent 
0.97 (0.70-1.34) 
1.12 (0.81-1.54) 
1.28 (0.93-1.78) 
1.00 (0.71-1.41) 
 
referent 
0.96 (0.70-1.33) 
1.07 (0.78-1.49) 
1.25 (0.90-1.73) 
0.98 (0.69-1.38) 
 
referent 
0.96 (0.69-1.33) 
1.08 (0.78-1.50) 
1.23 (0.89-1.72) 
1.00 (0.70-1.41) 
 
referent 
0.94 (0.68-1.31) 
1.06 (0.76-1.48) 
1.20 (0.76-1.48) 
0.98 (0.69-1.39) 
 
referent 
0.94  (0.67-1.30) 
1.06 (0.76-1.47) 
1.18 (0.84-1.65) 
0.97 (0.68-1.38) 
Dizzy: Yes   1.72 (1.38-2.15) 
 
1.34 (1.05-1.71) 
 
1.30 (1.02-1.67) 
 
1.31 (1.02-1.68) 
 
1.23 (0.95-1.58) 
 
1.23 (0.96-1.58) 
Hearing 
deficit: Yes  
  0.93 (0.71-1.23) 
 
0.90 (0.67-1.21) 
 
0.91 (0.68-1.23) 
 
0.91 (0.68-1.22) 
 
0.90 (0.67-1.22) 
 
0.91 (0.67-1.23) 
 
Visual 
deficit: Yes 
  1.24 (0.96-1.59) 1.14 (0.88-1.49) 1.13(0.86-1.48) 
 
1.15(0.88-1.50) 
 
1.11 (0.85-1.46) 
 
1.14 (0.86-1.49) 
 
CCI score 
0 
1 
2-8 
   
referent 
0.84 (0.64-1.12) 
0.80 (0.53-1.20) 
 
referent 
0.85(0.63-1.14) 
0.69(0.44-1.09) 
 
referent 
0.76 (0.56-1.04)  
0.55 (0.34-0.89) 
 
referent 
0.76(0.56-1.04) 
0.54 (0.33-0.88) 
 
referent 
0.77 (0.56-1.05) 
0.53 (0.33-0.87) 
 
referent 
0.75(0.55-1.03) 
0.54 (0.33-0.88) 
BMI    1.03(1.01-1.05) 1.03(1.01-1.05) 1.03(1.01-1.05) 1.03(1.01-1.05) 1.03(1.01-1.05) 1.02 (1.00-1.04) 
204 
 
Covariate  
OR (95% CI) 
Model 1 
n=4,386 
Model 2  
n=4,089 
Model 3  
n=4,015 
Model 4  
n=3,830 
Model 5 
n=3,830 
Model 6 
n=3,801 
Model 7 
n=3,801 
Model 8  
n=3,801  
Depression     1.03 (0.99-1.07) 1.02 (0.98-1.06) 1.01 (0.97-1.06) 1.02 (0.97-1.06) 1.01 (0.97-1.06) 
Anxiety     1.02 (0.98-1.05) 1.02 (0.99-1.06) 1.02 (0.99-1.06) 1.02 (0.99-1.06) 1.02 (0.99-1.06) 
Cognitive 
complaint 
   1.02 (1.01-1.02) 1.02 (1.01-1.02) 1.02 (1.01-1.02) 1.02 (1.01-1.02) 1.02 (1.01-1.02) 
Total 
medication 
    1.05 (1.00-1.09) 1.04 (1.00-1.09) 
 
1.04 (1.00-1.09) 
 
1.05 (1.00-1.09) 
 
Analgesics  
None 
Basic 
Weak op. 
Mod. op. 
Strong op. 
V.strong op. 
     
Referent 
1.04 (0.68-1.59) 
1.22 (0.78-1.89) 
1.26 (0.84-1.90) 
1.01 (1.01-1.02) 
1.60 (0.25-10.1) 
 
Referent 
1.05 (0.68-1.61) 
1.21 (0.78-1.88) 
1.20 (0.79-1.82) 
1.64 (1.07-2.49) 
1.51 (0.24-9.59) 
 
Referent 
1.09 (0.71-1.68) 
1.22 (0.78-1.91) 
1.17 (0.76-1.78) 
1.56 (1.01-2.39) 
1.32 (0.20-8.63) 
 
Referent 
1.16(0.76-1.79) 
1.43 (0.89-2.30) 
1.54 (0.94-2.54) 
2.34 (1.31-4.19) 
2.39 (0.29-19.64) 
NSAIDs: Yes     0.86 (0.62-1.19) 0.87 (0.63-1.20) 0.84 (0.60-1.17) 0.81 (0.58-1.13) 
Physical 
functioning 
No problem 
A little  
A lot  
      
 
Referent 
1.17 (0.86-1.60) 
1.21 (0.80-1.83) 
 
 
 
Referent  
1.15 (0.84-1.57) 
1.04 (0.68-1.60) 
 
 
 
Referent 
1.14 (0.84-1.55) 
1.13 (0.74-1.73) 
 
Previous 
fall: Yes 
      2.65(1.97-3.54) 2.60 (1.94-3.48) 
 
Model 1: unadjusted; Model 2: adjustment for demographic covariates; Model 3: Model 2 & adjustment for medical covariates; Model 4: Model 3 & adjustment for 
mental health covariates; Model 5: Model 4 & adjustment  for medication covariates; Model 6: Model 5 & adjustment for physical functioning; Model 7: Model 6 & 
adjustment for previous falls; Model 8: Model 7 & adjustment for all covariates and statistically significant interaction terms).  OR = odds ratios; 95% CI = 95% 
confidence interval; where p<0.05, this is considered statistically significant and results are highlighted in bold.  FT Ed >16y = continuing in full time education 
beyond aged 16 years; IMD= Index of Multiple Deprivation divided into quintiles, where: least dep.= least deprived, 2
nd
 least = 2
nd
 least deprived, mid dep. = middle 
deprivation category, 2
nd
 most = 2
nd
 most deprived, most dep. = most deprived category.  Charlson Comorbidity Index (CCI) score: 0 = no CCI comorbidities, 1 = 1 CCI 
comorbidity, 2-8 = 2 or more CCI comorbidities.  BMI = body mass index. Total medication = total medication count. Analgesics: weak op. = weak opiates, mod. op. = 
moderate strength opiates, strong op. = strong opiates, v. strong op. = very strong opiates. NSAID = non steroidal anti=inflammatory drug. Physical functioning = 
ability to walk 100 yards: no problem = no physical limitation, a little = a little limitation, a lot = a lot of limitation in ability to walk 100 yards. Previous fall = baseline 
self-reported fall recorded as ‘yes’.   
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10.4.2.2 Widespread pain and three year self-reported fall  
Table 10.2 presents odds ratios (the beta co-efficient) and 95% CIs for logistic 
regression predicting self-reported falls at three year follow up.  The table presents 
results from each step of the model build-up, from model 1 (unadjusted) through to 
model 7 (adjusted for all covariates).  There were no statistically significant 
interaction terms, thus model 7 is the final model containing all the covariates.   
The unadjusted association between ‘some pain’ and ‘widespread pain’ is 
statistically significantly associated with three-year self-reported falls; however the 
statistical significance is lost for ‘some pain’ when demographics are added to the 
model, and is lost for ‘widespread pain’ when physical functioning is added to the 
model.   The final models report, for ‘some pain’ odds ratio 1.00 (0.75-1.33) p=0.98 
and for ‘widespread pain’ OR 1.27 (0.92-1.75) p=0.14. 
Covariates that statistically significantly increase the odds of three year self-
reported falls in model 7 are age (OR 1.02 (1.01-1.04) p=<0.01), BMI (OR 1.03 
(1.00-1.05) p=0.02), strong opioids (OR 1.61 (1.05-2.47) p=0.03) and previous 
history of self-reported fall (OR 2.70 (2.01-3.61) p=<0.01).  The greatest predictor 
of three year self-reported fall is previous falls history, where the odds of falling in 
those reporting baseline falls is two and a half times that of those who did not 
report baseline falls.  Covariates that reduce the odds of falling in model 7 are non-
manual work (OR 0.76 (0.61-0.95) p=0.02) and a Charlson score of 2 or more 
comorbidities (OR 0.53 (0.32-0.87) p=0.01). 
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Table 10.2 Odds ratios (95% CIs and p-values) of a self-reported fall at three year follow up according to baseline pain 
widespreadness in a multivariate logistic regression model 
Covariate  
OR (95% CI) 
Model 1 
n=4,386 
Model 2  
n=4,089 
Model 3  
n=4,015 
Model 4  
n=3,830 
Model 5 
n=3,830 
Model 6 
n=3,801 
Model 7 
n=3,801 
No pain  
Some pain  
Widespread 
Referent  
1.54 (1.20-1.99) 
2.96 (2.31-3.80) 
Referent 
1.39 (1.06-1.80) 
2.57 (1.97-3.35) 
Referent 
1.25 (0.96-1.63) 
2.14 (1.62-2.82) 
Referent  
1.14 (0.85-1.50) 
1.60 (1.18-2.16) 
Referent  
1.06 (0.80-1.41) 
1.41 (1.03-1.92) 
Referent  
1.03 (0.77-1.37) 
1.32 (0.96-1.81) 
Referent 
1.00 (0.75-1.33) 
1.27 (0.92-1.75) 
Age (years)  1.03 (1.02-1.04) 1.03 (1.01-1.04) 1.03 (1.01-1.04) 1.02 (1.01-1.04) 1.02 (1.01-1.03) 1.02 (1.01-1.04) 
Sex: Male   0.72 (0.59-0.87)  0.77 (0.63-0.94) 0.73 (0.58-0.90) 0.76 (0.61-0.94) 0.77 (0.62-0.97) 0.83 (0.66-1.03) 
FT Ed >16y: 
No 
 0.97 (0.73-1.29) 0.98 (0.74-1.31) 1.10 (0.81-1.56) 1.10 (0.80-1.50) 
 
1.07 (0.78-1.46) 1.07 (0.78-1.47) 
 
Income 
adequate 
 0.75 (0.62-0.91) 0.80 (0.65-0.97) 
 
1.03 (0.83-1.29) 1.07 (0.85-1.33) 
 
1.09 (0.87-1.37) 
 
1.06 (0.84-1.33) 
 
Occ Class 
non-manual 
 0.77 (0.63-0.95) 0.78 (0.63-0.96) 
 
0.80 (0.64-1.00) 
 
0.80 (0.64-1.00) 
 
0.79 (0.63-0.98) 
 
0.76 (0.61-0.95) 
 
IMD  
1)least dep. 
2) 2
nd
 least 
3)mid dep. 
4) 2
nd
 most 
5)most dep. 
  
Referent  
0.94 (0.70-1.27) 
1.06 (0.78-1.43) 
1.25 (0.92-1.69)  
1.14 (0.59-0.87) 
 
Referent  
0.96 (0.70-1.30) 
1.09 (0.80-1.48) 
1.27(0.93 -1.73) 
1.07 (0.77-1.47) 
 
Referent  
0.98 (0.71-1.35) 
1.13 (0.82-1.56) 
1.30 (0.94-1.80) 
1.02 (0.72-1.43) 
 
Referent  
0.97 (0.70-1.34) 
1.08 (0.78 1.50) 
1.26 (0.91-1.75) 
0.99 (0.70-1.40) 
 
Referent  
0.97 (0.70-1.34) 
1.08 (0.78-1.50) 
1.24 (0.89-1.73) 
1.00 (0.71-1.42) 
 
Referent  
0.94 (0.68-1.31) 
1.07 (0.77-1.48) 
1.21 (0.86-1.69) 
0.99 (0.69-1.40) 
Dizzy: Yes   1.81 (1.46-2.25) 1.39 (1.09-1.77) 1.34 (1.05-1.71) 1.34 (1.04-1.72) 1.25 (0.97-1.60) 
Hearing 
deficit: Yes  
  0.94 (0.71-1.23) 0.90 (0.68-1.21) 
 
0.92 (0.68-1.23) 
 
0.91 (0.68-1.23) 
 
0.90 (0.67-1.22) 
Visual 
deficit: Yes 
  1.27 (0.99-1.63) 
 
1.16 (0.89-1.51) 1.14 (0.88-1.50) 
 
1.16 (0.89-1.53) 
 
1.12 (0.86-1.48) 
CCI score 
0 
1 
2-8 
   
Referent  
0.89 (0.67-1.18) 
0.81 (0.53-1.21) 
 
Referent 
0.88 (0.65-1.18) 
0.70 (0.45-1.09) 
 
Referent 
0.78 (0.57-1.06) 
0.54 (0.33-0.88) 
 
Referent 
0.77 (0.57-10.6) 
0.53 (0.57-0.87) 
 
Referent 
0.78 (0.57-1.07) 
0.53 (0.32-0.87) 
BMI    1.03 (1.01-1.05) 
 
1.02 (1.00-1.05) 
 
1.03 (1.01-1.05) 1.03(1.00-1.05) 1.03 (1.00-1.05) 
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Covariate  
OR (95% CI) 
Model 1 
n=4,386 
Model 2  
n=4,089 
Model 3  
n=4,015 
Model 4  
n=3,830 
Model 5 
n=3,830 
Model 6 
n=3,801 
Model 7 
n=3,801 
Depression     1.04 (1.00-1.08) 1.02 (0.98-1.07) 1.02 (0.97-1.06) 1.02 (0.97-1.06) 
Anxiety     1.02 (0.98-1.05) 1.02 (0.99-1.06) 1.02 (0.99-1.06) 1.02 (0.99-1.06) 
Cognitive 
complaint 
   1.02 (1.01-1.02) 1.02 (1.01-1.02) 1.02 (1.01-1.02) 1.01 (1.00-1.02) 
 
Total 
medication 
    1.05 (1.00-1.09) 
 
1.04 (1.00-1.02) 
 
1.04 (1.00-1.09) 
Analgesics  
None 
Basic 
Weak op 
Mod. op 
Strong op 
V. strong op 
     
Referent  
1.05 (0.68-1.60) 
1.24 (0.80-1.92) 
1.31 (0.88-1.97) 
1.82 (1.21-2.73) 
1.93 (0.31-12.0) 
 
Referent 
1.06 (0.69-1.63) 
1.22 (0.78-1.91) 
1.23 (0.81-1.87) 
1.71 (1.13-2.60) 
1.75 (0.28-10.9)  
 
Referent 
1.10 (0.71-1.69) 
1.23 (0.78-1.93) 
1.20 (0.78-1.83) 
1.61 (1.05-2.47) 
1.46 (0.22-9.83) 
NSAIDs: Yes     1.41 (1.01-1.99) 0.89 (0.65-1.23) 0.86 (0.62-1.19) 
Physical 
functioning 
No problem 
A little  
A lot  
      
 
Referent 
1.22 (0.90-1.66) 
1.30 (0.86-1.96) 
 
 
Referent  
1.18 (0.87-1.61) 
1.10 (0.73-1.68) 
 
Previous 
fall: Yes 
      2.70 (2.01-3.61) 
Model 1: unadjusted; Model 2: adjustment for demographic covariates; Model 3: Model 2 & adjustment for medical covariates; Model 4: Model 
3 & adjustment for mental health covariates; Model 5: Model 4 & adjustment  for medication covariates; Model 6: Model 5 & adjustment for 
physical functioning; Model 7: Model 6 & adjustment for previous falls;  OR = odds ratios; 95% CI = 95% confidence interval; where p<0.05, this 
is considered statistically significant and  results are highlighted in bold.  FT Ed >16y = continuing in full time education beyond aged 16 years; 
IMD= Index of Multiple Deprivation divided into quintiles, where: least dep.= least deprived, 2
nd
 least = 2
nd
 least deprived, mid dep. = middle 
deprivation category, 2
nd
 most = 2
nd
 most deprived, most dep. = most deprived category.  Charlson Comorbidity Index (CCI) score: 0 = no CCI 
comorbidities, 1 = 1 CCI comorbidity, 2-8 = 2 or more CCI comorbidities.  BMI = body mass index. Total medication = total medication count. 
Analgesics: weak op. = weak opiates, mod. op. = moderate strength opiates, strong op. = strong opiates, v. strong op. = very strong opiates. 
NSAID = non steroidal anti=inflammatory drug. Physical functioning = ability to walk 100 yards: no problem = no physical limitation, a little = a 
little limitation, a lot = a lot of limitation in ability to walk 100 yards. Previous fall = baseline self-reported fall recorded as ‘yes’.   
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10.4.2 Baseline pain and covariate measurements and six year self-reported fall 
10.4.3.1 Number of pain sites and six year self-reported fall  
Table 10.3 presents odds ratios (the beta co-efficient) and 95% CIs for logistic 
regression predicting self-reported falls at six year follow up.  The table presents 
results from each step of the model build-up, from model 1 (unadjusted) through to 
model 7 (adjusted for all covariates).  There were no statistically significant 
interactions to be included in the model, thus model 7 provides odds ratios to be 
interpreted for results.   
The number of pain sites remains statistically significantly associated with future 
six year self-reported fall across all models, with the level of significance changing 
when physical functioning and baseline self-reported fall are added to the analysis 
and model 7 giving an odds ratio of 1.02 (1.00-1.03), p=0.04.   
Covariates that statistically significantly increased the odds of reporting a six year 
self-reported fall once all covariates are adjusted for are age (OR 1.03 (1.02-1.04) 
p=<0.01),  dizziness (OR 1.69 (1.34-2.13) p=<0.01) , cognitive impairment (OR 
1.01 (1.00-1.01) p=<0.01), physical functioning (a little limitation OR 1.79 (1.35-
2.38, p=<0.01; a lot of limitation OR 1.84 (1.25-2.71) p=<0.01) and baseline self-
reported falls (OR1.94 (1.45-2.59), p=<0.01).  Adequate income reduced the odds 
of reporting a six year fall (OR 0.79 (0.64-0.98) p=0.03). 
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Table 10.3 Odds ratios (95% CIs and p-values) of a self-reported fall at six year follow up according to baseline number of pain 
sites in a multivariate logistic regression model 
Covariate  
OR (95% CI) 
Model 1 
n=4,386 
Model 2  
n=4,089 
Model 3  
n=4,015 
Model 4  
n=3,830 
Model 5 
n=3,830 
Model 6 
n=3,801 
Model 7 
n=3,801 
Number of 
pain sites 
1.06 (1.05-1.07) 1.06 (1.04-1.07) 1.04 (1.03-1.06) 
 
1.03 (1.02-1.05) 
 
1.03 (1.01-1.04) 
 
1.02 (1.00-1.04) 
 
1.02 (1.00-1.03) 
 
Age (years)  1.04 (1.03-1.05) 1.04 (1.03-1.05) 1.04 (1.02-1.05) 1.03 (1.02-1.05) 1.03 (1.02-1.05) 1.03 (1.02-1.05) 
Sex: Male   0.77 (0.64-0.93) 0.81 (0.66-0.98) 0.77 (0.63-0.95) 0.80 (0.65-0.98) 0.81 (0.66-1.00) 0.84 (0.68-1.04) 
FT Ed >16y: 
No 
 0.74 (0.57-0.96) 0.75 (0.58-0.98) 
 
0.79 (0.60-1.04) 0.80 (0.60-1.05) 0.77 (0.59-1.02) 
 
0.76 (0.59-1.02) 
 
Income 
adequate 
 0.67 (0.56-0.81) 0.70 (0.58-0.85) 0.76 (0.62-0.93) 
 
0.76 (0.62-0.93) 
 
0.81 (0.65-1.00) 
 
0.79 (0.64-0.98) 
Occ Class 
non-manual 
 0.93 (0.76-1.13) 
 
0.95 (0.77-1.16) 
 
0.95 (0.77-1.17) 
 
0.95 (0.77-1.17) 
 
0.95 (0.77-1.17) 
 
0.94 (0.76-1.16) 
 
IMD  
1)least dep. 
2) 2
nd
 least 
3)mid dep. 
4) 2
nd
 most 
5)most dep. 
  
Referent 
1.20 (0.91-1.60) 
1.19 (0.89-1.59) 
1.08 (0.79-1.47) 
1.30 (0.96-1.77) 
 
Referent  
1.25 (0.94-1.67) 
1.20 (0.89-1.62) 
1.08 (0.79-1.47) 
1.22 (0.89-1.67) 
 
Referent  
1.36 (1.01-1.83) 
1.20 (0.88-1.64) 
1.10 (0.79-1.52) 
1.19 (0.86-1.66) 
 
Referent  
1.36 (1.01-1.83) 
1.18 (0.86-1.61) 
1.09 (0.79-1.52) 
1.19 (0.86-1.65) 
 
Referent  
1.34 (0.99-1.81) 
1.17 (0.86-1.60) 
1.07 (0.77-1.48) 
1.13 (0.81-1.58) 
 
Referent  
1.32 (0.98-1.78) 
1.16 (0.85-1.58) 
1.05 (0.75-1.45) 
1.11 (0.80-1.55) 
Dizzy: Yes   2.08 (1.69-2.57) 1.81 (1.44-2.27) 1.78 (1.42-2.24) 1.76 (1.40-2.21) 1.69 (1.34-2.13) 
Hearing 
deficit: Yes  
  0.90 (0.69-1.17) 
 
0.87 (0.66-1.14) 
 
0.88 (0.67-1.16) 
 
0.86 (0.65-1.14) 
 
0.85 (0.64-1.13) 
 
Visual 
deficit: Yes 
  1.23 (0.97-1.57) 
 
1.21 (0.94-1.55) 
 
1.22 (0.95-1.57) 
 
1.25 (0.97-1.62) 
 
1.23 (0.95-1.59) 
 
CCI score 
0 
1 
2-8 
   
Referent  
0.88 (0.68-1.16) 
1.18 (0.82-1.70) 
 
Referent 
0.91 (0.69-1.20) 
1.08 (0.73-1.59) 
 
Referent  
0.87 (0.65-1.16) 
0.96 (0.63-1.44) 
 
Referent 
0.83 (0.62-1.11) 
0.89 (0.59-1.36) 
 
Referent  
0.83 (0.62-1.12) 
0.90 (0.59-1.36) 
BMI    1.01 (1.00-1.03) 1.01 (0.99-1.03) 1.01 (0.98-1.03) 1.00 (0.98-1.02) 1.00 (0.98-1.02) 
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Covariate  
OR (95% CI) 
Model 1 
n=4,386 
Model 2  
n=4,089 
Model 3  
n=4,015 
Model 4  
n=3,830 
Model 5 
n=3,830 
Model 6 
n=3,801 
Model 7 
n=3,801 
Depression     1.05 (1.01-1.09) 1.04 (1.00-1.08) 1.03 (0.98-1.07) 1.03 (0.99-1.07) 
Anxiety     0.98 (0.95-1.01) 0.98 (0.95-1.01) 0.98 (0.95-1.01) 0.98 (0.95-1.01) 
Cognitive 
complaint 
   1.01 (1.01-1.02) 1.01 (1.00-1.02) 
 
1.01 (1.00-1.02) 
 
1.01 (1.00-1.01) 
 
Total 
medication 
    1.03 (0.99-1.07) 
 
1.02 (0.98-1.06) 
 
1.02 (0.98-1.06) 
 
Analgesics  
None 
Basic 
Weak op 
Mod. op 
Strong op 
V. strong op 
     
Referent  
0.93 (0.62-1.40) 
1.14 (0.75-1.73) 
1.15 (0.78-1.70) 
1.54 (1.03-2.29) 
0.60 (0.06-5.79) 
 
 
Referent 
0.90 (0.59-1.35) 
0.95 (0.62-1.46) 
0.97 (0.65-1.45) 
1.27 (0.85-1.92) 
0.47 (0.05-4.59) 
 
 
Referent 
0.91 (0.60-1.37) 
0.95 (0.62-1.47) 
0.95 (0.63-1.42) 
1.23 (0.81-1.85) 
0.44 (0.05-4.18) 
NSAIDs: Yes     1.30 (0.98-1.74) 1.28 (0.96-1.72) 1.58 (0.94-1.70) 
Physical 
functioning 
No problem 
A little  
A lot 
      
 
Referent  
1.81 (1.37-2-40) 
2.02 (1.38-2.96) 
 
 
Referent  
1.79 (1.35-2.38) 
1.84 (1.25-2.71) 
Previous 
fall: Yes 
      1.94 (1.45-2.59) 
 
Model 1: unadjusted; Model 2: adjustment for demographic covariates; Model 3: Model 2 & adjustment for medical covariates; Model 4: Model 
3 & adjustment for mental health covariates; Model 5: Model 4 & adjustment  for medication covariates; Model 6: Model 5 & adjustment for 
physical functioning; Model 7: Model 6 & adjustment for previous falls;  OR = odds ratios; 95% CI = 95% confidence interval; where p<0.05, this 
is considered statistically significant and  results are highlighted in bold.  FT Ed >16y = continuing in full time education beyond aged 16 years; 
IMD= Index of Multiple Deprivation divided into quintiles, where: least dep.= least deprived, 2
nd
 least = 2
nd
 least deprived, mid dep. = middle 
deprivation category, 2
nd
 most = 2
nd
 most deprived, most dep. = most deprived category.  Charlson Comorbidity Index (CCI) score: 0 = no CCI 
comorbidities, 1 = 1 CCI comorbidity, 2-8 = 2 or more CCI comorbidities.  BMI = body mass index. Total medication = total medication count. 
Analgesics: weak op. = weak opiates, mod. op. = moderate strength opiates, strong op. = strong opiates, v. strong op. = very strong opiates. 
NSAID = non steroidal anti=inflammatory drug. Physical functioning = ability to walk 100 yards: no problem = no physical limitation, a little = a 
little limitation, a lot = a lot of limitation in ability to walk 100 yards. Previous fall = baseline self-reported fall recorded as ‘yes’.   
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11.4.3.2 Widespread pain measure and six year self-reported fall  
Table 10.4 presents odds ratios (the beta co-efficient) and 95% CIs for logistic 
regression predicting self-reported falls at six year follow up.  The table presents 
results from each step of the model build-up, from model 1 (unadjusted) through to 
model 7 (adjusted for all covariates).   Statistically significant interactions included 
were ‘widespread pain*hearing impairment’.   ‘The likelihood ratio test p-value is 
0.10, therefore model 7 can be accepted rather than the model including the 
interaction terms.   
‘Some pain’ is statistically significantly related to six year self-reported falls until 
physical functioning is added to the model; model 7 gives an odds ratio of 1.22 
(0.93-1.61) p=0.15 for ‘some pain’ compared to no pain for risk of six year self-
reported fall.   ‘Widespread pain’ remains statistically significantly related to six 
year self-reported fall across all models (model 7 OR 1.43 (1.06-1.95) p=0.02).   
Covariates that statistically significantly increase the odds of reporting a six year 
self-reported fall once all covariates are adjusted for are increasing age (OR 1.03 
(1.02-1.04) p=<0.01) , dizziness (OR 1.70 (1.35-2.140 p=<0.01), cognitive 
impairment (OR 1.01 (1.00-1.01) p=<0.01), physical functioning  ( a little limitation 
OR 1.81 (1.36-2.39) p=<0.01; a lot of limitation OR 1.91 (1.31-2.80) p=<0.01) and 
baseline self-reported falls (OR 1.96 (1.47-2.61) p=<0.01).  Adequate income 
reduces the odds of reporting a six year self-reported fall (OR 0.78 (0.63-0.97) 
p=0.03).  
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Table 10.4 Odds ratios (95% CIs and p-values) of a self-reported fall at six year follow up according to baseline pain 
widespreadness in a multivariate logistic regression model 
Covariate  
OR (95% CI) 
Model 1 
n=4,386 
Model 2  
n=4,089 
Model 3  
n=4,015 
Model 4  
n=3,830 
Model 5 
n=3,830 
Model 6 
n=3,801 
Model 7 
n=3,801 
No pain  
Some pain  
Widespread 
Referent  
1.63 (1.28-2.06) 
2.90 (2.27-3.79) 
Referent  
1.58 (1.23-2.03) 
2.60 (2.00-3.36) 
Referent  
1.44 (1.11-1.86) 
2.08 (1.59-2.73) 
Referent  
1.40 (1.08-1.83) 
1.83 (1.37-2.44) 
Referent  
1.31 (1.00-1.71) 
1.60 (1.19-2.16) 
Referent  
1.24 (0.95-1.63) 
1.46 (1.08-1.99) 
Referent  
1.22 (0.93-1.61) 
1.43 (1.06-1.95) 
Age (years)  1.04 (1.03-1.05) 1.04 (1.03-1.05) 1.04 (1.02-1.05) 1.03 (1.02-1.05) 1.03 (1.2-1.04) 1.03 (1.02-1.04) 
Sex: Male   0.75 (0.62-0.90) 0.79 (0.65-0.96) 0.76 (0.62-0.93) 0.79 (0.64-0.97) 0.80 (0.65-0.99) 0.84 (0.68-1.03) 
FT Ed >16y: 
No 
 0.75 (0.58-0.97) 
 
0.76 (0.59-0.99) 
 
0.80 (0.01-1.05) 
 
0.80 (0.61-1.06) 
 
0.77 (0.59-1.02) 
 
0.77 (0.59-1.02) 
 
Income 
adequate 
 0.63 (0.52-0.77) 0.67 (0.55-0.82) 0.75 (0.61-0.92) 0.76 (0.62-0.93) 
 
0.80 (0.65-0.99) 0.78 (0.63-0.97) 
 
Occ Class 
non-manual 
 0.97 (0.79-1.17) 0.97 (0.80-1.19) 
 
0.91 (0.79-1.19) 
 
0.97 (0.79-1.19) 
 
0.96 (0.78-1.19) 
 
0.95 (0.77-1.17) 
 
IMD  
1)least dep. 
2) 2
nd
 least 
3)mid dep. 
4) 2
nd
 most 
5)most dep. 
  
Referent 
1.22 (0.92-1.62) 
1.22 (0.91-1.64) 
1.14 (0.84-1.54) 
1.38 (1.02-1.86 
 
Referent 
1.26 (0.94-1.68) 
1.23 (0.91-1.65) 
1.11 (0.81-1.52) 
1.26 (0.92-1.72 
 
Referent  
1.37 (1.02-1.85) 
1.22 (0.89-1.66) 
1.13 (0.81-1.56) 
1.21 (0.88-1.68 
 
Referent 
1.37 (1.02-1.85) 
1.19 (0.87-1.63) 
1.11 (0.80-.154) 
1.20 (0.87-1.67 
 
 
Referent 
1.35 (1.00-1.82) 
1.18 (0.86-1.61) 
1.08 (0.78-1.51) 
1.14 (0.81-1.58) 
 
Referent 
1.32 (0.98-1.79) 
1.16 (0.85-1.59) 
1.06 (0.76-1.47) 
1.12 (0.80-1.56) 
Dizzy: Yes   2.20 (1.79-2.70) 1.86 (1.49-2.32) 1.82 (1.45-2.28) 1.78 (1.41-2.24) 1.70 (1.35-2.14) 
Hearing 
deficit: Yes  
  0.90 (0.69-1.17) 0.86 (0.66-1.13) 
 
0.88 (0.67-1.16) 
 
0.86 (0.65-1.14) 
 
0.85 (0.64-1.13) 
 
Visual 
deficit: Yes 
  1.27 (1.00-1.61) 
 
1.23 (0.95-1.57) 
 
1.23 (0.96-1.59) 
 
1.26 (0.98-1.63) 
 
1.24 (0.96-1.60) 
 
CCI score 
0 
1 
2-8 
   
Referent  
0.92 (l.71-1.72) 
1.20 (0.84-1.72) 
 
Referent 
0.93 (0.71-1.23) 
1.09 (0.74-1.60 
 
Referent 
0.86 (0.66-1.18) 
0.96 (0.64-1.45) 
 
Referent 
0.84 (0.63-1.12) 
0.89 (0.59-1.36) 
 
Referent  
0.84 (0.63-1.13) 
0.90 (0.59-1.36) 
BMI    1.02 (1.00-1.04) 1.01 (0.99-1.03) 
 
1.01 (0.98-1.03) 
 
1.00 (0.98-1.02) 
 
1.00 (0.98-1.02) 
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Covariate  
OR (95% CI) 
Model 1 
n=4,386 
Model 2  
n=4,089 
Model 3  
n=4,015 
Model 4  
n=3,830 
Model 5 
n=3,830 
Model 6 
n=3,801 
Model 7 
n=3,801 
Depression     1.06 (1.02-1.10) 1.04 (1.00-1.09) 1.03 (0.99-1.07) 1.03 (0.99-1.07) 
Anxiety     0.98 (0.94-1.01) 0.98 (0.95-1.01) 0.98 (0.95-1.01) 0.98 (0.95-1.01) 
Cognitive 
complaint 
   1.01 (1.01-1.02) 1.01 (1.01-1.02) 
 
1.01 (1.01-1.02) 
 
1.01 (1.00-1.01) 
Total 
medication 
    1.03 (0.99-1.07) 1.02 (0.98-1.06) 1.02 (0.98-1.06) 
 
Analgesics  
None 
Basic 
Weak op 
Mod. op 
Strong op 
V. strong op 
     
Referent 
0.92 (0.61-1.38) 
1.14 (0.75-1.73) 
1.17 (0.79-1.72) 
1.61 (1.09-2.38) 
0.74 (0.08-6.96) 
 
Referent 
0.88 (0.58-1.33) 
0.94 (0.61-1.45) 
0.97 (0.65-1.45) 
1.30 (0.87-1.95) 
0.53 (0.06-5.09) 
 
Referent  
0.90 (0.59-1.35) 
0.94 (0.61-1.45) 
0.94 (0.61-1.45) 
1.24 (0.83-1.87) 
0.48 (0.50-4.51) 
NSAIDs: Yes     1.32 (0.99-1.76) 1.29 (0.96-1.72) 1.27 (0.94-1.70) 
Physical 
functioning 
No problem 
A little  
A lot  
      
 
Referent  
1.83 (1.39-2.42) 
2.11 (1.45-3.08) 
 
 
Referent  
1.81 (1.36-2.39) 
1.91 (1.31-2.80) 
Previous 
fall: Yes 
      1.96 (1.47-2.61) 
Model 1: unadjusted; Model 2: adjustment for demographic covariates; Model 3: Model 2 & adjustment for medical covariates; Model 4: Model 
3 & adjustment for mental health covariates; Model 5: Model 4 & adjustment  for medication covariates; Model 6: Model 5 & adjustment for 
physical functioning; Model 7: Model 6 & adjustment for previous falls;  OR = odds ratios; 95% CI = 95% confidence interval; where p<0.05, this 
is considered statistically significant and  results are highlighted in bold.  FT Ed >16y = continuing in full time education beyond aged 16 years; 
IMD= Index of Multiple Deprivation divided into quintiles, where: least dep.= least deprived, 2
nd
 least = 2
nd
 least deprived, mid dep. = middle 
deprivation category, 2
nd
 most = 2
nd
 most deprived, most dep. = most deprived category.  Charlson Comorbidity Index (CCI) score: 0 = no CCI 
comorbidities, 1 = 1 CCI comorbidity, 2-8 = 2 or more CCI comorbidities.  BMI = body mass index. Total medication = total medication count. 
Analgesics: weak op. = weak opiates, mod. op. = moderate strength opiates, strong op. = strong opiates, v. strong op. = very strong opiates. 
NSAID = non steroidal anti=inflammatory drug. Physical functioning = ability to walk 100 yards: no problem = no physical limitation, a little = a 
little limitation, a lot = a lot of limitation in ability to walk 100 yards. Previous fall = baseline self-reported fall recorded as ‘yes’.   
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10.4.3 Multivariate analysis: summary  
An increasing number of pain sites statistically significantly increased the odds of 
self-reported falls at three and six years with odds ratios of 1.12 (1.01-1.24) p=0.04 
and 1.03 (1.02-1.04) p=<0.01 respectively.  Each additional pain site conferred a 
12% increased odds of falling at three years and a 3% increased odds of falling at 
six years.   
Widespread pain, as measured using the widespread pain measure, did not 
statistically significantly predict three year self-reported fall; the presence of 
widespread pain did however statistically significantly increase the odds of a self-
reported fall at six years by 43% compared to those with no pain (OR 1.43 (1.06-
1.95) p=0.02).   
Table10.5 presents the statistically significant covariates in the final models for 
three and six year falls.  The presence of dizziness and limitation in physical 
functioning were statistically significantly associated with increased odds of self-
reported fall at six years but not at three years.  Increasing BMI, increasing total 
medication count and a prescription for strong opioids were statistically 
significantly associated with increased odds of a three year self reported fall but 
not six year self-reported fall.   
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Table 10.5 Multivariable logistic regression of the relationship between multisite 
pain and future self-reported fall: statistically significant predictors at three year 
and six year follow up  
Three year self-reported fall Six year self-reported fall 
Covariates increasing the odds of falling: 
Number of pain sites Number of pain sites 
Increasing age Increasing age 
Increasing BMI Presence of dizziness 
Increased cognitive complaint score Increasing cognitive complaint 
Increased total medication count Limitation in physical functioning 
Strong opioid prescription History of baseline self-reported fall 
History of baseline self-reported fall  
Covariates reducing the odds of falling: 
Non-manual occupation Adequate income 
Higher multimorbidity score  
 
10.5 Discussion  
10.5.1 Summary of findings  
Univariate analysis of covariates and future falls has found that increasing age, 
higher deprivation levels, a higher BMI, the presence of dizziness, hearing 
difficulty and vision impairment, two or more CCI comorbidities, increasing  
anxiety, increasing depression and increasing cognitive complaint scores, 
increasing total medication count, opioid analgesics, NSAID use, limitation in 
physical functioning and baseline self-reported fall were all associated with a 
statistically significant increased odds of a future three, or six, year self-reported 
fall.  Being male and adequate income statistically significantly reduced the odds 
of reporting a fall at three and six years.  
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An increasing number of pain sites statistically significantly increased the odds of 
three, or six, year self-reported fall when all covariates were included in the logistic 
regression model.  This means that an increasing number of pain sites confer an 
increased risk of falling even when traditional falls risk factors and other putative 
influencing covariates are accounted for.   
The presence of widespread pain is also associated with statistically significantly 
increased odds of falling at six years when all covariates were included in the 
logistic regression model, thus meaning that widespread pain confers an additional 
risk of future self-reported falls in excess of that predicted by traditional falls risk 
factors and other putative influencing covariates are accounted for.  
 
10.5.2 How it fits into current literature and what is new  
Referring back to the systematic review and meta-analysis, where all of the 
included studies had self-reported falls as outcomes, the adjusted pooled effect 
estimate for the presence of multisite pain and falls was an odds ratio of 1.56 
(1.40-1.75); the unadjusted pooled effect estimate for prospective studies only was  
1.70 (1.49-1.94).  The adjusted odds ratio for the number of pain sites and three 
year and six falls in this thesis are 1.12 (1.01-1.24) and 1.03 (1.02-1.04) 
respectively.  The odds ratio for widespread pain and three and six year falls are 
1.27 (0.92-1.75) and 1.43 (1.06-1.95) respectively.  The effect estimates from this 
thesis are lower than that derived in the meta-analysis.  This may be due to the 
highly adjusted effect estimates in this thesis.  The meta-analysis demonstrated 
that, when adjusting for multiple variables, the pooled odds ratio reduced from 
1.83 (1.54-2.19).  This is unsurprising since, the more variables that are added to 
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the model, the more variables are available to explain effect size and the lower 
each individual variable’s contribution becomes.    
Other variables that were statistically significantly associated with increased odds 
of future self-reported fall in final adjusted models were expected and in line with 
traditional falls risk factors that are addressed in current falls prevention 
guidelines.  For example, the multifactorial risk assessment recommended by 
NICE (2013) explicitly advises assessment of cognitive functioning, medication 
review, the presence of dizziness, physical functioning and history of previous 
falls.  BMI assessment is not included in falls guidelines, and the magnitude of 
increased odds per unit increase in BMI of 1.03 (1.00-1.05) with the confidence 
interval including 1.00 is unlikely to be clinically significant.  
This study has found that a higher multimorbidity score (scoring 2 or more on the 
CCI) is associated with reduced odds of future three year self-reported fall.  This is 
the first study to demonstrate this protective effect and is most likely due to the 
composition of thesis sample B.  This sample has been derived from thesis 
sample A and includes those who are healthy enough to complete six years of 
study follow up with consistent pain data. This healthy cohort effect may explain 
this apparent protective effect if these higher-scoring respondents do not have any 
other falls risk factors, for example, they do not have a baseline self-reported fall, 
are not dizzy and do not take many medications.  Alternatively, it may be that 
those with multimorbidities are less able to move about and have few opportunities 
to fall though this is unlikely given the derivation of thesis sample B.   
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10.5.3 Strengths 
The major strength of this study is the inclusion of multiple covariates in analysis to 
enable the results to be as clinically relevant as possible.   Traditional falls risk 
factors and covariates known to be associated with pain are all included to ensure 
that any relationships beyond pain and falls are incorporated into the analysis.  
Interactions have also been tested and included in the final models where 
necessary, again increasing the clinical relevance of this result.    
The study uses prospective falls data, which means that causality can be inferred 
from the effect estimate.  Thus, it is possible to conclude that multisite pain does 
incur an additional risk of future self-reported fall in addition to traditional falls risk 
factors.  This is a more clinically useful conclusion than that derived from cross-
sectional data, where it is not possible to establish a temporal relationship.    
 
10.5.4 Limitations 
The problems around the self-reported measure including recall bias and the 
limited three month recall as discussed in Chapter 9 are also relevant to this 
analysis.   
Furthermore, although this analysis has considered 19 covariates, there are a few 
known falls risk factors that are not taken account of due to no data being 
available.  These include assessments of home hazards and urinary incontinence 
(NICE, 2013) and measures of gait, balance, mobility and strength such as those 
tests used by Leveille et al (2009) (chair stands test, gait speed, balance) and 
Stubbs et al (2015) (Timed Up and Go test).  No information on another 
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established risk factor, fear of falling, was available (Friedman et al, 2002).  Adding 
these factors to the model may attenuate the risk of future falls attributed to pain 
and render the effect estimate associated with pain statistically non-significant.   
The covariates used in this analysis all consist of information easily, and efficiently, 
available to GPs, thus this analysis is clinically useful as GPs will have information 
about these covariates to hand.  Assessing urinary incontinence and fear of falling 
is quick and possible to undertake in a ten minute GP consultation; formal 
measures of gait, balance, mobility and strength will be more challenging to 
complete within a standard consultation and including these in the model will 
render it less clinically useful.   
 
10.5.5  Informing the thesis  
This analysis has shown that multisite pain, when measured as number of pain 
sites and as widespread pain, is associated with adjusted increased odds of future 
self-reported falls.  Given the potential for recall bias and subsequent 
misclassification of self-reported fallers leading to an underestimate of self-
reported falls prevalence, the estimated effect size could be an underestimate of 
the true effect size in the general population of older adults.   
A prospective analysis will now be undertaken using GP and HES-recorded falls 
as the outcome measure to examine whether multisite pain also confers a 
statistically significant risk of health-care associated falls.  
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10.5.6 Chapter summary  
This chapter has examined the role of pain as a predictor of future risk of self-
reported falls using a prospective study design.  The knowledge gap highlighted by 
the systematic review and meta-analysis has been addressed and new evidence 
that multisite pain confers an additional risk of future self-reported falls even when 
adjusted for multiple covariates that have known associations with pain and falls 
has been generated by this thesis.   The next chapter will examine the relationship 
between multisite pain and future GP or HES-recorded fall.   
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Chapter 11: Pain as a predictor of falls requiring primary 
and secondary health care utilisation 
11.1 Overview  
This chapter explores the relationship between baseline pain status and covariate 
measurements with future GP and HES-recorded falls.  The rationale for the 
chapter is explained, methods are outlined and results are presented and 
summarised.  A discussion highlights key findings, strengths and limitations of the 
study and implications for future clinical practice are proposed.  
11.2 Rationale and chapter objectives  
This chapter seeks to examine the role of multisite pain as a predictor of future risk 
of falls requiring primary health care utilisation (GP-recorded fall) and falls 
requiring secondary health care utilisation (HES-recorded fall) using a prospective 
study design.  The systematic review and meta-analysis in Chapter 5 highlighted a 
lack of evidence around pain as a risk factor for falls and a paucity of large 
prospective studies to examine pain as a predictor of future fall risk.  This chapter 
aims to address this knowledge gap by using baseline pain and covariate 
measurements to predict future risk of GP or HES-recorded falls.  Survival 
analysis is used to analyse the data in thesis sample A (n=11,375, this sample 
contains NorStOP baseline responders who consented to further medical record 
review and answered the pain questions consistently) to meet the following 
objectives:  
i) to undertake prospective multivariate analysis to establish the 
relationship between multisite pain and future GP-recorded falls; 
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ii) to undertake prospective multivariate analysis to establish the 
relationship between multisite pain and future HES-recorded falls 
 
11.3 Methods  
11.3.1 Variable measurements 
Pain is analysed using the number of pain sites as a continuous measure and the 
categories of widespreadness (no pain / some pain / widespread pain) as a 
categorical measure, as described in Chapter 6.  Covariates are all measured as 
described in Chapter 6 and previous falls history is considered using self-reported 
falls at baseline.   
11.3.2 Falls  
GP-recorded and HES-recorded falls are used as a binary outcome (yes/no) 
according to ‘ever fallen’ status for GP or HES recorded falls i.e. respondents who 
have had one or more GP or HES recorded falls.   
11.3.3  A note on time periods 
The time period for this analysis matches that used in Chapter 10.  The time 
period begins at the start of the corresponding NorStOP cohort baseline survey 
mail out and ends at the end of the NorSTOP3 six year follow up mail out, except 
for respondents who did not complete three year follow up where their study 
period ends at the end of their corresponding NorStOP three year follow up mail 
out period.  The time that respondents spend in the study therefore differs 
according to the specific NorStOP cohort and three year follow up response.  
Thus, respondents in NorStOP1 who complete follow up surveys will have data 
over ten years, those in NorStOP3 who complete all follow up surveys will have 
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data over six years and those in any of the NorStOP cohorts who do not complete 
three year follow up will have their data collected over three years.  The 
implications of these differences are explored in this chapter’s discussion.   
11.3.4 Cox’s proportional hazard regressions   
Cox proportional hazards regression enables time to an event to be measured. For 
example, time from exposure (e.g. smoking) to death (e.g. from cancer), or from 
treatment (e.g. chemotherapy) to disease recurrence (e.g. breast cancer).  Hence 
this technique is often referred to as ‘survival analysis’ although it is commonly 
used when mortality is not the outcome of interest.   In the thesis, it is used to 
measure the risk of time to first fall and to investigate whether that time to first fall 
is different across different pain exposures.  This technique enables the effect of 
predictor covariates (for example, pain, depression, comorbidity) upon the 
outcome (falls) to be measured.  Continuous, binary and categorical data can be 
used in analysis as measurements are logarithmically transformed to enable a 
linear relationship between covariates and outcome to be measured (Peacock J & 
Peacock P, 2010).  After adjusting for all covariates in the model, the analysis 
gives regression coefficients for each covariate and the time-to-event fall outcome 
and these are back-transformed to provide an effect measurement as a hazard 
ratio.  For example, if the time to first fall is less for those with widespread pain 
compared to those reporting some pain or no pain, then the hazard ratio for falling 
would be greater in the widespread pain group.   Further details on how the data is 
prepared to enable survival analysis are provided in Appendix 9.   
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11.3.4.1 Testing univariate associations 
Prior to running the Cox regression, investigation of each covariate’s relationship 
with time-to-fall is necessary to establish univariate associations within the data 
that has been flagged or ‘set’ as time series data.  As with previous analyses, all 
covariates will be added to the Cox proportional hazard model to ensure clinical 
practice is reflected as far as possible.  Univariate analysis for categorical 
variables will use the log-rank test for equality of survivor functions and generation 
of Kaplan-Meier curves to assess relationship with time to first fall event.  The 
crude relationship of continuously measured covariates is measured using the Cox 
proportional hazard model with a single continuous predictor variable and as such 
may yield different results to those presented in Chapter 9.  
11.3.4.2 Testing interactions between covariates 
Interactions between covariates must be examined to ensure that any difference in 
association between one predictor variable and the outcome at different levels of 
another predictor variable is taken account of.  A description of interactions and 
how these might impact upon results is described in Chapter 10.  Interactions 
between pain and all covariates are tested by building Cox proportional hazard 
models using the two variables of interest and an interaction term containing those 
two variables.  If the interaction term has a statistically significant hazard ratio 
(p<0.05), then it must be included in the final Cox proportional hazard model 
(unless the likelihood ratio test accepts that a smaller model excluding the 
interaction terms is nested in the bigger model containing the interaction terms).  
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12.3.4.3 Interpreting Cox proportional hazard output  
The hazard ratio output in Stata 14 (Statacorp, 2015) provides a comparison of the 
hazard of falls in the pain group compared to the non-pain group.  If both groups 
have the same hazard of falling then the hazard ratio would equal 1.  A hazard 
ratio of <1 means that the hazard of falling is less than the control (non-pain) 
group and a hazard ratio >1 means that the hazard of falling is greater than the 
control group. 
12.3.4.4 Model building for Cox proportional hazards  
Univariate analysis is first undertaken within the dataset that is declared as time 
series.  Adopting the same approach as that described in Chapter 10, all 
covariates are entered into the model in groups using a stepwise approach.  
Firstly, an unadjusted analysis is undertaken to measure the hazard of falling 
associated with pain and no other covariates.  Covariates are then added to the 
model in a stepwise manner according to the schedule in Box 10.1, starting with 
physical health measures (BMI, dizziness, hearing impairment, visual impairment, 
multimorbidity), then adding mental health factors (anxiety, depression, cognitive 
impairment), medication factors (total mediation count, maximum analgesic 
category, NSAID use), physical functioning and previous falls history (baseline 
self-reported fall).    
Statistically significant interaction terms are then added to the most 
comprehensive model and a likelihood ratio test is conducted to assess whether 
the interaction terms significantly change the hazard ratios for each covariate.   
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12.3.4.6 Diagnostic testing of the final model  
Cox proportional hazards regression relies on the underlying assumption that the 
hazard ratio is constant over time and therefore independent of time, for example 
the risk of falls at two years equals the risk of falls at 4 years.  This assumption is 
tested using Schoenfeld residuals (Schoenfeld, 1982), in which residual values are 
measured i.e. those values that the model cannot explain).  In order for Cox’s 
Proportional Hazard testing to hold, the residual values must be proportional over 
time.  This assumption was tested using generalised linear regression of the 
scaled Schoenfeld residuals for each variable over time.  Where a non-straight line 
slope indicated a violation of the proportional hazard assumption, time dependent 
covariates were generated by creating interactions of the predictors and a function 
of survival time.  These were included these in the final model and time varying 
effects were accommodated using the tvc() option in Stata 14 (Statacorp, 2015).   
The hazard ratios of time varying covariates are interpreted using the tcv(variable) 
output.     
 
11.4 Results  
781 GP recorded falls and 804 HES recorded falls occurred between the start and 
end dates of the study period.    
11.4.1 Univariate associations between covariates and GP falls 
Univariate associations within the dataset are shown in table 11.1.  All covariates 
were statistically significantly related except education status, income adequacy, 
IMD and NSAIDs. 
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Table 11.1 Cox proportional hazard ratios for multisite pain and GP-recorded falls: 
report of statistically significant univariate associations  
 
Covariate  P value 
 
Widespread pain <0.01 
Full time education 0.10 
Occupational class <0.01 
Income adequacy 0.20 
IMD 0.61 
Sex <0.01 
Dizziness  <0.01 
Hearing difficulty <0.01 
Vision impairment  <0.01 
Maximum analgesic <0.01 
NSAIDs 0.10 
Multimorbidity <0.01 
Physical function <0.01 
Baseline self-reported fall <0.01 
Number of pain sites  <0.01 
Age  <0.01 
Anxiety <0.01 
Depression <0.01 
Cognitive complaint <0.01 
BMI <0.01 
Total medication count <0.01 
IMD = index of multiple deprivation; BMI = body mass index; NSAID = 
non-steroidal anti-inflammatory 
 
 
11.4.2 NPS and GP-recorded falls 
Statistically significant interaction terms added to the Cox proportional hazards 
model were interactions between the number of pain sites and age, cognitive 
complaint, depression, maximum analgesia, NSAID use and physical functioning.     
Table 11.2 presents hazard ratios (HR) and 95% confidence intervals for 
covariates in each model, from the unadjusted hazard ratio of pain and falls 
(model 1) through to model 8 (adjusted for all covariates and time-varying 
covariates); HRs with a p-value of <0.05 are highlighted in bold.  The likelihood 
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ratio test that the small model (contained all the covariates) was nested within the 
large model (contained all covariates and statistically significant interaction terms) 
was p=0.40 - therefore the small model was adopted and time-varying covariates 
were added to this model.  Four variables were found to violate the time-constant 
assumption and were therefore interacted with time (vision, hearing, BMI and 
maximum analgesic strength).   
The number of pain sites was statistically significantly associated with GP-
recorded falls until the analysis was adjusted for medication covariates, where the 
hazard ratio changed from 1.02 ((1.00-1.03) p=<0.01) to 1.01 (1.00-1.02) p=0.08).  
Model 8 gave the number of pain sites a HR of 1.01 (1.00-1.02) p=0.08. 
The final model (model 8) found that increasing age (HR 1.07 (1.06-1.08),  
p=<0.01), increasing total number of medications (HR 1.05 (1.02-1.08) p=<0.01) 
and history of self-reported falls at baseline (HR 1.51 (1.22-1.88) p=<0.01) were 
statistically significantly associated with an increased risk of GP-recorded falls; 
whilst being male (HR 0.52 (0.44-0.63) p=<0.01) was statistically significantly 
associated with a reduced risk of GP-recorded falls.   
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Table 11.2 Hazard ratios (95% CIs and p-values) of a GP recorded fall according to baseline number of pain sites in a 
multivariate Cox proportional hazard model 
Covariate  
OR (95% CI) 
Model 1 
n=11,373 
Model 2  
n=10,254 
Model 3 
n = 9,971 
Model 4  
n = 9,349  
Model 5 
n=9,349 
Model 6 
n=9,234 
Model 7 
n=9,234 
Model 8 
n=9,234 
Number of 
pain sites 
1.02 (1.02-1.03) 
 
1.02 (1.01-1.03) 
 
1.02 (1.01-1.03) 
 
1.02 (1.00-1.03) 
 
1.01 (1.00-1.02) 
 
1.01 (1.00-1.02) 
 
1.01 (1.00-1.02) 
 
1.01 (1.00-1.02) 
Age (years)  1.08 (1.07-1.09) 1.08 (1.07-1.09) 1.07 (1.06-1.08) 1.07 (1.06-1.08) 1.07 (1.06-1.08) 1.07 (1.06-1.08) 1.07 (1.06-1.08) 
Sex: Male   0.56 (0.47-0.65) 0.56 (0.47-0.66) 0.51 (0.43-0.62) 0.53 (0.44-0.63) 0.51 (0.43-0.62) 0.52 (0.43-0.63) 0.53 (0.44-0.63) 
FT Ed >16y: 
No 
 0.92 (0.72-1.17) 
 
0.97 (0.71-1.18) 
 
0.92 (0.71-1.19) 
 
0.91 (0.70-1.17) 
 
0.91 (0.70-1.18) 
 
0.90 (0.70-1.17) 
 
0.90 (0.69-1.16) 
 
Income 
adequate 
 0.96 (0.82-1.13) 
 
0.99 (0.84-1.17) 
 
1.00 (0.84-1.18) 
 
1.02 (0.85-1.21) 
 
1.02 (0.85-1.21) 
 
1.02 (0.85-1.21) 
 
1.01 (0.84-1.19) 
 
Occ Class 
non-manual 
 1.10 (0.93-1.29) 1.07 (0.90-1.27) 1.09 (0.91-1.30) 
 
1.09 (0.91-1.30) 
 
1.08 (0.91-1.29) 
 
1.08 (0.91-1.29) 
 
1.09 (0.91-1.30) 
 
IMD  
1)least dep. 
2) 2
nd
 least 
3)mid dep. 
4) 2
nd
 most 
5)most dep. 
  
Referent  
0.99 (0.78-1.25) 
0.81 (0.64-1.04) 
0.94 (0.74-1.19) 
0.94 (0.74-1.19 
 
Referent 
1.00 (0.79-1.27) 
0.79 (0.62-1.02) 
0.89 (0.69-1.14) 
0.89 (0.70-1.14) 
 
Referent 
1.00 (0.78-1.28) 
0.82 (0.63-2.06) 
0.89 (0.69-1.16) 
0.91 (0.70-1.17) 
 
Referent  
0.99 (0.77-1.28) 
0.80 (0.61-1.04) 
0.87 (0.67-1.13) 
0.88 (0.68-1.14) 
 
Referent  
1.01 (0.78-1.30) 
0.81 (0.62-1.05) 
0.87 (0.67-1.14) 
0.90 (0.69-1.16) 
 
Referent  
1.01 (0.79-1.30) 
0.81 (0.62-1.06) 
0.87 (0.67-1.14) 
0.90 (0.69-1.17) 
 
Referent 
1.01 (0.85-1.30) 
0.81 (0.62-1.05) 
0.87 (0.67-1.13) 
0.90 (0.70-1.17) 
Dizzy: Yes   1.33 (1.12-1.59) 1.22 (1.01-1.48) 1.19 (0.98-1.44) 1.22 (1.00-1.48) 1.19 (0.98-1.45) 1.19 (0.98-1.44) 
Hearing 
deficit: Yes  
  1.04 (0.86-1.26) 0.99 (0.81-1.21) 0.99 (0.81-.121) 0.98 (0.80-1.20) 0.98 (0.80-1.20) 
 
0.94 (0.88-1.01) 
 
Visual 
deficit: Yes 
  1.06 (0.88-1.27) 
 
1.01 (0.83-1.22) 
 
0.99 (0.81-1.20) 
 
0.99 (0.81-1.20) 
 
0.98 (0.81-1.19) 
 
1.02  (0.97-1.08) 
 
CCI score 
0 
1 
2-8 
   
Referent 
1.18 (0.97-1.44) 
1.30 (1.02-1.65) 
 
Referent  
1.20 (0.98-1.48) 
1.25 (0.97-1.62) 
 
Referent  
1.06 (0.85-1.32) 
1.02 (0.77-1.34) 
 
Referent  
1.08 (0.87-1.34) 
1.02 (0.77-1.35) 
 
Referent  
1.09 (0.88-1.36) 
1.03 (0.78-1.37) 
 
Referent  
1.08 (0.87-1.35) 
1.03 (0.78-1.37) 
BMI    1.01(0.99-1.02) 1.01(0.99-1.02) 1.00 (0.99-1.02) 1.00 (0.99-1.02) 1.00 (0.99-1.02) 1.00 (0.99-1.00) 
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Covariate  
OR (95% CI) 
Model 1 
n=11,373 
Model 2  
n=10,254 
Model 3 
n = 9,971 
Model 4  
n = 9,349  
Model 5 
n=9,349 
Model 6 
n=9,234 
Model 7 
n=9,234 
Model 8 
n=9,234 
Depression     1.03 (1.00-1.06) 
 
1.02 (0.95-1.05) 1.02 (0.99-1.06) 
 
1.02 (0.98-1.05) 
 
1.02 (0.99-1.05) 
 
Anxiety     0.98 (0.95-1.01) 
 
0.98 (0.95-1.01) 
 
0.98 (0.96-1.01) 
 
0.98 (0.96-1.01) 
 
0.98 (0.95-1.01) 
 
Cognitive 
complaint 
   1.00 (1.00-1.01) 
 
1.00 (1.00-1.01) 
 
1.00 (1.00-1.01) 
 
1.00 (1.00-1.01) 
 
1.00 (1.00-1.01) 
 
Total 
medication 
    1.05 (1.02-1.09) 
 
1.05 (1.02-1.08) 
 
1.05 (1.02-1.08) 
 
1.05 (1.02-1.08) 
 
Analgesics  
None 
Basic 
Weak op. 
Mod. op. 
Strong op. 
     
Referent  
0.91 (0.68-1.22) 
0.92 (0.67-1.25) 
1.19 (0.89-1.58) 
1.19 (0.86-1.65) 
 
Referent  
0.90 (0.67-1.21) 
0.89 (0.65-1.23) 
1.21 (0.91-1.62) 
1.21 (0.87-1.67) 
 
Referent 
0.92 (0.69-1.23) 
0.90 (0.65-1.23) 
1.20 (0.90-1.61) 
1.19 (0.86-1.65) 
 
Referent 
1.02 (0.94-1.11) 
0.98 (0.89-1.08) 
1.06 (0.97-1.15) 
1.03 (0.95-1.14) 
NSAIDs: Yes     1.01 (0.78-1.31) 
 
1.04 (0.80-1.35) 
 
1.02 (0.79-1.32) 
 
1.04 (0.80-1.34) 
 
Physical 
functioning 
No problem 
A little  
A lot  
      
 
Referent 
1.05 (0.84-1.33) 
0.83 (0.62-1.11) 
 
 
Referent 
1.04 (0.83-1.32) 
0.79 (0.59-1.06) 
 
 
Referent  
1.06 (0.84-1.33) 
0.81 (0.60-1.08) 
Previous 
fall: Yes 
      1.51 (1.21-1.88) 
 
1.51 (1.22-1.88) 
 
Model 1: unadjusted; Model 2: adjustment for demographic covariates; Model 3: Model 2 & adjustment for medical covariates; Model 4: Model 3 & adjustment for 
mental health covariates; Model 5: Model 4 & adjustment for medication covariates; Model 6: Model 5 & adjustment for physical functioning; Model 7: Model 6 & 
adjustment for previous falls; Model 8: Model 7 & adjustment for interaction terms and/or time varying covariates .  HR = hazard ratio; 95% CI = 95% confidence 
interval; where p<0.05, this is considered statistically significant and results are highlighted in bold.  FT Ed >16y = continuing in full time education beyond aged 16 
years; IMD= Index of Multiple Deprivation divided into quintiles, where: least dep.= least deprived, 2
nd
 least = 2
nd
 least deprived, mid dep. = middle deprivation 
category, 2
nd
 most = 2
nd
 most deprived, most dep. = most deprived category.  Charlson Comorbidity Index (CCI) score: 0 = no CCI comorbidities, 1 = 1 CCI 
comorbidity, 2-8 = 2 or more CCI comorbidities.  BMI = body mass index. Total medication = total medication count. Analgesics: weak op. = weak opiates, mod. op. = 
moderate strength opiates, strong op. = strong opiates and very strong opiates combined. NSAID = non steroidal anti=inflammatory drug. Physical functioning = 
ability to walk 100 yards: no problem = no physical limitation, a little = a little limitation, a lot = a lot of limitation in ability to walk 100 yards. Previous fall = baseline 
self-reported fall recorded as ‘yes’.   
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11.4.3 Widespread pain and GP-recorded falls  
Statistically significant interaction terms included in the analysis were widespread 
pain and income adequacy, and widespread pain and cognitive complaint. 
Table 11.3 presents hazard ratios and 95% confidence intervals for covariates in 
each model, from the unadjusted hazard ratio of pain and falls (model 1) through 
to model 8 (adjusted for all covariates and time-varying covariates).   Four 
variables were found to violate the time-constant assumption and were therefore 
interacted with time (BMI, depression, hearing and analgesia).  The likelihood ratio 
test between the large model (containing the interaction terms) and the smaller 
model (containing only covariates) found p=0.65, the small model could then be 
carried forward and time-varying adjusted covariates added accordingly.   
‘Some pain’ was statistically significantly associated with GP-recorded falls at all 
stages of model building, with the final model giving a hazard ratio of 1.26 ((1.01-
1.57) p=0.048)) for ‘some pain’ compared with no pain.  Widespread pain had a 
statistically significant increased hazard ratio for GP-recorded falls until medication 
was added to the model.  The hazard ratio for widespread pain in the final model 
(model 8) was 1.27 (0.98-1.65) p=0.07.     
Covariates that statistically significantly increased the hazard of GP-recorded falls 
were increasing age (HR 1.07 (1.05-1.09) p=<0.01), increasing cognitive complaint 
(HR1.003 (1.00-1.01) p=0.02), increasing number of total medication count (HR 
1.05 (1.02-1.08) p=<0.01) and a history of baseline self-reported fall (HR 1.53 
(1.23-1.91) p=<0.01).  Being male was statistically significantly associated with a 
lower hazard of falling (HR 0.54 (0.44-0.65) p=<0.01).  
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Table 11.3 Hazard ratios (95% CIs and p-values) of a GP recorded fall according to pain widespreadness in a multivariate Cox 
proportional hazard model 
Covariate  
OR (95% CI) 
Model 1 
n=11,373 
Model 2  
n=10,254 
Model 3 
n = 9,971 
Model 4  
n = 9,349  
Model 5 
n=9,349 
Model 6 
n=9,234 
Model 7 
n=9,234 
Model 8 
n=9,234 
No pain  
Some pain 
Widespread  
Referent 
1.37 (1.14-1.65) 
1.51 (1.24-1.84) 
Referent 
1.36 (1.12-1.66) 
1.58 (1.27-1.95) 
Referent  
1.29 (1.05-1.59) 
1.41 (1.12-1.76) 
Referent 
1.32 (1.06-1.63) 
1.40 (1.10-1.79) 
Referent 
1.26 (1.00-1.57) 
1.27 (0.99-1.64) 
Referent 
1.26 (1.01-1.58) 
1.26 (0.97-1.64) 
Referent 
1.25 (1.00-1.57) 
1.25 (0.96-1.62) 
Referent 
1.26 (1.01-1.57) 
1.27 (0.98-1.65) 
Age (years)  1.08 (1.07-1.09) 1.08 (1.07-1.09) 1.07 (1.06-1.08) 1.07 (1.06-1.08) 1.07 (1.06-1.08) 1.07 (1.06-1.08) 1.07 (1.06-1.08) 
Sex: Male   0.55 (0.47-0.65) 0.56 (0.47-0.66) 0.51 (0.43-0.61) 0.52 (0.44-0.63) 0.51 (0.42-0.61) 0.52 (0.43-0.63) 0.54 (0.44-0.65) 
FT Ed >16y: 
No 
 0.92 (0.72-1.17) 
 
0.91 (0.71-1.17) 
 
0.92 (0.71-1.18) 
 
0.90 (0.70-1.17) 
 
0.90 (0.70-1.17) 
 
0.90 (0.70-1.17) 
 
0.89 (0.69-1.19) 
 
Income 
adequate 
 0.94 (0.81-1.11) 
 
0.98 (0.83-1.16) 
 
0.99 (0.83-1.17) 
 
1.01 (0.85-1.20) 
 
1.01 (0.85-1.20) 
 
1.01 (0.85-1.20) 
 
0.99 (0.83-1.18) 
 
Occ Class 
non-manual 
 1.11 (0.94-1.31) 
 
1.08 (0.91-1.28) 
 
1.10 (0.92-1.31) 
 
1.10 (0.92-1.31) 
 
1.09 (0.91-1.30) 
 
1.09 (0.91-1.30) 
 
1.09 (0.91-1.30) 
 
IMD  
1)least dep. 
2) 2
nd
 least 
3)mid dep. 
4) 2
nd
 most 
5)most dep. 
  
Referent  
0.99 (0.78-1.25) 
0.82 (0.64-1.04) 
0.95 (0.75-1.21) 
0.95 (0.75-1.20) 
 
Referent 
1.00 (0.79-1.27) 
0.80 (0.62-1.03) 
0.89 (0.70-1.14) 
0.90 (0.70-1.15) 
 
Referent 
1.00 (0.78-1.28) 
0.82 (0.63-1.06) 
0.89 (0.69-1.16) 
0.91 (0.70-1.17) 
 
Referent 
1.00 (0.78-1.28) 
0.80 (0.62-1.04)  
0.87 (0.67-1.13) 
0.88 (0.68-1.14) 
 
Referent 
1.01 (0.79-1.30) 
0.81 (0.62-1.06) 
0.88 (0.67-1.14) 
0.90 (0.69-1.17) 
 
Referent 
1.02 (0.79-1.31) 
0.81 (0.62-1.06) 
0.88 (0.67-1.14) 
0.90 (0.70-1.17) 
 
Referent 
1.01 (0.79-1.30) 
0.81 (0.62-1.06) 
0.88 (0.67-1.14) 
0.91 (0.70-1.19) 
Dizzy: Yes   1.37 (1.15-1.62) 1.24 (1.02-1.50) 1.20 (0.99-1.45) 1.23 (1.01-1.49) 1.20 (0.99-1.46) 1.21 (1.00-1.47) 
Hearing 
deficit: Yes  
  1.04 (0.86-1.26) 
 
0.98 (0.80-1.20) 
 
0.99 (0.81-1.20) 
 
0.97 (0.79-1.19) 
 
0.97 (0.79-1.19) 
 
0.95 (0.89-1.01) 
 
Visual 
deficit: Yes 
  1.07 (0.90-1.29) 
 
1.0 (0.84-1.24) 
 
1.00 (0.82-1.21) 
 
1.00 (0.82-1.22) 
 
0.99 (0.81-1.20) 
 
0.99 (0.82-1.20) 
 
CCI score 
0 
1 
2-8 
   
Referent  
1.20 (0.98-1.46) 
1.32 (1.03-1.68) 
 
Referent  
1.21 (0.98-1.48) 
1.27 (0.98-1.64) 
 
Referent  
1.06 (0.85-1.32) 
1.02 (0.78-1.35) 
 
Referent  
1.08 (0.87-1.34) 
1.03 (0.78-1.36) 
 
Referent  
1.09 (0.88-1.36) 
1.03 (0.78-1.37) 
 
Referent  
1.09 (0.88-1.36) 
1.04 (0.78-1.38) 
BMI    1.00 (0.99-1.02) 
 
1.01 (0.99-1.02) 
 
1.00 (0.98-1.02) 
 
1.00 (0.99-1.02) 
 
1.00 (0.99-1.02) 
 
1.00 (0.99-1.00) 
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Covariate  
OR (95% CI) 
Model 1 
n=11,373 
Model 2  
n=10,254 
Model 3 
n = 9,971 
Model 4  
n = 9,349  
Model 5 
n=9,349 
Model 6 
n=9,234 
Model 7 
n=9,234 
Model 8 
n=9,234 
Depression     1.03 (1.00-1.06) 
 
1.02 (0.99-1.05) 
 
1.02 (0.99-1.06) 
 
1.02 (0.99-1.05) 
 
1.00 (0.99-1.01) 
 
Anxiety     0.98 (0.95-1.01) 
 
0.98 (0.95-1.01) 
 
0.98 (0.95-1.01) 
 
0.98 (0.95-1.01) 
 
0.99 (0.97-1.02) 
 
Cognitive 
complaint 
   1.00 (1.00-1.01) 
 
1.00 (1.00-1.01) 
 
1.00 (1.00-1.01) 
 
1.00 (1.00-1.01) 
 
1.00 (1.00-1.01) 
 
Total 
medication 
    1.06 (1.03-1.09) 
 
1.05 (1.02-1.09) 
 
1.05 (1.02-1.08) 
 
1.05 (1.02-1.08) 
 
Analgesics  
None 
Basic 
Weak op. 
Mod. op. 
Strong op. 
     
Referent 
0.90 (0.67-1.20) 
0.90 (0.66-1.24) 
1.17 (0.88-1.56) 
1.19 (0.87-1.64) 
 
Referent 
0.89 (0.66-1.19) 
0.89 (0.64-1.22) 
1.20 (0.90-1.60) 
1.21 (0.88-1.67) 
 
Referent 
0.90 (0.67-1.21) 
0.89 (0.64-1.22) 
1.19 (0.89-1.59) 
1.19 (0.86-1.65) 
 
Referent  
1.02 (0.94-1.11) 
0.97 (0.88-1.07) 
1.06 (0.97-1.15) 
1.04 (0.95-1.15) 
NSAIDs: Yes     1.01 (0.78-1.30) 1.04 (0.80-1.35) 1.02 (0.79-1.32) 1.02 (0.79-1.32) 
Physical 
functioning 
No problem 
A little  
A lot  
      
 
Referent 
1.05 (0.83-1.32) 
0.84 (0.63-1.12) 
 
 
Referent 
1.04 (0.83-1.31) 
0.80 (0.60-1.07) 
 
 
Referent 
1.09 (0.87-1.37) 
0.87 (0.66-1.15) 
 
Previous 
fall: Yes 
      1.51 (1.22-1.88) 
 
1.53 (1.23-1.91) 
 
Model 1: unadjusted; Model 2: adjustment for demographic covariates; Model 3: Model 2 & adjustment for medical covariates; Model 4: Model 3 & adjustment for 
mental health covariates; Model 5: Model 4 & adjustment for medication covariates; Model 6: Model 5 & adjustment for physical functioning; Model 7: Model 6 & 
adjustment for previous falls; Model 8: Model 7 & adjustment for interaction terms and/or time varying covariates .  HR = hazard ratio; 95% CI = 95% confidence 
interval; where p<0.05, this is considered statistically significant and results are highlighted in bold.  FT Ed >16y = continuing in full time education beyond aged 16 
years; IMD= Index of Multiple Deprivation divided into quintiles, where: least dep.= least deprived, 2
nd
 least = 2
nd
 least deprived, mid dep. = middle deprivation 
category, 2
nd
 most = 2
nd
 most deprived, most dep. = most deprived category.  Charlson Comorbidity Index (CCI) score: 0 = no CCI comorbidities, 1 = 1 CCI 
comorbidity, 2-8 = 2 or more CCI comorbidities.  BMI = body mass index. Total medication = total medication count. Analgesics: weak op. = weak opiates, mod. op. = 
moderate strength opiates, strong op. = strong opiates and very strong opiates combined. NSAID = non steroidal anti=inflammatory drug. Physical functioning = 
ability to walk 100 yards: no problem = no physical limitation, a little = a little limitation, a lot = a lot of limitation in ability to walk 100 yards. Previous fall = baseline 
self-reported fall recorded as ‘yes’.   
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11.4.4 Univariate associations between covariates and HES falls 
Univariate associations within the dataset are shown in table 11.4.  Pain measures 
and socio-economic position indicators (with the exception of IMD) are not 
statistically significantly associated with HES-recorded falls in univariate analysis.  
All physical health measures, age, sex, depression, cognitive impairment, total 
medication count, maximum analgesic category, physical functioning and previous 
history of self-reported baseline fall are statistically significantly associated with 
HES-recorded falls in univariate analysis.  
Table 11.4 Cox proportional hazard ratios for multisite pain and HES-recorded 
falls: report of statistically significant univariate associations  
Covariate  P value 
 
Widespread pain 0.30 
Full time education 0.08 
Occupational class 0.06 
Income adequacy 0.45 
IMD  0.03 
Sex <0.01 
Dizziness  <0.01 
Hearing impairment <0.01 
Vision impairment <0.01 
Maximum analgesic <0.01 
NSAIDs 0.42 
Multimorbidity <0.01 
Physical function <0.01 
Baseline self-reported fall <0.01 
NPS 0.06 
Age  <0.01 
Anxiety 0.08 
Depression <0.01 
Cognitive complaint <0.01 
BMI <0.01 
Total medication count <0.01 
BMI = body mass index, IMD = Index of Multiple 
Deprivation, NSAIDs = non-steroidal anti-inflammatory 
drugs 
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11.4.5 Number of pain sites and HES-recorded falls  
No statistically significant interactions existed when tested.  Table 11.5 presents 
hazard ratios and 95% confidence intervals for covariates in each model, from the 
unadjusted hazard ratio of pain and falls (model 1) through to model 8  (adjusted 
for all covariates and time-varying covariates).  Anxiety and IMD did not meet the 
time-constant assumption and were therefore interacted with time.   
The number of pain sites had a non-statistically significant relationship with HES 
falls in univariate analysis, and this moved into a statistically significant 
relationship when the model was adjusted for demographic factors (HR 1.01 (1.00-
1.02) p=0.02); this moved into a non-significant relationship once physical health 
factors were added to the model (HR 1.01 (0.96-1.02) p=0.25) and the final hazard 
ratio for HES-recorded falls was 1.00 ((0.99-1.01) p=0.94). 
Covariates with a statistically significant hazard ratio for increasing HES-recorded 
falls are increasing age (HR 1.07 (1.06-1.08) p=<0.01), an increase in total 
medication count (HR 1.03 (1.00-1.06) p=0.046) and being prescribed strong or 
very strong opioid medication (HR 1.45 (1.06-1.99) p=0.02).  
Being male reduced the hazard of having a HES-recorded fall by almost half 
compared to being female (HR 0.57 (0.48-0.68) p=<0.01) and a unit increase in 
BMI was associated with a reduced hazard of HES-recorded falls (HR 0.98 (0.96-
1.00) p=0.04).  
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Table 11.5 Hazard ratios (95% CIs and p-values) of a HES recorded fall according to number of pain sites in a multivariate Cox 
proportional hazard model 
Covariate  
OR (95% CI) 
Model 1 
n=11,373 
Model 2  
n=10,254 
Model 3 
n = 9,971 
Model 4  
n = 9,349  
Model 5 
n=9,349 
Model 6 
n=9,234 
Model 7 
n=9,234 
Model 8 
n=9,234 
Number of 
pain sites 
1.01 (1.00-1.02) 
 
1.01 (1.00-1.02) 1.01 (0.96-1.02) 1.00 (0.99-1.02) 1.00 (0.99-1.01) 1.00 (0.99-1.01) 1.00 (0.99-1.01) 1.00 (0.99-1.01) 
Age (years)  1.08 (1.07-1.09) 
 
1.08 (1.07-1.09) 
 
1.07 (1.06-1.08) 
 
1.07 (1.06-1.08) 
 
1.07 (1.06-1.08) 
 
1.07 (1.06-1.08) 
 
1.07 (1.06-1.08) 
 
Sex: Male   0.57 (0.49-0.67) 0.57 (0.48-0.67) 0.56 (0.47-0.67) 0.56 (0.47-0.67) 0.56 (0.47-0.67) 0.56 (0.47-0.67) 0.57 (0.48-0.68) 
FT Ed >16y: 
No 
 0.97 (0.75-1.26) 
 
0.99 (0.81-1.14) 
 
1.02 (0.77-1.34) 1.01 (0.76-1.32) 
 
1.00 (0.76-1.32) 
 
1.00 (0.76-1.31) 
 
1.01 (0.76-1.33) 
 
Income 
adequate 
 1.14 (0.98-1.34) 
 
1.14 (0.97-1.34) 
 
1.13 (0.95-1.34) 
 
1.14 (0.96-1.36) 
 
1.12 (0.94-1.33) 
 
1.12 (0.94-1.33) 
 
1.12 (0.94-1.33) 
 
Occ Class 
non-manual 
 0.96 (0.81-1.13) 
 
0.96 (0.81-1.14) 
 
0.99 (0.83-1.18) 
 
0.99 (0.83-1.18) 
 
0.99 (0.83-1.19) 
 
0.99 (0.83-1.18) 
 
0.98 (0.82-1.18) 
IMD  
1)least dep. 
2) 2
nd
 least 
3)mid dep. 
4) 2
nd
 most 
5)most dep. 
  
Referent  
1.05 (0.81-1.35) 
1.17 (0.91-1.50) 
1.16 (0.90-1.49) 
1.21 (0.95-1.56) 
 
Referent  
1.07 (0.83-1.39) 
1.16 (0.90-1.49) 
1.15 (0.89-1.48) 
1.19 (0.92-1.53) 
 
Referent  
1.01 (0.76-1.32) 
1.09 (0.84-1.42) 
1.06 (0.81-1.39) 
1.11 (0.85-1.45) 
 
Referent  
1.02 (0.78-1.33) 
1.08 (0.83-1.40) 
1.04 (0.80-1.36) 
1.09 (0.83-1.42) 
 
Referent  
1.00 (0.76-1.31) 
1.07 (0.82-1.40) 
1.04 (0.79-1.36) 
1.09 (0.83-1.43) 
 
Referent  
1.00 (0.76-1.31) 
1.07 (0.82-1.40) 
1.04 (0.79-1.36) 
1.09 (0.83-1.43) 
 
Referent  
0.99 (0.95-1.04) 
1.01 (0.97-1.05) 
0.99 (0.94-1.03) 
1.00 (0.96-1.05) 
Dizzy: Yes   1.17 (0.98-1.39) 1.09 (0.90-1.00) 1.07 (0.88-1.29) 1.07 (0.88-1.30) 1.07 (0.88-1.30) 1.06 (0.87-1.28) 
Hearing 
deficit: Yes  
  1.01 (0.84-1.22) 
 
1.00 (0.82-1.21) 
 
1.01 (0.83-1.23) 
 
0.99 (0.81-1.21) 
 
0.99 (0.81-1.21) 
 
0.99 (0.81-1.21) 
 
Visual 
deficit: Yes 
  1.04 (0.87-1.24) 
 
1.01 (0.84-1.22) 
 
1.00 (0.83-1.21) 
 
0.98 (0.81-1.19) 
 
0.98 (0.80-1.18) 
 
0.98 (0.80-1.18) 
 
CCI score 
0 
1 
2-8 
   
Referent 
1.13 (0.93-1.38) 
1.29 (1.02-1.64) 
 
Referent 
1.07 (0.87-1.32) 
1.31 (1.03-1.67) 
 
Referent 
0.98 (0.78-1.22) 
1.13 (0.87-1.47) 
 
Referent 
0.96 (0.77-1.21) 
1.16 (0.89-1.51) 
 
Referent 
0.97 (0.77-1.21) 
1.17 (0.89-1.52) 
 
Referent 
0.97 (0.78-1.21) 
1.17 (0.90-1.52) 
BMI    0.99 (0.97-1.01) 0.99 (0.97-1.00) 
 
0.98 (0.97-1.00) 
 
0.98 (0.96-1.00) 
 
0.98 (0.96-1.00) 
 
0.98 (0.96-1.00) 
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Covariate  
OR (95% CI) 
Model 1 
n=11,373 
Model 2  
n=10,254 
Model 3 
n = 9,971 
Model 4  
n = 9,349  
Model 5 
n=9,349 
Model 6 
n=9,234 
Model 7 
n=9,234 
Model 8 
n=9,234 
Depression     1.02 (0.99-1.05) 1.02(0.99-1.05) 1.02 (0.98-1.05) 1.02 (0.98-1.05) 1.01 (0.98-1.04) 
Anxiety     0.98 (0.96-1.01) 0.98 (0.96-1.01) 0.98 (0.95-1.01) 0.98 (0.96-1.01) 1.00 (1.00-1.00) 
Cognitive 
complaint 
   1.00 (1.00-1.01) 
 
1.00 (1.00-1.01) 
 
1.00 (1.00-1.01) 
 
1.00 (1.00-1.01) 
 
1.00 (1.00-1.01) 
 
Total 
medication 
    1.03 (1.00-1.06) 
 
1.03 (1.00-1.06) 
 
1.03 (1.00-1.06) 1.03 (1.00-1.06) 
 
Analgesics  
None 
Basic 
Weak op. 
Mod. op. 
Strong op. 
     
Referent  
1.05 (0.80-1.38) 
0.97 (0.72-1.31) 
0.87 (0.64-1.20) 
1.53 (1.14-2.10) 
 
Referent 
1.06 (0.80-1.39) 
0.92 (0.68-1.26)  
0.84 (0.61-1.17) 
1.46 (1.07-2.00) 
 
Referent 
1.06 (0.81-1.40) 
0.92 (0.68-1.26) 
0.84 (0.61-1.16) 
1.46 (1.06-1.99) 
 
Referent 
1.07 (0.81-1.40) 
0.92 (0.68-1.26) 
0.84 (0.61-1.16) 
1.45 (1.06-1.99) 
NSAIDs: Yes     0.95 (0.73-2.10) 0.92 (0.70-1.21) 0.92 (0.70-1.21) 0.92 (0.70-1.20) 
Physical 
functioning 
No problem 
A little  
A lot  
      
 
Referent  
1.15 (0.91-1.45) 
1.09 (0.82-1.44) 
 
 
Referent 
1.15 (0.91-1.44) 
1.08 (0.81-1.42) 
 
 
Referent 
1.15 (0.92-1.45) 
1.10 (0.83-1.45) 
Previous 
fall: Yes 
      1.10 (0.88-1.39) 1.11 (0.88-1.39) 
 
Model 1: unadjusted; Model 2: adjustment for demographic covariates; Model 3: Model 2 & adjustment for medical covariates; Model 4: Model 3 & adjustment for 
mental health covariates; Model 5: Model 4 & adjustment for medication covariates; Model 6: Model 5 & adjustment for physical functioning; Model 7: Model 6 & 
adjustment for previous falls; Model 8: Model 7 & adjustment for interaction terms and/or time varying covariates .  HR = hazard ratio; 95% CI = 95% confidence 
interval; where p<0.05, this is considered statistically significant and results are highlighted in bold.  FT Ed >16y = continuing in full time education beyond aged 16 
years; IMD= Index of Multiple Deprivation divided into quintiles, where: least dep.= least deprived, 2
nd
 least = 2
nd
 least deprived, mid dep. = middle deprivation 
category, 2
nd
 most = 2
nd
 most deprived, most dep. = most deprived category.  Charlson Comorbidity Index (CCI) score: 0 = no CCI comorbidities, 1 = 1 CCI 
comorbidity, 2-8 = 2 or more CCI comorbidities.  BMI = body mass index. Total medication = total medication count. Analgesics: weak op. = weak opiates, mod. op. = 
moderate strength opiates, strong op. = strong opiates and very strong opiates combined. NSAID = non steroidal anti=inflammatory drug. Physical functioning = 
ability to walk 100 yards: no problem = no physical limitation, a little = a little limitation, a lot = a lot of limitation in ability to walk 100 yards. Previous fall = baseline 
self-reported fall recorded as ‘yes’.   
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11.4.6 Widespread pain and HES-recorded falls  
Statistically significant interaction terms that were added to the Cox proportional 
hazards model were the widespread pain measure interacted with either pain, 
IMD, anxiety, total medication count or physical functioning.  
Table 11.6 presents hazard ratios and 95% confidence intervals for covariates in 
each model, from the unadjusted hazard ratio of pain and falls (model 1) through 
to model 8  (adjusted for time-varying covariate terms).  The likelihood ratio test 
between the model containing all covariates (model 7) and model 7 plus all 
interaction terms found p=0.21, this meant that the larger model containing the 
interaction terms was rejected and the time varying covariates were added to 
model 7; the hazard ratios presented in model 8 (covariates and time-varying 
covariates, excluding interactions) are therefore be used when interpreting risk 
associated with HES-recorded falls.  One covariate violated the time-constant 
assumption and was therefore interacted with time (IMD) and this is included in 
Model 8.   
When compared to those with no pain, the ‘some pain’ group and the ‘widespread 
pain’ groups have no statistically significant relationship with HES-recorded falls.      
Increasing age (HR 1.07 (1.06-1.08) p=<0.01), an increasing total medication 
count (HR1.03 (1.00-1.06) p=0.047) and a prescription for strong and very strong 
opioids (HR 1.47 (1.07-2.01) p=0.02) statistically significantly increased the hazard 
of HES-recorded falls.   Being male (HR 0.56 (0.47-0.67) p=<0.01) and an 
increase in BMI (HR 0.98 (0.96-1.00) p=0.04) were associated with statistically 
significantly lower hazards of HES-recorded falls compared to being female and 
having a lower BMI.    
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Table 11.6 Hazard ratios (95% CIs and p-values) of a HES recorded fall according to pain widespreadness in a multivariate Cox 
proportional hazard model 
Covariate  
OR (95% CI) 
Model 1 
n=11,373 
Model 2  
n=10,254 
Model 3 
n = 9,971 
Model 4  
n = 9,349  
Model 5 
n=9,349 
Model 6 
n=9,234 
Model 7 
n=9,234 
Model 8 
n=9,234 
No pain  
Some pain  
widespread 
Referent  
0.96 (0.81-1.13) 
1.09 (0.91-1.31) 
Referent  
0.90 (0.75-1.08) 
1.12 (0.91-1.36) 
Referent  
0.87 (0.72-1.04) 
1.04 (0.84-1.29) 
Referent  
0.86 (0.70-1.04) 
1.04 (0.83-1.31) 
Referent  
0.83 (0.68-1.01) 
0.97 (0.77-1.23) 
Referent  
0.85 (0.69-1.04) 
0.99 (0.78-1.26) 
Referent  
0.85 (0.69-1.04) 
0.99 (0.77-1.26) 
Referent  
0.84 (0.69-1.04) 
0.98 (0.77-1.25) 
Age (years)  1.08 (0.91-1.36) 1.08 (1.07-1.09) 1.07 (1.06-1.08) 1.07 (1.06-1.08) 1.07 (1.06-1.08) 1.07 (1.06-1.08) 1.07 (1.06-1.08) 
Sex: Male   0.57 (1.07-1.09) 0.56 (0.48-0.67) 0.56 (0.47-0.67) 0.57 (0.47-0.68) 0.56 (0.47-0.67) 0.56 (0.47-0.68) 0.56 (0.47-0.67) 
FT Ed >16y: 
No 
 0.98 (0.76-1.26) 0.99 (0.76-1.29) 1.02 (0.78-1.34) 
 
1.01 (0.77-1.33) 
 
1.00 (0.76-1.32) 
 
1.00 (0.76-1.32) 
 
1.01 (0.77-1.33) 
 
Income 
adequate 
 1.13 (0.97-1.33) 
 
1.14 (0.97-1.34) 
 
1.13 (0.95-1.34) 
 
1.15 (0.97-1.37) 
 
1.13 (0.95-1.34) 
 
1.13 (0.95-1.34) 
 
1.12 (0.94-1.34) 
 
Occ Class 
non-manual 
 0.96 (0.82-1.14) 
 
0.97 (0.81-1.14) 
 
0.99 (0.83-1.19) 
 
0.99 (0.83-1.18) 
 
0.99 (0.83-1.19) 
 
0.99 (0.83-1.19) 
 
0.98 (0.82-1.17) 
 
IMD  
1)least dep. 
2) 2
nd
 least 
3)mid dep. 
4) 2
nd
 most 
5)most dep. 
  
Referent  
1.05 (0.81-1.35) 
1.18 (0.92-1.51) 
1.17 (0.91-1.50) 
1.22 (0.95-1.56) 
 
Referent  
1.07 (0.82-1.39) 
1.16 (0.90-1.49) 
1.15 (0.89-1.49) 
1.19 (0.93-1.54) 
 
Referent  
1.00 (0.77-1.32) 
1.09 (0.84-1.42) 
1.07 (0.82-1.39) 
1.11 (0.86-1.45) 
 
Referent  
1.01 (0.77-1.33) 
1.01 (0.83-1.40) 
1.05 (0.80-1.37) 
1.09 (0.83-1.42) 
 
Referent  
1.00 (0.76-1.31) 
1.07 (0.82-1.40) 
1.04 (0.79-1.36) 
1.09 (0.83-1.43) 
 
Referent  
1.00 (0.76-1.31) 
1.07 (0.82-1.40) 
1.04 (0.79-1.36) 
1.09 (0.83-1.43) 
 
Referent  
0.99 (0.95-1.03) 
1.01 (0.97-1.05) 
0.99 (0.94-1.03) 
1.00 (0.96-1.05) 
Dizzy: Yes   1.18 (0.99-1.40) 1.09 (0.90-1.32) 1.06 (0.87-1.28) 1.07 (0.88-1.29) 1.06 (0.87-1.29) 1.06 (0.87-1.29) 
Hearing 
deficit: Yes  
  1.02 (0.85-1.23) 
 
1.00 (0.82-1.21) 
 
1.01 (0.83-1.23) 
 
0.99 (0.81-1.21) 
 
0.99 (0.81-1.21) 
 
0.99 (0.81-1.21) 
 
Visual 
deficit: Yes 
  1.04 (0.87-1.24) 
 
1.01 (0.84-1.22) 
 
0.99 (0.82-1.20) 
 
0.98 (0.81-1.18) 
 
0.97 (0.80-1.18) 
 
0.98 (0.81-1.18) 
 
CCI score 
0 
1 
2-8 
   
Referent  
1.14 (0.94-1.39) 
1.30 (1.03-1.64) 
 
Referent 
1.07 (0.87-1.32) 
1.30 (1.02-1.66) 
 
Referent 
0.98 (0.78-1.22) 
1.13 (0.87-1.47) 
 
Referent 
0.96 (0.77-1.21) 
1.15 (0.89-1.50) 
 
Referent 
0.97 (0.77-1.21) 
1.16 (0.89-1.51) 
 
Referent 
0.97 (0.77-1.21) 
1.16 (0.89-1.51) 
BMI    0.99 (0.97-1.01) 0.99 (0.97-1.01) 0.99 (0.97-1.00) 0.98 (0.96-1.00) 0.98 (0.96-1.00) 0.98 (0.96-1.00) 
240 
 
Covariate  
OR (95% CI) 
Model 1 
n=11,373 
Model 2  
n=10,254 
Model 3 
n = 9,971 
Model 4  
n = 9,349  
Model 5 
n=9,349 
Model 6 
n=9,234 
Model 7 
n=9,234 
Model 8 
n=9,234 
Depression     1.02 (0.99-1.05) 
 
1.02 (0.99-1.05) 
 
1.02 (0.98-1.05) 
 
1.01 (0.98-1.05) 
 
1.01 (0.98-1.05) 
 
Anxiety     0.98 (0.96-1.01) 
 
0.98 (0.96-1.01) 
 
0.98 (0.96-1.01) 
 
0.98 (0.96-1.01) 
 
0.98 (0.96-1.01) 
 
Cognitive 
complaint 
   1.00 (1.00-1.01) 
 
1.00 (1.00-1.01) 
 
1.00 (1.00-1.01) 
 
1.00 (1.00-1.01) 
 
1.00 (1.00-1.01) 
Total 
medication 
    1.03 (1.00-1.06) 
 
1.03 (1.00-1.06) 
 
1.03 (1.00-1.06) 
 
1.03 (1.00-1.06) 
 
Analgesics  
None 
Basic 
Weak op. 
Mod. op. 
Strong op. 
     
Referent  
1.07 (0.81-1.40) 
0.99 (0.73-1.34) 
0.90 (0.65-1.23) 
1.57 (1.15-2.13) 
 
Referent  
1.07 (0.81-1.41) 
0.94 (0.09-1.28) 
0.86 (0.62-1.19) 
1.48 (1.08-2.02) 
 
Referent  
1.07 (0.82-1.42) 
0.93 (0.69-1.27) 
0.86 (0.62-1.19) 
1.48 (1.07-2.01) 
 
Referent  
1.07 (0.82-1.42) 
0.94 (0.69-1.28) 
0.86 (0.62-1.19) 
1.47 (1.07-2.01) 
NSAIDs: Yes     0.96 (0.73-1.25) 0.93 (0.71-1.22) 0.93 (0.71-1.22) 0.92 (0.70-1.21) 
Physical 
functioning 
No problem 
A little  
A lot  
     
 
Referent 
 
 
Referent 
1.15 (0.91-1.45) 
1.10 (0.83-1.45) 
 
 
Referent 
1.15 (0.91-1.45) 
1.08 (0.82-1.43) 
 
 
Referent 
1.15 (0.92-1.45) 
1.09 (0.83-1.44) 
Previous 
fall: Yes 
      1.11 (0.88-1.39) 1.11 (0.88-1.39) 
Model 1: unadjusted; Model 2: adjustment for demographic covariates; Model 3: Model 2 & adjustment for medical covariates; Model 4: Model 3 & adjustment for 
mental health covariates; Model 5: Model 4 & adjustment for medication covariates; Model 6: Model 5 & adjustment for physical functioning; Model 7: Model 6 & 
adjustment for previous falls; Model 8: Model 7 & adjustment for interaction terms and/or time varying covariates .  HR = hazard ratio; 95% CI = 95% confidence 
interval; where p<0.05, this is considered statistically significant and results are highlighted in bold.  FT Ed >16y = continuing in full time education beyond aged 16 
years; IMD= Index of Multiple Deprivation divided into quintiles, where: least dep.= least deprived, 2
nd
 least = 2
nd
 least deprived, mid dep. = middle deprivation 
category, 2
nd
 most = 2
nd
 most deprived, most dep. = most deprived category.  Charlson Comorbidity Index (CCI) score: 0 = no CCI comorbidities, 1 = 1 CCI 
comorbidity, 2-8 = 2 or more CCI comorbidities.  BMI = body mass index. Total medication = total medication count. Analgesics: weak op. = weak opiates, mod. op. = 
moderate strength opiates, strong op. = strong opiates and very strong opiates combined. NSAID = non steroidal anti=inflammatory drug. Physical functioning = 
ability to walk 100 yards: no problem = no physical limitation, a little = a little limitation, a lot = a lot of limitation in ability to walk 100 yards. Previous fall = baseline 
self-reported fall recorded as ‘yes’.   
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11.4.7 Survival analysis: summary  
The number of pain sites was not statistically significantly associated with future 
GP-recorded fall.  ‘Some pain’ was statistically significantly associated with GP-
recorded falls, with the final adjusted model finding that those reporting ‘some 
pain’ have a 26% increased hazard of a future GP-recorded fall compared to their 
no pain counterparts (HR 1.26 (1.01-1.57) p=0.048).  The presence of widespread 
pain and future risk of GP-recorded fall almost reached statistical significance, with 
a HR of 1.27 (0.98-1.65) p=0.07.   
Neither the number of pain sites nor widespread pain has a statistically significant 
relationship with future HES-related falls.  
Covariates with a statistically significant relationship to GP and HES-recorded falls 
are displayed in table 11.7.  Of note, history of previous fall was not statistically 
significantly associated with HES-recorded falls, and physical functioning is not 
statistically significantly associated with either GP or HES-recorded falls.  
Table 11.7 Covariates that have a statistically significant association with GP and / 
or HES recorded falls in the Cox proportional hazard model after adjustment for all 
covariates 
 
GP-recorded falls 
 
HES-recorded falls 
 
Covariates increasing the hazard of falling: 
‘Some pain’ 
increasing age 
Increasing cognitive complaint 
increasing total medication 
history of self-reported falls at 
baseline 
increasing age 
increase in total medication count 
Prescription for strong or very 
strong opioid medication 
Covariates reducing the hazard of falling: 
being male Being male 
increase in BMI 
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11.5 Discussion  
11.5.1 Summary of findings  
Univariate Cox proportional hazard models found that all covariates except 
education status, income adequacy, IMD and NSAID use were statistically 
significantly associated with future risk of GP-recorded falls.   
Once the Cox proportional hazard ratio was adjusted for all covariates, including 
time-varying covariates, the number of pain sites was not statistically significantly 
associated with future GP-recorded fall (HR 1.01 (1.00-1.02) p=0.08).  The 
measure ‘some pain’ remained statistically significantly associated with an 
increased hazard of future GP-fall once all model adjustments had been made 
(HR 1.26 (1.01-1.57) p=0.048); the increased hazard associated the presence of 
widespread pain did not quite reach statistical significance (HR 1.27 (0.98-1.65) 
p=0.07). 
Covariates that conferred a statistically significant increased hazard of a GP-
recorded fall were increasing age, increasing cognitive complaint, increasing total 
medication count and history of previous self-reported fall.  Being male statistically 
significantly reduced the hazard of a GP-recorded fall.   
Univariate Cox proportional hazard models examining HES-recorded fall found 
that number of pain sites, the widespread pain measure, education status, income 
adequacy, NSAID use and anxiety did not statistically significantly predict HES-
recorded falls.  
The adjusted Cox proportional hazards models containing all covariates, including 
time-varying covariates, found that only increasing age, increasing medication 
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count and strong or very strong opioid prescriptions statistically significantly 
increased the hazard of a HES-recorded fall.  Being male and a unit increase in 
BMI statistically significantly reduced the hazard of falling.  The pain measures in 
these highly adjusted models were not statistically significantly associated with 
HES-recorded fall (number of pain sites: HR 1.00 (0.99-1.01) p=0.94; widespread 
pain measure: ‘some pain’ HR 0.84 (0.69-1.04) p=0.11; ‘widespread pain’ HR 0.98 
(0.77-1.25) p=0.88). 
11.5.2 How it fits into the literature and what is new  
The results of this chapter are somewhat surprising.  The analyses have found 
that some traditional falls risk factors that are included in falls prevention 
guidelines do not appear to statistically significantly predict future GP or HES-
recorded falls.  For example, previous history of fall does not predict HES-
recorded falls, limitation in physical functioning and dizziness do not predict either 
fall-type, and cognitive complaint does not predict HES-recorded falls.  This finding 
is relevant to the (lack of) association between pain measures and GP and HES-
recorded falls; possible explanations for the non-prediction of traditional falls risk 
factors must now be explored to appreciate the relevance to the relationship 
between pain measures and GP or HES-recorded falls.   
The failure of traditional falls risk factors to predict GP or HES-recorded falls may 
be due to a number of mutually non-exclusive reasons, four of which are 
summarised below and then discussed in turn:   
i) Misclassification of HES and GP fallers due to coding practice and 
resulting in underestimation of effect estimate; 
ii) Risk of bias from measurement of covariates;  
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iii) Preponderance for falls evidence base and guidelines to be based upon 
falls outcomes measured using recalled or prospective self-reported 
falls; 
iv) A ‘true’ result 
11.5.2.1 Misclassification of GP and HES fallers  
Falls may be under-recorded by GPs.  Although there is no firm evidence to 
support this statement, there are fewer falls recorded in the GP consultation data 
used in this thesis than in the GP consultation data used by Gribbin et al (2009).  
Moreover, discussions with local GPs who work in the practices included in the 
NorStOP cohort unanimously felt that falls are under-coded in GP records.  This 
potential for poor falls coding in GP records may lead to misclassification bias if 
responders are presenting with fall-related injuries and only the injury is coded, 
thus meaning the respondent will be classified as a non-faller due to the absence 
of a falls-code.  The same may be true of HES-APC data, as discussed in Chapter 
9.  This misclassification may lead to lower estimates of falls prevalence and an 
underestimated effect size.  It is therefore possible that some of the traditional falls 
risk factors, and pain, are not statistically significant predictors of GP and HES-
recorded falls simply because their associated hazard is underestimated.  
11.5.2.2 Risk of bias from covariate measurement  
Three covariates derived from GP records that have been comprehensively 
collected and reliably measured (age, sex and prescriptions) are the most strongly 
statistically significantly correlated with future GP and HES-recorded falls.  It is 
therefore possible that it is the measurement and collection of other covariate 
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information that might be impacting on the lack of relationship between other 
known falls risk factors and GP or HES-recorded falls.    
For example, using baseline self-reported fall as an indicator of previous fall may 
be problematic.  As discussed in Chapter 9, self-reported falls are subject to recall 
bias leading to misclassification of fallers as non-fallers when respondents fail to 
recall up to 25% of falls over a three month period (Hannan et al, 2010).   
Furthermore, the self-reported falls measure only provides a snapshot of the three 
months prior to survey distribution, thus this may not a long-enough time period for 
that at risk of falls to sustain a fall and thus become a ‘faller’; NICE guidelines 
recommend ascertaining previous falls history in the past year and use this answer 
as a basis for falls risk assessment (NICE, 2013).  
11.5.2.3 Current evidence base derived predominantly from self-reported falls  
Guidelines for falls prevention are developed based primarily upon evidence from 
studies using self-reported falls as an outcome measure.  For example NICE 
guideline CG161 (NICE, 2013) undertook a systematic review of prospective 
cohort studies to generate a summary of risk factors for falls in older people.  Of 
the 28 included studies, 20 were based upon self-reported fall outcomes, five were 
based upon hospital medical records from Finland, Sweden or USA, and three 
studies did not include details of how the falls outcome was measured.  It is 
therefore not surprising that established risk factors presented in guidelines, for 
example those by NICE (2013), do not predict GP-recorded or HES-recorded falls 
in UK data.  This thesis has therefore addressed the knowledge gap by providing 
evidence, in the form of a prospective analysis, of predictive factors for falls that 
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require GP attendance or hospital admission.  Thus, the results of this analysis 
may simply be reflective of the true population effect estimate.   
11.5.2.4 A true result 
If the results of the analyses are taken to be reflective of the true population effect 
estimate for each covariate and its associated hazard of falling, this may suggest 
that increasing age, sex and BMI are such strong predictors of a fall requiring 
hospital admission that all other covariate hazard ratios are rendered statistically 
insignificant.  This is biologically plausible since fall-related hospital admissions 
are often due to associated fragility fractures, which, in turn, are most highly 
correlated with osteoporosis (for which low BMI, female and older age are risk 
factors (NICE, 2012)).   
Returning to the role of multisite pain as a predictor for GP and HES-recorded 
falls, the measure of ‘some pain’ was found to be statistically significantly 
associated with an increased hazard of a GP-recorded fall.  Although this 
categorisation includes respondents with one pain site, and thus a conclusion 
cannot be firmly made that multisite pain contributes to GP-recorded fall risk, the 
majority of respondents in this category (89.1%, n=4665) reported 2 or more pain 
sites and it is therefore likely that this multisite pain is also associated with an 
increased hazard of a GP-recorded fall.   
11.5.3  Strengths 
This analysis is the first to examine to role of multisite pain as a predictor of GP 
and HES recorded falls.  The sample size is large (n=11,375) providing power in 
analysis to provide effect estimates that are close to the true population effect.  
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The long duration of follow up (from minimum 3 years to maximum 10 years) is a 
strength that enables clinically useful recommendations to be given over relevant 
time frames; as a clinician, it is useful to know what the risk of falling is over the 
medium and long term is so that preventative strategies that may take some time 
to be achieved can be put in place to reduce falls risk over a longer time frame.    
When appraising the literature to include in their falls prevention guidelines, NICE 
(2004) described a high quality study as one that did not rely on recall of falls as 
the outcome measure, a criteria that the analysis in this chapter fulfils, 
notwithstanding the challenges of falls coding.   
As discussed in Chapter 10, the inclusion of multiple covariates enables the 
analysis to be as reflective of real life clinical practice as possible.  
11.5.4 Limitations  
The major limitations of this analysis have been discussed above, including the 
potential bias introduced from poor falls coding and covariate measures.   
One further limitation in this analysis is the possible impact of missing data.  As the 
data tables in this chapter show (for example table 11.2), the more covariates 
added to the model, the fewer respondents are included in analysis.  Further 
interrogation of the data found that, for the covariates with the most missing data, 
respondents with missing data are generally older.  More females had missing 
physical functioning and cognitive complaint data than males, for example in 
physical functioning data, 56.6% of the missing-data sample were female 
compared with 53.7% in the non-missing sample; in the cognitive functioning data 
63.1% of the missing-data group were female compared with 53.2% of the non-
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missing group.    The converse is true for anxiety and depression measures.  This 
pattern of missing data may introduce bias into the analysis; it may be that the 
missing older people have higher degrees of cognitive complaint and worse 
physical functioning.  Associations between cognitive complaint or physical 
functioning and falls, or their influence on the relationship between pain and falls 
may therefore be underestimated since respondents who are more likely to have 
cognitive complaint or physical limitations are not included in the analysis.   
 
11.5.5 Informing the thesis  
The results of this analysis will now be carried forward into Chapter 12, where 
overall thesis conclusions will be drawn and discussed.  This discussion will centre 
upon the different role that multisite pain appears to have in the prediction of self-
reported, GP- and HES-recorded falls and the underlying mechanisms that might 
be responsible for these relationships.   
 
11.5.6  Chapter summary 
This chapter has examined the relationship between baseline pain status and 
covariate measurements and future GP and HES-recorded falls.  The use of 
survival analysis, specifically using Cox proportional hazard models, has been 
described and results of univariate and multivariate models were presented.  This 
chapter has addressed the knowledge gap by presenting a prospective analysis of 
GP and HES-recorded falls within a large sample and the results have been 
discussed.  The final chapter in this thesis will bring together all the results to draw 
an overall conclusion and put forward recommendations for clinical practice.   
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Chapter 12: Summary discussion  
12.1 Overview  
This chapter summarises this thesis’ findings, linking them back to the original 
aims and objectives.  Findings that are novel are highlighted, with the potential 
impact for clinical practice and policy highlighted. Finally, the implications for future 
research, building on the work from this thesis are presented.  
 
12.2 Summary of findings 
This thesis has examined the relationship between multisite pain and falls in older 
people.  The thesis objectives and their associated findings are revisited below:   
i) To describe the prevalence of self-reported falls, falls that require 
primary health care attendance and falls that require hospital admission 
in a population-based sample of community-dwelling older people  
Data from a large population cohort found the prevalence to be 12.5% for self-
reported falls, 6.9% for GP-recorded falls (falls that result in a utilisation of primary 
care) and 7.1% for HES-recorded falls (falls that result in utilisation of secondary 
care). 
ii) To test the hypothesis that older people with multisite pain are more 
likely to experience a future self-reported fall than older people with no 
pain 
This thesis found that an increasing number of pain sites were statistically 
significantly associated with increases odd of a future self-reported fall at three 
years and six year follow up, even when confounders and putative influencing 
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variables were accounted for.  Each additional pain site conferred a 12% 
increased odds of falling at three years (OR 1.12 (1.01-1.24) p=0.04) and a 3% 
increased odds of falling at six years (OR 1.03 (1.02-1.04) p=<0.01).  
Respondents classified as experiencing ‘widespread pain’ had 43% greater odds 
of a self-reported fall than their pain-free counterparts at six years (OR 1.43 (1.06-
1.95) p=0.02); the relationship with self-reported falls followed the same pattern 
but did not reach statistical significance (OR 1.27 (0.92-1.75) p=0.14).   
iii) To test the hypothesis that older people with multisite pain are more 
likely to seek primary health care for a future fall than older people with 
no pain 
This study found that the presence of ‘some pain’ was statistically significantly 
associated with future falls recorded in GP records compared to those with no 
pain; this association remained when analysis was adjusted for potential 
confounders and putative influencing variables.  Those reporting ‘some pain’ (89% 
of respondents in this group reported two or more pain sites) had a 26% increased 
risk of falling compared with their pain-free counterparts (HR 1.26 (1.01-1.57) 
p=0.048).  The presence of widespread pain increased the risk of a future GP 
consultation resulting in a consultation coded as a fall, although the hazard ratio 
did not reach statistical significance (HR 1.27 (0.98-1.65) p=0.07).  The number of 
pain sites also conferred a small increased risk of future GP-recorded consultation 
for a fall, although this result was not statistically significant (HR 1.01 (1.00-1.02) 
p=0.08).   
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iv) To test the hypothesis that older people with multisite pain are more 
likely to be admitted to hospital as a result of a future fall than older 
people with no pain  
Analysis did not find that multisite pain was associated with an increased risk of 
future hospital admission for falls (HES-recorded falls) in unadjusted univariate 
analysis or following adjustment for confounders and putative influencing 
variables.   
 
12.3 How it fits in with current literature and what is new  
The prevalence of self-reported falls within this thesis’ study population (12.5%) 
was lower than current evidence suggests; prevalence estimates from the most 
comparable study (data from the English Longitudinal Study of Ageing) by Gale et 
al (2016) found that 28.4% of older people self-reported a fall over the previous 
two years).  The prevalence of self-reported falls in this thesis as measured over a 
three month recall period is therefore similar, and may be higher than Gale et al’s 
(2016) finding when extrapolated to a two year prevalence.  The shorter recall 
period may therefore increase the accuracy of participant recall, although it does 
lead to the exclusion of many potential fallers in the analysis.   
The increased odds of self-reported falls associated with multisite pain found in 
this thesis (OR 1.03 (1.02-1.04) p=<0.01 for future six year self-reported fall) do 
reflect those reported in the meta-analysis of multisite pain and falls presented in 
Chapter 5 (OR 1.70 (1.49-1.94) for adjusted analysis of prospective cohort 
studies), albeit to a lesser degree.  There is no directly comparable evidence for 
the prevalence of GP-recorded or HES-recorded falls.  As such the data provided 
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in this thesis is an important additional to the literature, providing evidence from a 
large population based study on the role of pain on falls risk. The implications of 
this are discussed below.  
12.4 Strengths and weaknesses 
This thesis used a large population based sample to examine future falls risk, 
including 11,375 adults aged 50 years and older who responded to the baseline 
survey in thesis sample A to examine GP and HES-recorded falls and 4386 
participants who completed cohort study follow up (thesis sample B) to assess 
self-reported falls); thesis sample A is the largest sample size to date in which the 
relationship between multisite pain and falls is examined.    
The demographics of thesis sample A and B are broadly reflective of the local 
(Staffordshire) and national (UK) populations and thus results are broadly 
generalisable on a national level.  There are however important differences 
between healthcare service provision in the local area compared to the national 
picture that may impact upon consultation patterns and thus this thesis’ results.  
For example, North Staffordshire is a relatively under-doctored area compared to 
other regions so access to primary health care may be more challenging, 
particularly same-day appointments for acute problems, which may limit the 
attendance of people with falls unless there is a related problem that they cannot 
manage at home, for example a more significant injury, in which case it may be 
that the injury is what is coded as the cause of consultation.    Therefore, older 
people in this thesis’ study may not be consulting their GP about falls as often as 
those living in areas with better access to primary health care.  
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The selection of covariates to include in analysis was derived from review of the 
evidence base around falls risk factors, from the systematic review and meta-
analysis undertaken to explore to relationship between multisite pain and falls and 
from clinical experience and discussion with GP colleagues.  These 
complementary approaches are a strength of this thesis’ methodology; they enable 
the inclusion of relevant confounders and putative influencers of the multisite pain-
falls relationship to be maximised and therefore mean results are as reflective of 
real life and daily clinical primary care practice as possible given the choice of 
variables that were available in the datasets.   Despite this rigorous process, there 
were a few important putative influencers of the pain and falls relationship that 
would have been preferable to include in analysis if the data were available, for 
example, fear of falling.  If the study were to be repeated, an alternate measure for 
vision might be used, since the measure used in the thesis specifically excluded 
the ‘need for glasses’.  The use of multifocal lens glasses has been found to 
increase the risk of falls in older people (Lord et al, 2002), it is therefore necessary 
to include the use of glasses, particularly multifocal lens glasses as a putative 
influencing factor on the relationship between multisite pain and future falls risk.   
The measurements of self-reported, GP and HES-recorded falls are both strengths 
and limitations of this thesis.  For self-reported falls, the reliance on recall may 
lead to misclassification and underestimates of effect estimates for multisite pain 
on future falls risk.  This risk of underestimation is likely to be consistent across all 
evidence that uses recall of falls as the measure since the prevalence of self-
reported falls in this thesis is likely to be reflective of the current evidence when 
prevalence over a three month recall period is extrapolated to the two year recall 
period used by Gale et al (2016) in their UK-based population study of ageing.  
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The possible increased recall over a shorter duration (three months compared to 
two years) means that, although the overall prevalence for self-reported falls in the 
thesis was low, the recall may have been more reflective of the true number of 
falls sustained during the shorter recall period.  
The coding of falls in GP records may not accurately reflect the true prevalence of 
falls requiring primary health care utilisation for a number of reasons.  When a 
patient presents in general practice, a reason for the consultation is coded as a 
‘problem title’; this will often reflect the presenting complaint unless a definitive 
diagnosis can be made.  In scenarios where an older person is presenting with an 
injury due to a fall, it may be that the injury is coded as the ‘problem title’ and the 
history of the presenting complaint is documented in free text within the 
consultation records.  For example: “Problem title: pre-tibial laceration History: fell 
yesterday and landed on edge of kerb, sustained cut to shin.”   In this example, the 
READ code for the injury has been entered and a READ code for fall has not been 
entered.  Therefore, data extraction using READ codes to search for fall-related 
consultations would miss this attendance.  Data extraction using a free-text search 
would be preferable to extract data on fall-related attendances in primary care, 
although this approach is highly labour-intensive.  The discrepancy between the 
fall-related consultation and the exclusive coding of the presenting complaint is 
unlikely to be specific to the thesis’ dataset.  Discussions with GPs working in the 
local Research Network from which the primary care data is drawn confirmed that 
falls are not often documented using a READ code during consultations.  These 
GPs have received additional training in the use of READ codes through their 
employment within the research network.  It is therefore possible that, if this is a 
pattern amongst GPs who have a heightened awareness of the importance and 
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use of READ codes in research, the discrepancy between fall-related GP 
consultations and subsequent READ codes is even more common amongst GPs 
who have not received the additional training.   Thus it may be the case that, 
although the data used in this thesis may underestimate the true prevalence of fall-
related GP consultations, it may be more accurate than other primary care 
datasets which are populated by health care professionals who have not received 
additional training in consultation READ coding. 
Despite the potential underestimation of falls requiring primary health care 
utilisation, a strength of this thesis is the quality of the GP record data.  The 
information is taken from the Consultations in Primary Care Archive (CiPCA), a 
dataset that has been previously used for epidemiological research and has been 
demonstrated to be comparable to national datasets including the General 
Practice Research Database (now part of the Clinical Practice Research Datalink, 
the gold standard comprehensive UK dataset for epidemiological research which 
GP records for 22 million people (CPRD website) (Jordan et al, 2007).  The GP 
practices included in the CiPCA database have been through a robust training 
programme; this process has been shown to improve data quality and maintain 
high quality coding standards within the CiPCA practices (Porcheret et al, 2004).  
Therefore, the data extracted to generate comorbidity scores is likely to be of good 
quality and reflective of true population prevalences.    
In this thesis’ dataset, the number of falls requiring hospital inpatient admission 
coded in HES appears to reflect the number of fall-related injuries requiring 
hospital admission in HES; the coding of falls is therefore likely to be less of a 
problem than for falls requiring primary health care utilisation.   This difference 
may be due to the different role of coding in primary and secondary care. For 
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example, coding is used in secondary care to generate Healthcare Resource 
Group codes and subsequent payment for services, including falls and any fall-
related injury or association (for example, urinary tract infection or fracture).  The 
financial incentive therefore encourages thorough coding and thus HES admitted 
patient care data is likely to be reflective of the true prevalence of falls requiring 
hospital admission.   In primary care, there is no such system for billing expenses 
related to falls that required primary care utilisation.  Here, the coding is used to 
build a picture of the patient over time; the records are easy to search and 
consultations can be read and information easily obtained from the free-text entry; 
thus there is no strong incentive to code falls in addition to the presenting 
complaint in the consultation records.  The difference in coding practices between 
primary and secondary health care also may be due to the perceived severity of 
the fall.  For example, a fall that results in a minor soft tissue injury, or a non-
injurious fall that occurred as a consequence of a urinary tract infection may not be 
considered ‘severe’ and thus is not coded in addition to the presenting complaint in 
primary care records.  Falls that require hospital admission have more immediate, 
tangible consequences including physical health implications (for example trauma, 
subsequent pneumonia from hospital admission) and impact on the ability to self-
care and live independently; the severity of these consequences may also be 
driving the coding of falls more accurately within hospital datasets.    
The use of the complete dataset in thesis sample B, which consists of respondents 
who completed six years of cohort study follow up and who consistently completed 
the pain measures in the questionnaire (the pain screening question for the 
presence or absence of pain and body manikin), to measure the relationship 
between multisite pain and future self-reported falls is a strength of the study.  This 
257 
 
study population had fewer physical health problems, had fewer medications and 
strong analgesics prescribed and better physical functioning scores, possibly a 
consequence of the healthy cohort effect as the more ‘unhealthy’ baseline 
respondents dropped out of follow up due to their poor health.  This effect may 
again lead to an underestimation of the true risk that multisite pain contributes to 
falls within the general population.  Using this population adds a novel aspect to 
the current evidence base; this population were relatively ‘healthy’ during the 
cohort study and it is these older adults that will go on to become less healthy over 
time.  Therefore, the study findings relating to future self-reported falls are of 
particular benefit in primary prevention targeting older adults who have not yet 
accumulated additional falls risk factors including mulitmorbidity, cognitive 
impairment and increased medication use, specifically since interventions that may 
be used to manage pain in older people have the potential to conversely increase 
the risk of falls in those with complex multimorbidity (for example, analgesia).   
As discussed, the number of fall-related codes in HES is similar to the number of 
fall-related injuries coded in HES, thus only fall-related codes were used to 
categorise respondents as fallers requiring secondary care admission.  The impact 
of deciding to use only fall-related codes and the possible resulting 
misclassification bias could be assessed using sensitivity analysis, a technique 
developed to appraise how study conclusions might be altered by hidden biases, 
including misclassification bias (Rosenbaum, 2005).   Sensitivity analysis would 
also be useful to further explore the relationship between multisite pain and 
analgesic use.  The univariate analysis in Chapter 8 found that the use of 
analgesics was statistically significantly associated with an increasing number of 
pain sites.  The multivariate analyses in Chapters 10 and 11, particularly the 
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relationship between multisite pain categorised into widespread and some pain 
and both self-reported falls at 6 years and HES-recorded falls, demonstrate a 
marked change in risk estimate and associated confidence intervals when 
medication variables are added to the model, more so than with the addition of 
other covariates.   This may be due to the collinearity between the reporting of 
multisite pain and analgesic use and sensitivity analysis could further test this 
relationship and thus improve robustness of results.   
 
12.5 How multisite pain acts as a predictor of future falls  
Multisite pain is directly associated with an increased odds of self-reported falls, 
when adjusted for confounders and putative influencers.  This means that multisite 
pain confers additional odds of falling when controlling for other known falls risk 
factors.  Thus improving multisite pain might then lead to a reduction in self-
reported falls.  
Multisite pain is not directly statistically significantly associated with GP or HES 
recorded falls.  However, the covariates that statistically significantly increase the 
risk of future GP or HES recorded fall (increasing age, increasing cognitive 
complaint, increasing total medication count, history of previous fall, being female, 
strong or very strong opiates) are known, or likely to, be associated with multisite 
pain (except increasing age).  For example, it is known that older adults with 
multisite pain have poorer health outcomes in general (Lacey et al, 2014), more 
mobility limitation (Mottram et al, 2008), increasing cognitive complaint (Westoby 
et al, 2009) and increasing frailty (Wade et al, 2017).  In addition, this thesis has 
found that all covariates were statistically significantly associated with multisite 
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pain except for increasing age.  The influence that multisite pain has upon each of 
these covariates is biologically plausible and makes clinical sense.  For example, 
multisite pain may be a result of chronic comorbidities that require medication to 
manage and thus generate a falls risk factor; strong opiates might be prescribed in 
the management of multisite pain, the side effects of which then lead to future 
falls; the presence of multisite pain contributes to divided attention and thus 
impaired ability of those with cognitive impairment to regulate gait steadiness 
(Sheridan et al, 2003) and therefore increases falls risk.  Furthermore the non-
association with increasing age reflects the evidence that the number of pain sites 
is relatively fixed from an early age (Papageorgiou et al, 2002).   
These associations with multisite pain mean that the relationship between multisite 
pain and falls is not simply one whereby reducing the number of pain sites will 
directly reduce the odds of falling.  Multisite pain has a complex relationship with 
multiple covariates and as such it is the overall burden of multisite pain that is 
likely to be contributing to self-reported, GP and HES recorded falls; multisite pain 
is a risk factor for future self-reported falls and a likely influencer of the relationship 
between other risk factors and future falls.   
 
12.6 Implications for future research and clinical practice  
This research has implications for daily clinical practice for GPs and other primary 
health care professionals.  Whilst this research does not establish that reducing 
the pain will therefore reduce the risk of future falls, it is necessary for older people 
to be identified so that their other falls risk factors can be addressed.  Increased 
awareness of multisite pain as a risk factor and as a likely influencer of the 
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relationship between other falls risk factors and falls amongst the general public, 
GPs and other primary health care professionals will enable older adults with 
multisite pain to be identified and targeted specifically to reduce their risk of falls.  
Increasing awareness that multisite pain is an additional risk factor for falls in older 
people will be done through publication of this research in peer-reviewed journals.  
A wider audience will be reached through dissemination of findings in local 
healthcare bulletins (for example, the Arthritis Research UK Primary Care 
Musculoskeletal Centre’s regular bulletin Musculoskeletal Matters, made available 
to the general public through display at local GP surgeries), through feedback to 
the GP practices included in the research and through feedback to the Patient and 
Public Involvement groups.  Findings will also be shared with local GP and primary 
healthcare professional education groups.  This dissemination strategy will 
increase awareness of the general public and clinicians that multisite pain is a risk 
factor for falls in older people.   
In the context of increasing GP workloads and primary care demand, using an 
existing framework through which GPs can identify and manage their older 
patients with multisite pain is more likely to be successful since this will have a 
relatively small effect on workload compared to undertaking a new initiative.  The 
2017/2018 GP Contract (the contract of employment between general practices 
and the UK Government) now includes routine identification of frailty for adults 
aged 65 years and older, although there are no financial implications for this.  In 
practical terms, this means alerts are placed in the records of all patients aged 65 
years and older, which remind the clinician to carry out this assessment.   The 
frailty assessment includes a risk assessment for falls, to be conducted in line with 
NICE falls prevention guidelines (NICE, 2015; NHS England, 2017) which 
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emphasis a ‘multifactorial risk assessment and management plan’.  An 
assessment of pain would fit naturally into this framework and, since falls risk 
assessment is now included in a formal GP Contract, would theoretically be more 
likely to be carried out.  This may not be the case in clinical practice however, 
since there is no financial reward or penalty attached to the frailty assessment.   
In terms of identifying multisite pain as a risk factor for falls, this thesis has 
provided evidence to be considered in the next update of national guidelines on 
falls prevention.  Using NICE’s (2013) evidence grading system as described in 
the falls prevention guidelines, this research would be graded as ‘medium’ or ‘high’ 
due to the large sample, 70% response rate to the baseline questionnaire by 
respondents, clear methods of measurements of risk factors, adjustment and 
reporting of all covariates and the use of methods in addition to reliance on recall 
of fall events (NICE, 2013); it is therefore imperative that this evidence is published 
in a timely manner.   
This thesis has identified that multisite pain is an independent risk factor for self-
reported falls, and is likely to be an influencing factor on the pathway between 
other risk factors and falls and concluded that it is therefore important for clinicians 
to be identifying their older patients with multisite pain who are at an increased risk 
of falls and to manage their falls risk accordingly.  The next logical question is 
whether optimally managing multisite pain in older people reduces the risk of 
future falls.  For example, it may be that, although the number of pain sites is 
relatively stable over the life course, the overall burden of pain may be reduced 
with interventions aimed at managing pain.  General options for managing 
multisite pain in older people may include patient education and encouragement of 
self-management, exercise, physiotherapy, analgesics and onwards referral for 
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conditions likely to benefit from surgical intervention, for example total knee 
replacements for severe knee osteoarthritis (NICE, 2014).   These interventions 
have the potential to improve physical functioning and general health, reduce 
comorbidities and their associated medications, reduce the requirement for strong 
medication and the impact on cognitive functioning and thus reduce the risk of 
falls.  Conversely, it may be the case that, although multisite pain has been 
identified as a risk factor for self-reported falls in older people and a likely 
contributor to risk of falls requiring primary and secondary care utilisation, 
interventions to try and address the pain do not affect the incidence of future falls.  
In this case, multisite pain may be used as an indicator of falls risk that means 
individuals require optimisation of other falls risk factors, but that addressing the 
pain itself is unlikely to reduce future falls risk; of course this is not a reason to 
sub-optimally manage multisite pain in older people in order to gain other health 
benefits, for example improved physical functioning and general health.  
Thus the next steps are i) to establish whether managing multisite pain in older 
people reduces the risk of future falls; and ii) to establish what an optimal pain 
management package might include for older people with multisite pain.  A 
randomised controlled trial is recommended to establish whether managing 
multisite pain does impact on future falls risk in older people by comparing 
standard falls prevention assessment and management with standard falls 
prevention assessment and management and additional identification and 
management of pain.  A pragmatic trial using current standards of care within a 
community dwelling population who experience multisite pain would yield the most 
useful clinical information and provide a basis for establishing an optimal pain 
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management package for older people with multisite pain if the additional pain 
management in the trial led to reduced future falls risk.      
 
12.7 Conclusion  
Falls, whether they are self-reported or result in seeking healthcare, have 
significant detrimental consequences on individuals, communities and society.  
This thesis has provided new evidence that multisite pain increases the risk of 
future falls in older people and it is therefore recommended that older adults with 
multisite pain are identified in primary care so that appropriate falls prevention 
assessments and management plans are conducted and future falls are 
prevented.  The evidence presented in this thesis, including the results of the 
systematic review and meta-analysis, must now be considered for inclusion in 
national guidelines for the prevention of falls in older people.   The next step in the 
quest to find new interventions to reduce the risk of falls in older people is to 
establish if managing the multisite pain reduces the risk of future falls in addition to 
recommended falls prevention programmes.    
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Appendix 1: Systematic review and meta-analysis: databases and 
data sources searched 
Platform Database (dates)  
OVID Sp  Medline (1946 to present) 
Medline in-process and non-indexed  
Embase (1980 to present) 
AMED (inception to present) 
 HMIC Health Management Information 
Consortium: Department of Health, NICE and 
King’s Fund (inception to present) 
PsychInfo (1806 to present)  
 
NHS Healthcare Databases 
Advanced Search  
BNI (1992 to present)  
CiNAHL (1981 to present) 
 
Web of Science  the Science Citation Index Expanded (SCI-
EXPANDED) (from inception to present) 
Social Sciences Citation Index (SSCI) (From 
inception to present)  
Conference Proceedings Citation Index-Science 
(CPCI-S) (From inception to present)  
Conference Proceedings Citation Index-Social 
Science and Humanities (CPCI-SSH) including 
conference proceedings of the British Geriatrics 
Society, The American Geriatrics Society, The 
Gerontological Society of America and the 
International Association for the Study of Pain 
(from inception to present)   
 
Keele University interface Ageline (inception to present) 
 
Miscellaneous  Cochrane Database of Systematic Reviews 
(inception to present)  
Cochrane DARE database (inception to present) 
TRIP database (inception to present) 
The Electronic Thesis Online Service (EthOS) 
(1990 to present) 
 
Charity & Society websites  AgeUK  
Arthritis Research UK  
British Geriatrics Society  
The American Geriatric Society 
The Gerontological Society of America 
 International Association for the Study of Pain 
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Appendix 2: Systematic review and meta-analysis: search 
terminology and example of primary search using more specific 
terms than ‘pain’ and ‘falls’ 
MEDLINE  
Pain terms  Exp pain/  
Pain.m_titl. 
(chronic adj3 pain).mp.* 
(multisite adj3 pain).mp.* 
(multiple adj3 site anj3 pain).mp.* 
(multiple adj3 joint$2 adj3 pain).mp.*  
(multiple adj3 pain).mp.* 
(multi$ adj3 pain).mp.* 
Exp musculoskeletal diseases/  
Exp musculoskeletal pain/  
Musculoskeletal.mp.  
Exp Osteoarthritis  
Osteoarthritis.mp. or Osteoarthritis /  
Osteoarthr$.mp.  
OA.mp.  
Arthrosis.mp.  
(degenerative adj (arthritis or joint or joints)).mp.* 
Osteoarthritis / or exp osteoarthritis, hip/ or exp osteoarthritis, 
knee / or exp osteoarthritis, spine/  
(hip adj3 (pain or painful)).mp.* 
(knee adj3 (pain or painful)).mp.*  
(ankle adj3 (pain or painful)).mp.* 
(foot adj3 (pain or painful)).mp.* 
(multi$ adj3 joint$2 adj3 pain).mp. 
Arthralgia.mp or exp Arthralgia / 
(arthralgia adj3 (hip or knee or ankle or foot)).mp.  
*mp = title, abstract, original title, name of substance word, subject heading word, 
keyword heading word, protocol supplementary concept, rare disease supplementary 
concept, unique identifier)  
Fall terms  Exp Accidental Falls /  
Accidental fall$.mp.  
Falls.mp (this term excludes papers relating to the season ‘fall’)  
Faller$.mp.  
Falling.mp. 
Fallen.ti,ab. 
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Appendix 3: Systematic Review and Meta-analysis: QUIPS assessment for individual domains 
1. Study participation 
 a b c d e f Summary  
 Leveille 2002 Yes Yes Yes Yes Yes Yes Yes 
Oswald 2006 No Yes Yes Partial Partial Partial Unclear 
Furuya 2009 No partial Yes Partial Yes Partial Unclear 
Leveille 2009 Yes Yes Yes Yes Partial Yes Yes 
Bekibele 2010  yes partial Yes partial Yes Yes Yes 
Hayashibara 2010 No Partial unsure partial yes yes Unsure 
Holt 2011 No Partial unclear Yes Yes Yes Unclear 
Jones 2011 No Partial unclear yes unclear yes Partial 
Goes 2012 No No no Partial Partial Partial unclear 
Ho 1996  No No No Yes unclear no Unclear 
Dore 2015 Partial yes yes Partial yes Partial Partial 
Stanmore 2013 no yes yes yes Unclear yes Partial 
Patel 2014 Partial Partial Partial yes yes yes yes 
Harada 2015 no Partial No Partial Partial yes unclear 
Asai 2015 no no no yes unclear Partial unclear 
Kitayugachi 2015 no Partial yes yes unclear Partial unclear 
Marshall 2016 No  Yes  Yes  yes unclear yes unclear 
Stubbs 2015 no yes yes yes yes yes Partial  
Kitayuguchi 2016  no yes yes yes yes Partial Unclear  
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2. Study Attrition 
Study  a b c d (i) d (ii) Summary  
 Leveille 2002 Yes  No  Yes  No  Unsure  Unclear 
Oswald 2006 Partial  N/A n/a n/a n/a  Partial  
Furuya 2009 Yes  No  n/a n/a n/a Unclear 
Leveille 2009 Yes  Yes  Partial  No Unclear Unclear  
Bekibele 2010  Yes  Partial  n/a n/a unclear Unclear  
Hayashibara 2010 Yes  partial partial No  Unsure  Unsure  
Holt 2011 Yes  Yes  n/a  n/a Unclear  Unclear  
Jones 2011 unclear n/a n/a n/a n/a Unclear  
Goes 2012 unclear no n/a n/a unclear Unclear  
Ho 1996  unclear unclear n/a n/a Unclear Unclear  
Dore 2015 unclear unclear yes unclear Unclear Unclear  
Stanmore 2013 Unclear  no no no unclear No  
Patel 2014 yes no n/a n/a unclear Partial  
Harada 2015 Partial no n/a n/a Unclear  unclear 
Asai 2015 no no n/a n/a unclear unclear 
Kitayugachi 2015 No  no n/a n/a unclear unclear 
Marshall 2016 yes unclear yes no No  Unclear 
Stubbs 2015 yes Partial n/a n/a n/a unclear 
Kitayuguchi 2016  yes unclear no no unclear unclear 
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3. Prognostic factor measurement 
Study  a b (i) b (ii) c d e Summary  
 Leveille 2002 Yes  Yes  Yes  Yes  Yes  n/a   Yes  
Oswald 2006 Yes  yes  Yes  yes unsure Unsure Yes 
Furuya 2009 partial partial Yes  Unclear  Unclear  Unclear Partial  
Leveille 2009 Yes  Yes  Yes  Yes  Yes  n/a  Yes  
Bekibele 2010  Yes  Partial  yes yes unclear n/a  Partial  
Hayashibara 2010 Partial  yes yes unclear yes Unclear  Yes  
Holt 2011 Partial  Partial  yes unclear unclear n/a Partial  
Jones 2011 Yes  Yes  Yes  Partial unclear n/a  Yes  
Goes 2012 Partial yes Partial unclear unclear unclear Partial 
Ho 1996  Partial no Yes  unclear unclear n/a no 
Dore 2015 Partial Partial yes unclear Partial n/a Partial 
Stanmore 2013 yes yes Partial yes yes unclear Yes  
Patel 2014 Yes  yes yes yes yes n/a Partial  
Harada 2015 Partial  Partial yes yes unclear unclear Partial 
Asai 2015 Partial yes yes unclear unclear unclear Partial 
Kitayugachi 2015 yes yes yes unclear unclear n/a yes 
Marshall 2016 yes yes yes yes yes n/a yes 
Stubbs 2015 Partial Partial yes yes unclear unclear Partial 
Kitayuguchi 2016  yes yes yes yes yes n/a yes 
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4. Outcome measurement 
Study  a b  c Summary  
 Leveille 2002 No Partial  Yes Partial  
Oswald 2006 No  partial Unsure  Partial  
Furuya 2009 No  Partial Unsure  Partial  
Leveille 2009 Yes  Yes  Yes  Yes  
Bekibele 2010  No  Partial  Yes  Partial  
Hayashibara 2010 Yes  Yes  Unclear  Yes  
Holt 2011 No  Partial Unclear  Partial 
Jones 2011 Yes  Partial Yes  Partial 
Goes 2012 Yes  Partial  unclear Partial  
Ho 1996  Partial Partial Unclear  Partial 
Dore 2015 no Partial yes Partial 
Stanmore 2013 yes yes yes Yes  
Patel 2014 yes Partial yes Partial  
Harada 2015 no no yes Partial  
Asai 2015 no Partial unclear Partial 
Kitayugachi 2015 yes Partial unclear Partial 
Marshall 2016 Partial Partial yes Partial  
Stubbs 2015 yes Partial yes Partial 
Kitayuguchi 2016  Partial Partial yes Partial 
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5.  Confounding  
Study  a b c d  e F (i) F (ii) Summary  
 Leveille 2002 Yes  Yes  Yes  Unclear  Unclear  Yes  Yes  Partial 
Oswald 2006 Partial  Partial  Partial  Unsure  Unclear   N/A Partial  Partial  
Furuya 2009 partial no Partial  unsure Unsure  n/a  Partial  Partial  
Leveille 2009 Yes  Yes  Partial  Yes  n/a  Partial  Yes  Yes  
Bekibele 2010  Partial  Partial  Partial  Unsure  Unsure  Partial  Yes  Yes  
Hayashibara 2010 Yes  Partial  Unclear  Unclear  n/a n/a  Yes  Partial  
Holt 2011 Partial Partial Partial unclear unclear unclear No  No  
Jones 2011 Partial yes Partial unclear unclear no no No  
Goes 2012 No  Partial Partial unclear unclear Partial Partial Partial 
Ho 1996  Partial  Partial Partial  unclear unclear Partial Partial  Partial  
Dore 2015 yes unclear unclear yes unclear Partial yes Partial 
Stanmore 2013 yes yes yes yes unclear no yes Partial  
Patel 2014 yes yes Partial yes unclear no yes Partial  
Harada 2015 Partial yes Partial yes unclear No  Yes  No  
Asai 2015 Partial Partial Partial unclear unclear n/a Partial Partial 
Kitayugachi 2015 Partial Partial Unclear  unclear n/a n/a Partial Partial 
Marshall 2016 Partial yes Partial yes n/a n/a Partial Partial 
Stubbs 2015 Partial yes Partial yes n/a n/a yes Partial 
Kitayuguchi 2016  Partial Partial Partial yes yes n/a Partial Partial 
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6. Statistical analysis reporting  
Study  a B (i) B (ii) c Summary  
 Leveille 2002 Yes Partial  Yes  Yes  Yes  
Oswald 2006 Yes yes yes yes Yes 
Furuya 2009 Partial  Yes  Yes  Yes  Partial   
Leveille 2009 Yes  Yes  Yes  Yes  Yes  
Bekibele 2010  yes yes yes Partial  Partial  
Hayashibara 2010 Yes  Yes  Yes  Yes  Yes  
Holt 2011 Partial n/a n/a  Yes  Partial  
Jones 2011 Partial n/a n/a Yes  Partial 
Goes 2012 yes yes yes yes yes 
Ho 1996  Partial Partial Partial unclear Partial 
Dore 2015 yes Partial yes yes yes 
Stanmore 2013 yes yes yes  yes yes 
Patel 2014 yes yes yes yes yes 
Harada 2015 yes yes yes yes yes 
Asai 2015 yes Partial yes yes yes 
Kitayugachi 2015 yes yes Partial yes Partial  
Marshall 2016 Partial Partial Partial Partial Partial 
Stubbs 2015 yes Partial yes unclear Partial  
Kitayuguchi 2016  yes yes Partial yes Partial 
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Appendix 4: Multisite pain and falls: Systematic review and Meta-analysis 
Table containing all extracted results from the twenty studies included in the systematic review  
Author 
Outcome 
measure 
method 
No pain group / 
comparison 
group 
description 
Single site pain & risk of falls 
(OR with 95% CI) unless 
otherwise specified 
Multisite pain & risk of falls (OR with 
95% CI) unless otherwise specified 
Risk of bias 
(high/ low/ 
unclear) 
Ho 1996
 
 
Face-to-
face 
interviews 
No pain reported 
in interview 
Lower limb joint pain in left or 
right limb: 1.2 (0.8-1.8) 
Adjusted (age and sex) 
Bilateral lower limb joint pain: 1.4 (1.1-
1.8) 
Adjusted (age and sex) 
 
Bilateral wrist pain: 
1.28 (1.13-1.44) 
Unadjusted* 
High 
Leveille 
2002
 
 
In-home 
interviews 
No pain or only 
mild pain (score 
<4 on numerical 
rating scale) 
reported in 
interview 
No pain or mild pain one site is 
the referent group 
 
1 + falls: 
 
Moderate / severe pain lower 
extremities OR 1.27 (0.97-1.66) 
 
Widespread pain OR 1.66 (1.25-2.21) 
 
Recurrent falls: 
 
Moderate / severe pain lower 
extremities OR 1.38 (0.93-2.03) 
 
Widespread pain OR 1.66 (1.10-2.50) 
 
All adjusted (age, race education, BMI, 
confirmed diseases (hip fracture, 
angina pectoris, diabetes mellitus, 
peripheral arterial disease, stroke, 
Parkinson’s disease), walking 
disability, previous fall in 12 months 
before baseline, MMSE score, daily 
use of psychoactive medications, daily 
Medium 
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use of analgesic medications, gait 
speed, balance test score, proxy 
respondent and follow-up round) 
 
 
Oswald 
2006
 
 
Self-
completed 
survey 
Number of tender 
joints during 
clinical 
examination and 
indicated on 
mannequin 
Hip tenderness: 
no association 
Ankle tenderness: 
no association 
Foot tenderness: 
no association 
Knee tenderness: 
1.09 (1.1-2.1) Adjusted for age 
Knee deformity: 
2.1 (1.0-4.4) Adjusted for age 
1.2 (0.9-1.6) 
Per 10 count increase in joint 
tenderness 
Adjusted for age 
High 
Furuya 
2009
 
 
Self-
completed 
survey 
Number of tender 
joints reported 
during clinical 
examination and 
self-reported 
survey 
Unable to extract this 
information 
1.39 (1.14-1.70) 
Per tender joint count increase 
Adjusted (age, sex, BMI, disease 
duration, J-HAQ score, ESR, CRP, 
DAS-28. VAS pain, VAS general 
health,  swollen joint count, TKR or 
THR, NSAID use, prednisolone dose, 
methortrexate use, any osteoporosis 
drug use, active vitamin D3 use, 
bisphosponate use) 
High 
Leveille 
2009
 
 
Daily 
completion 
of monthly 
falls 
postcards 
No pain reported 
during interview 
% participants fall in past year 
No pain = 28.3% 
Polyarticular pain = 38.3% 
 
Single site rate ratios (no pain 
referent group): 
 
1.19 (0.90-1.56) adjusted for 
socioeconomic characteristics 
(Model 1) 
 
1.15 (0.86-1.53) adjusted for 
Model 1 plus chronic conditions, 
physical and cognitive status 
Polyarticular pain = 44.2% 
P <0.001 across groups no pain/ single 
site pain / multisite pain 
 
Multisite pain rate ratios (no pain 
referent group) 
 
1.70 (1.34-2.16) adjusted for 
socioeconomic characteristics (Model 
1) 
 
1.71 (1.33-2.20) adjusted for Model 1 
plus chronic conditions, physical and 
cognitive status (Model 2) 
Low 
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(Model 2) 
 
1.11 (8.84-1.47) adjusted for 
Model 2 plus physical 
performance and 
psychotherapeutic medications 
(Model 3) 
 
1.11 (0.84 – 1.48) adjusted for 
Model 3 plus analgesic use and 
hand and knee arthritis clinical 
criteria 
 
 
 
1.60 (1.23-2.06) adjusted for Model 2 
plus physical performance and 
psychotherapeutic medications (Model 
3) 
 
1.53 (1.17-1.99) adjusted for Model 3 
plus analgesic use and hand and knee 
arthritis clinical criteria 
 
 
Bekibele 
2010
 
 
Interviews 
No pain reported 
during interview 
1.0 (0.6-1.5) 
Adjusted (age and sex) 
1.2 (1.0-1.4) 
Adjusted (age and sex) 
Medium 
Hayashib
ara 2010
 
 
Daily 
completion 
of monthly 
falls 
calendars 
No tender joints 
reported during 
clinical 
examination 
Not possible to extract this 
information 
Mean tender joint count in fall group: 
4.30 (SD 7.02) 
Mean tender joint count in no-fall 
group: 3.18 (SD 4.88) 
p = 0.41 
No significant difference in the mean 
tender joint count between fall group 
and no-fall group 
Low 
Holt 2011
 
 
Structured 
interview 
Absence of neck 
and back pain 
2.42 (0.87-6.71) 
Unadjusted 
0.80 (0.29-2.19) 
Unadjusted 
High 
Jones 
2011
 
 
Self-
completed 
form 
Number of painful 
body regions 
recorded in self-
reported survey in 
healthy control 
group 
Not possible to extract this 
information 
5.31 (1.63-17.26) High 
Goes 
2012
append
ix 
 
Interview 
Physician-
assessed tender 
points in lower 
limbs and general 
pain in healthy 
Not possible to extract this 
information 
5.44 (0.91 – 32.31) High 
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control group 
Dore 
2015 
Unclear: 
participants 
underwent 
intial home 
interview, a 
clinic visit 
and a 
second 
home visit 
Symptomatic OA 
in hips or knees 
(presence of pain, 
aching and 
stiffness on most 
days associated 
with radiographic 
changes).  
Groups are no 
symptomatic OA, 
mild symptoms 
and moderate / 
severe symptoms. 
Author grouped 
into no pain, pain 
in either joint, pain 
in both joints 
Unable to compare no pain with 
pain as it is not clear that those 
grouped as no hip pain also had 
no knee pain. 
1 symptomatic joint OR 1.53 (1.10-
2.14) 
2 symptomatic joints OR 1.74 (1.19-
2.53) 
3-4 symptomatic joints OR 1.85 (0.96-
3.55) 
Medium 
Stanmore 
2013 
Prospective 
daily falls 
calendars 
and 
monthly 
telephone 
call where 
necessary. 
Number of 
swollen or tender 
joints and 
presence or 
absence of joint 
tenderness 
Unable to calculate this 
information 
Unadjusted bivariate LR compared to 
no swollen / tender joints: LR 1.0 
(0.98-1.04). 
 
Presence of lower extremity joint 
tenderness /swelling: OR 2.0 (1.3-2.8) 
unadjusted 
 
Presence of lower extremity joint 
tenderness / swelling : 1.7 (1.1-2.8) 
p<0.05 adjusted for 16 predictive risk 
factors (Swollen or tender lower 
extremity joints, DAS28 score, use of 
psychotrophic medications, taking 4 or 
more types of medications, taking 
steroids at baseline, VAS pain score, 
VAS fatigue score, 12 month history of 
single fall, 12 month history of multiple 
falls, history of fracture, history of 
injuries from previous falls, short FES-I 
score, HAQ score, Four-Test Balance 
Low 
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Scale, Symsptoms of feeling dizzy or 
unsteady, time taken to complete the 
Chair Stand Test) 
 
Presence of lower extremity joint 
tenderness / swelling OR 1.7 (1.1-2.7) 
p<0.05 adjusted for 12 explanatory risk 
factors (Swollen or tender lower 
extremity joints, DAS28 score, use of 
psychotrophic medications, taking 4 or 
more types of medications, taking 
steroids at baseline, VAS pain score, 
VAS fatigue score, short FES-I score, 
HAQ score, Four-Test Balance Scale, 
Symptoms of feeling dizzy or 
unsteady, time taken to complete the 
Chair Stand Test) 
 
 
Patel 
2014 
Interviewer 
question 
Total number of 
pain sites, no pain 
is referent group. 
Number of pain 
sites 0, 1,2,3 or 4. 
Unable to calculate this 
information 
Prevalence ratio for fall yes/no and 
pain, no pain is referent group: 
NPS 1 1.21 (1/06-1.38) 
NPS 2 1.53 (1.31-1.79) 
NPS3  1.54 (1.30-1.83) 
NPS4 1.75 (1.51-2.04) 
All adjusted for age, sex, ethnicity, 
education, smoking, BMI, depressive 
symptoms, obesity, dementia, arthritis, 
OP, hip fracture, chronic lung disease, 
MI, DM, hypertension, stroke, number 
of medical conditions, coginitive 
performance, exercise, frequency 
analgesic use, chair rise performance, 
gait speed, grip strength, standing 
balance performance 
 
Low 
Harada 
2015 
Postal 
questionnai
Knee pain or low 
back pain 
Risk of falls with one pain site 
OR 1.40 (0.97-2.03) unadjusted, 
Risk of falls with two pain sites OR 
2.19 (1.53-3.12) p<0.001 unadjusted, 
High 
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re experienced in 
the last month 
yes/no 
OR 1.42 (0.98-2.06) adjusted for 
age and sex, OR 1.37 (0.95-
2.00) adjusted for multiple 
variables** 
 
 
OR 2.19 (1.53-3.12) p<0.001 adjusted 
for age and sex, OR 1.93 (1.35-2.78) 
p<0.001 adjusted for multiple 
variables** 
Asia 
2015 
questionnai
re (no 
further 
information) 
Pain in the back, 
hip, knee, foot or 
toe lasting 1 
month or more in 
the previous year 
and also present 
in the previous 
month. Number of 
pain sites were 
counted and 
grouped into no 
pain, single-site 
pain and 2 or 
more pain sites 
The OR is presented using 
number of chronic MSK pain 
sites as a continuous variable: 
 
OR 5.02 (1.50-17.88) p=0.03 
unadjusted 
 
OR 5.31 (1.40-21.50) p=0.03 adjusted 
for physical function and fear of falls 
 
i.e. the odds of falling increases by 
5.02 for each additional site of pain 
High 
Kitayuguc
hi 2015 
Self-
administere
d survey 
and face-
to-face 
interview 
LBP and knee 
pain ‘how much 
pain have you 
had during the 
last week? None, 
mild, severe, very 
severe. None is 
no pain group, 
mild – very severe 
is pain group 
For single falls: 
 
Knee pain only: OR 0.83 (0.28-
2.50) adjusted for age, sex, BMI; 
OR 0.71 (0.23-2.21) adjusted for 
all*** 
 
LBP only: 1.56 (0.66-3.65) 
adjusted for age, sex, BMI; OR 
1.27 (0.52-3.07) adjusted for all 
*** 
 
For multiple falls: 
 
Knee pain only: OR 3.58 (0.32-
40.48) adjusted for age, sex, 
BMI; OR 3.34 (0.29-85.83) 
adjusted for all*** 
 
For single falls: 
 
Knee and LBP OR 2.16 (1.02-4.57) 
p<0.05) adjusted for age, sex, BMI; 
OR 1.50 (0.67-3.39) adjusted for all*** 
 
 
For multiple falls: 
 
Knee pain and LBP OR 11.07 
(1.43-85.83) < 0.05 adjusted for age, 
sex, BMI; OR 10.79 (1.33-87.19) 
p<0.05 adjusted for all*** 
High 
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LBP only: OR 2.69 (0.24-30.39) 
adjusted for age, sex, BMI; OR 
2.49 (0.22-28.52) adjusted for 
all*** 
Stubbs 
2015 
Interviewer 
administere
d 
questionnai
re 
Chronic MSK pain 
defined as report 
of MSK pain 
present over the 
past month and 
for at least 3 
months of the 
previous year. 
Then classified 
into no CMP, 
single site CMP 
and multisite CMP 
(pain at 2+ sites) 
Any fall: OR 1.83 (0.97-3.43) 
adjustment 1 (adjusted for age 
and sex); OR 1.50 (0.72-3.13) 
adjustment 2****; OR 1.18 (0.56-
2.56) adjustment 3**** 
 
Single fall: OR 1.34 (0.67-2.65) 
adjustment 1, OR 1.21 (0.54-
2.69) adjustment 2, OR 1.05 
(0.46-2.39) adjustment 3. 
 
Recurrent falls: OR 1.97 (0.85-
4.56) adjustment 1, OR 1.64 
(0.62-4.32) adjustment 2, OR 
1.40 (0.51-3.78) adjustment 3. 
 
Any fall: OR 3.53 (1.97-6.34) p<0.05 
adjustment 1, OR 2.36 (1.15-4.85) 
p<0.05 adjustment 2, OR 1.92 (0.89-
4.13) adjustment 3. 
 
Single fall: OR 1.39 (0.74-2.59) 
adjustment 1, OR 0.98 (0.44-2.10) 
adjustment 2, OR 0.78 (0.33-1.81) 
adjustment 3. 
 
Recurrent falls: OR 4.22 (2.08-8.56) 
adjustment 1, OR 3.56 (1.46-8.67) 
adjustment 2, OR 3.43 (1.34-8.65) 
adjustment 3. 
Medium 
Marshall 
2016 
****** 
 
 
(see 
results 
table for 
more 
results 
not 
strictly 
relating to 
SSP and 
MSP and 
falls) 
Survey 
administere
d in clinic 
Any back pain in 
the last 12 
months? Yes / 
No. Those 
reporting yes 
indicated on a 
drawing where 
their pain usually 
occurred – upper, 
middle or lower 
back.  Classified 
into no pain, lower 
only, middle only, 
upper only. Also 
number of pain 
sites as 0,1,2,3.  
Hip pain yes/ no 
Back pain single site and any 
fall: 
RR 1.26 adjusted for age 
 
RR 1.12 (1.10-1.33) adjustment 
2 
 
Back pain single site and 2+ 
falls: 
RR 1.58 adjusted for age 
 
RR 1.49 (1.12-1.78) adjustment 
2 
 
 
Back pain 2 sites and any falls: 
RR 1.34, adjusted for age 
 
RR 1.27 (1.12-1.44) adjustment 2 
 
Back pain 2 sites 2+ falls: 
RR 1.73 
 
RR 1.63 (1.30-2.05) adjustment 2 
 
Back pain 3 sites and any falls: 
RR 1.60 adjusted for age 
 
RR 1.50 (1.23-1.83) adjustment 2 
 
Back pain 3 sites and 2 + falls 
RR 1.60 
 
RR 1.50 (1.23-1.83) adjustment 2 
Medium 
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Kitayuguc
hi 2016 
******* 
Postal 
questionnai
re 
Presence or 
absence of knee 
pain of LBP on 
day of survey, 
classified into 
pain lasting > 3 
months, pain < 3 
months or no 
pain.  Multisite 
classified as no 
chronic LB or KP, 
either chronic 
LBP or knee pain 
and both chronic 
LBP and KP. 
Chronicity and 1+ falls: 
Either LBP or KP: 
OR 1.51 (1.01-2.27) unadjusted, 
OR 1.35 (0.87-2.09) adjusted 
 
Intensity and 1+ falls: 
Either moderate / severe LBP or 
KP: 
OR 1.57 (1.10-2.26) 
OR 1.40 (0.94-2.10) 
Chronicity and 2+ falls: 
Either chronic LBP or KP: 
OR 1.59 (0.88-2.89) 
OR 2.12 (0.67-6.74) adjusted 
 
Intensity and 2+ falls: 
Either chronic LBP and KP: 
OR 1.50 (0.83-2.71) 
OR 1.17 (0.63-2.20) adjusted 
Chronicity and 1+ falls: 
Both chronic LBP and KP: 
OR 2.42 (1.29-4.54) 
OR 2.03 (0.95-4.33) adjusted 
 
Intensity and 1+ falls: 
Both chronic LBP and KP: 
OR 2.99 (1.13-3.53) 
OR 1.57 (0.80-3.05) adjusted 
 
Chronicity and 2+ falls: 
OR 1.59 (0.88-2.89) 
OR 2.12 (0.67-6.74) adjusted 
 
Intensity and 2+ falls: 
OR 2.55 (1.18-5.53) 
OR 1.58 (0.60-4.17) 
Medium 
Brenton-
Rule 
2016 
Survey at a 
baseline 
visit 
Tender joint count 
Unable to calculate this 
information 
Tender joint count lower limb (mean, 
SD): 
Non-fallers 4.98 (6.9) 
Fallers        6.63 (7.37) 
P = 0.04 
Medium 
*classed as unadjusted as not clear from manuscript (manuscript explicitly states OR that are adjusted); BMI = body mass index; MMSE = 
Mini-Mental State Examination; J-HAQ = Japanese Health Assessment Questionnaire; ESR = Erythrocyte sedimentation rate; CRP = C-
reactive protein; DAS-28 = Disease activity score; VAS = Visual analogue scale; TKR = total knee replacement; THP = total hip 
replacement; NSAID = Non-steroidal anti-inflammatory drug; **Harada 2015 – multiple variable included in adjustment were age, sex, 
lower limb functional decline; *** Kitayuguchi 2015 – adjusted for age, sex, BMI, self-rated health, self-reported psychological distress, 
medication number, gait speed, exercise time; ****Stubbs 2015 – adjustment 2 for age, sex, number of chronic conditions, number of 
prescribed medications, HRQoL and TUG; ***** Stubbs 2015 – adjustment3 for adjustment 2 + physical activity and fear of falling; 
******Marshall 2016 – adjustment 2 is adjusted for age, education, smoking, alcohol, self-rated health, history of physician diagnosed 
conditions including Parkinson's Disease, stroke, and OA. Past 12 month history of falls, fainting, hip pain. ADK score, depression, 
medication use in past 12m , medications for sleep, anxiety, pain.  Physical performance measures, BMI, presence of vertebral fracture; 
******* Kitayugachi 2016 – adjusted for adjusted for age, sex, BMI, community, education years, self-rated health, depression, smoking, 
chronic disease history, medication use, consultation with physician; Dore 2015 adjusted for ethnicity, sex, age, BMI, falls at baseline, lung 
problems, neurological problems, narcotic use 
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Appendix 5: Ethical and legal aspects of using participant 
identifiable data for secondary data analysis without explicit 
consent  
 Introduction  
This section details the processes involved in preparing applications for the 
National Information Governance Board under Section 251 of the NHS Act 2006.   
The literature review and Patient and Public Involvement exercise that informed 
the subsequent applications required for data linkage are described.  The outcome 
of the application process is presented and a chapter summary is provided.   
 Overview  
In order to address this theses’ objectives, the NorStOP survey data, GP 
consultation records, prescription records, HES and ONS data need to be linked, a 
process is undertaken by the NHSIC using identifiable data sent by this thesis’s 
research team.  In research, the use of identifiable data generally requires the 
consent of the study participant, which this thesis’s author did not have thus giving 
rise to a challenging situation.  A thorough understanding of the ethical and legal 
aspects was therefore imperative to proceed correctly with the proposed research, 
starting with the basic concepts of confidentiality and consent in research.  These 
concepts are now discussed and the law governing a researcher’s duty of 
confidentiality is outlined and applied to the proposed research to define the 
specific ethical challenges.  Mechanisms to overcome the ethical challenges are 
then presented.  Finally, a literature review and description of PPI involvement are 
described and then used to justify the decisions made during the data acquisition 
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process in order to obtain permission to undertake data linkage.   Note that this 
work was undertaken and completed in 2012; the National Information 
Governance Board who oversaw the process of acquiring data ceased to function 
in May 2013 and its function has been transferred to the National Information 
Governance Committee  
The ethical principles of research: confidentiality and consent  
Researchers have a moral duty to conduct ethically-sound research.  Guidance 
has been produced to assist researchers in achieving good ethical standards in 
their research.  In the UK, guidance from the National Institute of Health Research 
(NIHR) states ‘clinical studies should be carried out according to the International 
Conference on Harmonisation and the World Health Organisation Good Clinical 
Practice standards’ (NIHR, 2011).  This guidance is drawn from the Declaration of 
Helsinki, which states:  
‘it is the duty of physicians [and others] who participate in medical research to 
protect the life, health, dignity, integrity, right to self-determination, privacy and 
confidentiality of personal information of research subjects.  Every precaution 
must be taken to protect the privacy of research subjects and the confidentiality 
of their personal information and to minimise the impact of the study on their 
physical, mental and social integrity’. (WMA 2008) 
A priority for researchers is therefore to design and conduct research that protects 
participants’ right to confidentiality.   
In the UK, an individual’s right to confidentiality is protected by the Human Rights 
Act 1998, The Data Protection Act 1998 and the English Common Law Duty of 
311 
 
Confidentiality.  The Human Rights Act 1998, Article 8 states that individuals have 
a right to private and family life including the right to have one’s medical 
information kept private and confidential (Department for Constitutional Affairs, 
2006).  The Data Protection Act 1998 regulates the use of personal information by 
organisations and individuals, including healthcare professionals and researchers, 
thus ensuring such information is kept private and confidential (Information 
Commissioner’s Office 2012).   The Common Law holds a general position that if 
information is given in circumstances where a duty of confidence is expected, that 
information cannot normally be disclosed without the information provider’s 
consent (DoH 2008).  Applying this to medical research, this means that patient 
information must not normally be disclosed without the consent of the patient (or 
research participant) (DoH 2008).  Therefore, seeking consent is a means of 
protecting patients’ and research participants’ rights to confidentiality.   Indeed, the 
NIHR’s Good Clinical Practice states ‘informed, voluntary consent to participate in 
research is a fundamental principle of ethical research practice’ (NIHR 2011).  
Respecting an individual’s right to dissent from research is therefore equally 
important in research practice. 
6.3.2 The context of identifiable, sensitive patient information 
Under the duty of confidentiality, the type of patient information used in the 
research is a key consideration.  Although the duty of confidentiality covers all 
aspects of an individual’s health and social care information, information required 
by researchers that is deemed ‘identifiable’ or ‘sensitive’ is of particular interest.  
Patient identifiable information is defined by the Department of Health (2003) as 
‘any information that may be used to identify a patient directly or indirectly’.  Direct 
identifiers include name, address, full postcode, date of birth, NHS number and 
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date of death (NHSIC 2012a).  Information can also be linked together to identify 
patients, for example a rare disease in a specific geographical area or a small 
population.  Sensitive information is defined by the Hospital Episode Statistics 
department (2012b) as information relating to the medical practitioners treating the 
patient and information about the patient’s legal status under Mental Health 
legislation.  In addition, the NHS Health and Social Care Information Centre 
(2012a) also include racial or ethnic origin and physical or mental health conditions 
as sensitive information. 
6.3.3 Defining the challenges of this thesis’ proposed research 
The proposed research involves linking participants’ pre-existing survey data with 
their medical records and national (HES and ONS) datasets.  The dataset used for 
analysis will therefore contain linked survey responses and health care records for 
each individual participant.  Obtaining consent from participants to partake in 
research is required to ensure sound ethical research practice.  The challenge 
specific to the proposed research in this thesis is now dicussed.     
Consent to participate in research was obtained during baseline and follow-up 
NorStOP surveys, as approved by the Local Research Ethics Committee 
(05/Q2604/20 NorStOP 1, 05/Q260472 NorStOP 2 and 06/Q2801/90 NorStOP 3).  
Consent to link survey responses to ‘medical records’ was requested in the 
NorStOP baseline surveys and was given by 75% of respondents.  Specifically, 
consent was sought through the following paragraph:  
 “it is important for us to find out what types of treatment and tests people need.  
We can do this by reviewing medical records.   Would you be willing to give your 
permission for this?  When we review the medical records, your name will not be 
used so that you will not be identified personally.  We can assure you that any 
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information will be held in the strictest confidence.”  (NorStOP 1 baseline General 
Health Questionnaire) 
 
4666 NorStOP participants therefore refused consent to access and link medical 
records with their survey data.   
It was not possible to obtain consent from NorStOP participants to access their 
HES and ONS information and link it with their survey responses for a number of 
reasons.   Firstly, the NorStOP surveys began recruiting in 2002. The recorded 
contact details of participants are were more than ten years old in some case 
which meant those participants would be very difficult to trace.   Secondly, it was 
possible that some participants had died, particularly given that the cohort 
compromised of older adults.  Therefore, it was considered that sending study 
correspondence to deceased participants or their surviving relatives was not in the 
best interests of the surviving relatives.  Finally, attempting to trace 18,497 
NorStOP baseline respondents who may have moved out of the area or died 
would have been an expensive process in terms of time, personnel and 
bureaucracy.  Thus, the situation of consent for the proposed research is 
challenging, since it was not possible to obtain participant consent for access to, 
and linkage of, HES and ONS data.   
This situation gives rise to two requirements:  
i) A mechanism that enables HES and ONS access and data-linkage despite 
the inability to obtain consent 
ii) An assessment of the wishes of those who dissented from medical record 
review with respect to accessing HES and ONS data 
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The following sections discuss address these important questions.  
6.3.4 A mechanism to enable HES and ONS data access and linkage despite no 
participant consent: the NHS Act 2006, section 251 
The first step towards finding a solution was to consider how the HES and ONS 
data is accessed and linked to the NorStOP participants.  The data was accessed 
and linked by the NHSIC.   The NHSIC required specific information about the 
NorStOP participants to allow the correct HES and ONS data to be extracted and 
linked.  The research team needed to provide the IC with individual identifiers 
including NHS number, post code, date of birth and sex; the pseudo-anonymised  
study number was also be provided for each participant.  The IC returned a 
dataset of ONS and HES data that is linked to each participant’s individual study 
number, thus the data was retuned in a pseudo-anonymised format.   ‘Pseudo-
anonymised’ describes a process whereby specific patient identifiers are replaced 
by alternative (and otherwise meaningless) alphanumeric fields (Care Record 
Development Group 2007).   
NHS number and post code were not held by the NorStOP Data Custodian (the 
person responsible for the ‘safekeeping of data and control of their use, and 
eventual disposal, all in accordance with legislation and terms of consent provided 
by the data-provider [i.e. patient]’), (Medical Research Council 2012).  Therefore, 
in order to obtain the identifiable data to send to the IC, the Data Custodian had to 
request the identifiable information from the primary key holder (the GP practices 
from which the NorStOP samples were drawn). Once the data linkage had been 
achieved in the Research Centre, identifiable data including NHS number and post 
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code were deleted.  Ethical permission was already in place to store date of birth 
and sex in the NorStOP database and these fields will be used in data analysis.   
 
Thus, to enable access to the HES and ONS data, two specific data-handling 
processes had to be undertaken, both of which required the use of identifiable 
data: 
i)  The research team had to liaise with the participant’s GP surgery in order to 
obtain the NHS number and post code for participants through secure encrypted 
pathways. The study team held the pseudo-anonymous practice identifier for 
individuals in the cohort. This is the primary key which enabled the GP surgery to 
establish a link back to participants’ identifiable data which was securely held in 
the surgery; and 
ii)  The research team to send NHS number, postcode, DOB and sex to the 
NHSIC through secure encrypted pathways to enable data-linkage with HES and 
ONS data. 
 
The HES and ONS data will include information about physical and mental health 
which is classified as sensitive data.    
In line with researchers’ duty to protect confidentiality through seeking consent, the 
NHSIC state that participant consent must be provided at the time of requesting 
the data.  If it is not possible to seek consent then ‘Section 251 approval’ must be 
obtained and sent with the data request (HES 2012a).   
 ‘Section 251 approval’ (also called ‘Section 251 support’) refers to Section 251 of 
the NHS Act 2006.  Section 251 support ‘permits the common law duty of 
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confidentiality [and thus the seeking of participant consent] to be set aside so that 
information which identifies patients can be used without their consent’ (NIGB 
2012a).   It is sought from the Secretary of State for Health through the Ethics and 
Confidentiality Committee (ECC), part of the National Information Governance 
Board (NIGB) (NIGB 2011a).  
To obtain section 251 support, the criteria set out in figure x.x have to be met 
(NIGB 2011a):  
 
The purpose of this thesis is to examine the relationship between multisite pain 
and falls in older people.  This will provide the first steps that will ultimately result 
in an improvement of patient care for older people.  Therefore, the information 
required was for a medical purpose, with the primary interest in improving patient 
care.   
Identifiable data was required to access the HES and ONS data and achieve 
linkage with NorStOP survey data.  De-identified data would not enable 
Requirements for Section 251 support  under the NHS Act 2006: 
 The research has to be for a medical purpose; and 
 The reason for using the information has to be for the purpose of improving patient 
care OR in the public interest; and 
 The purpose cannot be achieved using de-identified data; and 
 Seeking consent for the use of identifiable data is not practicable. 
 The ECC need to be satisfied that the reason for needing the information is of 
sufficient quality, and of benefit to the public, to justify disclosing the information. 
They also need to accept that the use of section 251 is necessary and the reason for 
using the information cannot be achieved by taking a different approach. 
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information relating to specific individuals to be released.  Moreover, de-identified 
aggregate level data (for example, total counts of exposures and outcomes within 
a population) would not enable allow the impact of putative mediating factors to be 
measured.   
Seeking consent for the use of identifiable data was not possible due to 
impracticalities and the associated financial and bureaucratic costs.  Finally, if 
identifiable information is not used then the relevant HES and ONS data could not 
be extracted or linked with NorStOP data.  Thus, the proposed research objectives 
could only be achieved through using identifiable information to access and link 
HES and ONS data. 
To summarise, the application to obtain HES and ONS data required section 251 
support, which was be sought from the NIGB.   The NHSIC stated that all requests 
for sensitive information are referred to the Ethics and Confidentiality Committee 
(HES 2012b), a branch of the NIGB.  Therefore an application to the ECC will be 
made for consideration of section 251 support and an evaluation of the sensitive 
data required for the proposed research.   The application to the ECC for section 
251 support, hereafter referred to in the thesis as ‘the NIGB application’, thus 
required a carefully considered justification for data use without participant 
consent, particularly in the case of NorStOP participants who dissented to medical 
record review.  
 
 
6.3.5 How a dissent from ‘medical record review’ is to be applied to the process 
of obtaining ONS and HES data 
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A fundamental principle of ethical research is obtaining valid participant consent.  
Equally, a decision to dissent from research participation must be respected to 
fulfil the duty of confidentiality.  This raises some interesting questions around the 
position of respondents who dissented from ‘medical record review’. An argument 
to support or reject the notion that the dissent from medical record review at 
baseline NorStOP is an ‘absolute’ was developed in order to justify the application 
for section 251 support for all NorStOP participants.  This was achieved through 
reviewing the literature and undertaking a Patient and Public Involvement (PPI) 
consultation, processes which are now described.  
6.3.6 Literature review: using personal identifiable sensitive data without consent  
6.3.6.1 Aims and objectives  
The objective of the literature review was to identify evidence examining the use of 
identifiable data without consent.   
6.3.6.2 Methods  
Medline, Embase, Cinahl and HMIC  were searched using the terms displayed in 1 
the search was limited to title and abstract.  Terms within groups (denoted by each 
row in table x.x) were combined using the Boolean operator ‘OR’ and then each 
group was combined with the Boolean operator ‘AND’.  This search revealed 14 
articles, all of which had their full text reviewed by VW.   
 
 
Table 1: search terms 
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 Search terms  
1. Identifiable OR sensitive  
2 Information OR data  
3.  Research 
4 Participant OR patient OR individual  
5 Consent OR dissent  
6 Without OR no OR unable  
 
Publications from such governing bodies as the General Medical Council, the 
Medical Research Council, the Department of Health, the NIHR and the Academy 
of Medical Sciences were searched.  The electronic database from the NIHR 
‘Involve’ group, a national advisory group that supports greater public involvement 
in research (NIHR 2012a), was also searched (NIHR 2012b).  References of 
retrieved articles were hand-searched.  Three further relevant articles were 
obtained in addition to those obtained from the database search. 
6.3.6.3 Narrative review    
The majority of the literature was commentary and opinion pieces; four studies 
were designed to explore the issue of using identifiable (and sensitive) data 
without consent.  Historically, the interpretation of the Human Rights Act 1998, the 
Common Law Duty of Confidentiality and the Data Protection Act 1998 by 
agencies governing access to data for research purposes (for example, the Patient  
Information Advisory Group, PIAG) proved challenging to researchers wishing to 
use previously collected health data (Academy of Medical Sciences, 2006; 
Souhami 2006).   This situation largely arose from a lack of knowledge of public 
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opinion towards using identifiable data in research.  Prior to this, only one study, a 
cross-sectional survey by Barrett e al (2006) had been published.  Barrett et al 
(2006) interviewed the British public on their views towards the use of personal 
data by the National Cancer Registry without individual consent (Barrett et al, 
2006).  From the 2872 interviewed (response rate 65.5%), 72% did not consider 
inclusion of postcode, name and address in the Registry and subsequent use 
without consent for identification of potential participation in research  to be an 
invasion of privacy; 2% of the sample however did consider this a privacy invasion 
(Barrett et al, 2006).   In 2006, The Academy of Medical Sciences  published a 
report into the use of personal data for public good; it concluded that more work 
needed to be undertaken to explore the public’s views towards use of identifiable 
data without consent and that agencies controlling access to data must consider 
the greater public interest that research may bring in their balancing of benefits 
and harms relating to approving requests for permission (Academy of Medical 
Sciences, 2006).   
Since the recommendations were made in 2006, two studies of public opinion 
have been completed.  In 2009, the Department of Health commissioned a 
consultation to explore the issues around patient consent and confidentiality in 
relation to using their medical data for research (Knight 2009).   Three in five 
respondents thought that researchers should be able to search patients’ notes to 
find people who might be approached to take part in research and half of these 
thought this should happen after permission is granted from the PIAG (Knight 
2009).  Despite this finding, the report concluded “it is clear that the public expects 
their consent to be sought if the data used is identifiable” (Knight 2009).  Finally, 
Buckley et al (2010) conducted a survey of 1575 members of the Irish general 
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public.  Achieving a response rate of 40%, the majority of respondents felt that 
having prior consent agreements in place with the GP would allow the GP to share 
anonymous information with researchers without the need for study-by-study 
consent (Buckley 2010).    One further publication of interest was a reflection upon 
lessons learnt of processing identifiable data without consent during the 
development of a disease register (Haynes 2007).  Explicit consent was not 
sought for practical reasons, however public awareness of the register was 
‘ensured’ though the sending of information leaflets to all local residents (30,000) 
detailing the register, how identifiable information will be used and how to withdraw 
from the register.  The register was also advertised in local and national 
newspapers and leaflets were placed in general practices and local hospitals 
explaining the use of personal information and how to withdraw from the register.   
The researchers received no expression of desire to have their data withdrawn 
from the register, suggesting that the public were implicitly satisfied with the use of 
their identifiable data without consent (Haynes 2007).   
It is clear from the literature summary that the public seem to generally accept the 
use of identifiable data for secondary research purposes providing it is within a 
framework of secure data and permission has been obtained from a central 
agency.  
 As for the problem of how to tackle the participants who dissented from medical 
record review, no specific advice in the literature can be applied to this situation.  It 
seemed that the ECC may consider a dissent at NorStOP baseline to be an 
absolute dissent to any form of medical record review, however clinical experience 
dictates otherwise.  Patients change their mind according to the context; indeed, 
the GMC (2008) state that consent is time, place and situation specific.  Public and 
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patient involvement (PPI, or ‘user involvement’) was thus undertaken to explore 
the public’s views towards using identifiable health care data and accessing HES 
and ONS data in patients who previously dissented from primary care medical 
record review.   
6.3.7 Patient and public involvement  
6.3.7.1 The role of patient and public involvement in research 
Patient and public involvement (PPI) is also known as ‘user involvement’ (Involve 
2012).  ‘The public’ means patients, potential patients, service users, carers and 
organisations that represent people who use services (Keele 2009).   ‘Involvement’ 
is defined as “active involvement where the people involved are not subjects” of 
research but are active participants. This means that research is carried out with 
and by members of the public rather than to, about or for them” (Hanley 2004).  
PPI can help to define what is ethically acceptable in research (Staley 2012); its 
importance is underlined through its integration into applications to Local Ethics 
Committees (Tarpey 2011).   The host Research Centre are “committed to taking 
an explicit and systematic approach to involving the public in research” and 
therefore have a well-established framework for PPI (Keele 2009) including a 
Research Users’ Group (RUG).    
6.3.7.2 Aims and objectives  
The aim of PPI was to explore the acceptability of using identifiable data to access 
HES/ONS data, and to link HES/ONS data to NorStOP survey responses for 
participants who dissented from primary care medical record review.  Specific 
objectives were to explore the PPI groups views on the following:   
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i) The risks, burdens and benefits to participants of using identifiable data 
without consent 
ii) Whether the use of identifiable data without participant consent is 
acceptable for proposed thesis study  
6.3.7.3 The PPI process 
 
This section provides a brief overview of the processes involved with PPI. 
There are three different approaches to public involvement in research: 
consultation, collaboration and user-controlled (Involve 2012).  A consultation 
process, whereby members of the public are asked for their views which are then 
used to inform decision making (Involve  2012) was undertaken to explore views 
towards using identifiable information without consent.  The mode of public 
consultation can range from informal meetings, structured focus groups or one-to-
one interviews (Involve 2012).   Since PPI formed an integral part of the research 
proposal, a formal systematic approach was taken to ensure that the views sought 
were after careful consideration of all related issues under minimum researcher 
influence.   The PPI was therefore developed using a focus-group format as a 
guide rather than relying on a more informal ‘group chat’ approach.  
Focus groups are a ‘form of group interview that capitalises on communication 
between research participants in order to generate data’ (Kitzinger 1995: 299).    
Compared with one-to-one interviews, focus groups have the advantage of the 
‘safety in numbers’ approach, which encourages respondents to reveal their 
thoughts (Kitzinger 1995).  However, the potential for hierarchies to form within the 
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group and the negative impact on group dynamics and willingness to disclose 
opinions must be considered (Finch & Lewis 2003).  
The PPI group were drawn from the existing RUG.  Five group members were 
requested and no specific background demographics (for example 
sociodemographic status, health conditions) were required.    
Participant invitation letters and information sheets were prepared, mindful of the 
need to write in language understandable to the lay public, avoiding jargon and 
providing clear simple explanations of the problem (Involve 2012).   
 The invites and information sheets were sent out two weeks prior to the meeting 
date to allow additional time for people to read the information (Involve 2012).  This 
information contained a diagram to summarise the challenge requiring discussion, as 
figure 1. 
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Figure 1: ethical dilemma 
 
 
6.3.7.4 PPI findings  
The group discussed their concerns around accessing data without consent and 
were primarily concerned with the media coverage of missing or stolen personal 
information.  The group highlighted the potential for participant distress if 
particularly ‘sensitive’ health information, for example HIV status or past history of 
termination of pregnancy, were shared non-confidentially and also raised 
concerned about the ‘identifiability’ of participants in related study publications.  
Concerns over using identifiable data and accessing HES and ONS data for 
participants who have already dissented from medical record review were raised 
by two group members at the outset of the meeting.  A discussion about the 
original consent procedure and the nature of ONS and HES data compared with 
primary care records followed and the group reached an agreement that it was 
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acceptable to use identifiable data to access and link HES and ONS data to 
survey responses for participants who did not consent to medical record review 
because the information sought was different from that implied in the original study 
(i.e. primary care records) and dissent was not specific for the purposes outlined in 
the proposed research.  
6.3.7.5 Strengths and limitations 
The purpose of the PPI was to explore consumer views towards the use of 
identifiable data without consent using a focus-group format.  Although not a 
formal qualitative research approach with respect to participant sampling, themes 
including scepticism towards data use and concerns over data security were 
explored using group dynamics to facilitate disclosure of views.  It is therefore 
appropriate to consider the limitations of using such a methodology in the context 
of qualitative research.   
Firstly, the participants were purposively sampled according to their availability on 
the meeting day.  This obviously excludes those working during the scheduled 
meeting time, those unable to travel, and those with other prior commitments.   
The written correspondence in English and the meeting format also precluded 
non-English speakers and those with low literacy skills.  However, the purpose of 
qualitative research is not to obtain an overall ‘representative’ view, rather to 
obtain an in-depth understanding of the experiences of particular groups or 
individuals.  This in-depth understanding derives from the selection of respondents 
that fulfil the criteria for group inclusion while appreciating the range of 
experiences of those individuals (Greenhalgh & Taylor 1997).  Therefore, the PPI 
members did meet the inclusion criteria (free on the scheduled meeting date, able 
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to understand and communicate in English and travel to the meeting venue) and 
ranges of experience including underlying medical problems and previous 
occupation were taken into consideration.  For example, one member previously 
worked in the NHS and her different approach to the problem was appreciated, for 
example her “inside knowledge” of record storage and information sharing.     
The possibility of the Chair (VW) influencing views was considered.  The Chair 
interjected as little as possible, only contributing to clarify policies and procedures 
and to keep the discussion on track, thus keeping the potential to influence views 
to a minimum.  The group dynamics worked well as all members were engaged 
equally in the discussion and respected each other’s opinions, perhaps as a result 
of having sat together on PPI panels before.   
 
 
6.3.7.6 Summary of findings from PPI exercise  
In summary, the group all agreed that using identifiable information without 
participant consent to access and link HES and ONS data was acceptable, and 
that this was also acceptable for participants who dissented from medical record 
review.  Regarding the use of identifiable data without consent, these views are 
generally reflected in the literature.  As discussed, the survey by Knight (2009) 
found that permission to use identifiable data without consent should be granted 
after review from the PIAG, who ensure the researchers have rigorous data 
security and confidentiality policies in place.  The PPI has also added a new 
dimension to the literature.  The PPI group felt that dissent from medical record 
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review, in some cases as long as ten years ago and inferred to be referencing 
primary care medical records, cannot be equated to a dissent to use of identifiable 
data to access and link HES and ONS data today.  This is because primary care 
and HES/ONS data are different, the consent during NorStOP was not specifically 
for the proposed use and that there are strict policies governing data handling, 
security, storage and confidentiality policies in place.   
6.3.8 Literature review and PPI impact upon data acquisition applications  
The literature relating to public opinions of identifiable data use without consent 
was sparse.  The PPI undertaken for the proposed study agreed with the 
published literature by finding that, in general, use of identifiable data for research 
without consent is acceptable providing adequate safeguards to protect 
confidentiality and data security are in place.  The situation regarding a previous 
dissent to medical record review is a trickier concept.  There is no published 
research to draw upon and bodies including the GMC state that consent is time, 
place and situation dependant.  The PPI felt that was is acceptable to apply for 
HES and ONS data for participants who declined medical record review and this is 
the stance that was taken for the LREC, NIGB and HES/ONS data applications.  
The application also highlighted that section 251 support was not sought to 
override participant dissent to primary care medical record review as this is 
already in place and would amount to a neglect of duty of confidentiality and thus 
poor ethical practice.   
Therefore, section 251 support was sought to use identifiable data without consent 
for all NorStOP participants to enable access and linkage of HES and ONS data 
with NorStOP survey responses, and in the cases of those who consented for 
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medical record review, with primary care records too.  The mechanisms protecting 
participants’ right to dissent were also highlighted.   
The National Information Governance Board and Ethics and Confidentiality 
Committee verdict  
The NIGB verdict was received on 20th September 2012.  The Secretary of State 
for Health has determined that the application should be approved for access to 
those who have previously provided consent for medical record review.  Therefore, 
section 251 support has been recommended to enable identifiable data to be used 
to obtain and link HES and ONS data for NorStOP participants who originally 
consented to medical record review.  4666 respondents will not have their survey 
data linked to HES and ONS; this may represent a missed opportunity given the 
PPI findings and the conditional nature of consent.  The justification of the decision 
described in the correspondence did not include any evidence base or 
consideration of the PPI work undertaken.  Unfortunately, due to the considerable 
length of time that this data acquisition had taken to date (the actual linked data 
was not received until May 2013), an appeal of the decision would not have been 
feasible.    
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Appendix 6: Ethical approvals and conditions:  
 
a) Approval From North Staffordshire Local Research Ethics Committee 
b) Conditional approval from the National Information Governance Board  
c) Condition of approval: poster to be displayed in NorStOP practice waiting 
rooms to inform respondents of further use of their data and to remind of 
dissent from reseach process 
d) Approval from the National Information Governance Board 
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Appendix 7: The Charlson Comorbidity Index diagnostic 
categories and weightings & practical considerations  
 
The Charlson Comorbidity Index considers 16 diagnostic categories and each 
category is defined a weight, for example ‘metastic tumour’ carries the highest 
weight of 6, and mild liver disease carries the lowest weight of 1; the table below 
provides disease categories and their weightings.  Each respondent is scored 
according to the presence of the listed diagnostic categories as indicated by the 
READCODE in their medical records.  
 
Charlson Diagnostic Category  Weighted score  
Acquired Immuno-Deficiency Syndrome 6 
Cerebrovascular disease 1 
Chronic pulmonary disease 1 
Congestive heart disease 1 
Dementia 1 
Diabetes 1 
Diabetes with complications  2 
Hemiplegia and paraplegia  2 
Mild liver disease 1 
Moderate or severe liver disease 3 
Myocardial infarction 1 
Peptic ulcer disease 1 
Peripheral vascular disease 1 
Renal disease 2 
Rheumatological disease 1 
Cancer 2 
Metastatic tumour  6 
  Reproduced from Khan et al, 2010 
 
Multimorbidity: using the Charlson score  
 
Khan et al. were contacted about their use of the Charlson score with the Clinical 
Practice Research Datalink (CPRD), a national dataset of anonymised primary 
care records (https://www.cprd.com/researchpractice/), Khan 2010).  Nada Khan 
kindly provided the READ and Oxmis codes that correspond to the conditions 
outlined in the Charlson Index.  3155 codes were received; after hand searching 
and removing Oxmis codes (not applicable to the present thesis’ data), 2535 
codes were ready to be extracted from the primary care electronic records.   
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These codes were written in 7 character format.  Each code was checked with a 
corresponding 5 byte (or character) format to ensure each matched.  Some 
medical conditions in the primary care electronic records are only held in 3-byte 
format and so each 5 byte code was checked as a 3 byte code to ensure that, if 
the coding was extracted based on only 3 byte format, irrelevant diagnoses would 
not be included.  This extensive check involved screening all the codes for each of 
the disease categories.   A spreadsheet was created for each disease category 
and each code within each database was cross matched with the Clinical 
Terminology Browser and the electronic GP records.   An additional column was 
added next to the code in each excel spreadsheet describing how many 
characters needed to be preserved in that code.  For example, some codes were 
acceptable to reduce to 3byte as this is what was coded in the GP database and 
all codes under that subheading were included in the Charlson score.  Some 
codes had to be longer, 4 or 5 byte, to ensure that irrelevant diagnoses were not 
captured in the subsequent merging process.  Again, these were cross referenced 
with the GP data so it wouldn’t miss any codes that were only 3 bytes long.   
After the additional column in the spreadsheet detailing how many characters 
need to be preserved was created, the codes were then transferred to the 
statistical analysis package (STATA).  A code was then written to truncate the 
original code into the required number of characters and the resulting databases 
were saved.   
Each diagnostic category by has a  list of the READCODES so a checking process 
must be in place to ensure that non-relevant conditions that would be included 
until a 3-byte code are not scored as a Charlson-defined diagnostic category.    An 
example of the checking process is highlighted by the category ‘AIDS’, 5-byte 
READ code A788. .  All codes with A788(x) are relevant to AIDs and should be 
included in the subsequent extraction process.  It is not possible to shorten this 
search to A78.. as this represents ‘other viral and chlamydial diseases’, including 
verrucas and warts, which are not all relevant to the ‘AIDS’ diagnostic category.  
Therefore, the codes to be extracted relating to AIDS must all be of the 4 byte 
READcode otherwise the many thousands of codes relating to verrucas will be 
extracted and scored as a Charlson ‘AIDS’ category.  
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Another specific example to present in this Methods chapter is the READcodes 
used to extract ‘diabetes’ rather than ‘diabetes with complications’.  Looking 
through the electronic GP records (ordered alphabetically according to diagnostic 
codes to facilitate hand searching), most diabetes is coded as C10F. (type II 
diabetes mellitus) or C10E (type I diabetes mellitus).  However, 189 respondents 
were coded as C10.. , which is the overarching code for diabetes mellitus including 
type I and type II and any associated complications.  From clinical experience, 
patients generally have more than one associated code for diabetes if they are 
experiencing complications, for example, one code for the disease itself (C10F.) 
and then specific codes for complications (C10F6 type II diabetes mellitus with 
retinopathy).  Thus, in order to generate a command to score ‘diabetes without 
complications’ and a command to score ‘diabetes with complications’ without 
overlap, diabetes was scored using the 4 byte codes C10F and C10E and 
diabetes with complications was searched using 4 byte codes and excluding C10F 
and C10E.  The patients with only 3 byte codes recorded had their records 
searched within the consultation database and coded as either ‘diabetes without 
complications’ or ‘diabetes with complications’.   
The scores generated for each Charlson disease category were then added 
together and a combined score was given as the Charlson Comorbidity Index 
score, ranging from 0 – 33 theoretically, although the highest score within the GP 
consultation database was 8.   All respondents with a final score of ‘missing’ were 
recorded with a score of ‘0’ since a missing score simply meant that there were no 
relevant consultations.   
   
There are more than 2500 codes, these are available upon request from the 
author.  
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Appendix 8: ABS-SIP scoring used in the NorStOP survey  
 
 
NorStOP General Health Questionnaire, adapted from  
Bergner M, Bobbit RA, Carter WB, Gilson BS. The Sickness Impact Profile: 
development and final revision of a health status measure. Medical Care 1981; 19: 
787-805.  
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Appendix 9:  Preparing the data for Cox’s proportional hazard modelling  
Firstly, the data has to be prepared to enable survival analysis.  This involves the 
following steps:  
i) The time period that each respondent has been in the study, from entry to 
exit needs to be defined.  To do this, each NorStOP cohort needs to be split 
into two groups: (a) those who did not respond to three year follow up; and 
(b) those who did respond to three year follow up who did or did not 
respond to six year follow up.  This enables dates to be assigned to each 
group:  
  
NorStoP Cohort  Entry year Exit year  
N1 a 2002 2005 
N1 b 2002 2008 
N2 a 2002 2005 
N2 b  2002 2008 
N3 a 2004 2008 
N3 b 2004 2011 
 
 
ii) Date of entry needs to be defined: this is the baseline survey return date 
(variable name is DOE).  This will be the same for the analysis for GP 
recorded falls and HES recorded falls.  
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iii) Date of exit needs to be defined: for those that didn’t complete three year 
follow up (group (a)), the date of exit is the end of the survey distribution 
wave of three year follow up.  For those that did complete three year follow 
up (group (b)), this is the end of the six year survey distribution wave.    
 
This is because, for the GP and HES-linked data for NorStOP consenters to 
medical record review, patients are included until point of drop-out. Hence a 
non-responder at three year follow up has medical records collated until the 
end of three year follow up survey distribution mail out, at which point they 
are withdrawn from further follow up as a non-response and therefore 
withdrawn consent is registered.  All responders at three year follow up 
have medical records to 6 year survey time point regardless of their 
response to six year follow up.       
 
iv) Respondents who died during the follow up period i.e. their date of death 
(and thus exit from the study) preceded survey end point are censored.  
(Censoring occurs when there is incomplete follow up available.  The 
variable ‘date of death’ was generated in a format compatible with date of 
exit and those who had a date of death preceding the date of exit were 
tagged.   
 
v) Next, respondents who fell during the survival analysis study time period 
are identified i.e. those whose first GP or HES-recorded fall date lies 
between the date of entry and the date of exit.   
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vi) Finally, a date of exit needs to be generated for all respondents.  This 
variable is ‘[GP/HES]fallDOExit’ and it describes an exit point for all 
respondents, either the date leaving the survey at three year or six year 
follow up, or the date of a fall.   Date of death is not included in this variable 
since it is taken account of in the command [censored].   
 
vii) The data is then declared to be ‘survival-time’ using the stset command in 
STATA14 and the variables to include in the analysis are defined.  This 
enables STATA to run data consistency checks to ensure that variables 
declared to be used in the survival analysis make sense.   The following 
command is used for GP recorded falls where the ‘scale’ unit is defined as 
days (365.25) (HES falls are measured in the same way, replacing GPfall 
variables with HES fall variables):  
 
stset GPfallDOExit, failure (GPfallinstudy ) origin ( DOE ) id ( surveyid ) 
scale (365.25)    
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Appendix 11: Research output  and contributions  
 
Welsh V, Mallen CD, McBeth J. Data-linkage studies: the ethical challenges of 
using patient identifiable data without consent. Society of Academic Primary Care 
Annual Conference 2013, Nottingham [National; Poster]. 
 
Hughes R, Welsh V. Achieving the IGT for Hosted Secondary Use Teams. NHS-
HE Jisc /JANET national meeting, hosted by the NIHR [National: Presentation 
(invited speaker)] 
 
Welsh V, Mallen CD, McBeth J. Multisite pain and falls: a systematic review to 
identify putative mediating factors. North American Primary Care Research Group 
Annual Conference, New Orleans 2012 [International; poster]  
 
National Institute for Health and Care Excellence Quality Standards Specialist 
Committee Member for Quality Standard 86: Falls prevention; 2017 update.   
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Appendix 11:  Reflections on the thesis  
Undertaking this thesis over the past six years, on a part time basis and with two 
gaps of maternity leave, has been an invaluable experience for my academic 
career development and on a personal level.  I have learnt about the processes of 
grant applications, ethics applications and the legal aspects of using patient 
identifiable data without consent.  Learning how to manage my time effectively and 
to work flexibly by reorganising the project timeline to enable the ethics and data 
applications to be completed as early as possible has been useful as I plan future 
research with an appreciation of the potential for unpredictable changeable 
requirements.  I received formal training in systematic reviewing and meta-
analysis, advanced epidemiology and statistics and have a sound understanding 
of how to use statistical software packages, all necessary in building my academic 
career.  I can handle large databases and have a good depth of knowledge for 
working with big datasets that will be incorporated into future grant applications.  I 
have learnt the value of patient and public involvement in research and will ensure 
that this process is included in future research design.  The most significant lesson 
I have learnt is how academic and clinical medicine interact and complement each 
other; this appreciation has allowed me to ask questions for future research that 
have been derived from clinical practice and enabled me to become more focused 
upon ensuring my research truly impacts clinicians and our patients in a useful and 
meaningful way.  
 
Reflecting upon what I might do differently, it would have perhaps been beneficial 
to design and conduct the questionnaire from the outset to enable the gold 
standard method of collecting data on self-reported falls (daily recording of falls 
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using a calendar) to be followed.  It may have been useful to undertake a pilot 
study to explore fall-related codes in GP records prior to designing the study to 
then perhaps find ways to maximise capture of fallers requiring primary care.  This 
might be done by analysing the full text of consultations and looking at which 
codes are most associated with having ‘falls’ documented in the free text (for 
example, ‘abrasion’ or ‘soft tissue injury’).  I would have used different questions to 
illicit information for potential confounders, for example asking specifically about 
multifocal spectacle use to then include this as a risk factor.  Other risk factors that 
would have been useful to include are a history of urinary incontinence and poor 
sleep.  Sensitivity analysis could have been employed to look at sub-groups and 
explore the potential influence of hidden biases.  It would have been interesting to 
compare falls prediction models within thesis sample A and thesis sample B, since 
thesis sample B contained a higher proportion of those with fewer comorbidities, 
medications and physical limitations.  Any differences between these thesis 
samples could potentially indicate that different groups of patients have different 
falls risk factors and that perhaps the current approach to falls prevention in which 
all patients undergo the same recommended multifactorial assessment might not 
be appropriate, that it might be possible to start to target falls assessments and 
that further work into this area is necessary.    
 
Throughout the process of completing this thesis I have developed as an 
academic, a clinician and as a person and I look forward to taking the lessons I 
have learnt forwards into the next stage of my academic clinical career.  
 
 
